
<html lang="en"     class="pb-page"  data-request-id="5d17a7e1-b860-4bce-a894-7e1eec17ac3e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c01044;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39" /></meta><meta name="dc.Creator" content="Jenna L.  Jeffrey" /></meta><meta name="dc.Creator" content="Kenneth V.  Lawson" /></meta><meta name="dc.Creator" content="Jay P.  Powers" /></meta><meta name="dc.Description" content="In the tumor microenvironment, unusually high concentrations of extracellular adenosine promote tumor proliferation through various immunosuppressive mechanisms. Blocking adenosine production by in..." /></meta><meta name="Description" content="In the tumor microenvironment, unusually high concentrations of extracellular adenosine promote tumor proliferation through various immunosuppressive mechanisms. Blocking adenosine production by in..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 13, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01044" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01044" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01044" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01044" /></link>
        
    
    

<title>Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01044" /></meta><meta property="og:title" content="Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0018.jpeg" /></meta><meta property="og:description" content="In the tumor microenvironment, unusually high concentrations of extracellular adenosine promote tumor proliferation through various immunosuppressive mechanisms. Blocking adenosine production by inhibiting nucleotide-metabolizing enzymes, such as ectonucleotidases CD73 and CD39, represents a promising therapeutic strategy that may synergize with other immuno-oncology mechanisms and chemotherapies. Emerging small-molecule ectonucleotidase inhibitors have recently entered clinical trials. This Perspective will outline challenges, strategies, and recent advancements in targeting this class with small-molecule inhibitors, including AB680, the first small-molecule CD73 inhibitor to enter clinical development. Specific case studies, including structure-based drug design and lead optimization, will be outlined. Preclinical data on these molecules and their ability to enhance antitumor immunity will be discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01044"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01044">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01044&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01044&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01044&amp;href=/doi/10.1021/acs.jmedchem.0c01044" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 13444-13465</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00994" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c01049" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jenna L. Jeffrey</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jenna L. Jeffrey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, 3928 Point Eden Way, Hayward, California 94545, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#fb91919e9d9d899e82bb9a89988e88999294d5989496"><span class="__cf_email__" data-cfemail="97fdfdf2f1f1e5f2eed7f6e5f4e2e4f5fef8b9f4f8fa">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jenna+L.++Jeffrey">Jenna L. Jeffrey</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9249-5984" title="Orcid link">http://orcid.org/0000-0001-9249-5984</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenneth V. Lawson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenneth V. Lawson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+V.++Lawson">Kenneth V. Lawson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5094-6337" title="Orcid link">http://orcid.org/0000-0001-5094-6337</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jay P. Powers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jay P. Powers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jay+P.++Powers">Jay P. Powers</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01044&amp;href=/doi/10.1021%2Facs.jmedchem.0c01044" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 13444–13465</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 13, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 June 2020</li><li><span class="item_label"><b>Published</b> online</span>13 August 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01044" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01044</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D13444%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJenna%2BL.%2BJeffrey%252C%2BKenneth%2BV.%2BLawson%252C%2BJay%2BP.%2BPowers%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D22%26contentID%3Dacs.jmedchem.0c01044%26title%3DTargeting%2BMetabolism%2Bof%2BExtracellular%2BNucleotides%2Bvia%2BInhibition%2Bof%2BEctonucleotidases%2BCD73%2Band%2BCD39%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D13465%26publicationDate%3DNovember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01044"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1832</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01044" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jenna&quot;,&quot;last_name&quot;:&quot;L. Jeffrey&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;V. Lawson&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;P. Powers&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;13444-13465&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01044&quot;},&quot;abstract&quot;:&quot;In the tumor microenvironment, unusually high concentrations of extracellular adenosine promote tumor proliferation through various immunosuppressive mechanisms. Blocking adenosine production by inhibiting nucleotide-metabolizing enzymes, such as ectonucleotidases CD73 and CD39, represents a promising therapeutic strategy that may synergize with other immuno-oncology mechanisms and chemotherapies. Emerging small-molecule ectonucleotidase inhibitors have recently entered clinical trials. This Perspective will outline challenges, strategies, and recent advancements in targeting this class with small-molecule inhibitors, including AB680, the first small-molecule CD73 inhibitor to enter clinical development. Specific case studies, including structure-based drug design and lead optimization, will be outlined. Preclinical data on these molecules and their ability to enhance antitumor immunity will be discussed.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01044&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01044" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01044&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01044" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01044&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01044" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01044&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01044&amp;href=/doi/10.1021/acs.jmedchem.0c01044" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01044" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01044" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01044%26sid%3Dliteratum%253Aachs%26pmid%3D32786396%26genre%3Darticle%26aulast%3DJeffrey%26date%3D2020%26atitle%3DTargeting%2BMetabolism%2Bof%2BExtracellular%2BNucleotides%2Bvia%2BInhibition%2Bof%2BEctonucleotidases%2BCD73%2Band%2BCD39%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D22%26spage%3D13444%26epage%3D13465%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/jmcmar.2020.63.issue-22/20201125/jmcmar.2020.63.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the tumor microenvironment, unusually high concentrations of extracellular adenosine promote tumor proliferation through various immunosuppressive mechanisms. Blocking adenosine production by inhibiting nucleotide-metabolizing enzymes, such as ectonucleotidases CD73 and CD39, represents a promising therapeutic strategy that may synergize with other immuno-oncology mechanisms and chemotherapies. Emerging small-molecule ectonucleotidase inhibitors have recently entered clinical trials. This Perspective will outline challenges, strategies, and recent advancements in targeting this class with small-molecule inhibitors, including AB680, the first small-molecule CD73 inhibitor to enter clinical development. Specific case studies, including structure-based drug design and lead optimization, will be outlined. Preclinical data on these molecules and their ability to enhance antitumor immunity will be discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the oxygen-deprived tumor microenvironment (TME), cell death generates high levels of extracellular adenosine triphosphate or ATP (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which is progressively dephosphorylated by two cell-surface ectoenzymes: CD39 (ectonucleoside triphosphate diphosphohydrolase 1, NTPDase 1, or EC 3.6.1.5) and CD73 (also known as ecto-5′-nucleotidase, ecto-5′-NT, NT5E, e5NT, or EC 3.1.3.5). CD39 belongs to a family of nucleotide-metabolizing diphosphohydrolases that catalyze the successive dephosphorylation of <b>1</b>, which proceeds through the intermediacy of adenosine diphosphate (ADP, <b>2</b>) and culminates in the production of adenosine monophosphate or AMP (<b>3</b>).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Extracellular AMP also arises from CD39-independent pathways, e.g., via the hydrolysis of NAD<sup>+</sup> by CD38 and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), all of which produce a common substrate for CD73.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In turn, membrane-bound CD73 catalyzes the final dephosphorylation of <b>3</b> to adenosine (<b>4</b>). The generation of high local concentrations of adenosine by CD73 leads to potent immunosuppression via the impairment of T cell and natural killer (NK) cell activation and function, with simultaneous enhancement of regulatory T cell (T<sub>reg</sub>) function and macrophage M2 differentiation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The ability to block adenosine generation by inhibiting the enzymatic activity of CD39 and/or CD73 would provide a direct line of attack on adenosine-mediated immunosuppression.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conversion of extracellular ATP to adenosine by CD39 and CD73. Upper graphic adapted from   <cite><i>Biochemistry</i></cite> <span class="NLM_year">2019</span>, <em>58</em>, 3331–3334.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Apart from CD73, other AMP-metabolizing enzymes, such as tissue nonspecific alkaline phosphatase (TNAP)<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> and prostatic acid phosphatase (PAP),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> may also contribute to extracellular adenosine production in specific tumor types. While a detailed discussion of these and other alkaline phosphatases is beyond the scope of this Perspective, it is important to understand the roles of CD39 and CD73 within the broader network of enzymes that contribute to the breakdown of ATP, some of which may function in a compensatory manner.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For example, the CD39-independent ENPP1/CD73 axis has been identified as an important adenosinergic pathway in some cells that lack CD39 and efforts to target this pathway have resulted in the design of several small molecule ENPP1 inhibitors in recent years.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a></div><div class="NLM_p">This Perspective will focus primarily on recent drug discovery efforts targeting CD73-mediated adenosine production. Given that CD73 catalyzes the final step in the production of extracellular adenosine, inhibition of CD73 represents a promising approach to decreasing adenosine levels and potentially restoring antitumor immunity.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Indeed, various preclinical studies have shown that CD73 inhibition <i>in vivo</i> limits the growth and metastasis of tumor cells, increases cytokine secretion, and enhances the antitumor effects of therapies targeting programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4).<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> Furthermore, increased levels of CD73 have been associated with poor prognosis in lung, ovarian, and prostate cancer patients<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> and have also been observed in tumors that were resistant to treatment with chemotherapy.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> Taken together, these observations provide strong biological rationale for targeting CD73 in immuno-oncology (IO) and have led to increased efforts across the biopharmaceutical industry to develop CD73 inhibitors.</div><div class="NLM_p">Related findings have also sparked increasing interest in the pharmacological inhibition of CD39, a key enzyme in ATP-driven adenosine production. While CD39 is not the only source of extracellular AMP,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> CD39 is overexpressed in many cancers<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and could alter the levels of both ATP and adenosine in the TME, which has led to expanded efforts on small-molecule and antibody inhibitors against CD39. However, efforts to develop potent and selective inhibitors of CD39 have so far yielded fewer promising candidates compared to CD73.</div><div class="NLM_p">Until very recently, clinical evaluation of CD73 inhibition in humans has been limited to a small number of anti-CD73 monoclonal antibodies (mAbs), which are briefly summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Oleclumab (developed by AstraZeneca) is an allosteric inhibitor of CD73 that prevents the enzyme from adopting its catalytically relevant conformation, leading to clustering and internalization of the enzyme.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A similar mechanism of action has been reported for BMS-986179, a human immunoglobulin (Ig) G1-G2 hybrid mAb developed by Bristol-Myers Squibb (BMS), which inhibits the catalytic activity of CD73 and also induces internalization of the enzyme.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Oleclumab showed early signs of activity in combination with durvalumab (an anti-PD-L1 mAb) in colorectal and pancreatic cancers (NCT02503774),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> which has prompted further investigation of oleclumab across multiple tumor types, as a single agent and in combination with immunotherapy or chemotherapy, in 20 ongoing clinical trials.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Clinical-Stage Anti-CD73 and Anti-CD39 mAbs Currently under Investigation for the Treatment of Cancer, as Monotherapies, and/or in Combination with Other Treatment Approaches<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">agent</th><th class="colsep0 rowsep0" align="center">clinical trial identifier</th><th class="colsep0 rowsep0" align="center">indications<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">start date</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Antibodies Directed against CD73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Oleclumab (MEDI9447)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></td><td class="colsep0 rowsep0" align="left">NCT02503774 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies</td><td class="colsep0 rowsep0" align="left">2015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT02740985 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies, metastatic CRPC</td><td class="colsep0 rowsep0" align="left">2016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03334617 (PhII)</td><td class="colsep0 rowsep0" align="left">PD1/PDL1 inhibition resistant NSCLC</td><td class="colsep0 rowsep0" align="left">2017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03267589 (PhII)</td><td class="colsep0 rowsep0" align="left">Relapsed ovarian cancer</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03742102 (PhIb/II)</td><td class="colsep0 rowsep0" align="left">Metastatic TNBC</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03611556 (PhIb/II)</td><td class="colsep0 rowsep0" align="left">Metastatic pancreatic cancer</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03381274 (PhIb/II)</td><td class="colsep0 rowsep0" align="left">Advanced NSCLC</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03616886 (PhI/II)</td><td class="colsep0 rowsep0" align="left">TNBC</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03822351 (PhII)</td><td class="colsep0 rowsep0" align="left">Stage III NSCLC</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03819465 (PhI)</td><td class="colsep0 rowsep0" align="left">Metastatic NSCLC</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03794544 (PhII)</td><td class="colsep0 rowsep0" align="left">NSCLC</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04068610 (PhI/II)</td><td class="colsep0 rowsep0" align="left">Metastatic MSS CRC</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04089553 (PhII)</td><td class="colsep0 rowsep0" align="left">Metastatic CRPC</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03875573 (PhII)</td><td class="colsep0 rowsep0" align="left">Luminal B breast cancer</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03773666 (PhI)</td><td class="colsep0 rowsep0" align="left">Muscle-invasive bladder cancer</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT03833440 (PhII)</td><td class="colsep0 rowsep0" align="left">NSCLC</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04145193 (PhII)</td><td class="colsep0 rowsep0" align="left">MSS CRC</td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04262375 (PhII)</td><td class="colsep0 rowsep0" align="left">NSCLC, RCC</td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04262388 (PhII)</td><td class="colsep0 rowsep0" align="left">PDAC, NSCLC, SCC</td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04261075 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies</td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS-986179<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a></td><td class="colsep0 rowsep0" align="left">NCT02754141 (PhI/IIa)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies</td><td class="colsep0 rowsep0" align="left">2016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPI-006<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td><td class="colsep0 rowsep0" align="left">NCT03454451 (PhI/IIb)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NZV930 (SRF373)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></td><td class="colsep0 rowsep0" align="left">NCT03549000 (PhI/IIa)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies</td><td class="colsep0 rowsep0" align="left">2018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04237649 (PhI)</td><td class="colsep0 rowsep0" align="left">Solid tumors</td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GS-1423 (AGEN1423)<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></td><td class="colsep0 rowsep0" align="left">NCT03954704 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid tumors</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TJ004309<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></td><td class="colsep0 rowsep0" align="left">NCT03835949 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid malignancies</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04322006 (PhI/II)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Antibodies Directed against CD39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TTX-030<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a></td><td class="colsep0 rowsep0" align="left">NCT03884556 (PhI)</td><td class="colsep0 rowsep0" align="left">Lymphoma, solid tumors</td><td class="colsep0 rowsep0" align="left">2019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NCT04306900 (PhI)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRF617<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></td><td class="colsep0 rowsep0" align="left">NCT04336098 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid tumors</td><td class="colsep0 rowsep0" align="left">2020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IPH5201<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a></td><td class="colsep0 rowsep0" align="left">NCT04261075 (PhI)</td><td class="colsep0 rowsep0" align="left">Advanced solid tumors</td><td class="colsep0 rowsep0" align="left">2020</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">As reported on clinicaltrials.gov on 5/25/2020.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">CRC, colorectal cancer; CRPC, castration-resistant prostate cancer; MSS, microsatellite-stable; NSCLC, non-small-cell lung cancer; TNBC, triple negative breast cancer.</p></div></div></div><div class="NLM_p">Four additional anti-CD73 mAbs are currently in phase I/II clinical trials across a range of advanced solid malignancies, as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. These include CPI-006 (Corvus Pharmaceuticals), a humanized IgG1 mAb that binds with high affinity to the active site and blocks the enzymatic activity of CD73 without internalization;<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> NZV930 (developed by Surface Oncology as SRF373 and subsequently licensed to Novartis), a fully human IgG4 mAb that inhibited tumor growth as a single agent and in combination with PD-1 inhibition in preclinical studies;<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> TJ004309 (in-licensed by Tracon Pharmaceuticals from I-Mab, a company developing the same molecule in China as TJD5);<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> and GS-1423 (developed by Agenus as AGEN1423 and subsequently licensed to Gilead), a bispecific antibody against CD73 and transforming growth factor β (TGFβ).<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></div><div class="NLM_p">Clinical evaluation of anti-CD39 mAbs has also recently been initiated, with comparatively fewer studies currently underway. TTX-030 (Tizona Therapeutics), a human IgG4 anti-CD39 mAb that binds human CD39 and allosterically inhibits its enzymatic activity, is currently being evaluated as a single agent and in combination with chemotherapy and/or immunotherapy for the treatment of lymphoma and solid tumors.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a> Researchers at Innate Pharma have developed IPH5201, a humanized Fc-silent IgG1 antibody that efficiently blocks both membrane-bound and soluble CD39, thereby preserving immune-stimulatory extracellular ATP and preventing the accumulation of extracellular adenosine <i>in vitro</i>. Moreover, in preclinical studies combining CD39 and CD73 inhibition, Innate Pharma has demonstrated a potential synergistic antitumor effect of simultaneously blocking both enzymes.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Guided by these results, AstraZeneca is currently evaluating the triple combination of CD39-blocking mAb IPH5201, oleclumab, and anti-PD-L1 therapy.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Finally, a clinical study was recently initiated to evaluate SRF617 (Surface Oncology), a fully human anti-CD39 mAb that binds to CD39 on primary immune cells and tumor cells, inhibits CD39-mediated ATP hydrolysis, and reduces systemic adenosine levels <i>in</i><i>vivo</i>.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></div><div class="NLM_p last">The blockade of adenosine signaling through administration of anti-CD73 or anti-CD39 mAbs has resulted in compelling antitumor efficacy in preclinical cancer models. Maturing clinical data across a range of indications provide a strong impetus for the development of new, more potent agents, such as small molecules, which target the adenosine signaling pathway via different mechanisms than antibodies. Small-molecule inhibitors offer several potential advantages over CD73/CD39 mAbs, including greater inhibition of enzymatic activity, deeper tumor penetration, enhanced distribution, and amenability to both intravenous and oral routes of administration. Consequently, recent years have witnessed a surge in the development of potent, small-molecule inhibitors of CD73, aided by several decades of research on CD73 inhibition.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Small-Molecule CD73 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  Discovery of α,β-Methyleneadenosine 5′-Diphosphate (AMPCP)</h3><div class="NLM_p">In 1970, Burger and Lowenstein described the isolation and properties of CD73 from the smooth muscle of porcine small intestine and demonstrated for the first time that nucleoside diphosphates, such as ADP (<b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a), are CD73 inhibitors, with inhibition constants (<i>K</i><sub>i</sub>) in the micromolar range.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Moreover, they discovered that α,β-methyleneadenosine 5′-diphosphate (AMPCP, also known as AOPCP or APCP, <b>5</b>), an analog of <b>2</b> in which the pyrophosphate group is replaced by methylenebisphosphonate (PCP), is a more potent inhibitor of CD73-mediated adenosine production. The presence of an α,β-methylene group renders <b>5</b> resistant to hydrolytic pyrophosphate cleavage and significantly increases its inhibitory capacity, as compared to <b>2</b>. In later studies, Naito and Lowenstein showed that both <b>2</b> and <b>5</b> inhibit CD73 most strongly in their dianionic forms and that at physiological pH, a greater percentage of <b>5</b> exists as the dianion in comparison to <b>2</b>, which may partly account for the enhanced potency of <b>5</b>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> These early studies, among others, laid the foundation for a large body of subsequent work centered around the design of more potent, selective, and metabolically stable (i.e., more resistant to both dephosphorylation and depurination) nucleotide-like CD73 inhibitors as potential drugs.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Structures of ADP (<b>2</b>) and AMPCP (<b>5</b>), a nonhydrolyzable analog of <b>2</b>, along with inhibitory potency against hCD73.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (b) Schematic of the key interactions between <b>5</b> and the active site of human CD73 based on Protein Data Bank (PDB) entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Figure adapted from   <cite><i>J. Med. Chem.</i></cite> <span class="NLM_year">2020</span>, DOI: <pub-id pub-id-type="doi" type="simple">10.1021/acs.jmedchem.0c00525</pub-id>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  CD73 Structure</h3><div class="NLM_p">Human CD73 functions as a noncovalent homodimer, which is anchored to the cell membrane by glycosylphosphatidylinositol (GPI).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In addition to membrane-bound CD73, the enzyme also exists within human tissues in a soluble form, generated by phospholipase-mediated cleavage of the GPI anchor. The rational design of small-molecule CD73 inhibitors has been guided in large part by X-ray structural data for CD73 in complex with both natural and synthetic ligands. In 2012, Sträter and co-workers reported crystal structures of human CD73 bound to adenosine and three different CD73 inhibitors, including <b>5</b> (Protein Data Bank [PDB] code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>), PSB-11552, and baicalin.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> These crystal structures revealed that the two structural domains of CD73 are connected by a small hinge region, which allows for relatively large domain movements required for the enzyme to switch between an open and closed conformation, a conformational switch that is believed to be required for catalytic activity. The enzyme active site is formed from residues at the interface of the N- and C-terminal domains and consists of a substrate binding site, as well as a dizinc catalytic center, which is critical for the enzymatic activity of CD73. Indeed, it has been shown that zinc deficiency impairs the catalytic activity of several major ectoenzymes, including CD73.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p last">Compound <b>5</b> binds tightly within the active site of the closed conformation of CD73 and forms several key interactions, as depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b. The adenosine scaffold is rigidly positioned by an array of hydrogen bonds between nearby aspartic acid and arginine residues and the ribose core of <b>5</b>. Furthermore, the purine heterocycle is aligned between two phenylalanine residues (F417 and F500) via π-stacking interactions. The bisphosphonate moiety of <b>5</b> forms several hydrogen bonds with the side chains of active site arginine (R354 and R395), asparagine (N245 and N117), and histidine (H118) residues. Finally, the β-phosphonate group of <b>5</b> binds to the dizinc catalytic center. These ionic interactions between the PCP group and the active site zinc ions appear to be critical for the inhibitory activity of many AMPCP-like CD73 inhibitors, in line with the established importance of zinc to the catalytic function of CD73.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> These X-ray structures also confirm the early hypothesis of Naito and Lowenstein that the inhibitory activity of <b>5</b> may be contingent on its ability to chelate the bivalent metal center at the active site of CD73.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.3.  CD73 Assays</h3><div class="NLM_p">As summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, several different types of assays are available for determining the potency and binding affinity of CD73 inhibitors. Each of these assays has unique features and limitations, which need to be considered when comparing reported inhibitor potencies and when determining the suitability of an assay for a given drug discovery project. The appropriate assay conditions are often dictated by the number and type of inhibitors (e.g., competitive vs uncompetitive) to be evaluated, as well as the physicochemical properties of individual inhibitors, such as solubility, color, and potency range.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of Common Assays Used To Measure Inhibition of CD73 Enzymatic Activity<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0015.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">LOD = limit of detection. HTS = high throughput screening.</p></div></div><div></div></div><div class="NLM_p">Commonly employed CD73 assays utilize colorimetric or luminescence-based systems to quantify the products of CD73-catalyzed AMP hydrolysis.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The malachite green (MG) colorimetric assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry a) detects inorganic phosphate released upon AMP dephosphorylation.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> In the presence of molybdate, MG forms a complex with inorganic phosphate, which is colored green and absorbs strongly in the range 620–640 nm. Absorbance in this range can be measured on a spectrophotometer or plate reader to quantify phosphate as a function of inhibitor concentration. The MG assay can detect a broad range of phosphate concentrations and is suitable for high-throughput screening (HTS) using either recombinant human CD73 (hCD73) or live cells that express CD73 on their surface. On the other hand, this assay is not suitable for evaluation of colored compounds, which can interfere with detection of the MG complex. Additionally, the presence of phosphate impurities, which may be present in biological or chemical samples, can cause significant background signal. Because of its low sensitivity, the MG assay also requires high substrate concentrations that are generally greater than the <i>K</i><sub>m</sub> value of the substrate. Despite these limitations, the MG assay platform has been extensively applied in the discovery of small-molecule CD73 inhibitors.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67">(52−67)</a> For example, researchers at Calithera Biosciences used an MG assay to evaluate inhibitors of both hCD73 (0.5 nM final concentration) and cellular CD73 in SK-MEL-28 cells, using 50 and 100 μM AMP, respectively.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> Similarly, researchers at Arcus Biosciences,<a onclick="showRef(event, 'ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58 ref59 ref60 ref61 ref62">(55−62)</a> ORIC Pharmaceuticals,<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> and Peloton Therapeutics<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> have employed MG assays to evaluate small-molecule inhibitors against hCD73 or cellular CD73 (U138 or CHO cells). In a representative example, under conditions optimized for the evaluation of recombinant hCD73 (2 μg/mL enzyme, a 90 min reaction time, and 40 μM AMP), the MG assay yielded an IC<sub>50</sub> for AMPCP of 1.1 ± 0.03 μM.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">Another widely employed assay uses a luciferase-based system (e.g., the Promega CellTiter-Glo assay kit) to indirectly measure CD73 enzymatic activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry b).<a onclick="showRef(event, 'ref68 ref49'); return false;" href="javascript:void(0);" class="ref ref68 ref49">(68,49)</a> The luciferase system converts ATP to AMP and pyrophosphate (PP<sub>i</sub>) with emission of light, providing a direct measure of ATP concentration. Since this reaction is inhibited by AMP, CD73-mediated dephosphorylation of AMP relieves the inhibition of the luciferase system. Thus, the coupled enzyme system indirectly quantifies CD73 activity in an assay format that is amenable to HTS and is frequently used for both small-molecule inhibitors and anti-CD73 antibodies.<a onclick="showRef(event, 'ref34 ref39'); return false;" href="javascript:void(0);" class="ref ref34 ref39">(34,39)</a> In contrast to the MG assay, the luciferase-based luminescence assay is not sensitive to phosphate impurities. Under typical conditions for the luciferase-based system using recombinant hCD73 (2 μg/mL enzyme, a 120 min reaction time, 350 μM AMP, and 100 μM ATP), the CellTiter-Glo assay yielded an IC<sub>50</sub> for AMPCP of 2.5 ± 0.5 μM.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">A similar coupled enzyme reaction method employs purine ribonucleoside phosphorylase (PNP), which uses inorganic phosphate to convert 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG, Abs<sub>max</sub> = 330 nm) to ribose 1-phosphate and 2-amino-6-mercapto-7-methyl purine (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry c). The PNP enzymatic reaction is accompanied by a shift in the absorbance maximum from 330 to 360 nm, which enables direct quantitation of phosphate consumed and indirect quantitation of AMP dephosphorylation. This assay format was employed by researchers at Peloton Therapeutics, who used the EnzChek pyrophosphate assay kit (Molecular Probes) in kinetic runs to determine initial velocity of the CD73 enzymatic reaction in the presence of 25 μM AMP and various inhibitors at 0.0002–300 μM, including AMPCP (IC<sub>50</sub> = 0.050 μM).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">Radiometric assays using tritium-labeled AMP ([<sup>3</sup>H]AMP) as a substrate for CD73 are suitable for evaluation of CD73 activity using recombinant protein or membrane preparations of CD73<sup>+</sup> cells<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> and have become increasingly prevalent in recent years (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry d).<a onclick="showRef(event, 'ref8 ref45 ref71 ref72 ref73 ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref8 ref45 ref71 ref72 ref73 ref74 ref75 ref76">(8,45,71−76)</a> Following the CD73 enzymatic reaction, [<sup>3</sup>H]adenosine is separated by precipitation/filtration and quantified by scintillation counting. Alternatively, [<sup>3</sup>H]AMP can be separated from its radiolabeled metabolites using thin-layer chromatography (TLC). This assay platform features a low limit of detection (LOD) of 0.028 μM for adenosine<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and thus enables compound screening at or below the <i>K</i><sub>m</sub> of the tritiated substrate (<i>K</i><sub>m</sub> = 40 μM for [<sup>3</sup>H]AMP using recombinant hCD73).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Furthermore, the assay tolerates colored compounds, inorganic phosphate impurities, and up to 2% DMSO for compounds with poor water solubility. Evaluation of AMPCP in the radiometric TLC assay of hCD73 yielded an inhibition constant, <i>K</i><sub>i</sub> = 88.4 ± 4.0 nM.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Finally, additional assay protocols utilize capillary electrophoresis (CE) coupled with UV detection (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry e)<a onclick="showRef(event, 'ref77 ref78 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79 ref80 ref81">(77−81)</a> or high performance liquid chromatography (HPLC) coupled with tandem mass spectrometry (MS/MS) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry f).<a onclick="showRef(event, 'ref82 ref83 ref84 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84 ref85 ref86">(82−86)</a> In the CE assay method, the products of the CD73 enzymatic reaction are separated based on different electrophoretic mobility within fused-silica capillaries exposed to a high voltage (15 kV).<a onclick="showRef(event, 'ref77 ref78 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79 ref80 ref81">(77−81)</a> Following the enzymatic reaction, which can be performed directly in a capillary, the products are then quantified by UV absorption at 260 nm. In the nanoscale CE protocol originally reported for rat CD73, the LOD for adenosine was ∼1 μM, the limit of quantitation (LOQ) was ∼4 μM, and AMPCP had a <i>K</i><sub>i</sub> value of 0.87 ± 0.02 μM (rat CD73),<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> which is 4-fold higher than the <i>K</i><sub>i</sub> determined using the radiometric TLC assay (AMPCP <i>K</i><sub>i</sub> = 197 ± 5 nM, rat CD73).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Given the comparatively low throughput of the CE assay, it has not been as widely applied in drug discovery campaigns as the aforementioned MG or luciferase-based assays.</div><div class="NLM_p last">Researchers at GlaxoSmithKline<a onclick="showRef(event, 'ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84">(82−84)</a> and Eli Lilly<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> used a RapidFire tandem mass spectrometry (RF-MS/MS) assay to quantify adenosine and AMP, which were normalized to isotopically labeled internal standards, such as [<sup>13</sup>C<sub>5</sub>]adenosine. The final assay conditions employed by scientists at GlaxoSmithKline (50 pM human flag-CD73 [residues 1–552, Thr376Ala] and 20 μM AMP) were used to measure compound potencies (pIC<sub>50</sub>) ranging from 5.0 to 8.6.<a onclick="showRef(event, 'ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84">(82−84)</a> Similarly, the team at Eli Lilly used C-terminal 6-HIS-tagged hCD73 (residues 1–547), with the final assay conditions consisting of 50 pM CD73 protein and 2 μM AMP.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In a further modification of this assay, compounds were tested at eight different concentrations in the presence of different concentrations of AMP, ranging from 0.023 to 50 μM, to determine the mechanism of CD73 inhibition (competitive vs uncompetitive). The data were plotted using mixed-model inhibition (<a class="ref internalNav" href="#eq1" aria-label="eqs 1">eqs 1</a>–<a class="ref internalNav" href="#eq3" aria-label="3">3</a>) to evaluate <i>V</i><sub>max</sub>, <i>K</i><sub>m</sub>, <i>K</i><sub>i</sub>, and α values for each compound as follows.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_m001.gif" alt="" id="_i9" /></img><span class="labelSpan">(1)</span></span><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_m002.gif" alt="" id="_i10" /></img><span class="labelSpan">(2)</span></span><span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_m003.gif" alt="" id="_i11" /></img><span class="labelSpan">(3)</span></span>Researchers at Sanofi developed a multiplexed RF-MS/MS assay suitable for HTS in which CD73 reactions were performed simultaneously with four different isotopically labeled AMP derivatives ([<sup>15</sup>N]<sub>5</sub>AMP, [<sup>13</sup>C]<sub>5</sub>[<sup>15</sup>N]<sub>5</sub>AMP, [<sup>2</sup>H]<sub>2</sub>AMP, and [<sup>13</sup>C]<sub>5</sub>AMP) as substrates.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> After quenching, the reaction mixtures from four different assay plates were pooled for the simultaneous analysis of their respective mass transitions by RF-MS/MS. Following validation with a collection of 8000 diverse compounds, which gave a <i>Z</i>′-factor of 0.88 and a correlation coefficient (<i>R</i><sup>2</sup>) of 0.66, this multiplexed assay enabled the screening of 762 400 compounds at a rate of 1536 reactions per 40–50 min.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.4.  Overview of Known CD73 Inhibitors</h3><div class="NLM_p">Over the past several years, numerous research groups have reported a range of promising small-molecule inhibitors of CD73, many of which are nucleotide-like structures consisting of a sugar (typically ribose or a derivative thereof) with an acidic moiety appended at the 5′ position and a glycosidic bond to a basic heterocycle. Selected examples are highlighted in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, including AB680 (<b>6</b>),<a onclick="showRef(event, 'ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref59">(56−59)</a> a remarkably potent and selective inhibitor developed by Arcus Biosciences that was the first small-molecule CD73 inhibitor to enter clinical trials. A variety of nucleoside-derived compounds have been reported by researchers across academia and industry, including by Müller and co-workers (e.g., <b>7</b>–<b>10</b>),<a onclick="showRef(event, 'ref45 ref72 ref73 ref74 ref75 ref76 ref80'); return false;" href="javascript:void(0);" class="ref ref45 ref72 ref73 ref74 ref75 ref76 ref80">(45,72−76,80)</a> Peloton Therapeutics (<b>11</b>),<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Arcus Biosciences (<b>12</b>),<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> ORIC Pharmaceuticals (<b>13</b>),<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> Calithera Biosciences (<b>14</b>),<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and Vitae Pharmaceuticals/Boehringer Ingelheim (<b>15</b>),<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> among others.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of selected nucleoside-derived or nucleotide mimetic CD73 inhibitors. Representative compounds or those that showcase unique structural features are shown, along with reported potencies (as available), shown as IC<sub>50</sub> values or <i>K</i><sub>i</sub> ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Guided by the X-ray cocrystal structure of <b>5</b> and CD73, Müller and co-workers designed and synthesized a wide variety of AMPCP analogs with improved potency and metabolic stability, including C2-chloro analog <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>)<a onclick="showRef(event, 'ref72 ref76'); return false;" href="javascript:void(0);" class="ref ref72 ref76">(72,76)</a> and PSB-12379 (<b>8</b>), which bears a benzylamine substituent at C6 of the nucleobase and displayed a <i>K</i><sub>i</sub> of 2.21 ± 0.40 nM vs hCD73.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Compound <b>8</b> was also more stable than <b>5</b> in rat liver microsomes and human plasma, wherein hydrolytic cleavage of the glycosidic bond was the main reaction observed for both analogs.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Following incubation with rat liver microsomes for 8 h, >77% of compound <b>8</b> was recovered unchanged, while <b>5</b> was rapidly metabolized within 15 min under the same conditions.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Similarly, compound <b>8</b> underwent negligible metabolism following a 5 h incubation in human blood plasma, while <b>5</b> was metabolized more rapidly (only ∼50% of <b>5</b> was recovered).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Detailed SAR investigations of nucleobase substitution revealed additional strategies for improving potency in this series,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> which have recently informed the design of more potent inhibitors, such as PSB-12489 (<b>9</b>)<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and pyrimidine nucleotides such as <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In general, substitution of the C6-amino group increased the potency of <b>5</b>, with sterically large, hydrophobic groups showing superior potency to smaller ones (2-phenylethyl > benzyl > phenyl > ethyl > methyl > H). Molecular modeling based on the previously reported X-ray structure of CD73-<b>5</b> suggested that the N6-benzyl group may form hydrophobic interactions with residues L184 and S185 of CD73, which may, in part, account for the observed enhancement in potency.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In addition to these studies, which helped establish the influence of nucleobase modifications on the properties of AMPCP-like CD73 inhibitors, academic research groups across multiple institutions have explored an array of both purine and pyrimidine nucleotide analogs, modifications to the ribose group, and alteration of the bisphosphonic acid moiety.<a onclick="showRef(event, 'ref45 ref72 ref73 ref74 ref76 ref80'); return false;" href="javascript:void(0);" class="ref ref45 ref72 ref73 ref74 ref76 ref80">(45,72−74,76,80)</a> Collectively, these studies have contributed to a deeper understanding of SAR within this class of nucleotide-based small-molecule CD73 inhibitors.</div><div class="NLM_p">Many non-nucleotide-like structures with nanomolar inhibitory activity against CD73 have also been designed by Arcus Biosciences and others, some of which are highlighted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. These include benzotriazoles (e.g., <b>16</b>),<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> sulfonamides (e.g., <b>17</b>),<a onclick="showRef(event, 'ref75 ref81'); return false;" href="javascript:void(0);" class="ref ref75 ref81">(75,81)</a> benzothiazines and hydroxybenzamides (<b>18</b><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> and <b>19</b>,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> respectively, GlaxoSmithKline),<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> and pyridazines (<b>20a</b>, Eli Lilly and Co.),<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> to name a few. A wide range of other non-nucleotide CD73 inhibitors with variable potency and selectivity have been reported, including polyphenolic flavonoids (e.g., quercetin<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and myricetin),<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88,89)</a> anthraquinones,<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a> sulfonic acids,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> polyoxometalates,<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and hydroxamic acids.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of selected non-nucleoside derived CD73 inhibitors. Representative structures are shown, along with reported potencies (as available).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A common structural feature shared by many of the most potent CD73 inhibitors is the presence of at least one acidic functional group, such as a phosphate, sulfonate, or carboxylic acid group. At physiological pH values, these acidic compounds are expected to be ionized, which limits their ability to cross intestinal membranes and makes them challenging candidates for development as orally administered drugs. Nevertheless, orally bioavailable CD73 inhibitors are now beginning to emerge. In addition to <b>6</b>, an oral formulation of which is in investigational new drug (IND)-enabling studies (see <a class="ref internalNav" href="#sec2_5" aria-label="section 2.5">section 2.5</a> for additional details), orally bioavailable CD73 inhibitors are in preclinical development by Calithera Biosciences (CB-708, structure not yet disclosed)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and ORIC Pharmaceuticals (ORIC-533; see <a class="ref internalNav" href="#sec2_6" aria-label="section 2.6">section 2.6</a> for additional discussion).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Eli Lilly also initiated a phase 1 trial in late 2019 to evaluate oral CD73 inhibitor LY3475070 (structure not yet disclosed) alone or in combination with pembrolizumab, an anti-PD-1 mAb, for the treatment of advanced cancer.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">2.4.1.  Pyrimidine-2,4-diones</h4><div class="NLM_p">In their 2019 patent application, researchers at Eli Lilly described a series of 5-[5]-[2-cycloalkyl]-6-pyridazin-3-yl]-1<i>H</i>-pyrimidine-2,4-diones, such as <b>20a</b>, which was the most potent of all the disclosed compounds in human serum (EC<sub>50</sub> = 51 nM).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> All examples claimed in the application exhibited IC<sub>50</sub> values less than 62 nM, as measured in the CD73 biochemical assay described above (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry f). Compound <b>20b</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), bearing an isopropyl group in place of the difluoromethyl group of <b>20a</b>, was profiled across a range of assays and identified as an uncompetitive inhibitor of CD73, which binds to the CD73-phosphate complex but not to the apoenzyme. As summarized in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, the IC<sub>50</sub> value of <b>20b</b> was dependent on the concentration of AMP present in the final assay conditions, with increased potency observed at AMP concentrations of ≥5.6 μM (IC<sub>50</sub> = 6.6 nM at 16.7 μM AMP).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> This property, if replicated <i>in vivo</i>, may be of importance, given that the concentration of AMP in the TME is expected to increase with CD73 inhibition. Furthermore, <b>20b</b> is reported to inhibit CD73 in human serum with only a modest loss of potency (EC<sub>50</sub> = 213 nM) and was shown to reverse adenosine-mediated inhibition of T cell proliferation and production of cytokines, such as interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), <i>in vitro</i>.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Characterization of uncompetitive CD73 inhibitor <b>20b</b> (example 2 described in patent application WO2019168744 by Eli Lilly). Increasing concentration of AMP enhances potency of <b>20b</b>. EC<sub>50</sub> value is corrected based on the fraction unbound, determined experimentally, or based on computational models.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> IC<sub>50</sub> values were determined by RF-MS/MS quantification of adenosine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.5.  Discovery and Characterization of AB680</h3><div class="NLM_p">Researchers at Arcus Biosciences recently reported SAR studies leading to the discovery of highly potent and selective bisphosphonic acid CD73 inhibitors.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Initially, they envisioned replacing the highly acidic PCP group of AMPCP-based inhibitors, as its physicochemical properties presented challenges for achieving oral bioavailability. While selected monophosphonic acid analogs, such as <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>),<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> did retain nanomolar potency, most attempts to replace the PCP group with less acidic moieties led to a loss of potency against CD73.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> The apparent necessity of the highly ionizable PCP group, coupled with a dearth of viable prodrug strategies, directed their ensuing discovery program toward the development of a molecule that would be suitable for intravenous (iv) administration, i.e., a potent compound with excellent pharmacokinetic (PK) properties, including very low clearance (CL) and a long circulating half-life (<i>t</i><sub>1/2</sub>).</div><div class="NLM_p">Initial SAR studies identified β-fluoroarabinose as a favorable alternative to the ribose core of 2-chloro-AMPCP derivative <b>7</b> (see <b>21</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, IC<sub>50</sub> = 3.4 nM).<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> To further improve potency, nucleobase modifications were explored within both the ribose and β-fluoroarabinose series. Previous X-ray structural data clearly showed that the C6-NH<sub>2</sub> group of <b>5</b> was oriented toward a solvent-exposed area, which provided ample opportunity for derivatization.<a onclick="showRef(event, 'ref56 ref57 ref58 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref60 ref61">(56−58,60,61)</a> Indeed, improved potency was observed upon substitution of the C6 position of the nucleobase with an array of alkyl- and benzylamines, consistent with previous observations by Müller and co-workers<a onclick="showRef(event, 'ref45 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref45 ref72 ref73 ref74">(45,72−74)</a> (selected examples are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compounds derived from β-fluoroarabinose generally exhibited favorable PK profiles, with long half-lives and low plasma clearance in rats (e.g., <b>29</b>, CL = 0.021 L h<sup>–1</sup> kg<sup>–1</sup>). However, while these compounds all displayed single-digit nanomolar to subnanomolar potency (<b>21</b>, <b>23</b>, <b>25</b>, <b>27</b> and <b>29</b>), they tended to be less potent than the corresponding ribose analogs (<b>22</b>, <b>24</b>, <b>26</b> and <b>28</b>), all of which exhibited remarkable potency (IC<sub>50</sub> < 1 nM). The general superiority of the ribose series became more evident in subsequent SAR studies.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Initial SAR Observations in a Series of β-Fluoroarabinose Analogs of AMPCP<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0016.gif" alt="" id="GRAPHIC-d7e1917-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">X = (<i>R</i>)-OH</th><th class="rowsep1 colsep0" colspan="3" align="center">X = (<i>S</i>)-F</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">R =</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">CL (L h<sup>–1</sup> kg<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-α-Me-Bn</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-α-Me-Bn</td><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">0.021</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">CL determined in rat following an iv dose of 0.5 mg/kg. ND = not determined.</p></div></div></div><div class="NLM_p">As outlined in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, modification of the purine heterocycle and the C6-benzyl moiety of <b>24</b> proved critical to achieving potent CD73 inhibitors with the desired PK profile. In general, compounds bearing the pyrazolopyrimidine heterocycle (e.g., <b>30</b>, IC<sub>50</sub> = 0.045 nM, CL = 0.064 L h<sup>–1</sup> kg<sup>–1</sup>) were characterized by excellent potency and low clearance but suffered from reduced chemical stability; the anomeric bond was readily cleaved in the presence of acid, and the C2-chloride was prone to displacement via S<sub>N</sub>Ar. In contrast, pyrazolopyridine analogs displayed enhanced chemical stability under both acidic and basic conditions, as well as favorable potency and PK properties. Further improvements in potency and PK properties were gained by replacing the C6-benzylamine group with (<i>S</i>)-(−)-α-methylbenzylamine bearing a single fluorine substituent at the <i>ortho</i> (<b>6</b>) or <i>para</i> (<b>31</b>) position. Both <b>6</b> and <b>31</b> displayed excellent potency in human blood CD8<sup>+</sup> T cells, as well as in human peripheral blood mononuclear cells (PBMCs). In addition to exhibiting picomolar activity against membrane-bound CD73, these compounds also retained subnanomolar potency against soluble hCD73, displayed excellent selectivity against a broad panel of 60 targets, including receptors, ion channels, and transporters (CEREP panel), and were highly selective over related ectonucleotidases, including CD39, NTPDase2, NTPDase3, and NTPDase8 (IC<sub>50</sub> > 10 μM for all).<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Optimization of <i>in vitro</i> CD73 potency and rat iv pharmacokinetics leading to <b>31</b> and <b>6</b>.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the two compounds, <b>6</b> presented the most favorable combination of potency and PK properties, with an IC<sub>50</sub> of 0.008 nM in human CD8<sup>+</sup> T cells, a remarkably low inhibition constant, <i>K</i><sub>i</sub> = 5 ± 3 pM,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and a projected human <i>t</i><sub>1/2</sub> of ∼4 days based on allometric scaling, which would make it suitable for iv administration every 2 weeks. Moreover, <b>6</b> exhibited a very favorable preclinical safety profile. Thus, <b>6</b> is currently in clinical development as AB680.</div><div class="NLM_p">The X-ray cocrystal structure of AB680 bound to the closed form of hCD73 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a) provides insight into the remarkable potency of AB680.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> A superposition of the bound conformation of AB680 with AMPCP (<b>5</b>) illustrates the parallel binding modes observed for the two compounds (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b). The terminal phosphate group of AB680 coordinates to the dizinc catalytic center, while the internal phosphate group participates in H-bonding interactions with N245 and R354. Additionally, the nucleobase of AB680 forms a π-stacking interaction with residues F417 and F500. In contrast to <b>5</b>, however, the nucleobase of AB680 is positioned closer to F500 than to F417, resulting in a potentially more energetically favorable edge-to-face interaction with F417 rather than a face-to-face interaction. The α-methylbenzylamine moiety of AB680 is observed in two different orientations within the active site of hCD73. In the predominant conformation depicted in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a (63% abundance), the benzyl group points toward residue F417. In the minor conformation, the benzyl group of AB680 points toward F500 (see <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>c) but the rotational isomers exhibit otherwise identical binding interactions within the active site of hCD73.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Schematic of the X-ray cocrystal structure of AB680 bound to the closed conformation of hCD73. Figure generated from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z9D">6Z9D</a> using Pymol version 2.0.4, Schrödinger, LLC, and Microsoft PowerPoint version 2002 (H220 structure omitted for clarity) and adapted from   <cite><i>J. Med. Chem.</i></cite> <span class="NLM_year">2020</span>, DOI: <pub-id pub-id-type="doi" type="simple">10.1021/acs.jmedchem.0c00525</pub-id>. (b) Superposition of the observed hCD73 binding modes of AB680 and <b>5</b> (colored in blue, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>). (c) Minor rotational isomer of AB680 bound to hCD73. Ligand is shown as a stick model and colored according to the atom type, with C in yellow, N in blue, O in red, F in cyan, Cl in green, and P in orange.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.5.1.  Effects of AB680 on AMP-/Adenosine-Mediated Tumor Immunosuppression</h4><div class="NLM_p">In 2018, Arcus Biosciences presented posters at the AACR Annual Meeting and the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, which described the ability of AB680 to enhance antitumor immunity.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> To assess the ability of AB680 to reverse adenosine-mediated immune suppression on human CD4<sup>+</sup> and CD8<sup>+</sup> T cells, AB680 was evaluated both as a monotherapy and in combination with immune checkpoint inhibition using T cell stimulation and cytolytic assays, as well as mixed lymphocyte reactions (MLRs).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> In human CD4<sup>+</sup> T cells, adenosine signaling through A<sub>2A</sub>R inhibits cell proliferation and reduces the production of cytokines, such as interleukin-2 (IL-2) and IFN-γ. For these studies, activation of human CD4<sup>+</sup> T cells was accomplished using anti-CD3/CD28/CD2 antibodies and IL-2, and IFN-γ production was quantified using cytokine bead arrays. In the absence of AMP, strong CD4<sup>+</sup> T cell activation could be accomplished and manifested in a high percentage of proliferating cells (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>a) and cytokine production (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>b,c).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> To simulate adenosine-mediated immune suppression, the combination of AMP (6.25 μM) and an adenosine deaminase inhibitor, erythro-9-(2-hydroxy-3-nonyl)adenine) (EHNA, 2.5 μM), was added to the cell cultures during activation, resulting in marked suppression of proliferation and cytokine production. Addition of exogenous AB680 completely restored CD4<sup>+</sup> T cell proliferation and cytokine production in a dose-dependent manner, and a similar effect was observed on CD8<sup>+</sup> T cell activation (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>d).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. AB680 restores the proliferation and function of CD4<sup>+</sup> T-cells (a–c), restores the activation of CD8<sup>+</sup> T-cells (d), and reverses the activity of AMP on immune checkpoint inhibition in MLRs (e).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Charts a–e are reproduced from refs <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The effects of AB680 in a combinatorial setting were also assessed, using a MLR assay to stimulate human CD4<sup>+</sup> T-cell activation and proliferation. Addition of zimberelimab (0.67 nM), an anti-PD-1 antibody, to CD4<sup>+</sup> T cells and monocytic DC cultures resulted in enhanced T cell activation and IFN-γ production mediated by blocking PD-1/PD-L1. This activation was inhibited by addition of 100 μM AMP (converted to adenosine by CD73<sup>+</sup> T cells). Furthermore, addition of AMP was found to repress the expression of activation markers and immune checkpoint proteins. Addition of AB680 reversed the inhibitory effect of AMP on zimberelimab activity in the MLR, resulting in complete restoration of IFN-γ production (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>e).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">In the second half of 2018, AB680 was evaluated in a phase I, placebo-controlled, single ascending dose (0.1, 0.6, 2.0, 4.0, 8.0, 16.0, and 25.0 mg) study in healthy volunteers (NCT03677973). The results of this study indicated an excellent safety profile across all cohorts. AB680 displayed a favorable human PK profile that is suitable for dosing every 2 weeks, with an observed half-life of 74 h following an iv infusion of 25 mg.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> On the basis of its excellent safety and PK/PD profile in healthy volunteers, AB680 is currently being evaluated in combination with the anti-PD-1 mAb zimberelimab and chemotherapy in advanced pancreatic cancer (NCT04104672) and in combination with dual A<sub>2A</sub>R/A<sub>2B</sub>R antagonist AB928, with or without zimberelimab, in metastatic castration-resistant prostate cancer (NCT04381832). Additionally, a proprietary oral formulation of AB680 has been identified, which is currently in IND-enabling studies.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">2.6.  Monophosphonic Acid CD73 Inhibitors</h3><div class="NLM_p">Researchers at multiple organizations, including Arcus Biosciences,<a onclick="showRef(event, 'ref55 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref55 ref60 ref61">(55,60,61)</a> Vitae Pharmaceuticals,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and ORIC Pharmaceuticals,<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> have evaluated nucleoside-derived methylene monophosphonic acids as CD73 inhibitors. Studies described by Arcus Biosciences showed that the SAR within this scaffold is in close alignment with that of bisphosphonic acid inhibitors, such as AB680.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Their research in this area culminated in the discovery of <b>12</b>, a potent and selective inhibitor of CD73, which incorporates many of the structural attributes of the progenitors of AB680 described above. Furthermore, <b>12</b> exhibited a favorable PK profile in preclinical species when dosed intravenously. However, further development of this series at Arcus was deprioritized in favor of AB680.</div><div class="NLM_p">As expected, the cocrystal structure of <b>12</b> bound to the closed form of CD73 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) revealed a binding orientation that is largely conserved with that of bisphosphonate inhibitors. The ionic interaction of the dizinc catalytic site and phosphonate moiety was retained, as were most polar and H-bonding interactions. However, due to replacement of the internal phosphonate group with a direct methylene linkage, methylene phosphonic acid ligands are not able to form a strong interaction with R354. Chemists at ORIC Pharmaceuticals noted the lack of this interaction as the likely cause of the reduced potency of this class of inhibitors and sought to design inhibitors that could interact with R354.<a onclick="showRef(event, 'ref64 ref9700'); return false;" href="javascript:void(0);" class="ref ref64 ref9700">(64,97)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) X-ray cocrystal structure of <b>12</b> bound to the closed conformation of hCD73. (b) Structure and potency of <b>12</b>. (c) SAR of α substitution. <sup><i>a</i></sup>Potency data generated by ORIC Pharmaceuticals shown for direct comparison.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Du and co-workers observed that substituents at the α-position of the phosphonate residue would be well-poised to interact with R354.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Accordingly, they designed a series of α-mono- and disubstituted inhibitors, a subset of which is shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>c. The series quickly revealed that their hypothesis was well-founded, with incorporation of hydroxymethyl (<b>33</b>) or methoxymethyl (<b>34</b>) substituents leading to substantial potency gains. Furthermore, disubstitution of the α-position, particularly with polar moieties, resulted in further potency gains and the discovery of OP-5244 (<b>13</b>). The α-diastereomer of OP-5244 (not shown) was 4-fold less potent (IC<sub>50</sub> = 1.0 nM). A cocrystal structure of OP-5244 with CD73 (not shown) confirmed the presence of an H-bond interaction of the α-methoxymethyl group with R354. Though the structure of their clinical candidate, ORIC-533, has not been disclosed prior to publication of this Perspective, it has been described as closely related to OP-5244.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p last">OP-5244 was found to rescue the immunosuppressive effects of AMP on T-cells in a dose-dependent manner, as measured by production of IFN-γ and TNF-α. Importantly, OP-5244 was found to be orally bioavailable in mice. When dosed at 200 mg/kg, very high exposure (<i>C</i><sub>max</sub> = 42.2 μM, AUC<sub>inf</sub> = 45.1 μM·h) was measured with a half-life of 3.3 h. OP-5244 exhibited single agent antitumor effects <i>in vivo</i> against the EMT-6 breast cancer model and EG7 lymphoma model. A decrease in tumor growth was observed in the EMT-6 model when dosed at 15 mg kg<sup>–1</sup> day<sup>–1</sup> via mini pump infusion, and the ratio of AMP-to-ADO in the tumor was reduced substantially. In the EG7 model, tumor-infiltrating lymphocyte (TIL) analysis revealed increased tumor infiltrating CD8<sup>+</sup> T cells and a statistically significant increase in the CD8<sup>+</sup>/T<sub>reg</sub> ratio when OP-5244 was dosed 150 mg/kg po twice-daily (BID). However, a reduction in tumor growth was not observed in this model.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">3.  Small-Molecule CD39 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An alternative approach to reducing extracellular adenosine production in the TME is to inhibit the enzymatic activity of CD39. The role of CD39 in immunosuppression is 2-fold: it (1) catalyzes critical steps in the conversion of extracellular ATP to adenosine, i.e., the hydrolysis of ATP and ADP into AMP, and thereby (2) eliminates extracellular ATP, which is released by dying cells to signal the recruitment of dendritic cells and other myeloid cells to the TME. Like CD73, CD39 is expressed on the cell surface of T<sub>regs</sub> and most monocytes, and an enrichment in the expression and activity of CD39<sup>+</sup> T<sub>regs</sub> has been observed in cancer patients.<a onclick="showRef(event, 'ref97 ref98 ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99 ref100">(98−101)</a> Moreover, CD39 expression is a well-recognized hallmark of antigen-experienced, potentially exhausted, intratumoral T cells.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(102)</a> Overexpression of CD39 has been observed in a variety of human cancers, including lymphoma, melanoma, colon, endometrial, gastric, ovary, pancreas, head and neck, kidney, testis, and thyroid cancers.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><i>In vitro</i>, cancer cells that express both CD39 and CD73 have been shown to inhibit the proliferation of CD4<sup>+</sup> and CD8<sup>+</sup> T cells, an effect that could be reversed by pharmacological inhibition of CD39 using an anti-CD39 antibody (OREG-103/BY40).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> CD39 inhibition also led to increased tumor cell killing mediated by increased activity of cytotoxic T-lymphocytes and NK cells, providing additional support for targeting CD39 in IO. Finally, in preclinical models, deletion of CD39 resulted in improved antitumor immunity and prolonged survival.<a onclick="showRef(event, 'ref102 ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref102 ref103 ref104">(103−105)</a></div><div class="NLM_p">The strong biological rationale supporting CD39 as a potential target for anticancer immunotherapy has attracted significant interest from the scientific community. In contrast to CD73 inhibitors, however, there is a relative scarcity of potent and selective CD39 inhibitors. In comparison to CD73, the structural biology of human CD39 has not been as thoroughly characterized. In 2007, Zebisch and Sträter used bacterial inclusion bodies to express and purify the extracellular domains of rat CD39, which has 74% sequence identity with the human enzyme.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(106)</a> Much like CD73, CD39 requires divalent metal ions, such as Zn<sup>2+</sup> or Mg<sup>2+</sup>, for full catalytic activity, but the two ectoenzymes possess substantially different substrate preferences: CD39 hydrolyzes a wide range of nucleotide di- and triphosphates. <named-content content-type="anchor" rid="fig9" type="simple"></named-content>While membrane-bound CD39 shows increased substrate specificity for ATP compared to ADP, the soluble form of the enzyme has higher selectivity for ADP, highlighting an important and well-documented role for the transmembrane interactions of membrane-bound CD39 in limiting dissociation of ADP from the active site following ATP hydrolysis.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(107,108)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">3.1.  CD39 Structure</h3><div class="NLM_p">X-ray crystal structures of soluble forms of rat,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a> bacterial,<a onclick="showRef(event, 'ref109 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111">(110−112)</a> plant,<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(113)</a> and <i>Toxoplasma gondii</i><a onclick="showRef(event, 'ref113 ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref113 ref114 ref115">(114−116)</a> CD39 that lack transmembrane helices have provided valuable insight on the structure and catalytic promiscuity of CD39. Some of these structures are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. The bacterial homolog of CD39, <i>Lp</i>NTPDase1 from <i>Legionella pneumophila</i> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a), has only 26% sequence identity with human CD39 but possesses a common fold and nucleotide binding site. Structurally, CD39 consists of two domains connected by a hinge region and anchored to the cell membrane by two interacting transmembrane helices. The domains can adopt “open” and “closed” conformations depending on the presence and nature of the ligand bound in the active site. Situated at the interface between the two domains, the substrate binding site of soluble CD39 is highly flexible and accommodates large rotational and translational movements of its substrates.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Selected X-ray Crystal Structures of CD39 Homologs from Various Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PDB code</th><th class="colsep0 rowsep0" align="center">resolution (Å)</th><th class="colsep0 rowsep0" align="center">ligand(s)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="char" char=":">Species: <i>Rattus norvegicus</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX2">3ZX2</a><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a></td><td class="colsep0 rowsep0" align="left">1.81</td><td class="colsep0 rowsep0" align="left">decavanadate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX0">3ZX0</a><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">heptamolybdate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX3">3ZX3</a><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="char" char=":">Species: <i>Legionella pneumophila</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAR">3AAR</a><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(110)</a></td><td class="colsep0 rowsep0" align="left">1.65</td><td class="colsep0 rowsep0" align="left">AMPPNP (<b>37</b>)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAQ">3AAQ</a><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(110)</a></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">ARL67156 (<b>39</b>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAP">3AAP</a><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(110)</a></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRE">4BRE</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">adenosine 5′-phosphovanadate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR7">4BR7</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">AMPNP (<b>38</b>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRF">4BRF</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">AMP, distorted orthomolybdate ion</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRL">4BRL</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">guanosine 5′-phosphovanadate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRN">4BRN</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.69</td><td class="colsep0 rowsep0" align="left">AMP, Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRD">4BRD</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">AMPPNP (<b>37</b>),<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRG">4BRG</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.45</td><td class="colsep0 rowsep0" align="left">GMPPNP,<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRI">4BRI</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.75</td><td class="colsep0 rowsep0" align="left">UMPPNP,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRK">4BRK</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">UMPPNP,<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRC">4BRC</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">AMPNP (<b>38</b>),<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA">4BRA</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">AMPPNP (<b>37</b>),<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRH">4BRH</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.69</td><td class="colsep0 rowsep0" align="left">thiamine phosphovanadate, Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRM">4BRM</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">2.02</td><td class="colsep0 rowsep0" align="left">Sulfate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRQ">4BRQ</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.45</td><td class="colsep0 rowsep0" align="left">AMP, phosphate, Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRO">4BRO</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.99</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR4">4BR4</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.45</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR9">4BR9</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRP">4BRP</a><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BVP">4BVP</a><a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(112)</a></td><td class="colsep0 rowsep0" align="left">1.49</td><td class="colsep0 rowsep0" align="left">heptamolybdate, octamolybdate</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BVO">4BVO</a><a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(112)</a></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">POM-1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="char" char=":">Species: <i>Toxoplasma gondii</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A5B">4A5B</a><a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(114)</a></td><td class="colsep0 rowsep0" align="left">2.48</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH5">4KH5</a><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(115)</a></td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">AMPNP (<b>38</b>),<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH6">4KH6</a><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(115)</a></td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">AMPNP (<b>38</b>),<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH4">4KH4</a><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(115)</a></td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">AMPPNP (<b>37</b>),<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> Mg<sup>2+</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JEP">4JEP</a><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(116)</a></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">none</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">AMPPNP, adenosine 5′-(β,γ-imido)triphosphate.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">AMPNP, adenosine 5′-[(α,β)-imido]diphosphate.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">GMPPNP, guanosine 5′-[β,γ-imido]triphosphate, a nonhydrolyzable analog of guanosine 5′-triphosphate (GTP).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">UMPPNP, uridine 5′-[β,γ-imido]triphosphate, a nonhydrolyzable analog of uridine 5′-triphosphate (UTP).</p></div></div></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Overall architecture of <i>Lp</i>NTPDase1 bound to <b>37</b>-Mg<sup>2+</sup> (generated from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA">4BRA</a> using Pymol version 2.0.4, Schrödinger, LLC). (b) Chemical structures of <b>37</b> and <b>38</b>. (c) Superposition of the <i>Lp</i>NTPDase1 binding modes of <b>37</b> and <b>38</b> observed in PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA">4BRA</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRC">4BRC</a>, respectively. Ligands are shown as stick models and colored according to the atom type, with C in cyan or yellow, N in blue, O in red, and P in orange.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To better understand the ability of CD39 to hydrolyze both nucleotide di- and triphosphates in the same active site, Sträter and co-workers cocrystallized <i>Lp</i>NTPDase1 with nonhydrolyzable analogs of ATP and ADP (adenosine 5′-(β,γ-imido)triphosphate (AMPPNP, <b>37</b>) and adenosine 5′-[(α,β)-imido]diphosphate (AMPNP, <b>38</b>), respectively) complexed with Mg<sup>2+</sup> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>b).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a> Superposition of the binding modes of <b>37</b> and <b>38</b> showed that the terminal [imido]diphosphate groups adopt similar conformations and occupy the same binding site (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>c).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a> This [imido]diphosphate group alignment is enabled by a rotation of the nucleobase and a 3 Å shift of the ribose group of <b>38</b>, which adopts a more extended conformation than <b>37</b>. The nucleobases of both ligands are positioned between the side chains of N302 and Y346, with only one direct H-bond formed between Y350 and the amino group of <b>38</b>. Aside from this, both ligands form only nonspecific, water-mediated interactions with the enzyme active site.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">3.2.  CD39 Assays</h3><div class="NLM_p">Perhaps owing, in part, to the flexibility of the nucleotide binding pocket and low substrate specificity, the development of potent and selective CD39 inhibitors has thus far proven challenging.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(117)</a> Historically, an additional impediment to the discovery and development of potent CD39 inhibitors has been the relative lack of sensitive assay platforms that could be used in screening campaigns.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(118)</a> Until very recently, the most common methods to assess CD39 inhibition were either not suitable for HTS or suffered from low sensitivity and high background signal. For example, the colorimetric MG assay (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry a), described above for CD73 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry a), has a LOD in the micromolar range and may require high concentrations of substrate (ATP or ADP) to overcome the background signal generated from phosphate contamination.<a onclick="showRef(event, 'ref50 ref51 ref117'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref117">(50,51,118)</a> Consequently, identification of weak or moderately potent CD39 inhibitors in an initial screen may require high concentrations of inhibitors and may be further limited by compound solubility. Moreover, assessment of CD39 activity using the MG assay often leads to an overestimation of enzymatic activity due to the ability of CD39 to catalyze the sequential dephosphorylation of ATP to AMP via ADP. Nevertheless, the MG assay has frequently been used to assess the potency of CD39 inhibitors.<a onclick="showRef(event, 'ref118 ref119 ref120 ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref118 ref119 ref120 ref121 ref122">(119−123)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of Common Assays Used To Measure Inhibition of CD39 Enzymatic Activity<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">LIF, laser-induced fluorescence; FPIA, fluorescence polarization immunoassay.</p></div></div><div></div></div><div class="NLM_p">As described above for CD73, assays based on CE coupled with UV detection enable the separation and quantification of nucleotide substrates and hydrolysis products of CD39 and offer a slight improvement in sensitivity compared to the MG assay, with a LOD of 800 nM (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry b).<a onclick="showRef(event, 'ref93 ref117 ref123 ref124 ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref93 ref117 ref123 ref124 ref125 ref126">(93,118,124−127)</a> While the CE/UV assay is relatively inexpensive and straightforward to perform, it is more time-consuming than the MG assay and not suitable for HTS applications. Recently, Müller and co-workers described a variation of the conventional CE/UV assay, which uses laser-induced fluorescence (LIF) to detect fluorescent analogs of ATP, ADP, and AMP (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry c).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(128)</a> The CE/LIF assay employs a fluorescein-labeled analog of ATP (PSB-170621A) as a substrate, which undergoes CD39-mediated dephosphorylation with similar kinetic parameters as ATP (ATP <i>K</i><sub>m</sub> = 11.4 μM, <i>k</i><sub>cat</sub> = 82.5 × 10<sup>–3</sup> s<sup>–1</sup>, <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> = 7250 M<sup>–1</sup> s<sup>–1</sup>) and can be efficiently separated from the fluorescein-labeled products, including AMP analog PSB-170621B and the corresponding ADP derivative. While the reported assay conditions did not enable separation/detection of the individual fluorescein-labeled nucleotide mono- and diphosphate products of CD39, the mixture of products was efficiently quantified by fluorescence detection at λ<sub>ex</sub> = 488 nm and λ<sub>em</sub> = 520 nm.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(128)</a> With a LOD of 2.00 pM under optimal conditions, the sensitivity of the CE/LIF assay is significantly higher than previous assay platforms.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(128)</a></div><div class="NLM_p">In addition to these colorimetric and CE-based assays, a highly sensitive fluorescence polarization immunoassay (FPIA) has been described,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(129)</a> which employs BellBrook Labs’ Transcreener platform (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, entry d).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(130)</a> In the FPIA, AMP generated by CD39 displaces an AMP-Alexa 633 tracer from an AMP-specific antibody, leading to a decrease in fluorescence polarization (FP).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(129)</a> Percent inhibition is calculated from the milipolarization values, mP, derived from the intensity of light emitted in planes that are vertical (<i>I</i><sub>vertical</sub>) or horizontal (<i>I</i><sub>horizontal</sub>) with respect to the excitation plane, as shown in <a class="ref internalNav" href="#eq4" aria-label="eqs 4">eqs 4</a> and <a class="ref internalNav" href="#eq5" aria-label="5">5</a>.<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_m004.gif" alt="" id="_i23" /></img><span class="labelSpan">(4)</span></span><span class="NLM_disp-formula" id="eq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_m005.gif" alt="" id="_i24" /></img><span class="labelSpan">(5)</span></span>With an LOD of 10–24 nM, the FPIA has the second highest sensitivity level of the assays summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(129)</a> Moreover, Kumar and co-workers recently demonstrated the utility and robustness of the Transcreener platform as an HTS-compatible assay for CD39 activity by screening 2880 compounds from two different compound libraries.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(131)</a> Their screening campaign resulted in the identification of 17 compounds with statistically significant activity levels (±3 standard deviations from the mean), some of which are currently under investigation as potential CD39 inhibitors.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(131)</a></div><div class="NLM_p last">Aside from the common assays outlined in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, which were used to determine the potency values discussed herein, various other analytical techniques have been employed for the evaluation of CD39 activity, including radiometric detection of inorganic phosphate released from [<sup>32</sup>P]-labeled nucleotides,<a onclick="showRef(event, 'ref118 ref131'); return false;" href="javascript:void(0);" class="ref ref118 ref131">(119,132)</a> radiometric detection of <sup>3</sup>H- or <sup>14</sup>C-labeled nucleotides following separation using TLC,<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(133)</a> and isothermal titration calorimetry.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a> For a detailed discussion of the advantages and limitations of each of these other assay approaches, as well as their applications in cells, tissues, and blood, interested readers are referred to an existing review.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(118)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">3.3.  Nucleotide Analogs</h3><div class="NLM_p">Most of the known small-molecule inhibitors of NTPDase family members are ATP analogs or mimetics, including ARL67156 (<b>39</b>, formerly known as FPL67156)<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(119,120)</a> and 8-thioether derivatives of ATP (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(122)</a> Compound <b>39</b> is a nonhydrolyzable analog of ATP that shows weak competitive inhibitory activity toward multiple mouse and human NTPDases, including CD39 (<i>K</i><sub>i</sub> = 11 ± 3 μM), NTPDase3 (<i>K</i><sub>i</sub> = 18 ± 4 μM), and NPP1 (<i>K</i><sub>i</sub> = 12 ± 3 μM), but does not significantly inhibit CD73, NTPDase2 or NPP3.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(120)</a> 8-Butylthio-ATP (<b>40</b>) is an analog of ATP that inhibits CD39 (hCD39 IC<sub>50</sub> = 5.6 ± 1.2 μM, <i>K</i><sub>i</sub> = 0.8 ± 0.2 μM) but is also a substrate for NTPDase2, NTPDase3, and NTPDase8.<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(121,122)</a> The corresponding 8-butylthio-ADP (<b>41</b>) and 8-butylthio-AMP (<b>42</b>) analogs are also inhibitors of CD39 and show improved resistance to hydrolysis by NTPDase1–3 and NTPDase8 compared to <b>40</b>.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(122)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0014.jpeg" id="GRAPHIC-d7e3554-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Selected nucleotide-based CD39 inhibitors <b>39</b><a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(120)</a> and <b>40</b>–<b>42</b>.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(122)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">3.4.  Sulfonate Dyes and Anthraquinones</h3><div class="NLM_p">In addition to nucleotide analogs, several sulfonate dyes, such as Evans Blue (<b>43</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>)<a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(134,135)</a> and pyridoxal phosphate-6-azophenyl-2′,4′-disulfonic acid or PPADS (<b>44</b>),<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(132)</a> have been identified as weak, nonselective inhibitors of CD39, with potency values generally in the low micromolar range. Suramin (<b>45</b>), as well as several of its derivatives, inhibits human CD39 (IC<sub>50</sub> = 16 ± 1 μM) but not mouse CD39 (IC<sub>50</sub> > 100 μM).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(123)</a> A closely related analog of <b>45</b>, NF279 (<b>46</b>), inhibits human CD39 (IC<sub>50</sub> = 5.2 ± 0.4 μM) and mouse CD39 (IC<sub>50</sub> = 52 ± 3 μM), and both compounds show similar inhibitory activity against other mouse and human NTPDases, including NTPDase2 and 3.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(123)</a> While <b>46</b> also weakly inhibits human NTPDase8 (IC<sub>50</sub> = 36 ± 2 μM), <b>45</b> does not (IC<sub>50</sub> > 100 μM).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(123)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of selected sulfonate dyes with weak inhibitory activity against CD39. Potency values for <b>45</b> and <b>46</b> were determined in the presence of 100 μM ATP using the MG assay.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(123)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Anthraquinones, such as Reactive Blue 2 (<b>47</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), are weak inhibitors of NTPDases and CD73.<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(136,137)</a> SAR investigations of various truncated analogs of <b>47</b>, such as PSB-069 (<b>48</b>) and the corresponding 2-naphthyl derivative (<b>49</b>), demonstrated that the 2-sulfonate group is important for potency, as compounds lacking this group were completely inactive.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(125)</a> Among the compounds evaluated, <b>49</b> was the most potent inhibitor of CD39 (rat CD39 <i>K</i><sub>i</sub> = 0.328 ± 0.110 μM), with 58-fold selectivity over NTPDase2 and ∼7-fold selectivity over NTPDase3.<a onclick="showRef(event, 'ref90 ref124'); return false;" href="javascript:void(0);" class="ref ref90 ref124">(90,125)</a> Compound <b>49</b>, as well as many of its derivatives, exhibits similar inhibitory activity against CD73 (rat CD73 <i>K</i><sub>i</sub> = 1.47 ± 0.33 μM).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of select anthraquinone inhibitors of CD39 with reported inhibitory activity against rat NTPDases<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(125)</a> and rat CD73.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Compound <b>47</b> is a mixture of <i>meta-</i> and <i>para-</i>sulfonate isomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">3.5.  Polyoxometallates (POMs)</h3><div class="NLM_p">Finally, a variety of inorganic metal complexes known as polyoxometallates (POMs) have been identified as noncompetitive inhibitors of CD39.<a onclick="showRef(event, 'ref93 ref125'); return false;" href="javascript:void(0);" class="ref ref93 ref125">(93,126)</a> POMs have been shown to possess a range of antibacterial, anticancer, antidiabetic, and antiviral effects, and their mechanism of action may be linked to their inhibition of ectonucleotidases, among other enzyme families. In 2012, Sträter and co-workers described the X-ray crystal structures of two POMs (decavanadate, [V<sub>10</sub>O<sub>28</sub>]<sup>6–</sup>, and heptamolybdate, [Mo<sub>7</sub>O<sub>24</sub>]<sup>6–</sup>) bound to the soluble ectodomain of rat CD39.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a> The two POMs were shown to bind electrostatically to a positively charged loop at the interface between the C-terminal and N-terminal domains, which is involved in binding the nucleobase of ATP and ADP. Specific electrostatic interactions were observed between the metal clusters and residues K406 and K408 (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). On the basis of these X-ray structures, it was postulated that POMs may inhibit CD39 by changing the structure or restricting the flexibility of this positively charged, nucleobase-binding loop.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical formulas and potency of POMs <b>51</b><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(128)</a> and <b>52</b><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and comparison of the binding sites observed for AMPNP (<b>38</b>) and decavanadate ([V<sub>10</sub>O<sub>28</sub>]<sup>6–</sup>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX2">3ZX2</a>) bound to CD39 from <i>Legionella pneumophila</i> and <i>Rattus norvegicus</i>, respectively. Structure of <b>38</b> copied from superimposed structure of <i>Lp</i>NTPDase1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR7">4BR7</a>). Metal and chloride ions are omitted for clarity. <b>38</b> is shown as a stick model and colored according to the atom type, with C in cyan, N in blue, O in red, and P in orange. Decavanadate is shown in red spheres.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As with the other classes of CD39 inhibitors described so far, POM-based CD39 inhibitors do not exhibit high NTPDase subtype specificity. For example, POM-4, also known as PSB-POM141 (<b>51</b>), is a polyoxotungstate with chemical formula [TiW<sub>11</sub>CoO<sub>40</sub>]<sup>8–</sup>, which inhibits hCD39 (<i>K</i><sub>i</sub> = 0.0456 ± 0.0023 μM) and NTPDase3 (<i>K</i><sub>i</sub> = 0.353 ± 0.055 μM) and also shows low micromolar inhibition of human TNAP (<i>K</i><sub>i</sub> = 7.89 ± 0.41 μM).<a onclick="showRef(event, 'ref93 ref125 ref127'); return false;" href="javascript:void(0);" class="ref ref93 ref125 ref127">(93,126,128)</a> A related POM with chemical formula [Co<sub>4</sub>(H<sub>2</sub>O)<sub>2</sub>(PW<sub>9</sub>O<sub>34</sub>)<sub>2</sub>]<sup>10–</sup> (PSB-POM142, <b>52</b>) was identified in 2015 as the most potent human CD39 inhibitor known, with <i>K</i><sub>i</sub> = 0.00388 ± 0.00140 μM.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Compound <b>52</b> also potently inhibits human NTPDase2 (<i>K</i><sub>i</sub> = 0.0184 ± 0.0035 μM) and NTPDase3 (<i>K</i><sub>i</sub> = 0.0596 ± 0.0092 μM) but shows significantly lower potency toward rat NTPDases (NTPDase1 <i>K</i><sub>i</sub> = 0.480 ± 0.010 μM, NTPDase2 <i>K</i><sub>i</sub> = 1.53 ± 0.20 μM, and NTPDase3 <i>K</i><sub>i</sub> = 2.61 ± 0.97 μM).<a onclick="showRef(event, 'ref93 ref125'); return false;" href="javascript:void(0);" class="ref ref93 ref125">(93,126)</a> Due to their high inhibitory potency, POMs have served as useful pharmacological tools to probe the biology of CD39.<a onclick="showRef(event, 'ref103 ref126 ref137'); return false;" href="javascript:void(0);" class="ref ref103 ref126 ref137">(104,127,138)</a> However, their therapeutic potential is limited by significant off-target activity, including effects on synaptic transmission.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(139)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">4.  Summary and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pharmacological inhibition of ectonucleotidases CD39 and CD73 represents a well-established mechanism for overcoming adenosine-mediated immunosuppression and a promising approach for treating human cancers. Multiple clinical trials are underway to evaluate the utility of anti-CD73/CD39 mAbs, either alone or in combination with other established agents, for the treatment of cancer. Expanding interest in targeting the adenosine signaling pathway has recently led to the discovery of several small-molecule inhibitors of CD73 with improved potency, selectivity, and drug-like properties, including AB680, the first small-molecule CD73 inhibitor to enter clinical trials. AB680 is a remarkably potent (<i>K</i><sub>i</sub> = 5 pM) and selective inhibitor of CD73, which was recently found to be safe and well tolerated in humans and is currently being evaluated in combination regimens to treat advanced pancreatic cancer and metastatic castration-resistant prostate cancer. The examples highlighted here clearly illustrate the potential of emerging small-molecule CD73 inhibitors to overcome many of the challenges associated with antibody-based therapies. The ability to potently inhibit the enzymatic activity of CD73 with tumor-penetrating, orally available small molecules represents a key step toward the realization of effective CD73-based cancer therapies.</div><div class="NLM_p last">While progress toward the discovery of more potent and drug-like small-molecule CD39 inhibitors has been comparatively slower, efforts in this area will likely benefit from the recent development of improved assays and more detailed structural characterization of human CD39. Small-molecule inhibitors of CD39 and CD73 have provided valuable insights into the therapeutic potential of targeting the adenosine pathway in immuno-oncology and hold significant promise as more effective therapies for human cancer.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01044" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenna L. Jeffrey</span> - <span class="hlFld-Affiliation affiliation">Arcus Biosciences, 3928 Point Eden Way, Hayward, California 94545, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9249-5984" title="Orcid link">http://orcid.org/0000-0001-9249-5984</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a6ccccc3c0c0d4c3dfe6c7d4c5d3d5c4cfc988c5c9cb"><span class="__cf_email__" data-cfemail="d5bfbfb0b3b3a7b0ac95b4a7b6a0a6b7bcbafbb6bab8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth V. Lawson</span> - <span class="hlFld-Affiliation affiliation">Arcus Biosciences, 3928 Point Eden Way, Hayward, California 94545, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5094-6337" title="Orcid link">http://orcid.org/0000-0001-5094-6337</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay P. Powers</span> - <span class="hlFld-Affiliation affiliation">Arcus Biosciences, 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are employees of Arcus Biosciences.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Jenna L. Jeffrey</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=BIO-d7e4263-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jenna L. Jeffrey</b> studied chemistry at the University of Oregon prior to pursuing her doctoral studies under the direction of Professor Richmond Sarpong at UC Berkeley. Following a National Institutes of Health postdoctoral fellowship with Professor David W. C. MacMillan at Princeton University, Jenna joined the Drug Discovery Department at Arcus Biosciences in 2016. Jenna is currently a Principal Investigator in the Drug Discovery group at Arcus.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Kenneth V. Lawson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=BIO-d7e4268-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kenneth V. Lawson</b> obtained a B.S. in Chemistry from California State University, Sacramento, and a Ph.D. from University of California Los Angeles, working in the laboratory of Professor Patrick Harran. He performed postdoctoral work under Professor Andrew Myers at Harvard University before joining Arcus Biosciences in 2016 where Ken is currently a Principal Investigator in the Drug Discovery group.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Jay P. Powers</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=BIO-d7e4273-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jay P. Powers</b> received a B.S. degree in Biochemistry and completed his Ph.D. studies in Organic Chemistry with Scott Rychnovsky at the University of Minnesota, followed by postdoctoral studies with Gilbert Stork at Columbia University. Following a long career in industry Jay is currently Senior Vice President of Drug Discovery at Arcus Biosciences. During his career Jay has been responsible for the discovery of 17 compounds that have gone into clinical development in the oncology, immunomodulation, inflammation, antiviral, and metabolic disease areas. Jay has published extensively in the areas of medicinal and synthetic chemistry and is an inventor on over 80 granted U.S. patents.</p></figure></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AACR</td><td class="NLM_def"><p class="first last">American Association for Cancer Research</p></td></tr><tr><td class="NLM_term">AMPCP</td><td class="NLM_def"><p class="first last">α,β-methyleneadenosine 5′-diphosphate</p></td></tr><tr><td class="NLM_term">AMPNP</td><td class="NLM_def"><p class="first last">adenosine 5′-[(α,β)-imido]diphosphate</p></td></tr><tr><td class="NLM_term">AMPPNP</td><td class="NLM_def"><p class="first last">adenosine 5′-(β,γ-imido)triphosphate</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last"><i>bis in die</i>, twice a day</p></td></tr><tr><td class="NLM_term">CRPC</td><td class="NLM_def"><p class="first last">castration-resistant prostate cancer</p></td></tr><tr><td class="NLM_term">CD39</td><td class="NLM_def"><p class="first last">cluster of differentiation 39</p></td></tr><tr><td class="NLM_term">CD73</td><td class="NLM_def"><p class="first last">cluster of differentiation 73</p></td></tr><tr><td class="NLM_term">CE</td><td class="NLM_def"><p class="first last">capillary electrophoresis</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CIMT</td><td class="NLM_def"><p class="first last">Association for Cancer Immunotherapy</p></td></tr><tr><td class="NLM_term">CMP</td><td class="NLM_def"><p class="first last">cytidine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">colorectal cancer</p></td></tr><tr><td class="NLM_term">CRI</td><td class="NLM_def"><p class="first last">Cancer Research Institute</p></td></tr><tr><td class="NLM_term">CTLA-4</td><td class="NLM_def"><p class="first last">cytotoxic T-lymphocyte-associated protein 4</p></td></tr><tr><td class="NLM_term">EATI</td><td class="NLM_def"><p class="first last">European Academy of Tumor Immunology</p></td></tr><tr><td class="NLM_term">EHNA</td><td class="NLM_def"><p class="first last">erythro-9-(2-hydroxy-3-nonyl)adenine</p></td></tr><tr><td class="NLM_term">GMPPNP</td><td class="NLM_def"><p class="first last">guanosine 5′-[β,γ-imido]triphosphate</p></td></tr><tr><td class="NLM_term">GPI</td><td class="NLM_def"><p class="first last">glycosylphosphatidylinositol</p></td></tr><tr><td class="NLM_term">IFN-γ</td><td class="NLM_def"><p class="first last">interferon-γ</p></td></tr><tr><td class="NLM_term">IL-2</td><td class="NLM_def"><p class="first last">interleukin-2</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug</p></td></tr><tr><td class="NLM_term">IO</td><td class="NLM_def"><p class="first last">immuno-oncology</p></td></tr><tr><td class="NLM_term">LOD</td><td class="NLM_def"><p class="first last">limit of detection</p></td></tr><tr><td class="NLM_term">LOQ</td><td class="NLM_def"><p class="first last">limit of quantitation</p></td></tr><tr><td class="NLM_term"><i>Lp</i></td><td class="NLM_def"><p class="first last"><i>Legionella pneumophila</i></p></td></tr><tr><td class="NLM_term">mAb</td><td class="NLM_def"><p class="first last">monoclonal antibody</p></td></tr><tr><td class="NLM_term">MESG</td><td class="NLM_def"><p class="first last">2-amino-6-mercapto-7-methylpurine ribonucleoside</p></td></tr><tr><td class="NLM_term">MG</td><td class="NLM_def"><p class="first last">malachite green</p></td></tr><tr><td class="NLM_term">MLR</td><td class="NLM_def"><p class="first last">mixed lymphocyte reaction</p></td></tr><tr><td class="NLM_term">MSS</td><td class="NLM_def"><p class="first last">microsatellite-stable</p></td></tr><tr><td class="NLM_term">NK</td><td class="NLM_def"><p class="first last">natural killer</p></td></tr><tr><td class="NLM_term">NPP1</td><td class="NLM_def"><p class="first last">nucleotide pyrophosphatase/phosphodiesterase 1</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">NTPDase</td><td class="NLM_def"><p class="first last">ectonucleoside triphosphate diphosphohydrolase</p></td></tr><tr><td class="NLM_term">PAP</td><td class="NLM_def"><p class="first last">prostatic acid phosphatase</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">human peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PCP</td><td class="NLM_def"><p class="first last">methylenebisphosphonate</p></td></tr><tr><td class="NLM_term">PD-1</td><td class="NLM_def"><p class="first last">programmed cell death protein 1</p></td></tr><tr><td class="NLM_term">PD-L1</td><td class="NLM_def"><p class="first last">programmed death-ligand 1</p></td></tr><tr><td class="NLM_term">PNP</td><td class="NLM_def"><p class="first last">purine ribonucleoside phosphorylase</p></td></tr><tr><td class="NLM_term">POM</td><td class="NLM_def"><p class="first last">polyoxometalate</p></td></tr><tr><td class="NLM_term">PPADS</td><td class="NLM_def"><p class="first last">pyridoxal phosphate-6-azophenyl-2′,4′-disulfonic acid</p></td></tr><tr><td class="NLM_term">hCD73</td><td class="NLM_def"><p class="first last">recombinant human CD73</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TGFβ</td><td class="NLM_def"><p class="first last">transforming growth factor β</p></td></tr><tr><td class="NLM_term">TIL</td><td class="NLM_def"><p class="first last">tumor-infiltrating lymphocyte</p></td></tr><tr><td class="NLM_term">TME</td><td class="NLM_def"><p class="first last">tumor microenvironment</p></td></tr><tr><td class="NLM_term">TNAP</td><td class="NLM_def"><p class="first last">tissue nonspecific alkaline phosphatase</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple negative breast cancer</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">T<sub>reg</sub></td><td class="NLM_def"><p class="first last">regulatory T cell</p></td></tr><tr><td class="NLM_term">UMPPNP</td><td class="NLM_def"><p class="first last">uridine 5′-[β,γ-imido]triphosphate</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 139 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Cellular function and molecular structure of <i>ecto</i>-nucleotidases</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9309-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs11302-012-9309-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22555564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=437-502&author=H.+Zimmermannauthor=M.+Zebischauthor=N.+Str%C3%A4ter&title=Cellular+function+and+molecular+structure+of+ecto-nucleotidases&doi=10.1007%2Fs11302-012-9309-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular function and molecular structure of ecto-nucleotidases</span></div><div class="casAuthors">Zimmermann, Herbert; Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-502</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotidases play a pivotal role in purinergic signal transmission.  They hydrolyze extracellular nucleotides and thus can control their availability at purinergic P2 receptors.  They generate extracellular nucleosides for cellular reuptake and salvage via nucleoside transporters of the plasma membrane.  The extracellular adenosine formed acts as an agonist of purinergic P1 receptors.  They also can produce and hydrolyze extracellular inorg. pyrophosphate that is of major relevance in the control of bone mineralization.  This review discusses and compares four major groups of ecto-nucleotidases: the ecto-nucleoside triphosphate diphosphohydrolases, ecto-5'-nucleotidase, ecto-nucleotide pyrophosphatase/phosphodiesterases, and alk. phosphatases.  Only recently and based on crystal structures, detailed information regarding the spatial structures and catalytic mechanisms has become available for members of these four ecto-nucleotidase families.  This permits detailed predictions of their catalytic mechanisms and a comparison between the individual enzyme groups.  The review focuses on the principal biochem., cell biol., catalytic, and structural properties of the enzymes and provides brief ref. to tissue distribution, and physiol. and pathophysiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwf4PFcTEl0LVg90H21EOLACvtfcHk0lhldgdmUhlW0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D&md5=d36e58f25676e47b9749e43896ac4cb2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9309-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9309-4%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCellular%2520function%2520and%2520molecular%2520structure%2520of%2520ecto-nucleotidases%26jtitle%3DPurinergic%2520Signalling%26date%3D2012%26volume%3D8%26spage%3D437%26epage%3D502%26doi%3D10.1007%2Fs11302-012-9309-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span> <span> </span><span class="NLM_article-title">Ecto-Nucleotidases</span>. In  <i>Purinergic and Pyrimidinergic Signaling I</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbrachio, M. P.</span>, <span class="NLM_string-name">Williams, M.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2001</span>; Vol.  <span class="NLM_volume">151</span>, pp  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">250</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2F978-3-662-09604-8_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=209-250&author=H.+Zimmermannauthor=M.+P.+Abbrachio&author=M.+Williams&title=Purinergic+and+Pyrimidinergic+Signaling+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F978-3-662-09604-8_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-662-09604-8_8%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26atitle%3DEcto-Nucleotidases%26btitle%3DPurinergic%2520and%2520Pyrimidinergic%2520Signaling%2520I%26aulast%3DAbbrachio%26aufirst%3DM.%2BP.%26pub%3DSpringer%26date%3D2001%26volume%3D151%26spage%3D209%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Adenosine metabolism: emerging concepts for cancer therapy</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2019.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ccell.2019.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31821783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOmtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=582-596&author=D.+Boisonauthor=G.+G.+Yegutkin&title=Adenosine+metabolism%3A+emerging+concepts+for+cancer+therapy&doi=10.1016%2Fj.ccell.2019.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Metabolism: Emerging Concepts for Cancer Therapy</span></div><div class="casAuthors">Boison, Detlev; Yegutkin, Gennady G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">582-596</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Adenosine is a key metabolic and immune-checkpoint regulator implicated in the tumor escape from the host immune system.  Major gaps in knowledge that impede the development of effective adenosine-based therapeutics include: (1) lack of consideration of redundant pathways controlling ATP and adenosine levels; (2) lack of distinction between receptor-dependent and -independent effects of adenosine, and (3) focus on extracellular adenosine without consideration of intracellular metab. and compartmentalization.  In light of current clin. trials, we provide an overview of adenosine metab. and point out the need for a more careful evaluation of the entire purinome in emerging cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2ZdU0gtISMrVg90H21EOLACvtfcHk0lj5gpWH98Z_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOmtL3F&md5=e087a03d692d332eca328b1cd251e4a6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2019.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2019.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBoison%26aufirst%3DD.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DAdenosine%2520metabolism%253A%2520emerging%2520concepts%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Cell%26date%3D2019%26volume%3D36%26spage%3D582%26epage%3D596%26doi%3D10.1016%2Fj.ccell.2019.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deaglio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usheva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjyoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span> <span> </span><span class="NLM_article-title">Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1084/jem.20062512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1084%2Fjem.20062512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17502665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1aktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2007&pages=1257-1265&author=S.+Deaglioauthor=K.+M.+Dwyerauthor=W.+Gaoauthor=D.+Friedmanauthor=A.+Ushevaauthor=A.+Eratauthor=J.-F.+Chenauthor=K.+Enjyojiauthor=J.+Lindenauthor=M.+Oukkaauthor=V.+K.+Kuchrooauthor=T.+B.+Stromauthor=S.+C.+Robson&title=Adenosine+generation+catalyzed+by+CD39+and+CD73+expressed+on+regulatory+T+cells+mediates+immune+suppression&doi=10.1084%2Fjem.20062512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression</span></div><div class="casAuthors">Deaglio, Silvia; Dwyer, Karen M.; Gao, Wenda; Friedman, David; Usheva, Anny; Erat, Anna; Chen, Jiang-Fan; Enjyoji, Keiichii; Linden, Joel; Oukka, Mohamed; Kuchroo, Vijay K.; Strom, Terry B.; Robson, Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1257-1265</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The study of T regulatory cells (T reg cells) has been limited by the lack of sp. surface markers and an inability to define mechanisms of suppression.  We show that the expression of CD39/ENTPD1 in concert with CD73/ecto-5'-nucleotidase distinguishes CD4+/CD25+/Foxp3+ T reg cells from other T cells.  These ectoenzymes generate pericellular adenosine from extracellular nucleotides.  The coordinated expression of CD39/CD73 on T reg cells and the adenosine A2A receptor on activated T effector cells generates immunosuppressive loops, indicating roles in the inhibitory function of T reg cells.  Consequently, T reg cells from Cd39-null mice show impaired suppressive properties in vitro and fail to block allograft rejection in vivo.  We conclude that CD39 and CD73 are surface markers of T reg cells that impart a specific biochem. signature characterized by adenosine generation that has functional relevance for cellular immunoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaFCyxsPRZ_rVg90H21EOLACvtfcHk0lj5gpWH98Z_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1aktrs%253D&md5=4f1c7e4fc65c0b14fc55cc0460bd2df3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1084%2Fjem.20062512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20062512%26sid%3Dliteratum%253Aachs%26aulast%3DDeaglio%26aufirst%3DS.%26aulast%3DDwyer%26aufirst%3DK.%2BM.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DFriedman%26aufirst%3DD.%26aulast%3DUsheva%26aufirst%3DA.%26aulast%3DErat%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DEnjyoji%26aufirst%3DK.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26atitle%3DAdenosine%2520generation%2520catalyzed%2520by%2520CD39%2520and%2520CD73%2520expressed%2520on%2520regulatory%2520T%2520cells%2520mediates%2520immune%2520suppression%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2007%26volume%3D204%26spage%3D1257%26epage%3D1265%26doi%3D10.1084%2Fjem.20062512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span> <i>Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2F3527608060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+L.+Mill%C3%A1n&title=Mammalian+Alkaline+Phosphatases%3A+From+Biology+to+Applications+in+Medicine+and+Biotechnology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F3527608060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F3527608060%26sid%3Dliteratum%253Aachs%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26btitle%3DMammalian%2520Alkaline%2520Phosphatases%253A%2520From%2520Biology%2520to%2520Applications%2520in%2520Medicine%2520and%2520Biotechnology%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rader, B. A.</span></span> <span> </span><span class="NLM_article-title">Alkaline phosphatase, an unconventional immune protein</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">897</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.3389%2Ffimmu.2017.00897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=28824625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWns7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=897&author=B.+A.+Rader&title=Alkaline+phosphatase%2C+an+unconventional+immune+protein&doi=10.3389%2Ffimmu.2017.00897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Alkaline phosphatase, an unconventional immune protein</span></div><div class="casAuthors">Rader, Bethany A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">897/1-897/6</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Recent years have seen an increase in the no. of studies focusing on alk. phosphatases (APs), revealing an expanding complexity of function of these enzymes.  Of the four human AP (hAP) proteins, most is known about tissue non-specific AP (TNAP) and intestinal AP (IAP).  This review highlights current understanding of TNAP and IAP in relation to human health and disease.  TNAP plays a role in multiple processes, including bone mineralization, vitamin B6 metab., and neurogenesis, is the genetic cause of hypophosphatasia, influences inflammation through regulation of purinergic signaling, and has been implicated in Alzheimer's disease.  IAP regulates fatty acid absorption and has been implicated in the regulation of diet-induced obesity and metabolic syndrome.  IAP and TNAP can dephosphorylate bacterial-derived lipopolysaccharide, and IAP has been identified as a potential regulator of the compn. of the intestinal microbiome, an evolutionarily conserved function.  Endogenous and recombinant bovine APs and recombinant hAPs are currently being explored for their potential as pharmacol. agents to treat AP-assocd. diseases and mitigate multiple sources of inflammation.  Continued research on these versatile proteins will undoubtedly provide insight into human pathophysiol., biochem., and the human holobiont.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD-RIxFHkmWrVg90H21EOLACvtfcHk0lhnEkIjxxEUlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWns7%252FN&md5=93c424d70cb67902c028d524778c458d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00897%26sid%3Dliteratum%253Aachs%26aulast%3DRader%26aufirst%3DB.%2BA.%26atitle%3DAlkaline%2520phosphatase%252C%2520an%2520unconventional%2520immune%2520protein%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D897%26doi%3D10.3389%2Ffimmu.2017.00897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muniyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaGrange, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaney, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-F.</span></span> <span> </span><span class="NLM_article-title">Human prostatic acid phosphatase: structure, function and regulation</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">10438</span>– <span class="NLM_lpage">10464</span>, <span class="refDoi"> DOI: 10.3390/ijms140510438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.3390%2Fijms140510438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23698773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2jtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=10438-10464&author=S.+Muniyanauthor=N.+K.+Chaturvediauthor=J.+G.+Dwyerauthor=C.+A.+LaGrangeauthor=W.+G.+Chaneyauthor=M.-F.+Lin&title=Human+prostatic+acid+phosphatase%3A+structure%2C+function+and+regulation&doi=10.3390%2Fijms140510438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Human prostatic acid phosphatase: structure, function and regulation</span></div><div class="casAuthors">Muniyan, Sakthivel; Chaturvedi, Nagendra K.; Dwyer, Jennifer G.; LaGrange, Chad A.; Chaney, William G.; Lin, Ming-Fong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">10438-10464, 27 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Human prostatic acid phosphatase (PAcP) is a 100 kDa glycoprotein composed of two subunits.  Recent advances demonstrate that cellular PAcP (cPAcP) functions as a protein tyrosine phosphatase by dephosphorylating ErbB-2/Neu/HER-2 at the phosphotyrosine residues in prostate cancer (PCa) cells, which results in reduced tumorigenicity.  Further, the interaction of cPAcP and ErbB-2 regulates androgen sensitivity of PCa cells.  Knockdown of cPAcP expression allows androgen-sensitive PCa cells to develop the castration-resistant phenotype, where cells proliferate under an androgen-reduced condition.  Thus, cPAcP has a significant influence on PCa cell growth.  Interestingly, promoter anal. suggests that PAcP expression can be regulated by NF-κB, via a novel binding sequence in an androgen-independent manner.  Further understanding of PAcP function and regulation of expression will have a significant impact on understanding PCa progression and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow-MoHQNm5L7Vg90H21EOLACvtfcHk0lj9LZOg_x4-JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2jtr3L&md5=a76b7c3ee2178cf456f7ac2207e5cd03</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fijms140510438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140510438%26sid%3Dliteratum%253Aachs%26aulast%3DMuniyan%26aufirst%3DS.%26aulast%3DChaturvedi%26aufirst%3DN.%2BK.%26aulast%3DDwyer%26aufirst%3DJ.%2BG.%26aulast%3DLaGrange%26aufirst%3DC.%2BA.%26aulast%3DChaney%26aufirst%3DW.%2BG.%26aulast%3DLin%26aufirst%3DM.-F.%26atitle%3DHuman%2520prostatic%2520acid%2520phosphatase%253A%2520structure%252C%2520function%2520and%2520regulation%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D10438%26epage%3D10464%26doi%3D10.3390%2Fijms140510438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Losenkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccarini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karikoski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">jcs241463</span>, <span class="refDoi"> DOI: 10.1242/jcs.241463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1242%2Fjcs.241463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=32317394" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2020&pages=jcs241463&author=K.+Losenkovaauthor=M.+Zuccariniauthor=M.+Karikoskiauthor=J.+Laurilaauthor=D.+Boisonauthor=S.+Jalkanenauthor=G.+G.+Yegutkin&title=Compartmentalization+of+adenosine+metabolism+in+cancer+cells+and+its+modulation+during+acute+hypoxia&doi=10.1242%2Fjcs.241463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1242%2Fjcs.241463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.241463%26sid%3Dliteratum%253Aachs%26aulast%3DLosenkova%26aufirst%3DK.%26aulast%3DZuccarini%26aufirst%3DM.%26aulast%3DKarikoski%26aufirst%3DM.%26aulast%3DLaurila%26aufirst%3DJ.%26aulast%3DBoison%26aufirst%3DD.%26aulast%3DJalkanen%26aufirst%3DS.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DCompartmentalization%2520of%2520adenosine%2520metabolism%2520in%2520cancer%2520cells%2520and%2520its%2520modulation%2520during%2520acute%2520hypoxia%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2020%26volume%3D133%26spage%3Djcs241463%26doi%3D10.1242%2Fjcs.241463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1039/C7MD00015D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1039%2FC7MD00015D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30108800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=823-840&author=S.-Y.+Leeauthor=C.+E.+M%C3%BCller&title=Nucleotide+pyrophosphatase%2Fphosphodiesterase+1+%28NPP1%29+and+its+inhibitors&doi=10.1039%2FC7MD00015D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors</span></div><div class="casAuthors">Lee, Sang-Yong; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-840</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1, EC 3.1.4.1) is a metalloenzyme that belongs to the NPP family, which comprises seven subtypes (NPP1-7).  NPP1 hydrolyzes a wide range of phosphodiester bonds, e.g. in nucleoside triphosphates, (cyclic) dinucleotides, and nucleotide sugars yielding nucleoside 5'-monophosphates as products.  Its main substrate is ATP which is cleaved to AMP and diphosphate.  The enzyme is involved in various biol. processes including bone mineralization, soft-tissue calcification, insulin receptor signalling, cancer cell proliferation and immune modulation.  Therefore, NPP1 inhibitors have potential as novel drugs, e.g. for (immuno)oncol.  In the last two decades several inhibitors of NPP1 derived from nucleotide- or non-nucleotide scaffolds have been developed.  The most potent and selective NPP1-inhibitory substrate analog is adenosine 5'-α,β-methylene-γ-thiotriphosphate (Ki = 20 nM vs. p-Nph-5'-TMP, human membrane-bound NPP1).  Non-nucleotide-derived NPP1 inhibitors comprise polysulfonates, polysaccharides, polyoxometalates and small heterocyclic compds.  The polyoxometalate [TiW11CoO40]8- (PSB-POM141) is the most potent and selective NPP1 inhibitor described to date (Ki = 1.46 nM vs. ATP, human sol. NPP1); it displays an allosteric mechanism of inhibition and represents a useful pharmacol. tool for evaluating the potential of NPP1 as a novel drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYX4x_-RuSKbVg90H21EOLACvtfcHk0liAdJ92uETM2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D&md5=59169b98f5f53799ae43cde20df7c000</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1039%2FC7MD00015D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00015D%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DNucleotide%2520pyrophosphatase%252Fphosphodiesterase%25201%2520%2528NPP1%2529%2520and%2520its%2520inhibitors%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D823%26epage%3D840%26doi%3D10.1039%2FC7MD00015D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Channar, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afzal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejaz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larik, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahesar, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erben, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span> <span> </span><span class="NLM_article-title">Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ejmech.2018.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30015078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlajtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=461-478&author=P.+A.+Channarauthor=S.+Afzalauthor=S.+A.+Ejazauthor=A.+Saeedauthor=F.+A.+Larikauthor=P.+A.+Mahesarauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=M.+F.+Erbenauthor=J.+Iqbal&title=Exploration+of+carboxy+pyrazole+derivatives%3A+Synthesis%2C+alkaline+phosphatase%2C+nucleotide+pyrophosphatase%2Fphosphodiesterase+and+nucleoside+triphosphate+diphosphohydrolase+inhibition+studies+with+potential+anticancer+profile&doi=10.1016%2Fj.ejmech.2018.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile</span></div><div class="casAuthors">Channar, Pervaiz Ali; Afzal, Saira; Ejaz, Syeda Abida; Saeed, Aamer; Larik, Fayaz Ali; Mahesar, Parvez Ali; Lecka, Joanna; Sevigny, Jean; Erben, Mauricio F.; Iqbal, Jamshed</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">461-478</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the present work, the synthesis of new aryl pyrazole derivs. using 1,3-dicarbonyl motifs is reported.  The reaction was proceeded by the cyclization of pentane-2,4-dione, 3-chloropentane-2,4-dione or Et 3-oxobutanoate with different aryl hydrazides.  The products, which can be regarded as 1H-pyrazol-1-yl-one analogs and represent drug like mols. along with well-developed structure-activity relationships, were obtained in good to excellent yield.  Considering alk. phosphatases (APs), nucleotide pyrophosphatases/phosphodiesterases (NPPs) and nucleoside triphosphate diphosphohydrolase as the mol. targets, the effects of these synthesized compds. were investigated on different isoenzymes of APs, NPPs and NTPDases.  The data revealed that the synthesized compds. inhibited both enzymes but most of them inhibited tissue non-specific alk. phosphatase (TNAP) more selectively.  The antitumor activity results indicated that the synthesized derivs. have strong inhibitory effects on the growth of selected cell lines from different tissues such as breast, bone marrow and cervix (MCF-7, K-562 and Hela) but with varying intensities.  Moreover the binding mode of interactions were explained on the basis of mol. docking and in-silico studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfL-99cafVarVg90H21EOLACvtfcHk0liAdJ92uETM2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlajtLfF&md5=13958c2510afd80c6185223285990787</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DChannar%26aufirst%3DP.%2BA.%26aulast%3DAfzal%26aufirst%3DS.%26aulast%3DEjaz%26aufirst%3DS.%2BA.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DLarik%26aufirst%3DF.%2BA.%26aulast%3DMahesar%26aufirst%3DP.%2BA.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DErben%26aufirst%3DM.%2BF.%26aulast%3DIqbal%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520carboxy%2520pyrazole%2520derivatives%253A%2520Synthesis%252C%2520alkaline%2520phosphatase%252C%2520nucleotide%2520pyrophosphatase%252Fphosphodiesterase%2520and%2520nucleoside%2520triphosphate%2520diphosphohydrolase%2520inhibition%2520studies%2520with%2520potential%2520anticancer%2520profile%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D461%26epage%3D478%26doi%3D10.1016%2Fj.ejmech.2018.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">CD73: A Novel target for cancer immunotherapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">6407</span>– <span class="NLM_lpage">6411</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-10-1544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20682793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWqu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=6407-6411&author=B.+Zhang&title=CD73%3A+A+Novel+target+for+cancer+immunotherapy&doi=10.1158%2F0008-5472.CAN-10-1544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CD73: A Novel Target for Cancer Immunotherapy</span></div><div class="casAuthors">Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6407-6411</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The promise of cancer immunotherapy has not been translated into clin. successes, in large part because of tumor-assocd. immune suppression that blocks effective antitumor immunity.  Recent findings show a tumor-induced immunosuppressive mechanism, whereby tumor-derived CD73 functions as an ecto-enzyme to produce extracellular adenosine, which promotes tumor growth by limiting antitumor T-cell immunity via adenosine receptor signaling.  Results with small mol. inhibitors, or monoclonal antibodies targeting CD73 in murine tumor models, suggest that targeted CD73 therapy is an important alternative and realistic approach to effective control of tumor growth.  In particular, it helps T-cell-based therapy by enhancing the adaptive immune response machinery, which may increase the function of tumor-infiltrating T lymphocytes, and subsequently lead to improved survival in cancer patients.  Cancer Res; 70(16); 6407-11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbHxuETqRsE7Vg90H21EOLACvtfcHk0lj22V938kkjRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWqu7jN&md5=837efbbd36cff106a9fde6afea427a14</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1544%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DCD73%253A%2520A%2520Novel%2520target%2520for%2520cancer%2520immunotherapy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D6407%26epage%3D6411%26doi%3D10.1158%2F0008-5472.CAN-10-1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beavis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">CD73: A Potent suppressor of antitumor immune responses</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.it.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.it.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22487321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Kks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=231-237&author=P.+A.+Beavisauthor=J.+Staggauthor=P.+K.+Darcyauthor=M.+J.+Smyth&title=CD73%3A+A+Potent+suppressor+of+antitumor+immune+responses&doi=10.1016%2Fj.it.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CD73: a potent suppressor of antitumor immune responses</span></div><div class="casAuthors">Beavis, Paul. A.; Stagg, John; Darcy, Phillip K.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">231-237</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumors use several strategies to evade immunosurveillance.  One such mechanism is the generation of adenosine within the tumor microenvironment, which potently suppresses antitumor T cell responses.  Adenosine within the tumor is generated by CD73, a membrane-bound nucleotidase that is expressed by tumor cells, suppressive immune subsets such as T regulatory cells (Tregs) and myeloid-derived suppressor cells and endothelial cells.  Recent evidence suggests that targeted inhibition of CD73 has the potential to reduce tumorigenesis and metastasis, as well as enhancing the potency of T-cell-directed therapies.  This review outlines the impact of adenosine on suppressing the antitumor response and the evidence supporting the rationale for CD73 targeting in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0nmj4rwt8J7Vg90H21EOLACvtfcHk0lj22V938kkjRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Kks78%253D&md5=bc393315fe03e9d3b4061c0c06fab2bb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DBeavis%26aufirst%3DP.%2BA.%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DCD73%253A%2520A%2520Potent%2520suppressor%2520of%2520antitumor%2520immune%2520responses%26jtitle%3DTrends%2520Immunol.%26date%3D2012%26volume%3D33%26spage%3D231%26epage%3D237%26doi%3D10.1016%2Fj.it.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisseret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">The adenosine pathway in immuno-oncology</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1038/s41571-020-0382-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fs41571-020-0382-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=B.+Allardauthor=D.+Allardauthor=L.+Buisseretauthor=J.+Stagg&title=The+adenosine+pathway+in+immuno-oncology&doi=10.1038%2Fs41571-020-0382-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fs41571-020-0382-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41571-020-0382-2%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DBuisseret%26aufirst%3DL.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DThe%2520adenosine%2520pathway%2520in%2520immuno-oncology%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2020%26doi%3D10.1038%2Fs41571-020-0382-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divisekera, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duret, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparwasser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">CD73-Deficient mice have increased antitumor immunity and are resistant to experimental metastasis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2892</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-4246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-10-4246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=21292811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2892-2900&author=J.+Staggauthor=U.+Divisekeraauthor=H.+Duretauthor=T.+Sparwasserauthor=M.+W.+Tengauthor=P.+K.+Darcyauthor=M.+J.+Smyth&title=CD73-Deficient+mice+have+increased+antitumor+immunity+and+are+resistant+to+experimental+metastasis&doi=10.1158%2F0008-5472.CAN-10-4246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis</span></div><div class="casAuthors">Stagg, John; Divisekera, Upulie; Duret, Helene; Sparwasser, Tim; Teng, Michele W. L.; Darcy, Phillip K.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2892-2900</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CD73 is a cell-surface enzyme that suppresses immune responses by producing extracellular adenosine.  In this study, we employed CD73 gene-targeted mice to investigate the role of host-derived CD73 on antitumor immunity and tumor cell metastasis.  We found that CD73 ablation significantly suppressed the growth of ovalbumin-expressing MC38 colon cancer, EG7 lymphoma, AT-3 mammary tumors, and B16F10 melanoma.  The protective effect of CD73 deficiency on primary tumors was dependent on CD8+ T cells and assocd. with an increased frequency of antigen-specific CD8+ T cells in peripheral blood and tumors and increased antigen-specific IFN-γ prodn.  Replicate studies in bone marrow chimeras established that both hematopoietic and nonhematopoietic expression of CD73 was important to promote tumor immune escape.  Using adoptive reconstitution of T regulatory cell (Treg)-depleted DEREG (depletion of regulatory T cells) mice, we demonstrated that part of the protumorigenic effect of Tregs was dependent on their expression of CD73.  CD73-deficient mice were also protected against pulmonary metastasis of B16F10 melanoma cells after i.v. injection.  Unexpectedly, we found that the prometastatic effect of host-derived CD73 was dependent on CD73 expression on nonhematopoietic cells.  CD73 expression on nonhematopoietic cells, most likely endothelial cells, was crit. for promoting lung metastasis in a manner independent from immunosuppressive effects.  Notably, in vivo blockade of CD73 with a selective inhibitor or anti-CD73 monoclonal antibody significantly reduced tumor growth and metastasis of CD73-neg. tumors.  Taken together, our findings indicate that CD73 may be targeted at multiple levels to induce anticancer effects including at the level of tumor cells, Tregs, and nonhematopoietic cells.  Cancer Res; 71(8); 2892-900.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMQxUwCZ8XerVg90H21EOLACvtfcHk0lhECv0Yg76_wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWjs78%253D&md5=94cc37e9eb84e5e8cce990252cc0e7a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-4246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-4246%26sid%3Dliteratum%253Aachs%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DDivisekera%26aufirst%3DU.%26aulast%3DDuret%26aufirst%3DH.%26aulast%3DSparwasser%26aufirst%3DT.%26aulast%3DTeng%26aufirst%3DM.%2BW.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DCD73-Deficient%2520mice%2520have%2520increased%2520antitumor%2520immunity%2520and%2520are%2520resistant%2520to%2520experimental%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2892%26epage%3D2900%26doi%3D10.1158%2F0008-5472.CAN-10-4246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. B. L.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Ginn, E.</span>; <span class="NLM_string-name">Ashok, D.</span>; <span class="NLM_string-name">Anderson, A. E.</span>; <span class="NLM_string-name">Banuelos, J.</span>; <span class="NLM_string-name">Zhang, K.</span>; <span class="NLM_string-name">Pham, A.</span>; <span class="NLM_string-name">Park, T.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Jeffrey, J. L.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Walters, M. J.</span>; <span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical Pharmacokinetic and Pharmacodynamic Characterization of AB680, a Small-Molecule CD73 Inhibitor for Cancer Immunotherapy</span>.  <i>Proceedings</i>, 4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, New York, NY, Sep 30–Oct 3, 2018; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+B.+L.+Tan&author=J.+Chen&author=E.+Ginn&author=D.+Ashok&author=A.+E.+Anderson&author=J.+Banuelos&author=K.+Zhang&author=A.+Pham&author=T.+Park&author=A.+Chen&author=X.+Zhao&author=K.+V.+Lawson&author=J.+L.+Jeffrey&author=J.+Kalisiak&author=M.+R.+Leleti&author=M.+J.+Walters&author=J.+P.+Powers&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DJ.%2BB.%2BL.%26atitle%3DPreclinical%2520Pharmacokinetic%2520and%2520Pharmacodynamic%2520Characterization%2520of%2520AB680%252C%2520a%2520Small-Molecule%2520CD73%2520Inhibitor%2520for%2520Cancer%2520Immunotherapy%26btitle%3DProceedings%26pub%3DAACR%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span>; <span class="NLM_string-name">Narasappa, N.</span>; <span class="NLM_string-name">Yin, F.</span>; <span class="NLM_string-name">Zhang, K.</span>; <span class="NLM_string-name">DiRenzo, D.</span>; <span class="NLM_string-name">Park, T.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K.</span>; <span class="NLM_string-name">Jeffrey, J. L.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Schindler, U.</span>; <span class="NLM_string-name">Walters, M. J.</span>; <span class="NLM_string-name">Tan, J. B.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors (CD73i) Reverse the AMP/Adenosine-Mediated Impairment of Immune Effector Cell Activation by Immune Checkpoint Inhibitors (ICI)</span>.  <i>Proceedings</i>, AACR Annual Meeting, Chicago, IL, Apr 14–18, 2018; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Becker&author=N.+Narasappa&author=F.+Yin&author=K.+Zhang&author=D.+DiRenzo&author=T.+Park&author=J.+Kalisiak&author=K.+Lawson&author=J.+L.+Jeffrey&author=J.+P.+Powers&author=U.+Schindler&author=M.+J.+Walters&author=J.+B.+Tan&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26atitle%3DCD73%2520Inhibitors%2520%2528CD73i%2529%2520Reverse%2520the%2520AMP%252FAdenosine-Mediated%2520Impairment%2520of%2520Immune%2520Effector%2520Cell%2520Activation%2520by%2520Immune%2520Checkpoint%2520Inhibitors%2520%2528ICI%2529%26btitle%3DProceedings%26pub%3DAACR%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousineau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendoo, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahimi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Page, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provencher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mes-Masson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Is associated with poor prognosis in high-grade serous ovarian cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">4494</span>– <span class="NLM_lpage">4503</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-14-3569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=26363007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGnu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=4494-4503&author=M.+Turcotteauthor=K.+Springauthor=S.+Pommeyauthor=G.+Chouinardauthor=I.+Cousineauauthor=J.+Georgeauthor=G.+M.+Chenauthor=D.+M.+Gendooauthor=B.+Haibe-Kainsauthor=T.+Karnauthor=K.+Rahimiauthor=C.+Le+Pageauthor=D.+Provencherauthor=A.+M.+Mes-Massonauthor=J.+Stagg&title=CD73+Is+associated+with+poor+prognosis+in+high-grade+serous+ovarian+cancer&doi=10.1158%2F0008-5472.CAN-14-3569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer</span></div><div class="casAuthors">Turcotte, Martin; Spring, Kathleen; Pommey, Sandra; Chouinard, Guillaume; Cousineau, Isabelle; George, Joshy; Chen, Gregory M.; Gendoo, Deena M. A.; Haibe-Kains, Benjamin; Karn, Thomas; Rahimi, Kurosh; Le Page, Cecile; Provencher, Diane; Mes-Masson, Anne-Marie; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4494-4503</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The cell surface nucleotidase CD73 is an immunosuppressive enzyme involved in tumor progression and metastasis.  Although preclin. studies suggest that CD73 can be targeted for cancer treatment, the clin. impact of CD73 in ovarian cancer remains unclear.  In this study, we investigated the prognostic value of CD73 in high-grade serous (HGS) ovarian cancer using gene and protein expression analyses.  Our results demonstrate that high levels of CD73 are significantly assocd. with shorter disease-free survival and overall survival in patients with HGS ovarian cancer.  Furthermore, high levels of CD73 expression in ovarian tumor cells abolished the good prognosis assocd. with intraepithelial CD8+ cells.  Notably, CD73 gene expression was highest in the C1/stromal mol. subtype of HGS ovarian cancer and pos. correlated with an epithelial-to-mesenchymal transition gene signature.  Moreover, in vitro studies revealed that CD73 and extracellular adenosine enhance ovarian tumor cell growth as well as expression of antiapoptotic BCL-2 family members.  Finally, in vivo coinjection of ID8 mouse ovarian tumor cells with mouse embryonic fibroblasts showed that CD73 expression in fibroblasts promotes tumor immune escape and thereby tumor growth.  In conclusion, our study highlights a role for CD73 as a prognostic marker of patient survival and also as a candidate therapeutic target in HGS ovarian cancers.  Cancer Res; 75(21); 4494-503. 2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0cI-iFGChprVg90H21EOLACvtfcHk0lhECv0Yg76_wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGnu7vF&md5=168775cf106084e44de08a6f6a302255</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3569%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DK.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DChouinard%26aufirst%3DG.%26aulast%3DCousineau%26aufirst%3DI.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%2BM.%26aulast%3DGendoo%26aufirst%3DD.%2BM.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DKarn%26aufirst%3DT.%26aulast%3DRahimi%26aufirst%3DK.%26aulast%3DLe%2BPage%26aufirst%3DC.%26aulast%3DProvencher%26aufirst%3DD.%26aulast%3DMes-Masson%26aufirst%3DA.%2BM.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Is%2520associated%2520with%2520poor%2520prognosis%2520in%2520high-grade%2520serous%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D4494%26epage%3D4503%26doi%3D10.1158%2F0008-5472.CAN-14-3569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, L.</span></span> <span> </span><span class="NLM_article-title">Overexpression of CD73 in prostate cancer is associated with lymph node metastasis</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">811</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1007/s12253-013-9648-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs12253-013-9648-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23653114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=811-814&author=Q.+Yangauthor=J.+Duauthor=L.+Zu&title=Overexpression+of+CD73+in+prostate+cancer+is+associated+with+lymph+node+metastasis&doi=10.1007%2Fs12253-013-9648-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis</span></div><div class="casAuthors">Yang, Qing; Du, Jun; Zu, Lingling</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">811-814</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Prostate cancer is the most common malignancy in men in Europe and North America.  At present, it is becoming an increasingly common cancer in China.  CD73 (ecto-5'-nucleotidase) is a glycosylphosphatidylinositol (GPI)-linked 70-kDa cell surface enzyme.  It is also broadly expressed in many types of tissues.  Recent studies have showed that CD73 is widely expressed on malignancies and is up-regulated in cancerous tissues.  Consequently, we analyzed the expression of CD73 in prostate cancer tissue.  The expression of the CD73 protein was evaluated by Immunohistochem. staining in 116 tissue specimens.  The expression was further examd. by quant. real-time PCR (qRT-PCR) and Western blot in the same set of patients.  The intense cell membrane staining for the CD73 protein was obsd.  The expression of CD73 in lymph node non-metastasizing prostate cancer tissues can be seen at low levels, and is generally undetectable.  RT-PCR and Western blot showed that the expression of CD73 in lymph node metastasizing prostate cancer was higher compared with non-metastasizing ones.  These results suggest that CD73 could be considered as a relevant-specific target for mol. therapy of prostate cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFnnKE3rlInrVg90H21EOLACvtfcHk0limjmUwfOtyvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrnP&md5=d756e344be0932523aefdf2cc21e6836</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs12253-013-9648-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-013-9648-7%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DZu%26aufirst%3DL.%26atitle%3DOverexpression%2520of%2520CD73%2520in%2520prostate%2520cancer%2520is%2520associated%2520with%2520lymph%2520node%2520metastasis%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D811%26epage%3D814%26doi%3D10.1007%2Fs12253-013-9648-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlebois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Expression is an independent prognostic factor in prostate cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-1181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F1078-0432.CCR-15-1181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=26253870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=158-166&author=B.+G.+Leclercauthor=R.+Charleboisauthor=G.+Chouinardauthor=B.+Allardauthor=S.+Pommeyauthor=F.+Saadauthor=J.+Stagg&title=CD73+Expression+is+an+independent+prognostic+factor+in+prostate+cancer&doi=10.1158%2F1078-0432.CCR-15-1181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer</span></div><div class="casAuthors">Leclerc, Bruno G.; Charlebois, Roxanne; Chouinard, Guillaume; Allard, Bertrand; Pommey, Sandra; Saad, Fred; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">158-166</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: CD73 is an adenosine-generating ecto-enzyme that suppresses antitumor immunity in mouse models of cancer, including prostate cancer.  Although high levels of CD73 are assocd. with poor prognosis in various types of cancer, the clin. impact of CD73 in prostate cancer remains unclear.  Exptl. Design: We evaluated the prognostic value of CD73 protein expression and CD8+ cell d. in 285 cases of prostate cancer on tissue microarray (TMA).  Normal adjacent and tumor tissues were evaluated in duplicates.  Results: Univariate and multivariate analyses revealed that high levels of CD73 in normal adjacent prostate epithelium were significantly assocd. with shorter biochem. recurrence (BCR)-free survival.  Notably, CD73 expression in normal epithelium conferred a neg. prognostic value to prostate-infiltrating CD8+ cells.  Surprisingly, high levels of CD73 in the tumor stroma were assocd. with longer BCR-free survival in univariate anal.  In vitro studies revealed that adenosine signaling inhibited NF-κB activity in human prostate cancer cells via A2B adenosine receptors.  Consistent with these results, CD73 expression in the prostate tumor stroma neg. correlated with p65 expression in the nuclei of prostate tumor cells.  Conclusions: Our study revealed that CD73 is an independent prognostic factor in prostate cancer.  Our data support a model in which CD73 expression in the prostate epithelium suppresses immunosurveillance by CD8+ T cells, whereas CD73 expression in the tumor stroma reduces NF-κB signaling in tumor cells via A2B adenosine receptor signaling.  CD73 expression, including in normal adjacent prostate epithelium, can thus effectively discriminate between aggressive and indolent forms of prostate cancer.  Clin Cancer Res; 22(1); 158-66. 2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9HCI_kLOGLVg90H21EOLACvtfcHk0limjmUwfOtyvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGqsrk%253D&md5=f775efcc9f67005fcc4d0696399ab79f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-1181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-1181%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DB.%2BG.%26aulast%3DCharlebois%26aufirst%3DR.%26aulast%3DChouinard%26aufirst%3DG.%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Expression%2520is%2520an%2520independent%2520prognostic%2520factor%2520in%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D158%26epage%3D166%26doi%3D10.1158%2F1078-0432.CCR-15-1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Promotes anthracycline resistance and poor prognosis in triple negative breast cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">11091</span>– <span class="NLM_lpage">11096</span>, <span class="refDoi"> DOI: 10.1073/pnas.1222251110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1073%2Fpnas.1222251110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23776241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=11091-11096&author=S.+Loiauthor=S.+Pommeyauthor=B.+Haibe-Kainsauthor=P.+A.+Beavisauthor=P.+K.+Darcyauthor=M.+J.+Smythauthor=J.+Stagg&title=CD73+Promotes+anthracycline+resistance+and+poor+prognosis+in+triple+negative+breast+cancer&doi=10.1073%2Fpnas.1222251110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer</span></div><div class="casAuthors">Loi, Sherene; Pommey, Sandra; Haibe-Kains, Benjamin; Beavis, Paul A.; Darcy, Phillip K.; Smyth, Mark J.; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">11091-11096,S11091/1-S11091/21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using gene-expression data from over 6,000 breast cancer patients, we report herein that high CD73 expression is assocd. with a poor prognosis in triple-neg. breast cancers (TNBC).  Because anthracycline-based chemotherapy regimens are std. treatment for TNBC, we investigated the relationship between CD73 and anthracycline efficacy.  In TNBC patients treated with anthracycline-only preoperative chemotherapy, high CD73 gene expression was significantly assocd. with a lower rate of pathol. complete response or the disappearance of invasive tumor at surgery.  Using mouse models of breast cancer, we demonstrated that CD73 overexpression in tumor cells conferred chemoresistance to doxorubicin, a commonly used anthracycline, by suppressing adaptive antitumor immune responses via activation of A2A adenosine receptors.  Targeted blockade of CD73 enhanced doxorubicin-mediated antitumor immune responses and significantly prolonged the survival of mice with established metastatic breast cancer.  Taken together, our data suggest that CD73 constitutes a therapeutic target in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6KtLUgWgbYbVg90H21EOLACvtfcHk0lj1-ojJ4BkFvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLrO&md5=97b58f664273accfcab7096dcbc76db6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1222251110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1222251110%26sid%3Dliteratum%253Aachs%26aulast%3DLoi%26aufirst%3DS.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DBeavis%26aufirst%3DP.%2BA.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Promotes%2520anthracycline%2520resistance%2520and%2520poor%2520prognosis%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D11091%26epage%3D11096%26doi%3D10.1073%2Fpnas.1222251110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quezada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzún, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobrevia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Martín, R.</span></span> <span> </span><span class="NLM_article-title">5′-Ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1002/jcp.24168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fjcp.24168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22833450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKht7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2013&pages=602-608&author=C.+Quezadaauthor=W.+Garridoauthor=C.+Oyarz%C3%BAnauthor=K.+Fern%C3%A1ndezauthor=R.+Seguraauthor=R.+Meloauthor=P.+Casanelloauthor=L.+Sobreviaauthor=R.+San+Mart%C3%ADn&title=5%E2%80%B2-Ectonucleotidase+mediates+multiple-drug+resistance+in+glioblastoma+multiforme+cells&doi=10.1002%2Fjcp.24168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells</span></div><div class="casAuthors">Quezada, Claudia; Garrido, Wallys; Oyarzun, Carlos; Fernandez, Katia; Segura, Rodrigo; Melo, Romulo; Casanello, Paola; Sobrevia, Luis; San Martin, Rody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">602-608</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) cells are characterised by their extreme chemoresistance.  The activity of multiple-drug resistance (MDR) transporters that extrude antitumor drugs from cells plays the most important role in this phenomenon.  To date, the mechanism controlling the expression and activity of MDR transporters is poorly understood.  Activity of the enzyme ecto-5'-nucleotidase (CD73) in tumor cells, which hydrolyzes AMP to adenosine, has been linked to immunosuppression and prometastatic effects in breast cancer and to the proliferation of glioma cells.  In this study, we identify a high expression of CD73 in surgically resected samples of human GBM.  In primary cultures of GBM, inhibition of CD73 activity or knocking down its expression by siRNA reversed the MDR phenotype and cell viability was decreased up to 60% on exposure to the antitumoral drug vincristine.  This GBM chemosensitization was caused by a decrease in the expression and activity of the multiple drug assocd. protein 1 (Mrp1), the most important transporter conferring multiple drug resistance in these cells.  Using pharmacol. modulators, we have recognized the adenosine A3 receptor subtype in mediation of the chemoresistant phenotype in these cells.  In conclusion, we have detd. that the activity of CD73 to trigger adenosine signaling sustains chemoresistant phenotype in GBM cells.  J. Cell. Physiol. 228: 602-608, 2013. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsE28rS1xXqrVg90H21EOLACvtfcHk0lj1ngvW1-h-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKht7vM&md5=fc3af89ece5197ad661f5eb50a6bd667</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjcp.24168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.24168%26sid%3Dliteratum%253Aachs%26aulast%3DQuezada%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DW.%26aulast%3DOyarz%25C3%25BAn%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DK.%26aulast%3DSegura%26aufirst%3DR.%26aulast%3DMelo%26aufirst%3DR.%26aulast%3DCasanello%26aufirst%3DP.%26aulast%3DSobrevia%26aufirst%3DL.%26aulast%3DSan%2BMart%25C3%25ADn%26aufirst%3DR.%26atitle%3D5%25E2%2580%25B2-Ectonucleotidase%2520mediates%2520multiple-drug%2520resistance%2520in%2520glioblastoma%2520multiforme%2520cells%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2013%26volume%3D228%26spage%3D602%26epage%3D608%26doi%3D10.1002%2Fjcp.24168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bareche, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisseret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">José, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delisle, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensuu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellokumpu-Lehtinen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotiriou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Promotes resistance to HER2/ErbB2 antibody therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">5652</span>– <span class="NLM_lpage">5663</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-17-0707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-17-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=28855210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CqtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=5652-5663&author=M.+Turcotteauthor=D.+Allardauthor=D.+Mittalauthor=Y.+Barecheauthor=L.+Buisseretauthor=V.+Jos%C3%A9author=S.+Pommeyauthor=V.+Delisleauthor=S.+Loiauthor=H.+Joensuuauthor=P.+L.+Kellokumpu-Lehtinenauthor=C.+Sotiriouauthor=M.+J.+Smythauthor=J.+Stagg&title=CD73+Promotes+resistance+to+HER2%2FErbB2+antibody+therapy&doi=10.1158%2F0008-5472.CAN-17-0707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy</span></div><div class="casAuthors">Turcotte, Martin; Allard, David; Mittal, Deepak; Bareche, Yacine; Buisseret, Laurence; Jose, Vinu; Pommey, Sandra; Delisle, Vincent; Loi, Sherene; Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Sotiriou, Christos; Smyth, Mark J.; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5652-5663</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of the ectonucleotidase CD73 by tumor cells, stromal cells, and immune cells is assocd. in cancer with immune suppression.  In this study, we investigated the role of CD73 on the activity of the anti-HER2/ErbB2 monoclonal antibody (mAb) trastuzumab.  In a prospective, randomized phase III clin. trial evaluating the activity of trastuzumab, high levels of CD73 gene expression were assocd. significantly with poor clin. outcome.  In contrast, high levels of PD-1 and PD-L1 were assocd. with improved clin. outcome.  In immunocompetent mouse models of HER2/ErbB2-driven breast cancer, CD73 expression by tumor cells and host cells significantly suppressed immune-mediated responses mediated by anti-ErbB2 mAb.  Furthermore, anti-CD73 mAb therapy enhanced the activity of anti-ErbB2 mAb to treat engrafted or spontaneous tumors as well as lung metastases.  Gene ontol. enrichment anal. from gene-expression data revealed a pos. assocn. of CD73 expression with extracellular matrix organization, TGFβ genes, epithelial-to-mesenchymal transition (EMT) transcription factors and hypoxia-inducible-factor (HIF)-1 gene signature.  Human mammary cells treated with TGFβ or undergoing EMT upregulated CD73 cell-surface expression, confirming roles for these pathways.  In conclusion, our findings establish CD73 in mediating resistance to trastuzumab and provide new insights into how CD73 is regulated in breast cancer.  Cancer Res; 77(20); 5652-63. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSI2kxEAJ5cbVg90H21EOLACvtfcHk0lj1ngvW1-h-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CqtLnM&md5=a71749b68bb6fd0bf6c7fd79410323b4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-0707%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DM.%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DMittal%26aufirst%3DD.%26aulast%3DBareche%26aufirst%3DY.%26aulast%3DBuisseret%26aufirst%3DL.%26aulast%3DJos%25C3%25A9%26aufirst%3DV.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DDelisle%26aufirst%3DV.%26aulast%3DLoi%26aufirst%3DS.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DKellokumpu-Lehtinen%26aufirst%3DP.%2BL.%26aulast%3DSotiriou%26aufirst%3DC.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Promotes%2520resistance%2520to%2520HER2%252FErbB2%2520antibody%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D5652%26epage%3D5663%26doi%3D10.1158%2F0008-5472.CAN-17-0707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horenstein, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillemi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccarello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruzzone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarona, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malavasi, F.</span></span> <span> </span><span class="NLM_article-title">A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes</span>. <i>OncoImmunology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e26246</span>, <span class="refDoi"> DOI: 10.4161/onci.26246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.4161%2Fonci.26246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24319640" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e26246&author=A.+L.+Horensteinauthor=A.+Chillemiauthor=G.+Zaccarelloauthor=S.+Bruzzoneauthor=V.+Quaronaauthor=A.+Zitoauthor=S.+Serraauthor=F.+Malavasi&title=A+CD38%2FCD203a%2FCD73+ectoenzymatic+pathway+independent+of+CD39+drives+a+novel+adenosinergic+loop+in+human+T+lymphocytes&doi=10.4161%2Fonci.26246"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fonci.26246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fonci.26246%26sid%3Dliteratum%253Aachs%26aulast%3DHorenstein%26aufirst%3DA.%2BL.%26aulast%3DChillemi%26aufirst%3DA.%26aulast%3DZaccarello%26aufirst%3DG.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DQuarona%26aufirst%3DV.%26aulast%3DZito%26aufirst%3DA.%26aulast%3DSerra%26aufirst%3DS.%26aulast%3DMalavasi%26aufirst%3DF.%26atitle%3DA%2520CD38%252FCD203a%252FCD73%2520ectoenzymatic%2520pathway%2520independent%2520of%2520CD39%2520drives%2520a%2520novel%2520adenosinergic%2520loop%2520in%2520human%2520T%2520lymphocytes%26jtitle%3DOncoImmunology%26date%3D2013%26volume%3D2%26spage%3De26246%26doi%3D10.4161%2Fonci.26246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regairaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déjou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustiniani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheurte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprevotte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funck-Brentano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larroque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberici, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensussan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliaou, J.-F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-14-0018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F2326-6066.CIR-14-0018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25403716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=254-265&author=J.+Bastidauthor=A.+Regairazauthor=N.+Bonnefoyauthor=C.+D%C3%A9jouauthor=J.+Giustinianiauthor=C.+Laheurteauthor=S.+Cochaudauthor=E.+Laprevotteauthor=E.+Funck-Brentanoauthor=P.+Hemonauthor=L.+Grosauthor=N.+Becauthor=C.+Larroqueauthor=G.+Albericiauthor=A.+Bensussanauthor=J.-F.+Eliaou&title=Inhibition+of+CD39+enzymatic+function+at+the+surface+of+tumor+cells+alleviates+their+immunosuppressive+activity&doi=10.1158%2F2326-6066.CIR-14-0018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity</span></div><div class="casAuthors">Bastid, Jeremy; Regairaz, Anne; Bonnefoy, Nathalie; Dejou, Cecile; Giustiniani, Jerome; Laheurte, Caroline; Cochaud, Stephanie; Laprevotte, Emilie; Funck-Brentano, Elisa; Hemon, Patrice; Gros, Laurent; Bec, Nicole; Larroque, Christian; Alberici, Gilles; Bensussan, Armand; Eliaou, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">254-265</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bastid and colleagues show that CD39 is highly expressed on tumor-infiltrating lymphocytes, tumor stroma, but also on tumor cells; treatment with CD39 inhibitors or blocking antibody alleviated the tumor-induced inhibition of T-cell proliferation and increased CTL- and NK cell-mediated cytotoxicity.  The ectonucleotidases CD39 and CD73 hydrolyze extracellular ATP and ADP to generate adenosine, which binds to adenosine receptors and inhibits T-cell and natural killer (NK)-cell responses, thereby suppressing the immune system.  The generation of adenosine via the CD39/CD73 pathway is recognized as a major mechanism of regulatory T cell (Treg) immunosuppressive function.  The no. of CD39+ Tregs is increased in some human cancers, and the importance of CD39+ Tregs in promoting tumor growth and metastasis has been demonstrated using several in vivo models.  Here, we addressed whether CD39 is expressed by tumor cells and whether CD39+ tumor cells mediate immunosuppression via the adenosine pathway.  Immunohistochem. staining of normal and tumor tissues revealed that CD39 expression is significantly higher in several types of human cancer than in normal tissues.  In cancer specimens, CD39 is expressed by infiltrating lymphocytes, the tumor stroma, and tumor cells.  Furthermore, the expression of CD39 at the cell surface of tumor cells was directly demonstrated via flow cytometry of human cancer cell lines.  CD39 in cancer cells displays ATPase activity and, together with CD73, generates adenosine.  CD39+CD73+ cancer cells inhibited the proliferation of CD4 and CD8 T cells and the generation of cytotoxic effector CD8 T cells (CTL) in a CD39- and adenosine-dependent manner.  Treatment with a CD39 inhibitor or blocking antibody alleviated the tumor-induced inhibition of CD4 and CD8 T-cell proliferation and increased CTL- and NK cell-mediated cytotoxicity.  In conclusion, interfering with the CD39-adenosine pathway may represent a novel immunotherapeutic strategy for inhibiting tumor cell-mediated immunosuppression.  Cancer Immunol Res; 3(3); 254-65. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0DdZv0TAlbVg90H21EOLACvtfcHk0ljKM6gBpXryCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFemsrw%253D&md5=a1bf760865ce195d078895fe611b992a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-14-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-14-0018%26sid%3Dliteratum%253Aachs%26aulast%3DBastid%26aufirst%3DJ.%26aulast%3DRegairaz%26aufirst%3DA.%26aulast%3DBonnefoy%26aufirst%3DN.%26aulast%3DD%25C3%25A9jou%26aufirst%3DC.%26aulast%3DGiustiniani%26aufirst%3DJ.%26aulast%3DLaheurte%26aufirst%3DC.%26aulast%3DCochaud%26aufirst%3DS.%26aulast%3DLaprevotte%26aufirst%3DE.%26aulast%3DFunck-Brentano%26aufirst%3DE.%26aulast%3DHemon%26aufirst%3DP.%26aulast%3DGros%26aufirst%3DL.%26aulast%3DBec%26aufirst%3DN.%26aulast%3DLarroque%26aufirst%3DC.%26aulast%3DAlberici%26aufirst%3DG.%26aulast%3DBensussan%26aufirst%3DA.%26aulast%3DEliaou%26aufirst%3DJ.-F.%26atitle%3DInhibition%2520of%2520CD39%2520enzymatic%2520function%2520at%2520the%2520surface%2520of%2520tumor%2520cells%2520alleviates%2520their%2520immunosuppressive%2520activity%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2015%26volume%3D3%26spage%3D254%26epage%3D265%26doi%3D10.1158%2F2326-6066.CIR-14-0018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachsenmeier, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dall’Acqua, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damschroder, M. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action</span>. <i>MABs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1080/19420862.2016.1143182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1080%2F19420862.2016.1143182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=26854859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=454-467&author=J.+C.+Geogheganauthor=G.+Diedrichauthor=X.+Luauthor=K.+Rosenthalauthor=K.+F.+Sachsenmeierauthor=H.+Wuauthor=W.+F.+Dall%E2%80%99Acquaauthor=M.+M.+Damschroder&title=Inhibition+of+CD73+AMP+hydrolysis+by+a+therapeutic+antibody+with+a+dual%2C+non-competitive+mechanism+of+action&doi=10.1080%2F19420862.2016.1143182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action</span></div><div class="casAuthors">Geoghegan, James C.; Diedrich, Gundo; Lu, Xiaojun; Rosenthal, Kim; Sachsenmeier, Kris F.; Wu, Herren; Dall'Acqua, William F.; Damschroder, Melissa M.</div><div class="citationInfo"><span class="NLM_cas:title">mAbs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">454-467</span>CODEN:
                <span class="NLM_cas:coden">MABSCP</span>;
        ISSN:<span class="NLM_cas:issn">1942-0870</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">CD73 (ecto-5'-nucleotidase) has recently been established as a promising immuno-oncol. target.  Given its role in activating purinergic signaling pathways to elicit immune suppression, antagonizing CD73 (i.e., releasing the brake) offers a complimentary pathway to inducing anti-tumor immune responses.  Here, we describe the mechanistic activity of a new clin. therapeutic, MEDI9447, a human monoclonal antibody that non-competitively inhibits CD73 activity.  Epitope mapping, structural, and mechanistic studies revealed that MEDI9447 antagonizes CD73 through dual mechanisms of inter-CD73 dimer crosslinking and/or steric blocking that prevent CD73 from adopting a catalytically active conformation.  To our knowledge, this is the first report of an antibody that inhibits an enzyme's function through 2 distinct modes of action.  These results provide a finely mapped epitope that can be targeted for selective, potent, and non-competitive inhibition of CD73, as well as establish a strategy for inhibiting enzymes that function in both membrane-bound and sol. states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgPbLcUfy-FbVg90H21EOLACvtfcHk0ljKM6gBpXryCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVWmt7o%253D&md5=5a7d1f227f282dfe3106a7438d279b50</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F19420862.2016.1143182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F19420862.2016.1143182%26sid%3Dliteratum%253Aachs%26aulast%3DGeoghegan%26aufirst%3DJ.%2BC.%26aulast%3DDiedrich%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DRosenthal%26aufirst%3DK.%26aulast%3DSachsenmeier%26aufirst%3DK.%2BF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DDall%25E2%2580%2599Acqua%26aufirst%3DW.%2BF.%26aulast%3DDamschroder%26aufirst%3DM.%2BM.%26atitle%3DInhibition%2520of%2520CD73%2520AMP%2520hydrolysis%2520by%2520a%2520therapeutic%2520antibody%2520with%2520a%2520dual%252C%2520non-competitive%2520mechanism%2520of%2520action%26jtitle%3DMABs%26date%3D2016%26volume%3D8%26spage%3D454%26epage%3D467%26doi%3D10.1080%2F19420862.2016.1143182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnhart, B. C.</span>; <span class="NLM_string-name">Sega, E.</span>; <span class="NLM_string-name">Yamniuk, A.</span>; <span class="NLM_string-name">Hatcher, S.</span>; <span class="NLM_string-name">Lei, M.</span>; <span class="NLM_string-name">Ghermazien, H.</span>; <span class="NLM_string-name">Lewin, A.</span>; <span class="NLM_string-name">Wang, X.-T.</span>; <span class="NLM_string-name">Huang, H.</span>; <span class="NLM_string-name">Zhang, P.</span>; <span class="NLM_string-name">Korman, A.</span></span> <span> </span><span class="NLM_article-title">A Therapeutic Antibody that Inhibits CD73 Activity by Dual Mechanisms</span>.  <i>Proceedings</i>, 107th Annual Meeting of the AACR, New Orleans, LA, Apr 16–20, 2016; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+C.+Barnhart&author=E.+Sega&author=A.+Yamniuk&author=S.+Hatcher&author=M.+Lei&author=H.+Ghermazien&author=A.+Lewin&author=X.-T.+Wang&author=H.+Huang&author=P.+Zhang&author=A.+Korman&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBarnhart%26aufirst%3DB.%2BC.%26atitle%3DA%2520Therapeutic%2520Antibody%2520that%2520Inhibits%2520CD73%2520Activity%2520by%2520Dual%2520Mechanisms%26btitle%3DProceedings%26pub%3DAACR%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, L. L.</span>; <span class="NLM_string-name">Burris, H.</span>; <span class="NLM_string-name">Le, D. T.</span>; <span class="NLM_string-name">Hollebecque, A.</span>; <span class="NLM_string-name">Steeghs, N.</span>; <span class="NLM_string-name">Delord, J.-P.</span>; <span class="NLM_string-name">Hilton, J.</span>; <span class="NLM_string-name">Barnhart, B.</span>; <span class="NLM_string-name">Sega, E.</span>; <span class="NLM_string-name">Sanghavi, K.</span>; <span class="NLM_string-name">Klippel, A.</span>; <span class="NLM_string-name">Hedvat, C.</span>; <span class="NLM_string-name">Hilt, E.</span>; <span class="NLM_string-name">Donovan, M.</span>; <span class="NLM_string-name">Gipson, A.</span>; <span class="NLM_string-name">Basciano, P.</span>; <span class="NLM_string-name">Postelnek, J.</span>; <span class="NLM_string-name">Zhao, Y.</span>; <span class="NLM_string-name">Perez, R. P.</span>; <span class="NLM_string-name">Carvajal, R. D.</span></span> <span> </span><span class="NLM_article-title">Preliminary Phase 1 Profile of BMS-986179, an Anti-CD73 Antibody, in Combination with Nivolumab in Patients with Advanced Solid Tumors</span>.  <i>Proceedings</i>, AACR Annual Meeting; Chicago, IL, Apr 14–18, 2018; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+L.+Siu&author=H.+Burris&author=D.+T.+Le&author=A.+Hollebecque&author=N.+Steeghs&author=J.-P.+Delord&author=J.+Hilton&author=B.+Barnhart&author=E.+Sega&author=K.+Sanghavi&author=A.+Klippel&author=C.+Hedvat&author=E.+Hilt&author=M.+Donovan&author=A.+Gipson&author=P.+Basciano&author=J.+Postelnek&author=Y.+Zhao&author=R.+P.+Perez&author=R.+D.+Carvajal&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DL.%2BL.%26atitle%3DPreliminary%2520Phase%25201%2520Profile%2520of%2520BMS-986179%252C%2520an%2520Anti-CD73%2520Antibody%252C%2520in%2520Combination%2520with%2520Nivolumab%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumors%26btitle%3DProceedings%26pub%3DAACR%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickler, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasanna, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemunaitis, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Byrne, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. D.</span></span> <span> </span><span class="NLM_article-title">Safety, Efficacy and Pharmacodynamics (PD) of MEDI9447 (Oleclumab) Alone or in Combination with Durvalumab in Advanced Colorectal Cancer (CRC) or Pancreatic Cancer (Panc)</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">15, Suppl.</span>),  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4123</span>, <span class="refDoi"> DOI: 10.1200/JCO.2018.36.15_suppl.4123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1200%2FJCO.2018.36.15_suppl.4123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=4123-4123&issue=15%2C+Suppl.&author=M.+J.+Overmanauthor=P.+LoRussoauthor=J.+H.+Stricklerauthor=S.+P.+Patelauthor=S.+J.+Clarkeauthor=A.+M.+Noonanauthor=T.+Prasannaauthor=M.+A.+Aminauthor=J.+J.+Nemunaitisauthor=J.+Desaiauthor=K.+J.+O%E2%80%99Byrneauthor=T.+J.+Georgeauthor=J.+Englertauthor=D.+Sheauthor=Z.+A.+Cooperauthor=Y.+Wuauthor=A.+Khanauthor=R.+Kumarauthor=J.+D.+Bendell&title=Safety%2C+Efficacy+and+Pharmacodynamics+%28PD%29+of+MEDI9447+%28Oleclumab%29+Alone+or+in+Combination+with+Durvalumab+in+Advanced+Colorectal+Cancer+%28CRC%29+or+Pancreatic+Cancer+%28Panc%29&doi=10.1200%2FJCO.2018.36.15_suppl.4123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1200%2FJCO.2018.36.15_suppl.4123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2018.36.15_suppl.4123%26sid%3Dliteratum%253Aachs%26aulast%3DOverman%26aufirst%3DM.%2BJ.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DStrickler%26aufirst%3DJ.%2BH.%26aulast%3DPatel%26aufirst%3DS.%2BP.%26aulast%3DClarke%26aufirst%3DS.%2BJ.%26aulast%3DNoonan%26aufirst%3DA.%2BM.%26aulast%3DPrasanna%26aufirst%3DT.%26aulast%3DAmin%26aufirst%3DM.%2BA.%26aulast%3DNemunaitis%26aufirst%3DJ.%2BJ.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Byrne%26aufirst%3DK.%2BJ.%26aulast%3DGeorge%26aufirst%3DT.%2BJ.%26aulast%3DEnglert%26aufirst%3DJ.%26aulast%3DShe%26aufirst%3DD.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DBendell%26aufirst%3DJ.%2BD.%26atitle%3DSafety%252C%2520Efficacy%2520and%2520Pharmacodynamics%2520%2528PD%2529%2520of%2520MEDI9447%2520%2528Oleclumab%2529%2520Alone%2520or%2520in%2520Combination%2520with%2520Durvalumab%2520in%2520Advanced%2520Colorectal%2520Cancer%2520%2528CRC%2529%2520or%2520Pancreatic%2520Cancer%2520%2528Panc%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D36%26issue%3D15%252C%2520Suppl%26spage%3D4123%26epage%3D4123%26doi%3D10.1200%2FJCO.2018.36.15_suppl.4123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piccione, E. C.</span>; <span class="NLM_string-name">Mikesell, G.</span>; <span class="NLM_string-name">Daine-Matsuoka, B.</span>; <span class="NLM_string-name">Walter, K.</span>; <span class="NLM_string-name">Miller, R.</span>; <span class="NLM_string-name">McCaffery, I.</span></span> <span> </span><span class="NLM_article-title">A Novel CD73-Blocking Antibody Reduces Production of Immunosuppressive Adenosine and Restores T Cell Function</span>.  <i>Proceedings</i>, AACR Annual Meeting, Washington, DC, Apr 1–5, 2017; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2017</span>; <span class="refDoi"> DOI: 10.1158/1538-7445.AM2017-5577</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F1538-7445.AM2017-5577" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=E.+C.+Piccione&author=G.+Mikesell&author=B.+Daine-Matsuoka&author=K.+Walter&author=R.+Miller&author=I.+McCaffery&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2017-5577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1158%252F1538-7445.AM2017-5577%26sid%3Dliteratum%253Aachs%26aulast%3DPiccione%26aufirst%3DE.%2BC.%26atitle%3DA%2520Novel%2520CD73-Blocking%2520Antibody%2520Reduces%2520Production%2520of%2520Immunosuppressive%2520Adenosine%2520and%2520Restores%2520T%2520Cell%2520Function%26btitle%3DProceedings%26pub%3DAACR%26date%3D2017%26doi%3D10.1158%2F1538-7445.AM2017-5577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span>Surface
Oncology, Inc. <a href="https://investors.surfaceoncology.com/news-releases/news-release-details/surface-oncology-announces-initiation-phase-i-clinical-trial" class="extLink">https://investors.surfaceoncology.com/news-releases/news-release-details/surface-oncology-announces-initiation-phase-i-clinical-trial</a> (accessed Jun 1, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Surface%0AOncology%2C+Inc.+https%3A%2F%2Finvestors.surfaceoncology.com%2Fnews-releases%2Fnews-release-details%2Fsurface-oncology-announces-initiation-phase-i-clinical-trial+%28accessed+Jun+1%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span> </span><span class="NLM_article-title">Study
of TJ004309 in Combination with Atezolizumab (Tecentriq®)
in Patients with Advanced or Metastatic Cancer</span>. Last
updated Mar 2, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT03835949" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03835949</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+TJ004309+in+Combination+with+Atezolizumab+%28Tecentriq%C2%AE%29%0Ain+Patients+with+Advanced+or+Metastatic+Cancer.+Last%0Aupdated+Mar+2%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03835949+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%250Aof%2520TJ004309%2520in%2520Combination%2520with%2520Atezolizumab%2520%2528Tecentriq%25C2%25AE%2529%250Ain%2520Patients%2520with%2520Advanced%2520or%2520Metastatic%2520Cancer%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span> </span><span class="NLM_article-title">A Phase
I/II Study of TJ004309 for Advanced Solid Tumor</span>. Last
updated May 21, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04322006" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04322006</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase%0AI%2FII+Study+of+TJ004309+for+Advanced+Solid+Tumor.+Last%0Aupdated+May+21%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04322006+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%250AI%252FII%2520Study%2520of%2520TJ004309%2520for%2520Advanced%2520Solid%2520Tumor%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span> </span><span class="NLM_article-title">Study
of GS-1423 in Participants with Advanced Solid Tumors</span>. Last updated Apr 7, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT03954704" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03954704</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+GS-1423+in+Participants+with+Advanced+Solid+Tumors.+Last+updated+Apr+7%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03954704+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%250Aof%2520GS-1423%2520in%2520Participants%2520with%2520Advanced%2520Solid%2520Tumors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, N. S.</span>; <span class="NLM_string-name">Waight, J. D.</span>; <span class="NLM_string-name">Jennings, S. M.</span>; <span class="NLM_string-name">Ignatovich, O.</span>; <span class="NLM_string-name">Briend, E. C. P.</span>; <span class="NLM_string-name">Morin, B. M.</span>; <span class="NLM_string-name">Schon, O.</span>; <span class="NLM_string-name">Campbell, S.</span></span> <span> </span><span class="NLM_article-title">Anti-CD73 Antibodies and Methods of Use Thereof</span>. U.S. Patent Appl. <span class="NLM_patent">US20190352418 A1</span>, Nov 21, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=N.+S.+Wilson&author=J.+D.+Waight&author=S.+M.+Jennings&author=O.+Ignatovich&author=E.+C.+P.+Briend&author=B.+M.+Morin&author=O.+Schon&author=S.+Campbell&title=Anti-CD73+Antibodies+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DN.%2BS.%26atitle%3DAnti-CD73%2520Antibodies%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, A. G.</span>; <span class="NLM_string-name">Kovalenko, M.</span>; <span class="NLM_string-name">Welch, M.</span>; <span class="NLM_string-name">dela Cruz, T.</span>; <span class="NLM_string-name">Jones, J.</span>; <span class="NLM_string-name">Wong, C.</span>; <span class="NLM_string-name">Spatola, B.</span>; <span class="NLM_string-name">Eberhardt, M.</span>; <span class="NLM_string-name">Wong, A.</span>; <span class="NLM_string-name">Fung, W.</span>; <span class="NLM_string-name">Lagpacan, L.</span>; <span class="NLM_string-name">Losenkova, K.</span>; <span class="NLM_string-name">Yegutkin, G.</span>; <span class="NLM_string-name">Soros, V.</span>; <span class="NLM_string-name">Corbin, J.</span>; <span class="NLM_string-name">Beers, C.</span>; <span class="NLM_string-name">Moesta, A. L.</span></span> <span> </span><span class="NLM_article-title">Targeting CD39 with a First-in-Class Inhibitory Antibody Prevents ATP Processing and Increases T-Cell Activation</span>.  <i>Proceedings</i>, AACR Annual Meeting, Atlanta, GA, Mar 29–Apr 3, 2019; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=A.+G.+Lerner&author=M.+Kovalenko&author=M.+Welch&author=T.+dela+Cruz&author=J.+Jones&author=C.+Wong&author=B.+Spatola&author=M.+Eberhardt&author=A.+Wong&author=W.+Fung&author=L.+Lagpacan&author=K.+Losenkova&author=G.+Yegutkin&author=V.+Soros&author=J.+Corbin&author=C.+Beers&author=A.+L.+Moesta&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DA.%2BG.%26atitle%3DTargeting%2520CD39%2520with%2520a%2520First-in-Class%2520Inhibitory%2520Antibody%2520Prevents%2520ATP%2520Processing%2520and%2520Increases%2520T-Cell%2520Activation%26btitle%3DProceedings%26pub%3DAACR%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moesta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepletier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundarrajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacoberger-Foissac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dela Cruz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spatola, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soros, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Effern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bald, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Targeting CD39 in cancer reveals an extracellular ATP and inflammasome driven tumor immunity</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1754</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-0541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F2159-8290.CD-19-0541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31699796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Ght77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1754&author=X.-Y.+Liauthor=A.+K.+Moestaauthor=C.+Xiaoauthor=K.+Nakamuraauthor=M.+Caseyauthor=H.+Zhangauthor=J.+Madoreauthor=A.+Lepletierauthor=A.+R.+Aguileraauthor=A.+Sundarrajanauthor=C.+Jacoberger-Foissacauthor=C.+Wongauthor=T.+dela+Cruzauthor=M.+Welchauthor=A.+G.+Lernerauthor=B.+N.+Spatolaauthor=V.+B.+Sorosauthor=J.+Corbinauthor=A.+C.+Andersonauthor=M.+Effernauthor=M.+Holzelauthor=S.+C.+Robsonauthor=R.+L.+Johnstonauthor=N.+Waddellauthor=C.+Smithauthor=T.+Baldauthor=N.+Geethaauthor=C.+Beersauthor=M.+W.+L.+Tengauthor=M.+J.+Smyth&title=Targeting+CD39+in+cancer+reveals+an+extracellular+ATP+and+inflammasome+driven+tumor+immunity&doi=10.1158%2F2159-8290.CD-19-0541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity</span></div><div class="casAuthors">Li, Xian-Yang; Moesta, Achim K.; Xiao, Christos; Nakamura, Kyohei; Casey, Mika; Zhang, Haiyan; Madore, Jason; Lepletier, Ailin; Aguilera, Amelia Roman; Sundarrajan, Ashmitha; Jacoberger-Foissac, Celia; Wong, Clifford; dela Cruz, Tracy; Welch, Megan; Lerner, Alana G.; Spatola, Bradley N.; Soros, Vanessa B.; Corbin, John; Anderson, Ana C.; Effern, Maike; Hoelzel, Michael; Robson, Simon C.; Johnston, Rebecca L.; Waddell, Nicola; Smith, Corey; Bald, Tobias; Geetha, Nishamol; Beers, Courtney; Teng, Michele W. L.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1754-1773</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39 conversion of extracellular ATP (eATP) to AMP and thus potentially augment eATP-P2-mediated proinflammatory responses.  Using syngeneic and humanized tumor models, we contrast the potency and mechanism of anti-CD39 mAbs with other agents targeting the adenosinergic pathway.  We demonstrate the crit. importance of an eATP-P2X7-ASC-NALP3-inflammasome-IL18 pathway in the antitumor activity mediated by CD39 enzyme blockade, rather than simply reducing adenosine as mechanism of action.  Efficacy of anti-CD39 activity was underpinned by CD39 and P2X7 coexpression on intratumor myeloid subsets, an early signature of macrophage depletion, and active IL18 release that facilitated the significant expansion of intratumor effector T cells.  More importantly, anti-CD39 facilitated infiltration into T cell-poor tumors and rescued anti-PD-1 resistance.  Anti-human CD39 enhanced human T-cell proliferation and Th1 cytokine prodn. and suppressed human B-cell lymphoma in the context of autologous Epstein-Barr virus-specific T-cell transfer.  Significance: Overall, these data describe a potent and novel mechanism of action of antibodies that block mouse or human CD39, triggering an eATP-P2X7-inflammasome-IL18 axis that reduces intratumor macrophage no., enhances intratumor T-cell effector function, overcomes anti-PD-1 resistance, and potentially enhances the efficacy of adoptive T-cell transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFHRZC4MnGIbVg90H21EOLACvtfcHk0lgMqoNzbwqr2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Ght77K&md5=9441688a4079ec65c9c56efd6a9e6db2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-0541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-0541%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DMoesta%26aufirst%3DA.%2BK.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DCasey%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMadore%26aufirst%3DJ.%26aulast%3DLepletier%26aufirst%3DA.%26aulast%3DAguilera%26aufirst%3DA.%2BR.%26aulast%3DSundarrajan%26aufirst%3DA.%26aulast%3DJacoberger-Foissac%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DC.%26aulast%3Ddela%2BCruz%26aufirst%3DT.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DLerner%26aufirst%3DA.%2BG.%26aulast%3DSpatola%26aufirst%3DB.%2BN.%26aulast%3DSoros%26aufirst%3DV.%2BB.%26aulast%3DCorbin%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26aulast%3DEffern%26aufirst%3DM.%26aulast%3DHolzel%26aufirst%3DM.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DJohnston%26aufirst%3DR.%2BL.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DBald%26aufirst%3DT.%26aulast%3DGeetha%26aufirst%3DN.%26aulast%3DBeers%26aufirst%3DC.%26aulast%3DTeng%26aufirst%3DM.%2BW.%2BL.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DTargeting%2520CD39%2520in%2520cancer%2520reveals%2520an%2520extracellular%2520ATP%2520and%2520inflammasome%2520driven%2520tumor%2520immunity%26jtitle%3DCancer%2520Discovery%26date%3D2019%26volume%3D9%26spage%3D1754%26doi%3D10.1158%2F2159-8290.CD-19-0541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span> </span><span class="NLM_article-title">TTX-030 Single Agent and in Combination with Immunotherapy
or Chemotherapy
for Patients with Advanced Cancers</span>. Last updated May
11, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT03884556" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03884556</a> (accessed Jun
2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TTX-030+Single+Agent+and+in+Combination+with+Immunotherapy%0Aor+Chemotherapy%0Afor+Patients+with+Advanced+Cancers.+Last+updated+May%0A11%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03884556+%28accessed+Jun%0A2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DTTX-030%2520Single%2520Agent%2520and%2520in%2520Combination%2520with%2520Immunotherapy%250Aor%2520Chemotherapy%250Afor%2520Patients%2520with%2520Advanced%2520Cancers%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span> </span><span class="NLM_article-title">TTX-030 in Combination
With Immunotherapy and/or Chemotherapy in
Subjects With Advanced Cancers</span>. Last updated May 13,
2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04306900" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04306900</a> (accessed Jun
2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TTX-030+in+Combination%0AWith+Immunotherapy+and%2For+Chemotherapy+in%0ASubjects+With+Advanced+Cancers.+Last+updated+May+13%2C%0A2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04306900+%28accessed+Jun%0A2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DTTX-030%2520in%2520Combination%250AWith%2520Immunotherapy%2520and%252For%2520Chemotherapy%2520in%250ASubjects%2520With%2520Advanced%2520Cancers%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, H.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraudon-Paoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docquier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jecko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becquart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rispaud-Blanc, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourdin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amigues, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensussan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliaou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narni-Mancinelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paturel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, N.</span></span> <span> </span><span class="NLM_article-title">Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2411</span>– <span class="NLM_lpage">2425</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2019.04.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.celrep.2019.04.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31116985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVWksb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=2411-2425&author=I.+Perrotauthor=H.-A.+Michaudauthor=M.+Giraudon-Paoliauthor=S.+Augierauthor=A.+Docquierauthor=L.+Grosauthor=R.+Courtoisauthor=C.+Dejouauthor=D.+Jeckoauthor=O.+Becquartauthor=H.+Rispaud-Blancauthor=L.+Gauthierauthor=B.+Rossiauthor=S.+Chanteuxauthor=N.+Gourdinauthor=B.+Amiguesauthor=A.+Rousselauthor=A.+Bensussanauthor=J.-F.+Eliaouauthor=J.+Bastidauthor=F.+Romagneauthor=Y.+Morelauthor=E.+Narni-Mancinelliauthor=E.+Vivierauthor=C.+Paturelauthor=N.+Bonnefoy&title=Blocking+antibodies+targeting+the+CD39%2FCD73+immunosuppressive+pathway+unleash+immune+responses+in+combination+cancer+therapies&doi=10.1016%2Fj.celrep.2019.04.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies</span></div><div class="casAuthors">Perrot, Ivan; Michaud, Henri-Alexandre; Giraudon-Paoli, Marc; Augier, Severine; Docquier, Aurelie; Gros, Laurent; Courtois, Rachel; Dejou, Cecile; Jecko, Diana; Becquart, Ondine; Rispaud-Blanc, Helene; Gauthier, Laurent; Rossi, Benjamin; Chanteux, Stephanie; Gourdin, Nicolas; Amigues, Beatrice; Roussel, Alain; Bensussan, Armand; Eliaou, Jean-Francois; Bastid, Jeremy; Romagne, Francois; Morel, Yannis; Narni-Mancinelli, Emilie; Vivier, Eric; Paturel, Carine; Bonnefoy, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2411-2425.e9</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Immune checkpoint inhibitors have revolutionized cancer treatment.  However, many cancers are resistant to ICIs, and the targeting of addnl. inhibitory signals is crucial for limiting tumor evasion.  The prodn. of adenosine via the sequential activity of CD39 and CD73 ectoenzymes participates to the generation of an immunosuppressive tumor microenvironment.  In order to disrupt the adenosine pathway, we generated two antibodies, IPH5201 and IPH5301, targeting human membrane-assocd. and sol. forms of CD39 and CD73, resp., and efficiently blocking the hydrolysis of immunogenic ATP into immunosuppressive adenosine.  These antibodies promoted antitumor immunity by stimulating dendritic cells and macrophages and by restoring the activation of T cells isolated from cancer patients.  In a human CD39 knockin mouse preclin. model, IPH5201 increased the anti-tumor activity of the ATP-inducing chemotherapeutic drug oxaliplatin.  These results support the use of anti-CD39 and anti-CD73 monoclonal antibodies and their combination with immune checkpoint inhibitors and chemotherapies in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4T46HApEaJbVg90H21EOLACvtfcHk0li66VIzkY-AtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVWksb7M&md5=b2642873d6ab147a849b16d2866c3ed6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2019.04.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2019.04.091%26sid%3Dliteratum%253Aachs%26aulast%3DPerrot%26aufirst%3DI.%26aulast%3DMichaud%26aufirst%3DH.-A.%26aulast%3DGiraudon-Paoli%26aufirst%3DM.%26aulast%3DAugier%26aufirst%3DS.%26aulast%3DDocquier%26aufirst%3DA.%26aulast%3DGros%26aufirst%3DL.%26aulast%3DCourtois%26aufirst%3DR.%26aulast%3DDejou%26aufirst%3DC.%26aulast%3DJecko%26aufirst%3DD.%26aulast%3DBecquart%26aufirst%3DO.%26aulast%3DRispaud-Blanc%26aufirst%3DH.%26aulast%3DGauthier%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DB.%26aulast%3DChanteux%26aufirst%3DS.%26aulast%3DGourdin%26aufirst%3DN.%26aulast%3DAmigues%26aufirst%3DB.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DBensussan%26aufirst%3DA.%26aulast%3DEliaou%26aufirst%3DJ.-F.%26aulast%3DBastid%26aufirst%3DJ.%26aulast%3DRomagne%26aufirst%3DF.%26aulast%3DMorel%26aufirst%3DY.%26aulast%3DNarni-Mancinelli%26aufirst%3DE.%26aulast%3DVivier%26aufirst%3DE.%26aulast%3DPaturel%26aufirst%3DC.%26aulast%3DBonnefoy%26aufirst%3DN.%26atitle%3DBlocking%2520antibodies%2520targeting%2520the%2520CD39%252FCD73%2520immunosuppressive%2520pathway%2520unleash%2520immune%2520responses%2520in%2520combination%2520cancer%2520therapies%26jtitle%3DCell%2520Rep.%26date%3D2019%26volume%3D27%26spage%3D2411%26epage%3D2425%26doi%3D10.1016%2Fj.celrep.2019.04.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span> </span><span class="NLM_article-title">IPH5201 as Monotherapy or in Combination with Durvalumab
± Oleclumab
in Subjects with Advanced Solid Tumors</span>. Last updated
May 28, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04261075" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04261075</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IPH5201+as+Monotherapy+or+in+Combination+with+Durvalumab%0A%C2%B1+Oleclumab%0Ain+Subjects+with+Advanced+Solid+Tumors.+Last+updated%0AMay+28%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04261075+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DIPH5201%2520as%2520Monotherapy%2520or%2520in%2520Combination%2520with%2520Durvalumab%250A%25C2%25B1%2520Oleclumab%250Ain%2520Subjects%2520with%2520Advanced%2520Solid%2520Tumors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, M. C.</span>; <span class="NLM_string-name">Das, S. G.</span>; <span class="NLM_string-name">Dulak, A.</span>; <span class="NLM_string-name">Zaidi, T. H.</span>; <span class="NLM_string-name">Devereaux, E.</span>; <span class="NLM_string-name">Strand, J.</span>; <span class="NLM_string-name">Koseoglu, S.</span>; <span class="NLM_string-name">Lee, B. H.</span>; <span class="NLM_string-name">Riordan, C.</span>; <span class="NLM_string-name">Holland, P. M.</span>; <span class="NLM_string-name">Palombella, V. J.</span>; <span class="NLM_string-name">Lake, A. C.</span></span> <span> </span><span class="NLM_article-title">The Fully Human Antibody SRF617 is a Potent Enzymatic Inhibitor of CD39 with Strong Immunomodulatory Activity</span>. Presented at The Society for Immunotherapy of Cancer Annual Meeting, Nov 9, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+C.+Warren&author=S.+G.+Das&author=A.+Dulak&author=T.+H.+Zaidi&author=E.+Devereaux&author=J.+Strand&author=S.+Koseoglu&author=B.+H.+Lee&author=C.+Riordan&author=P.+M.+Holland&author=V.+J.+Palombella&author=A.+C.+Lake&title=The+Fully+Human+Antibody+SRF617+is+a+Potent+Enzymatic+Inhibitor+of+CD39+with+Strong+Immunomodulatory+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DM.%2BC.%26atitle%3DThe%2520Fully%2520Human%2520Antibody%2520SRF617%2520is%2520a%2520Potent%2520Enzymatic%2520Inhibitor%2520of%2520CD39%2520with%2520Strong%2520Immunomodulatory%2520Activity%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span> </span><span class="NLM_article-title">Study of SRF617 in Patients with Advanced
Solid Tumors</span>. Last updated Apr 7, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04336098" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04336098</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+SRF617+in+Patients+with+Advanced%0ASolid+Tumors.+Last+updated+Apr+7%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04336098+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520of%2520SRF617%2520in%2520Patients%2520with%2520Advanced%250ASolid%2520Tumors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowenstein, J. M.</span></span> <span> </span><span class="NLM_article-title">Preparation and properties of 5′-nucleotidase from smooth muscle of small intestine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">6274</span>– <span class="NLM_lpage">6280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=4320834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaE3MXjvVGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1970&pages=6274-6280&author=R.+M.+Burgerauthor=J.+M.+Lowenstein&title=Preparation+and+properties+of+5%E2%80%B2-nucleotidase+from+smooth+muscle+of+small+intestine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and properties of 5'-nucleotidase from smooth muscle of small intestine</span></div><div class="casAuthors">Burger, Richard; Lowenstein, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6274-80</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">ADP strongly inhibited a 5' -nucleotidase prepd. from pig smooth muscle.  This inhibition was much stronger than the previously described inhibition of 5' -nucleotidase by ATP.  Α,β-Methylene adenosine 5' -diphosphate (I) was an exceptionally powerful inhibitor of the enzyme.  The enzyme had 3 pH optima.  The lowest of these optima was seen only when the enzyme was not inhibited by buffer anions; the highest was seen only in the presence of Mg2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdkMkr4_XWRbVg90H21EOLACvtfcHk0lgQzsnDAndceQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXjvVGgsQ%253D%253D&md5=a60b798fa2da1eb9dd34eb446040301a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DR.%2BM.%26aulast%3DLowenstein%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520and%2520properties%2520of%25205%25E2%2580%25B2-nucleotidase%2520from%2520smooth%2520muscle%2520of%2520small%2520intestine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1970%26volume%3D245%26spage%3D6274%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowenstein, J. M.</span></span> <span> </span><span class="NLM_article-title">5′-Nucleotidase from rat heart membranes. Inhibition by adenine nucleotides and related compounds</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1042/bj2260645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1042%2Fbj2260645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=2985044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaL2MXhvVWgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1985&pages=645-651&author=Y.+Naitoauthor=J.+M.+Lowenstein&title=5%E2%80%B2-Nucleotidase+from+rat+heart+membranes.+Inhibition+by+adenine+nucleotides+and+related+compounds&doi=10.1042%2Fbj2260645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">5'-Nucleotidase from rat heart membranes.  Inhibition by adenine nucleotides and related compounds</span></div><div class="casAuthors">Naito, Yoshitsugu; Lowenstein, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">645-51</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">ADP and ATP and their analogs were evaluated as inhibitors of 5'-nucleotidase purified from heart plasma membrane.  ADP analogs were more powerful inhibitors than the corresponding ATP analogs.  The most powerful inhibitor found was adenosine 5'-[αβ-methylene]diphosphate (AOPCP) for which the enzyme showed a Ki of 5 nM at pH 7.2.  Measurements of pKi values for ADP and AOPCP as a function of pH indicated that the major inhibitory species of both nucleotides was the dianion.  In the physiol. range of pH values, AOPCP was a more powerful inhibitor than ADP principally because a higher percentage of AOPCP exists in the dianion form.  The methylenephosphonate analog of AMP (ACP), although not a substrate, was a moderately effective inhibitor.  The corresponding analogs of ADP (ACPOP) and ATP (ACPOPOP) were as good inhibitors as ADP and ATP, resp.  The thiophosphate analogs of ADP all inhibited 5'-nucleotidase, although not as powerfully as ADP, the most effective of these analogs being adenosine 5'-O-(1-thiodiphosphate) diastereoisomer B [ADP[αS](B)].  Other nucleotides inhibited the enzyme, but none was as effective as AOPCP.  Inorg. tripolyphosphate and methylenediphosphonate were better inhibitors of the enzyme than was inorg. pyrophosphate.  Inorg. thiophosphate was a better inhibitor than was orthophosphate.  Hill plots of the ADP and AOPCP inhibition yielded slopes close to 1; Hill plots of the ATP inhibition yielded slopes of ∼0.6.  MgADP- was not an inhibitor, and MgATP2- was at best a very weak inhibitor of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxWq0Y0d2ubLVg90H21EOLACvtfcHk0likXJE0EiZkAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhvVWgtrc%253D&md5=2454e331e7e1432fa7d68d1d1c5ed08f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1042%2Fbj2260645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2260645%26sid%3Dliteratum%253Aachs%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DLowenstein%26aufirst%3DJ.%2BM.%26atitle%3D5%25E2%2580%25B2-Nucleotidase%2520from%2520rat%2520heart%2520membranes.%2520Inhibition%2520by%2520adenine%2520nucleotides%2520and%2520related%2520compounds%26jtitle%3DBiochem.%2520J.%26date%3D1985%26volume%3D226%26spage%3D645%26epage%3D651%26doi%3D10.1042%2Fbj2260645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">α,β-Methylene-ADP (AOPCP) derivatives and analogues: development of potent and selective <i>ecto</i>-5′-nucleotidase (CD73) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6248</span>– <span class="NLM_lpage">6263</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6248-6263&author=S.+Bhattaraiauthor=M.+Freundliebauthor=J.+Pippelauthor=A.+Meyerauthor=A.+Abdelrahmanauthor=A.+Fieneauthor=S.-Y.+Leeauthor=H.+Zimmermannauthor=G.+G.+Yegutkinauthor=N.+Str%C3%A4terauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCller&title=%CE%B1%2C%CE%B2-Methylene-ADP+%28AOPCP%29+derivatives+and+analogues%3A+development+of+potent+and+selective+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors&doi=10.1021%2Facs.jmedchem.5b00802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors</span></div><div class="casAuthors">Bhattarai, Sanjay; Freundlieb, Marianne; Pippel, Jan; Meyer, Anne; Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert; Yegutkin, Gennady G.; Straeter, Norbert; El-Tayeb, Ali; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6248-6263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-Nucleotidase (eN, CD73) catalyzes the hydrolysis of extracellular AMP to adenosine. eN inhibitors have potential for use as cancer therapeutics.  The eN inhibitor α,β-methylene-ADP (AOPCP, adenosine-5'-O-[(phosphonomethyl)phosphonic acid]) was used as a lead structure, and derivs. modified in various positions were prepd.  Products were tested at rat recombinant eN.  6-(Ar)alkylamino substitution led to the largest improvement in potency.  N6-Monosubstitution was superior to sym. N6,N6-disubstitution.  The most potent inhibitors were N6-(4-chlorobenzyl)- (PSB-12441, Ki 7.23 nM), N6-phenylethyl- (PSB-12425, Ki 8.04 nM), and N6-benzyl-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] I (PSB-12379, Ki 9.03 nM).  Replacement of the 6-NH group in I by O (PSB-12431) or S (PSB-12553) yielded equally potent inhibitors (9.20 nM and 9.50 nM, resp.).  Selected compds. investigated at the human enzyme did not show species differences; they displayed high selectivity vs. other ecto-nucleotidases and ADP-activated P2Y receptors.  Moreover, high metabolic stability was obsd.  These compds. represent the most potent eN inhibitors described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmxberqVtKLVg90H21EOLACvtfcHk0likXJE0EiZkAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF&md5=5f1231a662dd86345b9d3803f1c4e716</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00802%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520%2528AOPCP%2529%2520derivatives%2520and%2520analogues%253A%2520development%2520of%2520potent%2520and%2520selective%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6248%26epage%3D6263%26doi%3D10.1021%2Facs.jmedchem.5b00802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Delgado, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campoy, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Flores, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-López, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, C. J.</span></span> <span> </span><span class="NLM_article-title">The ecto-5′-nucleotidase subunits in dimers are not linked by disulfide bridges but by non-covalent bonds</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1478</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1016/S0167-4838(00)00035-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2FS0167-4838%2800%2900035-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10825541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVGht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1478&publication_year=2000&pages=300-308&author=A.+Mart%C3%ADnez-Mart%C3%ADnezauthor=E.+Mu%C3%B1oz-Delgadoauthor=F.+J.+Campoyauthor=C.+Flores-Floresauthor=J.+N.+Rodr%C3%ADguez-L%C3%B3pezauthor=C.+Finiauthor=C.+J.+Vidal&title=The+ecto-5%E2%80%B2-nucleotidase+subunits+in+dimers+are+not+linked+by+disulfide+bridges+but+by+non-covalent+bonds&doi=10.1016%2FS0167-4838%2800%2900035-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The ecto-5'-nucleotidase subunits in dimers are not linked by disulfide bridges but by non-covalent bonds</span></div><div class="casAuthors">Martinez-Martinez, A.; Munoz-Delgado, E.; Campoy, F. J.; Flores-Flores, C.; Rodriguez-Lopez, J. N.; Fini, C.; Vidal, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1478</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It has long been considered that ecto-5'-nucleotidase (eNT) dimers consist of subunits linked by disulfide bonds.  Hydrophilic (6.7S) and amphiphilic (4.0S) dimers were sepd. by sedimentation anal. of eNT purified from bull seminal plasma.  Hydrophilic (4.2S) and amphiphilic (2.6S) eNT monomers were obtained after redn. of disulfide bonds in dimers.  The amphiphilic eNT dimers or monomers were converted into their hydrophilic variants with phosphatidylinositol-specific phospholipase C.  SDS-PAGE plus Western blot showed 68-kDa subunits, regardless of the addn. of β-mercaptoethanol to the SDS mixt.  Active eNT monomers were obtained by addn. of 1M guanidinium chloride (Gdn) to dimers, and unfolded subunits by addn. of 4M Gdn.  The results unambiguously demonstrated that the subunits in eNT dimers were not linked by disulfide bridges, but by noncovalent bonds, and that dissocn. preceded inactivation and unfolding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrDHC_yimbLVg90H21EOLACvtfcHk0lgKztVaoW_jZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVGht78%253D&md5=968b20196706e45277f9fff7180f83f1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2800%2900035-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252800%252900035-2%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DMu%25C3%25B1oz-Delgado%26aufirst%3DE.%26aulast%3DCampoy%26aufirst%3DF.%2BJ.%26aulast%3DFlores-Flores%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADguez-L%25C3%25B3pez%26aufirst%3DJ.%2BN.%26aulast%3DFini%26aufirst%3DC.%26aulast%3DVidal%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520ecto-5%25E2%2580%25B2-nucleotidase%2520subunits%2520in%2520dimers%2520are%2520not%2520linked%2520by%2520disulfide%2520bridges%2520but%2520by%2520non-covalent%2520bonds%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2000%26volume%3D1478%26spage%3D300%26epage%3D308%26doi%3D10.1016%2FS0167-4838%2800%2900035-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human ecto-5′-nucleotidase (CD73): insights into the regulation of purinergic signaling</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2161</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.str.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23142347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2161-2173&author=K.+Knappauthor=M.+Zebischauthor=J.+Pippelauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=Crystal+structure+of+the+human+ecto-5%E2%80%B2-nucleotidase+%28CD73%29%3A+insights+into+the+regulation+of+purinergic+signaling&doi=10.1016%2Fj.str.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling</span></div><div class="casAuthors">Knapp, Karen; Zebisch, Matthias; Pippel, Jan; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2161-2173</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In vertebrates ecto-5'-nucleotidase (e5NT) catalyzes the hydrolysis of extracellular AMP to adenosine and represents the major control point for extracellular adenosine levels.  Due to its pivotal role for activation of P1 adenosine receptors, e5NT has emerged as an appealing drug target for treatment of inflammation, chronic pain, hypoxia, and cancer.  Crystal structures of the dimeric human e5NT reveal an extensive 114° conformational switch between the open and closed forms of the enzyme.  The dimerization interface is formed by the C-terminal domains and exhibits interchain motions of up to 13°.  Complex structures with adenosine and AMPCP indicate that structural control of the domain movement dets. the selectivity for monophosphate nucleotides.  Binding modes of nucleotide-derived and flavonoid-based compds. complexed to the C-terminal domain in the open form reveal an addnl. binding pocket of ∼210 Å3 that might be explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8MOj4dwx2J7Vg90H21EOLACvtfcHk0lgKztVaoW_jZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK&md5=e108171e8079cca4dd11483dfacb909e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DK.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%253A%2520insights%2520into%2520the%2520regulation%2520of%2520purinergic%2520signaling%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D2161%26epage%3D2173%26doi%3D10.1016%2Fj.str.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambe, T.</span></span> <span> </span><span class="NLM_article-title">Zinc deficiency causes delayed ATP clearance and adenosine generation in rats and cell culture models</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">113</span>, <span class="refDoi"> DOI: 10.1038/s42003-018-0118-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fs42003-018-0118-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30271993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADC%252BB3czksVCrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&pages=113&author=T.+A.+Takedaauthor=S.+Miyazakiauthor=M.+Kobayashiauthor=K.+Nishinoauthor=T.+Gotoauthor=M.+Matsunagaauthor=M.+Ooiauthor=H.+Shirakawaauthor=F.+Taniauthor=T.+Kawamuraauthor=M.+Komaiauthor=T.+Kambe&title=Zinc+deficiency+causes+delayed+ATP+clearance+and+adenosine+generation+in+rats+and+cell+culture+models&doi=10.1038%2Fs42003-018-0118-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc deficiency causes delayed ATP clearance and adenosine generation in rats and cell culture models</span></div><div class="casAuthors">Takeda Taka-Aki; Miyazaki Shiho; Kobayashi Miki; Nishino Katsutoshi; Matsunaga Mayu; Kambe Taiho; Goto Tomoko; Ooi Minami; Shirakawa Hitoshi; Komai Michio; Goto Tomoko; Tani Fumito; Kawamura Tatsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Communications biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Zinc deficiency causes myriad pathophysiological symptoms, but why distinct phenotypes are generated by zinc deficiency remains unclear.  Considering that several ectoenzymes involved in purinergic signaling through extracellular adenine-nucleotide hydrolysis possess zinc ions in their active sites, and disorders in purinergic signaling result in diverse diseases that are frequently similar to those caused by zinc deficiency, herein we examine whether zinc deficiency affects extracellular adenine-nucleotide metabolism.  Zinc deficiency severely impairs the activities of major ectoenzymes (ENPP1, ENPP3, NT5E/CD73, and TNAP), and also strongly suppresses adenine-nucleotide hydrolysis in cell-membrane preparations or rat plasma, thereby increasing ATP and ADP levels and decreasing adenosine levels.  Thus, zinc deficiency delays both extracellular ATP clearance and adenosine generation, and zinc modulates extracellular adenine-nucleotide metabolism.  Since the finely tuned balance between extracellular adenine nucleotides and adenosine is critical for purinergic signaling, these findings provide a novel insight into why zinc deficiency results in diverse symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQilKiHIro9_DC850By6mxpfW6udTcc2eYDGHPbwKnUBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czksVCrtw%253D%253D&md5=787431754ac98418cc6e2acb43ac6bd0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs42003-018-0118-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-018-0118-3%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DT.%2BA.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DM.%26aulast%3DOoi%26aufirst%3DM.%26aulast%3DShirakawa%26aufirst%3DH.%26aulast%3DTani%26aufirst%3DF.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DKomai%26aufirst%3DM.%26aulast%3DKambe%26aufirst%3DT.%26atitle%3DZinc%2520deficiency%2520causes%2520delayed%2520ATP%2520clearance%2520and%2520adenosine%2520generation%2520in%2520rats%2520and%2520cell%2520culture%2520models%26jtitle%3DCommun.%2520Biol.%26date%3D2018%26volume%3D1%26spage%3D113%26doi%3D10.1038%2Fs42003-018-0118-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span>; <span class="NLM_string-name">Cousineau, I.</span>; <span class="NLM_string-name">Spring, K.</span>; <span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">Measurement of CD73 Enzymatic Activity Using Luminescence-Based and Colorimetric Assays</span>. In  <i>Tumor Immunology and Immunotherapy—Molecular Methods</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span>, <span class="NLM_string-name">Rudvist, N.-P.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2019</span>; Vol.  <span class="NLM_volume">629</span>, pp  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">289</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fbs.mie.2019.10.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=269-289&author=B.+Allard&author=I.+Cousineau&author=K.+Spring&author=J.+Staggauthor=L.+Galluzzi&author=N.-P.+Rudvist&title=Tumor+Immunology+and+Immunotherapy%E2%80%94Molecular+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fbs.mie.2019.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.mie.2019.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DB.%26atitle%3DMeasurement%2520of%2520CD73%2520Enzymatic%2520Activity%2520Using%2520Luminescence-Based%2520and%2520Colorimetric%2520Assays%26btitle%3DTumor%2520Immunology%2520and%2520Immunotherapy%25E2%2580%2594Molecular%2520Methods%26aulast%3DGalluzzi%26aufirst%3DL.%26pub%3DAcademic%2520Press%26date%3D2019%26volume%3D629%26spage%3D269%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baykov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evtushenko, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avaeva, S. M.</span></span> <span> </span><span class="NLM_article-title">A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(88)90484-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2F0003-2697%2888%2990484-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=3044186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADyaL1czgsl2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1988&pages=266-270&author=A.+A.+Baykovauthor=O.+A.+Evtushenkoauthor=S.+M.+Avaeva&title=A+malachite+green+procedure+for+orthophosphate+determination+and+its+use+in+alkaline+phosphatase-based+enzyme+immunoassay&doi=10.1016%2F0003-2697%2888%2990484-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay</span></div><div class="casAuthors">Baykov A A; Evtushenko O A; Avaeva S M</div><div class="citationInfo"><span class="NLM_cas:title">Analytical biochemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">266-70</span>
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">An improved procedure for phosphate determination based on a highly colored complex of phosphomolybdate and malachite green is described.  All necessary reagents are combined in one concentrated solution, making the assay sensitive and convenient.  The procedure is based on the finding that the dye is easily soluble and stable in the presence of 6 N acid.  The addition of Tween 20 is required to stabilize the dye-phosphomolybdate complex at phosphate concentrations above 10 microM.  The time of color development at 25 degrees C is about 3 min.  The procedure was adopted to measure alkaline phosphate activity in heterogeneous enzyme immunoassay with rho-nitrophenyl phosphate and pyrophosphate as substrates.  In both cases, a 4-fold increase in sensitivity in terms of absorbance readings was obtained compared to the standard method based on rho-nitrophenol measurement.  In visual analysis, the gain in sensitivity was as high as 20-fold, due to contrast color change (yellow to greenish blue).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXY80nJAkYslw2ofyr07jXfW6udTcc2eYDGHPbwKnUBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1czgsl2juw%253D%253D&md5=67f9d40723eb01ec49109c4b0c01a461</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2888%2990484-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252888%252990484-8%26sid%3Dliteratum%253Aachs%26aulast%3DBaykov%26aufirst%3DA.%2BA.%26aulast%3DEvtushenko%26aufirst%3DO.%2BA.%26aulast%3DAvaeva%26aufirst%3DS.%2BM.%26atitle%3DA%2520malachite%2520green%2520procedure%2520for%2520orthophosphate%2520determination%2520and%2520its%2520use%2520in%2520alkaline%2520phosphatase-based%2520enzyme%2520immunoassay%26jtitle%3DAnal.%2520Biochem.%26date%3D1988%26volume%3D171%26spage%3D266%26epage%3D270%26doi%3D10.1016%2F0003-2697%2888%2990484-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cogan, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, O. H.</span></span> <span> </span><span class="NLM_article-title">A robotics-based automated assay for inorganic and organic phosphates</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1006/abio.1999.4100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1006%2Fabio.1999.4100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10361001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1MXjsFKgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1999&pages=29-35&author=E.+B.+Coganauthor=G.+B.+Birrellauthor=O.+H.+Griffith&title=A+robotics-based+automated+assay+for+inorganic+and+organic+phosphates&doi=10.1006%2Fabio.1999.4100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A Robotics-Based Automated Assay for Inorganic and Organic Phosphates</span></div><div class="casAuthors">Cogan, Elizabeth B.; Birrell, G. Bruce; Griffith, O. Hayes</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Phosphate analyses are fundamental to a broad range of biochem. applications involving inorg. phosphate and org. phosphoesters such as phospholipids, phosphorylated proteins, and nucleic acids.  A practical automated method using robotics is described.  Five colorimetric methods of phosphate analyses based on formation of a phosphomolybdate complex and compatible with the automated assay were tested, and the fundamental chem. is discussed.  The relative sensitivities are malachite green > crystal violet > quinaldine red > ascorbate redn. > Sb-modified ascorbate redn., although only a 4-fold improvement was obsd. in going from the modified ascorbate procedure to malachite green.  Malachite green was selected to optimize the assay because this dye provided the highest sensitivity.  However, where color stability and low blanks are more important than sensitivity, the ascorbate redn. and quinaldine red methods are better choices than malachite green.  Automation using a robotic liq.-handling system substantially reduces the labor required to process large arrays of samples.  The result is a sensitive, nonradioactive assay of inorg. phosphate with high throughput.  A digestion step in an acid-resistant 96-well plate was developed to extend the assay to phosphate esters.  The robotic-based assay was demonstrated with inorg. phosphate and a common phospholipid, phosphatidylcholine.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_C0EvWOmKG7Vg90H21EOLACvtfcHk0lgyONaDkb5iKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsFKgu74%253D&md5=c7f9aa91fefa51c724e552fe50fce42c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4100%26sid%3Dliteratum%253Aachs%26aulast%3DCogan%26aufirst%3DE.%2BB.%26aulast%3DBirrell%26aufirst%3DG.%2BB.%26aulast%3DGriffith%26aufirst%3DO.%2BH.%26atitle%3DA%2520robotics-based%2520automated%2520assay%2520for%2520inorganic%2520and%2520organic%2520phosphates%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D271%26spage%3D29%26epage%3D35%26doi%3D10.1006%2Fabio.1999.4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billedeau, R. J.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidase Inhibitors and Methods of Use Thereof</span>. U.S. Patent <span class="NLM_patent">10570167</span>, Feb 25, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+J.+Billedeau&author=J.+Li&author=L.+Chen&title=Ectonucleotidase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBilledeau%26aufirst%3DR.%2BJ.%26atitle%3DEctonucleotidase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span>; <span class="NLM_string-name">Bhupathi, D.</span>; <span class="NLM_string-name">Billedeau, R. J.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Emberley, E. D.</span>; <span class="NLM_string-name">Gross, M. I.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">Ma, Y.</span>; <span class="NLM_string-name">Mackinnon, A. L.</span>; <span class="NLM_string-name">Makkouk, A.</span>; <span class="NLM_string-name">Marguier, G. M.</span>; <span class="NLM_string-name">Neou, S.</span>; <span class="NLM_string-name">Parlati, F.</span>; <span class="NLM_string-name">Sotirovska, N.</span>; <span class="NLM_string-name">Stanton, T. F.</span>; <span class="NLM_string-name">Steggerda, S. M.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Zhang, W.</span>; <span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Reversal of Adenosine-Mediated Immune Suppression by CB-708, an Orally Bioavailable and Potent Small Molecule Inhibitor of CD73</span>.  <i>Proceedings</i>, AACR Annual Meeting, Atlanta, GA, Mar 29–Apr 3, 2019; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=C.+C.+Lee&author=D.+Bhupathi&author=R.+J.+Billedeau&author=J.+Chen&author=L.+Chen&author=E.+D.+Emberley&author=M.+I.+Gross&author=T.+Huang&author=W.+Li&author=Y.+Ma&author=A.+L.+Mackinnon&author=A.+Makkouk&author=G.+M.+Marguier&author=S.+Neou&author=F.+Parlati&author=N.+Sotirovska&author=T.+F.+Stanton&author=S.+M.+Steggerda&author=J.+Zhang&author=W.+Zhang&author=J.+Li&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BC.%26atitle%3DReversal%2520of%2520Adenosine-Mediated%2520Immune%2520Suppression%2520by%2520CB-708%252C%2520an%2520Orally%2520Bioavailable%2520and%2520Potent%2520Small%2520Molecule%2520Inhibitor%2520of%2520CD73%26btitle%3DProceedings%26pub%3DAACR%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cacatian, S.</span>; <span class="NLM_string-name">Claremon, D. A.</span>; <span class="NLM_string-name">Jia, L.</span>; <span class="NLM_string-name">Morales-Ramos, A.</span>; <span class="NLM_string-name">Singh, S. B.</span>; <span class="NLM_string-name">Venkatraman, S.</span>; <span class="NLM_string-name">Xu, Z.</span>; <span class="NLM_string-name">Zheng, Y.</span></span> <span> </span><span class="NLM_article-title">Purine Derivatives as CD73 Inhibitors for the Treatment of Cancer</span>. U.S. Patent <span class="NLM_patent">10654884</span>, May 19, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=S.+Cacatian&author=D.+A.+Claremon&author=L.+Jia&author=A.+Morales-Ramos&author=S.+B.+Singh&author=S.+Venkatraman&author=Z.+Xu&author=Y.+Zheng&title=Purine+Derivatives+as+CD73+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCacatian%26aufirst%3DS.%26atitle%3DPurine%2520Derivatives%2520as%2520CD73%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Jaen, J. C.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Modulators of 5′-Nucleotidase, Ecto and the Use Thereof</span>. U.S. Patent <span class="NLM_patent">10239912</span>, Mar 26, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=L.+P.+P.+Debien&author=J.+C.+Jaen&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=B.+R.+Rosen&author=E.+U.+Sharif&title=Modulators+of+5%E2%80%B2-Nucleotidase%2C+Ecto+and+the+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26atitle%3DModulators%2520of%25205%25E2%2580%25B2-Nucleotidase%252C%2520Ecto%2520and%2520the%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalisiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of AB680: a potent and selective inhibitor of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=K.+V.+Lawsonauthor=J.+Kalisiakauthor=E.+A.+Lindseyauthor=E.+T.+Newcombauthor=M.+R.+Leletiauthor=L.+Debienauthor=B.+R.+Rosenauthor=D.+H.+Milesauthor=E.+U.+Sharifauthor=J.+L.+Jeffreyauthor=J.+B.+L.+Tanauthor=A.+Chenauthor=S.+Zhaoauthor=G.+Xuauthor=L.+Fuauthor=L.+Jinauthor=T.+W.+Parkauthor=W.+Berryauthor=S.+Moschutzauthor=E.+Scalettiauthor=N.+Straterauthor=N.+P.+Walkerauthor=S.+W.+Youngauthor=M.+J.+Waltersauthor=U.+Schindlerauthor=J.+P.+Powers&title=Discovery+of+AB680%3A+a+potent+and+selective+inhibitor+of+CD73&doi=10.1021%2Facs.jmedchem.0c00525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00525%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BV.%26aulast%3DKalisiak%26aufirst%3DJ.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DNewcomb%26aufirst%3DE.%2BT.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DDebien%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DB.%2BR.%26aulast%3DMiles%26aufirst%3DD.%2BH.%26aulast%3DSharif%26aufirst%3DE.%2BU.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DTan%26aufirst%3DJ.%2BB.%2BL.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DT.%2BW.%26aulast%3DBerry%26aufirst%3DW.%26aulast%3DMoschutz%26aufirst%3DS.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DStrater%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DSchindler%26aufirst%3DU.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520AB680%253A%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.0c00525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Tan, J.</span>; <span class="NLM_string-name">Schindler, U.</span>; <span class="NLM_string-name">Young, S.</span>; <span class="NLM_string-name">Jaen, J.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Kalisiak, K.</span>; <span class="NLM_string-name">Lindsey, E.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Sharif, E.</span>; <span class="NLM_string-name">Miles, D.</span>; <span class="NLM_string-name">Jeffrey, J.</span>; <span class="NLM_string-name">Leleti, M.</span>; <span class="NLM_string-name">Chen, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of AB680: A Potent and Selective CD73 Inhibitor for Cancer Immunotherapy</span>.  <i>Proceedings</i>, American Chemical Society National Meeting, Orlando, FL, Apr 3, 2019; <span class="NLM_publisher-name">American Chemical Society</span>, <span class="NLM_year">2019</span>; Abstract MEDI-0257.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=K.+V.+Lawson&author=L.+Jin&author=J.+Tan&author=U.+Schindler&author=S.+Young&author=J.+Jaen&author=J.+P.+Powers&author=K.+Kalisiak&author=E.+Lindsey&author=E.+Newcomb&author=E.+Sharif&author=D.+Miles&author=J.+Jeffrey&author=M.+Leleti&author=A.+Chen&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520AB680%253A%2520A%2520Potent%2520and%2520Selective%2520CD73%2520Inhibitor%2520for%2520Cancer%2520Immunotherapy%26btitle%3DProceedings%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span> <span> </span><span class="NLM_article-title">Development of Potent and Selective CD73 Inhibitors: Discovery and Characterization of AB680</span>.  <i>Proceedings</i>, AACR Annual Meeting, Atlanta, GA, Mar 30, 2019; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.+L.+Jeffrey&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520of%2520Potent%2520and%2520Selective%2520CD73%2520Inhibitors%253A%2520Discovery%2520and%2520Characterization%2520of%2520AB680%26btitle%3DProceedings%26pub%3DAACR%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span> <span> </span><span class="NLM_article-title">An exceptionally potent inhibitor of human CD73</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3331</span>– <span class="NLM_lpage">3334</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.9b00448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.9b00448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=3331-3334&author=C.+E.+Bowmanauthor=R.+G.+da+Silvaauthor=A.+Phamauthor=S.+W.+Young&title=An+exceptionally+potent+inhibitor+of+human+CD73&doi=10.1021%2Facs.biochem.9b00448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">An Exceptionally Potent Inhibitor of Human CD73</span></div><div class="casAuthors">Bowman, Christine E.; da Silva, Rafael G.; Pham, Amber; Young, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3331-3334</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently reported the initiation of a Phase I clin. trial with AB680, a potent human CD73 inhibitor, being developed for the treatment of solid tumors (NCT03677973).  We undertook a detailed kinetic anal. of the interaction between human CD73 and AB680 to det. the mode of inhibition.  We found AB680 to be a reversible, slow-onset competitive inhibitor of human CD73 with a Ki of 5 pM.  Clin. candidates of this potency are uncommon and deserve special consideration during lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYGag3hdjGb7Vg90H21EOLACvtfcHk0lh99gvFRzAiIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O&md5=ad600cb74b603c4daa3c5f002e1c5f4a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.9b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.9b00448%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DC.%2BE.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BG.%26aulast%3DPham%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26atitle%3DAn%2520exceptionally%2520potent%2520inhibitor%2520of%2520human%2520CD73%26jtitle%3DBiochemistry%26date%3D2019%26volume%3D58%26spage%3D3331%26epage%3D3334%26doi%3D10.1021%2Facs.biochem.9b00448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E.</span>; <span class="NLM_string-name">Lawson, K.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lindsey, E.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Rosen, B.</span>; <span class="NLM_string-name">Walker, N.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Scaletti, E. R.</span>; <span class="NLM_string-name">Sträter, N.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Leleti, M.</span>; <span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Potent and Selective Small-Molecule Inhibitors of Ecto-Nucleotidase CD73 for Cancer Immunotherapy</span>.  <i>Proceedings</i>, American Chemical Society National Meeting, Orlando, FL, Apr 3, 2019; <span class="NLM_publisher-name">American Chemical Society</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=E.+Sharif&author=K.+Lawson&author=J.+Kalisiak&author=E.+Lindsey&author=E.+Newcomb&author=B.+Rosen&author=N.+Walker&author=L.+Jin&author=E.+R.+Scaletti&author=N.+Str%C3%A4ter&author=A.+Chen&author=M.+Leleti&author=J.+P.+Powers&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Potent%2520and%2520Selective%2520Small-Molecule%2520Inhibitors%2520of%2520Ecto-Nucleotidase%2520CD73%2520for%2520Cancer%2520Immunotherapy%26btitle%3DProceedings%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Zhao, S.</span>; <span class="NLM_string-name">Young, S. W.</span>; <span class="NLM_string-name">Walker, N.</span>; <span class="NLM_string-name">Sträter, N.</span>; <span class="NLM_string-name">Scaletti, E. R.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Xu, G.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Lawson, K. V.</span></span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sharif%2C+E.+U.%3B+Kalisiak%2C+J.%3B+Miles%2C+D.+H.%3B+Rosen%2C+B.+R.%3B+Debien%2C+L.+P.+P.%3B+Newcomb%2C+E.%3B+Lindsey%2C+E.+A.%3B+Leleti%2C+M.+R.%3B+Chen%2C+A.%3B+Zhao%2C+S.%3B+Young%2C+S.+W.%3B+Walker%2C+N.%3B+Str%C3%A4ter%2C+N.%3B+Scaletti%2C+E.+R.%3B+Jin%2C+L.%3B+Xu%2C+G.%3B+Powers%2C+J.+P.%3B+Lawson%2C+K.+V.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DE.%2BU." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas-Tran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective non-nucleotide small molecule inhibitors of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3935</span>– <span class="NLM_lpage">3955</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01713</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3935-3955&author=J.+W.+Beattyauthor=E.+A.+Lindseyauthor=R.+Thomas-Tranauthor=L.+Debienauthor=D.+Mandalauthor=J.+L.+Jeffreyauthor=A.+T.+Tranauthor=J.+Fournierauthor=S.+D.+Jacobauthor=X.+Yanauthor=S.+L.+Drewauthor=E.+Ginnauthor=A.+Chenauthor=A.+T.+Phamauthor=S.+Zhaoauthor=L.+Jinauthor=S.+W.+Youngauthor=N.+P.+Walkerauthor=M.+R.+Leletiauthor=S.+Moschutzauthor=N.+Straterauthor=J.+P.+Powersauthor=K.+V.+Lawson&title=Discovery+of+potent+and+selective+non-nucleotide+small+molecule+inhibitors+of+CD73&doi=10.1021%2Facs.jmedchem.9b01713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73</span></div><div class="casAuthors">Beatty, Joel W.; Lindsey, Erick A.; Thomas-Tran, Rhiannon; Debien, Laurent; Mandal, Debashis; Jeffrey, Jenna L.; Tran, Anh T.; Fournier, Jeremy; Jacob, Steven D.; Yan, Xuelei; Drew, Samuel L.; Ginn, Elaine; Chen, Ada; Pham, Amber T.; Zhao, Sharon; Jin, Lixia; Young, Stephen W.; Walker, Nigel P.; Leleti, Manmohan Reddy; Moschutz, Susanne; Strater, Norbert; Powers, Jay P.; Lawson, Kenneth V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3935-3955</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 is an extracellular mediator of purinergic signaling.  When upregulated in the tumor microenvironment, CD73 has been implicated in the inhibition of immune function through overprodn. of adenosine.  Traditional efforts to inhibit CD73 have involved antibody therapy or the development of small mols., the most potent of which mimic the acidic and ionizable structure of the enzyme's natural substrate, AMP (AMP).  Here, we report the systematic discovery of a novel class of non-nucleotide CD73 inhibitors that are more potent than all other nonphosphonate inhibitor classes reported to date.  These efforts have culminated in the discovery of 4-({5-[4-fluoro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (73, IC50 = 12 nM) and 4-({5-[4-chloro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (74, IC50 = 19 nM).  Cocrystn. of 74 with human CD73 demonstrates a competitive binding mode.  These compds. show promise for the improvement of drug-like character via the attenuation of the acidity and low membrane permeability inherent to known nucleoside inhibitors of CD73.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxjIt23HCPD7Vg90H21EOLACvtfcHk0lh99gvFRzAiIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D&md5=52f39aa24bfc4e36a2e8218404ab2079</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01713%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DThomas-Tran%26aufirst%3DR.%26aulast%3DDebien%26aufirst%3DL.%26aulast%3DMandal%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DTran%26aufirst%3DA.%2BT.%26aulast%3DFournier%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DS.%2BD.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DDrew%26aufirst%3DS.%2BL.%26aulast%3DGinn%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DPham%26aufirst%3DA.%2BT.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DMoschutz%26aufirst%3DS.%26aulast%3DStrater%26aufirst%3DN.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DLawson%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520non-nucleotide%2520small%2520molecule%2520inhibitors%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3935%26epage%3D3955%26doi%3D10.1021%2Facs.jmedchem.9b01713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Eksterowicz, J.</span>; <span class="NLM_string-name">Fantin, V. R.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Moore, J.</span>; <span class="NLM_string-name">Zavorotinskaya, T.</span>; <span class="NLM_string-name">Blank, B. R.</span>; <span class="NLM_string-name">Rew, Y.</span>; <span class="NLM_string-name">Wu, K.</span>; <span class="NLM_string-name">Zhu, L.</span>; <span class="NLM_string-name">Pham, J.</span>; <span class="NLM_string-name">Kawai, H.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors</span>. Int. Appl. PCT/US2019/030068, WO Patent <span class="NLM_patent">WO2019213174 A1</span>, Nov 7, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=X.+Du&author=J.+Eksterowicz&author=V.+R.+Fantin&author=D.+Sun&author=Q.+Ye&author=J.+Moore&author=T.+Zavorotinskaya&author=B.+R.+Blank&author=Y.+Rew&author=K.+Wu&author=L.+Zhu&author=J.+Pham&author=H.+Kawai&title=CD73+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26atitle%3DCD73%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Orally Bioavailable Small Molecule CD73 Inhibitor Reverses Immunosuppression by Reduction of Adenosine Production</span>.  <i>Proceedings</i>, AACR Annual Meeting (Virtual), Apr 4, 2020; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=X.+Du&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26atitle%3DOrally%2520Bioavailable%2520Small%2520Molecule%2520CD73%2520Inhibitor%2520Reverses%2520Immunosuppression%2520by%2520Reduction%2520of%2520Adenosine%2520Production%26btitle%3DProceedings%26pub%3DAACR%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, T. C.</span>; <span class="NLM_string-name">Blank, B. R.</span>; <span class="NLM_string-name">Chan, B.</span>; <span class="NLM_string-name">Chen, C.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Duong, F.</span>; <span class="NLM_string-name">Fantin, V. R.</span>; <span class="NLM_string-name">Friedman, L. S.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Junttila, M. R.</span>; <span class="NLM_string-name">Moore, J. T.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Sun, J.</span>; <span class="NLM_string-name">Sutimantanapi, D.</span>; <span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Yuen, N.</span>; <span class="NLM_string-name">Zavorotinskaya, T.</span></span> <span> </span><span class="NLM_article-title">Intratumoral Immunosuppression Is Reversed by Blocking Adenosine Production with an Oral Inhibitor of CD73</span>.  <i>Proceedings</i>, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Boston, MA, Oct 27, 2019; <span class="NLM_publisher-name">AACR-NCI-EORTC</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=T.+C.+Metzger&author=B.+R.+Blank&author=B.+Chan&author=C.+Chen&author=Y.+Chen&author=X.+Du&author=F.+Duong&author=V.+R.+Fantin&author=L.+S.+Friedman&author=T.+Huang&author=M.+R.+Junttila&author=J.+T.+Moore&author=D.+Sun&author=J.+Sun&author=D.+Sutimantanapi&author=Q.+Ye&author=N.+Yuen&author=T.+Zavorotinskaya&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DT.%2BC.%26atitle%3DIntratumoral%2520Immunosuppression%2520Is%2520Reversed%2520by%2520Blocking%2520Adenosine%2520Production%2520with%2520an%2520Oral%2520Inhibitor%2520of%2520CD73%26btitle%3DProceedings%26pub%3DAACR-NCI-EORTC%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span>; <span class="NLM_string-name">Yang, H.</span>; <span class="NLM_string-name">Bedke, K.</span>; <span class="NLM_string-name">When, P.</span>; <span class="NLM_string-name">Rizzi, J. P.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors and Uses Thereof</span>. U.S. Patent <span class="NLM_patent">16498338</span>, Apr 16, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=B.+Wang&author=H.+Yang&author=K.+Bedke&author=P.+When&author=J.+P.+Rizzi&title=CD73+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26atitle%3DCD73%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoteimi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahimova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosjean, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cros-Perrial, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttaro, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaloin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordheim, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyrottes, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted 5′-aminoadenosine derivatives and evaluation of their inhibitory potential toward CD73</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1431</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fcmdc.201900348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31264794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVaqtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1431-1443&author=R.+Ghoteimiauthor=V.+T.+Nguyenauthor=R.+Rahimovaauthor=F.+Grosjeanauthor=E.+Cros-Perrialauthor=J.-P.+Uttaroauthor=C.+Matheauthor=L.+Chaloinauthor=L.+P.+Jordheimauthor=S.+Peyrottes&title=Synthesis+of+substituted+5%E2%80%B2-aminoadenosine+derivatives+and+evaluation+of+their+inhibitory+potential+toward+CD73&doi=10.1002%2Fcmdc.201900348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73</span></div><div class="casAuthors">Ghoteimi, Rayane; Nguyen, Van Tai; Rahimova, Rahila; Grosjean, Felix; Cros-Perrial, Emeline; Uttaro, Jean-Pierre; Mathe, Christophe; Chaloin, Laurent; Jordheim, Lars Peter; Peyrottes, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1431-1443</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Derivs. of 5'-aminoadenosine contg. Me carboxylate, Me phosphonate, gem-bisphosphonate, bis(methylphosphonate), and α-carboxylmethylphosphonate or phosphonoacetate moieties were synthesized from key intermediate 5'-aminonucleoside.  These nucleotide analogs were envisaged as 5'-mono- or diphosphate nucleoside mimics.  All compds. were evaluated for CD73 inhibition in a cell-based assay (MDA-MB-231) and toward the purified recombinant protein.  Most of them failed to reach significant inhibition of AMP hydrolysis by CD73 at 100 μM.  Among the new compds., the most interesting candidates, 5 (5'-deoxy-5'-N-phosphonomethyladenosine) and 7 (5'-deoxy-5'-N-(ethoxyphosphorylacetate)adenosine), inhibited recombinant CD73 by 36 and 46 % and cellular CD73 by 61 and 45 % at 100 μM, resp.  Mol. modeling partially explains this lack of activity, as the initially predicted docking scores had been encouraging, esp. for compd. 7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn-sm5uIoznbVg90H21EOLACvtfcHk0lh2YomBxDpzPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVaqtrbM&md5=89bf0ef24f6384afe43ccb3b4e3741d9</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900348%26sid%3Dliteratum%253Aachs%26aulast%3DGhoteimi%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BT.%26aulast%3DRahimova%26aufirst%3DR.%26aulast%3DGrosjean%26aufirst%3DF.%26aulast%3DCros-Perrial%26aufirst%3DE.%26aulast%3DUttaro%26aufirst%3DJ.-P.%26aulast%3DMathe%26aufirst%3DC.%26aulast%3DChaloin%26aufirst%3DL.%26aulast%3DJordheim%26aufirst%3DL.%2BP.%26aulast%3DPeyrottes%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520substituted%25205%25E2%2580%25B2-aminoadenosine%2520derivatives%2520and%2520evaluation%2520of%2520their%2520inhibitory%2520potential%2520toward%2520CD73%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1431%26epage%3D1443%26doi%3D10.1002%2Fcmdc.201900348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sachsenmeier, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, R.</span></span> <span> </span><span class="NLM_article-title">Development of a novel ectonucleotidase assay suitable for high-throughput screening</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1177/1087057112443987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1177%2F1087057112443987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22522649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADC%252BC38rmvFCmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=993-998&author=K.+F.+Sachsenmeierauthor=C.+Hayauthor=E.+Brandauthor=L.+Clarkeauthor=K.+Rosenthalauthor=S.+Guillardauthor=S.+Rustauthor=R.+Minterauthor=R.+Hollingsworth&title=Development+of+a+novel+ectonucleotidase+assay+suitable+for+high-throughput+screening&doi=10.1177%2F1087057112443987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel ectonucleotidase assay suitable for high-throughput screening</span></div><div class="casAuthors">Sachsenmeier Kris F; Hay Carl; Brand Erin; Clarke Lori; Rosenthal Kim; Guillard Sandrine; Rust Steven; Minter Ralph; Hollingsworth Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">993-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">5'-Ectonucleotidase (NT5E) catalyzes the conversion of adenosine monophosphate to adenosine and free phosphate.  The role of this ectonucleotidase and its production of adenosine are linked with immune function, angiogenesis, and cancer.  NT5E activity is typically assayed either by chromatographic quantification of substrates and products using high-performance liquid chromatography (HPLC) or by quantification of free phosphate using malachite green.  These methods are not suitable for robust screening assays of NT5E activity.  HPLC is not readily suitable for the rapid and efficient assay of multiple samples and malachite green is highly sensitive to the phosphate-containing buffers common in various media and sample buffers.  Here the development and validation of a novel high-throughput ectonucleotidase screening assay are described, which makes use of a luciferase-based assay reagent, the Promega CellTiter-Glo kit, to measure the catabolism of AMP by NT5E.  This multiwell plate-based assay facilitates the screening of potential ectonucleotidase antagonists and is unaffected by the presence of contaminating phosphate molecules present in screening samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXoa-zA8OWpiEJCPKhJPuqfW6udTcc2eY8-c0Uxcrh9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rmvFCmtQ%253D%253D&md5=3324780b5f3fcddbe9166ebec1137303</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1177%2F1087057112443987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112443987%26sid%3Dliteratum%253Aachs%26aulast%3DSachsenmeier%26aufirst%3DK.%2BF.%26aulast%3DHay%26aufirst%3DC.%26aulast%3DBrand%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DL.%26aulast%3DRosenthal%26aufirst%3DK.%26aulast%3DGuillard%26aufirst%3DS.%26aulast%3DRust%26aufirst%3DS.%26aulast%3DMinter%26aufirst%3DR.%26aulast%3DHollingsworth%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520ectonucleotidase%2520assay%2520suitable%2520for%2520high-throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D993%26epage%3D998%26doi%3D10.1177%2F1087057112443987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carleton, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, J. L.</span></span> <span> </span><span class="NLM_article-title">Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1042/bj1900421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1042%2Fbj1900421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=6258567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaL3cXmtlGku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1980&pages=421-429&author=J.+D.+Pearsonauthor=J.+S.+Carletonauthor=J.+L.+Gordon&title=Metabolism+of+adenine+nucleotides+by+ectoenzymes+of+vascular+endothelial+and+smooth-muscle+cells+in+culture&doi=10.1042%2Fbj1900421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture</span></div><div class="casAuthors">Pearson, Jeremy D.; Carleton, J. Susan; Gordon, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-9</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Pig aortic endothelial and smooth muscle cells in culture rapidly catabolized exogenous ATP, ADP, and AMP, and in both cell types catabolism was due to Mg-stimulated ectoenzymes (Km 350, 125, and 20-50 μM, resp., in endothelium and 100-50 μM in smooth muscle).  Inhibition and substrate-specificity studies suggested that both cell types possessed 3 distinct ectonucleotidases, namely nucleoside triphosphatase (EC 3.6.1.15), nucleoside diphosphatase (EC 3.6.1.6), and 5'-nucleotidase (EC 3.1.3.5), as well as nucleoside diphosphate kinase (EC 2.7.4.6).  These ectonucleotidase systems may be important in the regulation of neurotransmission, blood platelet function, and vasodilation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXudFznORhvrVg90H21EOLACvtfcHk0ljrJm0D9NbzdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmtlGku78%253D&md5=c7bf5e1b4aaba6b824e530e9a3d22aeb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1042%2Fbj1900421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1900421%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DJ.%2BD.%26aulast%3DCarleton%26aufirst%3DJ.%2BS.%26aulast%3DGordon%26aufirst%3DJ.%2BL.%26atitle%3DMetabolism%2520of%2520adenine%2520nucleotides%2520by%2520ectoenzymes%2520of%2520vascular%2520endothelial%2520and%2520smooth-muscle%2520cells%2520in%2520culture%26jtitle%3DBiochem.%2520J.%26date%3D1980%26volume%3D190%26spage%3D421%26epage%3D429%26doi%3D10.1042%2Fbj1900421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henttinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span> <span> </span><span class="NLM_article-title">Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1096/fj.00-0268com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1096%2Ffj.00-0268com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=11149913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Snsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=251-260&author=G.+G.+Yegutkinauthor=T.+Henttinenauthor=S.+Jalkanen&title=Extracellular+ATP+formation+on+vascular+endothelial+cells+is+mediated+by+ecto-nucleotide+kinase+activities+via+phosphotransfer+reactions&doi=10.1096%2Ffj.00-0268com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions</span></div><div class="casAuthors">Yegutkin, Gennady G.; Henttinen, Tiina; Jalkanen, Sirpa</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Cell surface ecto-nucleotidases are considered the major effector system for inactivation of extracellular adenine nucleotides, whereas the alternative possibility of ATP synthesis has received little attention.  Using a TLC assay, we investigated the main exchange activities of 3H-labeled adenine nucleotides on the cultured human umbilical vein endothelial cells.  Stepwise nucleotide degrdn. to adenosine occurred when a particular nucleotide was present alone, whereas combined cell treatment with ATP and either [3H]AMP or [3H]ADP caused unexpected phosphorylation of 3H-nucleotides via the backward reactions AMP → ADP → ATP.  The following two groups of nucleotide-converting ecto-enzymes were identified based on inhibition and substrate specificity studies: 1) ecto-nucleotidases, ATP-diphosphohydrolase, and 5'-nucleotidase; 2) ecto-nucleotide kinases, adenylate kinase, and nucleoside diphosphate kinase.  Ecto-nucleoside diphosphate kinase possessed the highest activity, as revealed by comparative kinetic anal., and was capable of using both adenine and nonadenine nucleotides as phosphate donors and acceptors.  The transphosphorylation mechanism was confirmed by direct transfer of the γ-phosphate from [γ-32P]ATP to AMP or nucleoside diphosphates and by measurement of extracellular ATP synthesis using luciferin-luciferase luminometry.  The data demonstrate the coexistence of opposite, ATP-consuming and ATP-generating, pathways on the cell surface and provide a novel mechanism for regulating the duration and magnitude of purinergic signaling in the vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqfei6Vec55rVg90H21EOLACvtfcHk0lhxT8ldTVuLBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Snsbc%253D&md5=8217432a87f488f1e303ad8dae035dd2</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1096%2Ffj.00-0268com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.00-0268com%26sid%3Dliteratum%253Aachs%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DHenttinen%26aufirst%3DT.%26aulast%3DJalkanen%26aufirst%3DS.%26atitle%3DExtracellular%2520ATP%2520formation%2520on%2520vascular%2520endothelial%2520cells%2520is%2520mediated%2520by%2520ecto-nucleotide%2520kinase%2520activities%2520via%2520phosphotransfer%2520reactions%26jtitle%3DFASEB%2520J.%26date%3D2001%26volume%3D15%26spage%3D251%26epage%3D260%26doi%3D10.1096%2Ffj.00-0268com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">A new, sensitive ecto-5′-nucleotidase assay for compound screening</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>446</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2013.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ab.2013.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24144488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1ersg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2014&pages=53-58&author=M.+Freundliebauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=A+new%2C+sensitive+ecto-5%E2%80%B2-nucleotidase+assay+for+compound+screening&doi=10.1016%2Fj.ab.2013.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A new, sensitive ecto-5'-nucleotidase assay for compound screening</span></div><div class="casAuthors">Freundlieb, Marianne; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-58</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (eN) is a membrane-bound enzyme that hydrolyzes extracellular nucleoside-5'-monophosphates yielding the resp. nucleoside and phosphate.  Increased levels of eN expression have been obsd. in many cancer cells.  By increasing extracellular adenosine concns., they contribute to their proliferative, angiogenic, metastatic, and immunosuppressive effects.  Therefore, eN is of considerable interest as a novel drug target for the treatment of cancer as well as of inflammatory diseases.  In this study, we developed, optimized, and applied a highly sensitive radiometric assay using [3H]adenosine-5'-monophosphate (AMP) as a substrate.  The reaction product [3H]adenosine was sepd. from [3H]AMP by pptn. of the latter with lanthanum chloride and subsequent filtration through glass fiber filters.  Conditions were optimized to reproducibly collect the [3H]adenosine-contg. filtrate used for quant. detn.  Validation of the assay yielded a mean Z' factor of 0.73, which demonstrates its suitability for high-throughput screening.  The new assay shows a limit of detection that is at least 30-fold lower than those of common colorimetric methods (e.g., optimized malachite green assay and capillary electrophoresis-based assay procedures), and it is also superior to a recently developed luciferase-based assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz9O8R8a38_7Vg90H21EOLACvtfcHk0lhxT8ldTVuLBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1ersg%253D%253D&md5=f7170e77a1b8677721dd8ed3b97e1a11</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DA%2520new%252C%2520sensitive%2520ecto-5%25E2%2580%25B2-nucleotidase%2520assay%2520for%2520compound%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2014%26volume%3D446%26spage%3D53%26epage%3D58%26doi%3D10.1016%2Fj.ab.2013.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationships of α,β-Methylene-ADP Derivatives: Potent and Selective ecto-5′-Nucleotidase Inhibitors</span>. Ph.D. Dissertation, University of Bonn, Bonn, Germany, <span class="NLM_year">2015</span>; <a href="https://hss.ulb.uni-bonn.de/2015/4098/4098.htm" class="extLink">https://hss.ulb.uni-bonn.de/2015/4098/4098.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Bhattarai&title=Synthesis+and+Structure-Activity+Relationships+of+%CE%B1%2C%CE%B2-Methylene-ADP+Derivatives%3A+Potent+and+Selective+ecto-5%E2%80%B2-Nucleotidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationships%2520of%2520%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520Derivatives%253A%2520Potent%2520and%2520Selective%2520ecto-5%25E2%2580%25B2-Nucleotidase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">X-Ray co-crystal structure guides the way to subnanomolar competitive ecto-5′-nucleotidase (CD73) inhibitors for cancer immunotherapy</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1900075</span>, <span class="refDoi"> DOI: 10.1002/adtp.201900075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fadtp.201900075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCjurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2019&pages=1900075&author=S.+Bhattaraiauthor=J.+Pippelauthor=A.+Meyerauthor=M.+Freundliebauthor=C.+Schmiesauthor=A.+Abdelrahmanauthor=A.+Fieneauthor=S.-Y.+Leeauthor=H.+Zimmermannauthor=A.+El-Tayebauthor=G.+G.+Yegutkinauthor=N.+Str%C3%A4terauthor=C.+E.+M%C3%BCller&title=X-Ray+co-crystal+structure+guides+the+way+to+subnanomolar+competitive+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors+for+cancer+immunotherapy&doi=10.1002%2Fadtp.201900075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">X-Ray Co-Crystal Structure Guides the Way to Subnanomolar Competitive Ecto-5'-Nucleotidase (CD73) Inhibitors for Cancer Immunotherapy</span></div><div class="casAuthors">Bhattarai, Sanjay; Pippel, Jan; Meyer, Anne; Freundlieb, Marianne; Schmies, Constanze; Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert; El-Tayeb, Ali; Yegutkin, Gennady G.; Straeter, Norbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Therapeutics (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1900075</span>CODEN:
                <span class="NLM_cas:coden">ATWGAP</span>;
        ISSN:<span class="NLM_cas:issn">2366-3987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (CD73, EC 3.1.3.5) catalyzes the extracellular hydrolysis of AMP yielding adenosine, which induces immunosuppression, angiogenesis, metastasis, and proliferation of cancer cells.  CD73 inhibition is therefore proposed as a novel strategy for cancer (immuno)therapy, and CD73 antibodies are currently undergoing clin. trials.  Despite considerable efforts, the development of small mol. CD73 inhibitors has met with limited success.  To develop a suitable drug candidate, a high resoln. (2.05 Å) co-crystal structure of the CD73 inhibitor PSB-12379, a nucleotide analog, in complex with human CD73 is detd.  This allows the rational design and development of a novel inhibitor (PSB-12489) with subnanomolar inhibitory potency toward human and rat CD73, high selectivity, as well as high metabolic stability.  A co-crystal structure of PSB-12489 with CD73 (1.85 Å) reveals the interactions responsible for increased potency.  PSB-12489 is the most potent CD73 inhibitor to date representing a powerful tool compd. and novel lead structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2d7CK7UeK87Vg90H21EOLACvtfcHk0lioowjdXF1pjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCjurnF&md5=dd24eb1f7b34714c513a8f4523b7d3d5</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fadtp.201900075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadtp.201900075%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DSchmies%26aufirst%3DC.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DX-Ray%2520co-crystal%2520structure%2520guides%2520the%2520way%2520to%2520subnanomolar%2520competitive%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%2520for%2520cancer%2520immunotherapy%26jtitle%3DAdv.%2520Ther.%26date%3D2019%26volume%3D2%26spage%3D1900075%26doi%3D10.1002%2Fadtp.201900075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Junker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobelmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Losenkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irjala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of purine and pyrimidine nucleotides as ecto-5′-nucleotidase (CD73) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3677</span>– <span class="NLM_lpage">3695</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00164</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00164" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltlSmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3677-3695&author=A.+Junkerauthor=C.+Rennauthor=C.+Dobelmannauthor=V.+Namasivayamauthor=S.+Jainauthor=K.+Losenkovaauthor=H.+Irjalaauthor=S.+Ducaauthor=R.+Balasubramanianauthor=S.+Chakrabortyauthor=F.+Borgelauthor=H.+Zimmermannauthor=G.+G.+Yegutkinauthor=C.+E.+M%C3%BCllerauthor=K.+A.+Jacobson&title=Structure-activity+relationship+of+purine+and+pyrimidine+nucleotides+as+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors&doi=10.1021%2Facs.jmedchem.9b00164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors</span></div><div class="casAuthors">Junker, Anna; Renn, Christian; Dobelmann, Clemens; Namasivayam, Vigneshwaran; Jain, Shanu; Losenkova, Karolina; Irjala, Heikki; Duca, Sierra; Balasubramanian, Ramachandran; Chakraborty, Saibal; Borgel, Frederik; Zimmermann, Herbert; Yegutkin, Gennady G.; Muller, Christa E.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3677-3695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cluster of differentiation 73 (CD73) converts AMP to immunosuppressive adenosine, and its inhibition was proposed as a new strategy for cancer treatment.  We synthesized 5'-O-[(phosphonomethyl)phosphonic acid] derivs. of purine and pyrimidine nucleosides, which represent nucleoside diphosphate analogs, and compared their CD73 inhibitory potencies.  In the adenine series, most ribose modifications and 1-deaza and 3-deaza were detrimental, but 7-deaza was tolerated.  Uracil substitution with N3-Me, but not larger groups, or 2-thio, was tolerated. 1,2-Diphosphono-Et modifications were not tolerated.  N4-(Aryl)alkyloxy-cytosine derivs., esp. with bulky benzyloxy substituents, showed increased potency.  Among the most potent inhibitors were the 5'-O-[(phosphonomethyl)phosphonic acid] derivs. of 5-fluorouridine, N4-benzoyl-cytidine, N4-[O-(4-benzyloxy)]-cytidine, and N4-[O-(4-naphth-2-ylmethyloxy)]-cytidine (Ki values 5-10 nM at human CD73).  Selected compds. tested at the two uridine diphosphate-activated P2Y receptor subtypes showed high CD73 selectivity, esp. those with large nucleobase substituents.  These nucleotide analogs are among the most potent CD73 inhibitors reported and may be considered for development as parenteral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosmqsc2IyljbVg90H21EOLACvtfcHk0lioowjdXF1pjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltlSmsb8%253D&md5=374b1862da172f31363dc74a4545661a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00164%26sid%3Dliteratum%253Aachs%26aulast%3DJunker%26aufirst%3DA.%26aulast%3DRenn%26aufirst%3DC.%26aulast%3DDobelmann%26aufirst%3DC.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DLosenkova%26aufirst%3DK.%26aulast%3DIrjala%26aufirst%3DH.%26aulast%3DDuca%26aufirst%3DS.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DBorgel%26aufirst%3DF.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-activity%2520relationship%2520of%2520purine%2520and%2520pyrimidine%2520nucleotides%2520as%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3677%26epage%3D3695%26doi%3D10.1021%2Facs.jmedchem.9b00164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ripphausen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunschweiger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Virtual screening identifies novel sulfonamide inhibitors of <i>ecto</i>-5′-nucleotidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6576</span>– <span class="NLM_lpage">6581</span>, <span class="refDoi"> DOI: 10.1021/jm300658n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300658n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XptF2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6576-6581&author=P.+Ripphausenauthor=M.+Freundliebauthor=A.+Brunschweigerauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCllerauthor=J.+Bajorath&title=Virtual+screening+identifies+novel+sulfonamide+inhibitors+of+ecto-5%E2%80%B2-nucleotidase&doi=10.1021%2Fjm300658n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Identifies Novel Sulfonamide Inhibitors of ecto-5'-Nucleotidase</span></div><div class="casAuthors">Ripphausen, Peter; Freundlieb, Marianne; Brunschweiger, Andreas; Zimmermann, Herbert; Mueller, Christa E.; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6576-6581</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We aimed to identify inhibitors of ecto-5'-nucleotidase (ecto-5'-NT, CD73), a membrane-bound metallophosphoesterase that is implicated in the control of purinergic receptor signaling and a no. of assocd. therapeutically relevant effects.  Currently, only very few compds., including ADP, its more stable analog α,β-methylene-ADP, ATP, and anthraquinone derivs. are known to inhibit this enzyme.  In the search for inhibitors with more drug-like properties, we applied a model structure-based virtual screening approach augmented by chem. similarity searching.  On the basis of this anal., 51 candidate compds. were finally selected for exptl. evaluation.  A total of 13 of these mols. were confirmed to have competitive inhibitory activity.  The most potent inhibitor, 6-chloro-2-oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxylic acid amide (17), showed an IC50 value of 1.90 μM.  In contrast to the nucleotide- and anthraquinone-derived antagonists, the newly identified competitive inhibitors are uncharged at physiol. pH values, possess a drug-like structure, and are structurally distinct from known active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0goFQAkEQe7Vg90H21EOLACvtfcHk0lipLnBVmHfy2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptF2gtL4%253D&md5=106abecfd7469af4be3acfb516d237f5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm300658n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300658n%26sid%3Dliteratum%253Aachs%26aulast%3DRipphausen%26aufirst%3DP.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DBrunschweiger%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DVirtual%2520screening%2520identifies%2520novel%2520sulfonamide%2520inhibitors%2520of%2520ecto-5%25E2%2580%25B2-nucleotidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6576%26epage%3D6581%26doi%3D10.1021%2Fjm300658n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolshoven, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">2-Substituted α,β-methylene-ADP derivatives: potent competitive ecto-5′-nucleotidase (CD73) inhibitors with variable binding modes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2957</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2941-2957&author=S.+Bhattaraiauthor=J.+Pippelauthor=E.+Scalettiauthor=R.+Idrisauthor=M.+Freundliebauthor=G.+Rolshovenauthor=C.+Rennauthor=S.-Y.+Leeauthor=A.+Abdelrahmanauthor=H.+Zimmermannauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=2-Substituted+%CE%B1%2C%CE%B2-methylene-ADP+derivatives%3A+potent+competitive+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors+with+variable+binding+modes&doi=10.1021%2Facs.jmedchem.9b01611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes</span></div><div class="casAuthors">Bhattarai, Sanjay; Pippel, Jan; Scaletti, Emma; Idris, Riham; Freundlieb, Marianne; Rolshoven, Georg; Renn, Christian; Lee, Sang-Yong; Abdelrahman, Aliaa; Zimmermann, Herbert; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2941-2957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 inhibitors are promising drugs for the (immuno)therapy of cancer.  Here, we present the synthesis, structure-activity relationships, and co-crystal structures of novel derivs. of the competitive CD73 inhibitor α,β-methylene-ADP (AOPCP) substituted in the 2-position.  Small polar or lipophilic residues increased potency, 2-iodo- and 2-chloro-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] (15, 16) being the most potent inhibitors with Ki values towards human CD73 of 3-6 nM.  Subject to the size and nature of the 2-substituent, variable binding modes were obsd. by X-ray crystallog.  Depending on the binding mode, large species differences were found, e.g. 2-piperazinyl-AOPCP (21) was >12-fold less potent against rat CD73 compared to human CD73.  This study shows that high CD73-inhibitory potency can be achieved by simply introducing a small substituent into the 2-position of AOPCP without the necessity of addnl. bulky N6-substituents.  Moreover, it provides valuable insights into the binding modes of competitive CD73 inhibitors, representing an excellent basis for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0OpQBzKNX7Vg90H21EOLACvtfcHk0lipLnBVmHfy2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D&md5=453dcd3d41f20b380c951ddf6e05fe3a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01611%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DIdris%26aufirst%3DR.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DRolshoven%26aufirst%3DG.%26aulast%3DRenn%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3D2-Substituted%2520%25CE%25B1%252C%25CE%25B2-methylene-ADP%2520derivatives%253A%2520potent%2520competitive%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%2520with%2520variable%2520binding%2520modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2941%26epage%3D2957%26doi%3D10.1021%2Facs.jmedchem.9b01611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annovazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viglio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iadarola, P.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine 5′-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3270</span>– <span class="NLM_lpage">3276</span>, <span class="refDoi"> DOI: 10.1002/elps.200406057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Felps.200406057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=15472954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFCgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=3270-3276&author=C.+Zanoneauthor=L.+R.+Chiarelliauthor=G.+Valentiniauthor=E.+Peraniauthor=L.+Annovazziauthor=S.+Viglioauthor=P.+Iadarola&title=Pyrimidine+5%E2%80%B2-nucleotidase+activities+detected+in+real+samples+by+means+of+micellar+electrokinetic+chromatography&doi=10.1002%2Felps.200406057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography</span></div><div class="casAuthors">Zanone, Chiara; Chiarelli, Laurent R.; Valentini, Giovanna; Perani, Eleonora; Annovazzi, Laura; Viglio, Simona; Iadarola, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">18-19</span>),
    <span class="NLM_cas:pages">3270-3276</span>CODEN:
                <span class="NLM_cas:coden">ELCTDN</span>;
        ISSN:<span class="NLM_cas:issn">0173-0835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A micellar electrokinetic chromatog. method that allows simultaneous detn. of both nucleotidase and transferase activities of cytosolic 5'-nucleotidase III is presented.  This electrophoretic approach was successfully applied to human erythrocyte lysates to monitor the enzyme activities indicated above, using either physiol. substrate or the nucleoside analog 3'-azido-3'-deoxythymidine as the phosphate acceptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_bdHW9CdBTbVg90H21EOLACvtfcHk0lgRoubdokWieQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFCgtLs%253D&md5=b5d24392721348d35648a9993a96e97e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Felps.200406057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.200406057%26sid%3Dliteratum%253Aachs%26aulast%3DZanone%26aufirst%3DC.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DValentini%26aufirst%3DG.%26aulast%3DPerani%26aufirst%3DE.%26aulast%3DAnnovazzi%26aufirst%3DL.%26aulast%3DViglio%26aufirst%3DS.%26aulast%3DIadarola%26aufirst%3DP.%26atitle%3DPyrimidine%25205%25E2%2580%25B2-nucleotidase%2520activities%2520detected%2520in%2520real%2520samples%2520by%2520means%2520of%2520micellar%2520electrokinetic%2520chromatography%26jtitle%3DElectrophoresis%26date%3D2004%26volume%3D25%26spage%3D3270%26epage%3D3276%26doi%3D10.1002%2Felps.200406057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzeng, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, H. P.</span></span> <span> </span><span class="NLM_article-title">Simultaneous determination of adenosine and its metabolites by capillary electrophoresis as a rapid monitoring tool for 5′-nucleotidase activity</span>. <i>J. Chromatogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1129</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.chroma.2006.08.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.chroma.2006.08.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1129&publication_year=2006&pages=149-152&author=H.+F.+Tzengauthor=C.+H.+Hungauthor=J.+Y.+Wangauthor=C.+H.+Chouauthor=H.+P.+Hung&title=Simultaneous+determination+of+adenosine+and+its+metabolites+by+capillary+electrophoresis+as+a+rapid+monitoring+tool+for+5%E2%80%B2-nucleotidase+activity&doi=10.1016%2Fj.chroma.2006.08.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of adenosine and its metabolites by capillary electrophoresis as a rapid monitoring tool for 5'-nucleotidase activity</span></div><div class="casAuthors">Tzeng, Huey-Fen; Hung, Chao-Hsien; Wang, Jeng-Yu; Chou, Chih-Hong; Hung, Hsueh-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-152</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A simple and rapid capillary electrophoretic method was developed for the simultaneous detn. of micro-molar adenosine, hypoxanthine and inosine in enzyme assays without using radioactive labeled substrates.  Prior to electrophoretic sepn., addn. of acetonitrile and sodium chloride to the assay soln. and brief centrifugation are recommended for the purpose of sample cleanup and sample stacking.  Under the optimal condition, the good sepn. with high efficiency was achieved in 6 min.  Using deoxyadenylate as an internal std., the linear range of the method was 5-200 μM, and the concn. limits of detection of adenosine, hypoxanthine and inosine were 2.2, 3.6 and 1.4 μM, resp.  Application of the proposed method was demonstrated by the activity assay of 5'-nucleotidase from Hep G2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptvdjqKucQ2LVg90H21EOLACvtfcHk0lgRoubdokWieQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWkt7k%253D&md5=78a352a45db61313be563c21959cacb7</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2006.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2006.08.030%26sid%3Dliteratum%253Aachs%26aulast%3DTzeng%26aufirst%3DH.%2BF.%26aulast%3DHung%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DChou%26aufirst%3DC.%2BH.%26aulast%3DHung%26aufirst%3DH.%2BP.%26atitle%3DSimultaneous%2520determination%2520of%2520adenosine%2520and%2520its%2520metabolites%2520by%2520capillary%2520electrophoresis%2520as%2520a%2520rapid%2520monitoring%2520tool%2520for%25205%25E2%2580%25B2-nucleotidase%2520activity%26jtitle%3DJ.%2520Chromatogr.%26date%3D2006%26volume%3D1129%26spage%3D149%26epage%3D152%26doi%3D10.1016%2Fj.chroma.2006.08.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirovsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Capillary electrophoresis-based nanoscale assays for monitoring ecto-5′-nucleotidase activity and inhibition in preparations of recombinant enzyme and melanoma cell membranes</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2007.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ab.2007.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17980347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCks77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=129-140&author=J.+Iqbalauthor=D.+Jirovskyauthor=S.-Y.+Leeauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=Capillary+electrophoresis-based+nanoscale+assays+for+monitoring+ecto-5%E2%80%B2-nucleotidase+activity+and+inhibition+in+preparations+of+recombinant+enzyme+and+melanoma+cell+membranes&doi=10.1016%2Fj.ab.2007.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Capillary electrophoresis-based nanoscale assays for monitoring ecto-5'-nucleotidase activity and inhibition in preparations of recombinant enzyme and melanoma cell membranes</span></div><div class="casAuthors">Iqbal, Jamshed; Jirovsky, David; Lee, Sang-Yong; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-140</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Powerful capillary electrophoresis (CE) methods were developed for monitoring the reaction of ecto-5'-nucleotidase (ecto-5'-NT, CD73), a (patho)biochem. important enzyme that hydrolyzes nucleoside-5'-monophosphates to the corresponding nucleosides.  The enzymic reaction was performed either before injection into the capillary (method A) or directly within the capillary (method B).  In method A, sepn. of substrates and products was achieved within 8 min using an eCAP fused-silica capillary (20 cm effective length, 75 μM i.d., UV detection at 260 nm), 40 mM sodium borate buffer (pH 9.1), normal polarity, and a const. voltage of 15 kV.  In method B, the sandwich technique was applied; substrate dissolved in reaction buffer (10 mM Hepes [pH 7.4], 2 mM MgCl2, and 1 mM CaCl2) was hydrodynamically injected into a fused-silica capillary (30 cm, 75 μM i.d.), followed by enzyme (recombinant rat ecto-5'-NT) and subsequent injection of substrate soln.  The reaction was initiated by the application of 1 kV voltage for 1 min.  The voltage was turned off for 1 min and again turned on at a const. voltage of 15 kV to elute products (nucleosides) within 4 min using borate buffer (40 mM, pH 9.1).  Thus, assays could be performed within 6 min, including enzymic reaction, sepn., and quantification of the formed nucleoside.  The CE methods were used for measuring enzyme kinetics and for assaying inhibitors and substrates.  In addn., the online assay was successfully applied to melanoma cell membrane prepns. natively expressing the human ecto-5'-NT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM8Kd00BurN7Vg90H21EOLACvtfcHk0liqVlmz5bTIvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCks77N&md5=5f6ec78237c4ad6c1632630d66d252a9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2007.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2007.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DJirovsky%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DCapillary%2520electrophoresis-based%2520nanoscale%2520assays%2520for%2520monitoring%2520ecto-5%25E2%2580%25B2-nucleotidase%2520activity%2520and%2520inhibition%2520in%2520preparations%2520of%2520recombinant%2520enzyme%2520and%2520melanoma%2520cell%2520membranes%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D129%26epage%3D140%26doi%3D10.1016%2Fj.ab.2007.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Important Enzymes with Polar Substrates or Products: Characterization by Capillary Electrophoresis and Identification of Inhibitors</span>. Ph.D. Dissertation, University of Bonn, Bonn, Germany, <span class="NLM_year">2014</span>; <a href="https://hss.ulb.uni-bonn.de/2015/3840/3840.htm" class="extLink">https://hss.ulb.uni-bonn.de/2015/3840/3840.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.+Li&title=Therapeutically+Important+Enzymes+with+Polar+Substrates+or+Products%3A+Characterization+by+Capillary+Electrophoresis+and+Identification+of+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26atitle%3DTherapeutically%2520Important%2520Enzymes%2520with%2520Polar%2520Substrates%2520or%2520Products%253A%2520Characterization%2520by%2520Capillary%2520Electrophoresis%2520and%2520Identification%2520of%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Rashida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batool, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejaz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span> <span> </span><span class="NLM_article-title">2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ejmech.2016.02.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=27054295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=484-494&author=M.+Al-Rashidaauthor=G.+Batoolauthor=A.+Sattarauthor=S.+A.+Ejazauthor=S.+Khanauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=A.+Hameedauthor=J.+Iqbal&title=2-Alkoxy-3-%28sulfonylarylaminomethylene%29-chroman-4-ones+as+potent+and+selective+inhibitors+of+ectonucleotidases&doi=10.1016%2Fj.ejmech.2016.02.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases</span></div><div class="casAuthors">al-Rashida, Mariya; Batool, Gazala; Sattar, Almas; Ejaz, Syeda Abida; Khan, Samiullah; Lecka, Joanna; Sevigny, Jean; Hameed, Abdul; Iqbal, Jamshed</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">484-494</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A facile method for the modulation of 2-alkoxy side chain of 3-formylchromone enamines was exploited for the synthesis of a series of 2-alkoxy-3-(sulfonylphenylaminomethylene)-chroman-4-ones I [R1 = H, F, Cl, etc.; R2 = H, Br, Cl; R3 = Me, Et, i-Pr, n-Bu].  This modulation was achieved by simply changing the alc. reaction media from methanol to ethanol, iso-propanol and n-butanol while reacting various 3-formylchromones with aminobenzenesulfonamides.  Alcs. were sufficiently nucleophilic and add into the C2-C3 olefinic bond of 3-formylchromones without causing any ring cleavage.  The resulting compds. I were found to be potent and selective inhibitors of ecto-5'-nucleotidase and alk. phosphatases (TNAP and IAP).  Detailed enzyme kinetics studies revealed competitive inhibition against alk. phosphatases and un-competitive inhibition against rat and human ecto-5'-nucleotidase.  The most active TNAP inhibitor I [R1 = R3 = Me; R2 = H] (Ki = 0.078 ± 0.001 μM), exhibited 28 times more selectivity for TNAP over IAP (Ki = 2.18 ± 0.12 μM).  Compd. I [ R1 = R2 = H; R3 = Me] was most active IAP inhibitor (Ki = 0.24 ± 0.01 μM) and was 300 times more selective towards IAP than TNAP (Ki = 72.9 ± 1.68 μM).  Compd. I [R1 = R2 = H; R3 = CH(CH3)2] was most active human ecto-5'-nucleotidase inhibitor exhibiting inhibition in low nanomolar range (Ki = 14 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjKeGE_sBOrVg90H21EOLACvtfcHk0liqVlmz5bTIvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValtLk%253D&md5=6545b2e44a6ac9683776ad9f37326934</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.073%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Rashida%26aufirst%3DM.%26aulast%3DBatool%26aufirst%3DG.%26aulast%3DSattar%26aufirst%3DA.%26aulast%3DEjaz%26aufirst%3DS.%2BA.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DHameed%26aufirst%3DA.%26aulast%3DIqbal%26aufirst%3DJ.%26atitle%3D2-Alkoxy-3-%2528sulfonylarylaminomethylene%2529-chroman-4-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ectonucleotidases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D484%26epage%3D494%26doi%3D10.1016%2Fj.ejmech.2016.02.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Ator, L. E.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Kiesow, T. J.</span>; <span class="NLM_string-name">Kiesow, T. J.</span>; <span class="NLM_string-name">Lian, Y.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Ridgers, L. H.</span></span> <span> </span><span class="NLM_article-title">Benzothiadiazine Compounds</span>. Int. Appl. PCT/IB2016/057415, WO Patent <span class="NLM_patent">WO2017098421 A1</span>, Jun 15, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=L.+E.+Ator&author=K.+J.+Duffy&author=T.+L.+Graybill&author=T.+J.+Kiesow&author=T.+J.+Kiesow&author=Y.+Lian&author=M.+L.+Moore&author=J.+M.+Ralph&author=L.+H.+Ridgers&title=Benzothiadiazine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DBenzothiadiazine%2520Compounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Neipp, C. E.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Squire, M. D.</span></span> <span> </span><span class="NLM_article-title">5-Sulfamoyl-2-hydroxybenzamide Derivatives</span>. Int. Appl. PCT/IB2017/051399, WO Patent <span class="NLM_patent">WO2017153952 A1</span>, Sep 14, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=K.+J.+Duffy&author=T.+L.+Graybill&author=M.+L.+Moore&author=C.+E.+Neipp&author=J.+M.+Ralph&author=M.+D.+Squire&title=5-Sulfamoyl-2-hydroxybenzamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3D5-Sulfamoyl-2-hydroxybenzamide%2520Derivatives%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, R.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of WO2017098421: GSK’s benzothiazine compounds as CD73 inhibitor filings</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1080/13543776.2018.1407756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1080%2F13543776.2018.1407756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=29166791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGitLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=167-171&author=Y.-P.+Gongauthor=R.-Z.+Wanauthor=Z.-P.+Liu&title=Evaluation+of+WO2017098421%3A+GSK%E2%80%99s+benzothiazine+compounds+as+CD73+inhibitor+filings&doi=10.1080%2F13543776.2018.1407756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings</span></div><div class="casAuthors">Gong, Ya-Ping; Wan, Ren-Zhong; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-171</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">There are considerable interests in the development of novel small-mol. CD73 inhibitors for the treatment of cancers, autoimmune diseases, precancerous syndromes, and other diseases assocd. with CD73 activity.: The application claims novel substituted benzothiadiazine derivs. as CD73 inhibitors for the treatment of cancer, precancerous syndromes, AIDS, autoimmune diseases, infections, atherosclerosis, and ischemia-reperfusion injury.  Many of the exemplified compds. have pIC50 values between 5 to 8.4 against CD73.: These benzothiadiazine derivs. provide good leads for the discovery of potent CD73 inhibitors for the treatment of cancer and other diseases mediated by adenosine and its action on adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx1Q4KYDdU8rVg90H21EOLACvtfcHk0lhRPrqC3w9gdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGitLrO&md5=fff650ec1a8cf93f0f67fb5dd4f05fc0</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1080%2F13543776.2018.1407756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2018.1407756%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.-P.%26aulast%3DWan%26aufirst%3DR.-Z.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DEvaluation%2520of%2520WO2017098421%253A%2520GSK%25E2%2580%2599s%2520benzothiazine%2520compounds%2520as%2520CD73%2520inhibitor%2520filings%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2018%26volume%3D28%26spage%3D167%26epage%3D171%26doi%3D10.1080%2F13543776.2018.1407756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dally, R. D.</span>; <span class="NLM_string-name">Garcia Paredes, M. C.</span>; <span class="NLM_string-name">Heinz, L. J.,  II</span>; <span class="NLM_string-name">Howell, J. M.</span>; <span class="NLM_string-name">Njoroge, F. G.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Zhao, G.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors</span>. Int. Appl. PCT/US2019/019074, WO Patent <span class="NLM_patent">WO2019168744</span>, Sep 6, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=R.+D.+Dally&author=M.+C.+Garcia+Paredes&author=L.+J.+Heinz&author=J.+M.+Howell&author=F.+G.+Njoroge&author=Y.+Wang&author=G.+Zhao&title=CD73+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDally%26aufirst%3DR.%2BD.%26atitle%3DCD73%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McManus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavigan, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vougier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrebola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span> <span> </span><span class="NLM_article-title">A robust multiplex mass spectrometric assay for screening small-molecule inhibitors of CD73 with diverse inhibition modalities</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1177/2472555217750386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1177%2F2472555217750386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=29336194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFCqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=264-273&author=J.+McManusauthor=T.+Heauthor=J.-A.+Gaviganauthor=G.+Marchandauthor=S.+Vougierauthor=O.+Bedelauthor=P.+Ferrariauthor=R.+Arrebolaauthor=T.+Gillespyauthor=R.+C.+Gregoryauthor=S.+Lichtauthor=H.+Chengauthor=B.+Zhangauthor=G.+Deng&title=A+robust+multiplex+mass+spectrometric+assay+for+screening+small-molecule+inhibitors+of+CD73+with+diverse+inhibition+modalities&doi=10.1177%2F2472555217750386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors of CD73 with Diverse Inhibition Modalities</span></div><div class="casAuthors">McManus, Jessica; He, Timothy; Gavigan, Julie-Ann; Marchand, Ghislaine; Vougier, Stephanie; Bedel, Olivier; Ferrari, Paul; Arrebola, Rosalia; Gillespy, Timothy; Gregory, Richard C.; Licht, Stuart; Cheng, Hong; Zhang, Bailin; Deng, Gejing</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">264-273</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">CD73/Ecto-5'-nucleotidase is a membrane-tethered ecto-enzyme that works in tandem with CD39 to convert extracellular ATP (ATP) into adenosine.  CD73 is highly expressed on various types of cancer cells and on infiltrating suppressive immune cells, leading to an elevated concn. of adenosine in the tumor microenvironment, which elicits a strong immunosuppressive effect.  In preclin. studies, targeting CD73 with anti-CD73 antibody results in favorable antitumor effects.  Despite initial studies using antibodies, inhibition of CD73 catalytic activity using small-mol. inhibitors may be more effective in lowering extracellular adenosine due to better tumor penetration and distribution.  To screen small-mol. libraries, we explored multiple approaches, including colorimetric and fluorescent biochem. assays, and due to some limitations with these assays, we developed a mass spectrometry (MS)-based assay.  Only the MS-based assay offers the sensitivity and dynamic range required for screening small-mol. libraries at a substrate concn. close to the Km value of substrate and for evaluating the mode of binding of screening hits.  To achieve a throughput suitable for high-throughput screening (HTS), we developed a RapidFire-tandem mass spectrometry (RF-MS/MS)-based multiplex assay.  This assay allowed a large diverse compd. library to be screened at a speed of 1536 reactions per 40-50 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4jrxzupDntbVg90H21EOLACvtfcHk0lhRPrqC3w9gdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFCqsbk%253D&md5=e4a3e88707a4f4f2ecd0fe73c37cc556</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1177%2F2472555217750386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555217750386%26sid%3Dliteratum%253Aachs%26aulast%3DMcManus%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DGavigan%26aufirst%3DJ.-A.%26aulast%3DMarchand%26aufirst%3DG.%26aulast%3DVougier%26aufirst%3DS.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DFerrari%26aufirst%3DP.%26aulast%3DArrebola%26aufirst%3DR.%26aulast%3DGillespy%26aufirst%3DT.%26aulast%3DGregory%26aufirst%3DR.%2BC.%26aulast%3DLicht%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DG.%26atitle%3DA%2520robust%2520multiplex%2520mass%2520spectrometric%2520assay%2520for%2520screening%2520small-molecule%2520inhibitors%2520of%2520CD73%2520with%2520diverse%2520inhibition%2520modalities%26jtitle%3DSLAS%2520Discovery%26date%3D2018%26volume%3D23%26spage%3D264%26epage%3D273%26doi%3D10.1177%2F2472555217750386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braganhol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamajusuku, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battastini, A. M.</span></span> <span> </span><span class="NLM_article-title">Ecto-5′-Nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1770</i></span>,  <span class="NLM_fpage">1352</span>– <span class="NLM_lpage">1359</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2007.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bbagen.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17643826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1CmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1770&publication_year=2007&pages=1352-1359&author=E.+Braganholauthor=A.+S.+Tamajusukuauthor=A.+Bernardiauthor=M.+R.+Winkauthor=A.+M.+Battastini&title=Ecto-5%E2%80%B2-Nucleotidase%2FCD73+inhibition+by+quercetin+in+the+human+U138MG+glioma+cell+line&doi=10.1016%2Fj.bbagen.2007.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line</span></div><div class="casAuthors">Braganhol, Elizandra; Tamajusuku, Alessandra S. K.; Bernardi, Andressa; Wink, Marcia R.; Battastini, Ana M. O.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1770</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1352-1359</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gliomas are the most malignant of the primary brain tumors.  Nucleotides represent an important class of extracellular mols. that are crucial for the normal function of the nervous system.  ATP and adenosine can stimulate cell proliferation in different glioma cell lines; the events induced by extracellular adenine nucleotides are controlled by the action of ecto-nucleotidases, which hydrolyze ATP into adenosine in the extracellular space.  Recent studies have shown that quercetin has an anti-proliferative effect on the U138MG glioma cell line.  Since evidence suggests that purinergic signaling is involved in the growth and progression of glioma and, taking into consideration the anti-proliferative effect elicited by quercetin in this tumor type, the aim of the present study was to better investigate the extracellular metab. of AMP and evaluate the effect of quercetin on this system in the human U138MG glioma cell line.  The adenine products secreted by glioma cells were first characterized; extracellular AMP was efficiently metabolized by the glioma culture, demonstrating a very active ecto-5'-NT/CD73.  Quercetin was able to inhibit the ecto-5'-NT/CD73 activity and modulate its expression.  In addn., the cell treatment with APCP (α,β-methyleneadenosine-5'-diphosphate), an ecto-5'-NT/CD73 inhibitor, led to a significant redn. in glioma cell proliferation.  We suggest that the inhibition of ecto-5'-NT/CD73 may result in a decrease in extracellular adenosine prodn. with a consequent redn. in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq76-vFDbju7rVg90H21EOLACvtfcHk0lhd1ZS0Xcb-NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1CmsL8%253D&md5=120b4326e880c0780fa7efe48f50fd90</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DBraganhol%26aufirst%3DE.%26aulast%3DTamajusuku%26aufirst%3DA.%2BS.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DWink%26aufirst%3DM.%2BR.%26aulast%3DBattastini%26aufirst%3DA.%2BM.%26atitle%3DEcto-5%25E2%2580%25B2-Nucleotidase%252FCD73%2520inhibition%2520by%2520quercetin%2520in%2520the%2520human%2520U138MG%2520glioma%2520cell%2520line%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2007%26volume%3D1770%26spage%3D1352%26epage%3D1359%26doi%3D10.1016%2Fj.bbagen.2007.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonosaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuchi, A.</span></span> <span> </span><span class="NLM_article-title">New 5′-nucleotidase inhibitors, NPF-86IA, NPF-86IB, NPF-86IIA, and NPF-86IIB from Areca catechu; Part 1. Isolation and biological properties</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1055/s-2006-962487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1055%2Fs-2006-962487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=2849139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaL1MXhtFWksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1988&pages=419-422&author=K.+Uchinoauthor=T.+Matsuoauthor=M.+Iwamotoauthor=Y.+Tonosakiauthor=A.+Fukuchi&title=New+5%E2%80%B2-nucleotidase+inhibitors%2C+NPF-86IA%2C+NPF-86IB%2C+NPF-86IIA%2C+and+NPF-86IIB+from+Areca+catechu%3B+Part+1.+Isolation+and+biological+properties&doi=10.1055%2Fs-2006-962487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">New 5'-nucleotidase inhibitors, NPF-86IA, NPF-86IB, NPF-86IIA, and NPF-86IIB from Areca catechu; Part I.  Isolation and biological properties</span></div><div class="casAuthors">Uchino, Keijiro; Matsuo, Toshiharu; Iwamoto, Masaya; Tonosaki, Yasuhiro; Fukuchi, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">419-22</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    </div><div class="casAbstract">Four bioactive polyphenolic substances (NPF-86IA, NPF-86IB, NPF-86IIA, and NPF-86IIB) that inhibit the 5'-nucleotidase were isolated from the seeds of A. catechu.  These inhibitors were purified by solvent extn., dialysis bag, and reversed-phase HPLC.  Isolation, physicochem. properties, and some biol. activities of these compds. are reported.  They are polyphenolic compds. and inhibit 5'-nucleotidase from snake venom and rat liver membrane.  The av. relative mol. masses of NPF-86IA, -86IB, -86IIA, and -86IIB were estd. to be 5620, 5000, 29,400, and 8610 by GPC anal., resp.  They also showed antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxOeb4kHfOVLVg90H21EOLACvtfcHk0lgfUqZkoVW3GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtFWksr0%253D&md5=11542ea625e75973a98e70dc990c2590</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-962487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-962487%26sid%3Dliteratum%253Aachs%26aulast%3DUchino%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DT.%26aulast%3DIwamoto%26aufirst%3DM.%26aulast%3DTonosaki%26aufirst%3DY.%26aulast%3DFukuchi%26aufirst%3DA.%26atitle%3DNew%25205%25E2%2580%25B2-nucleotidase%2520inhibitors%252C%2520NPF-86IA%252C%2520NPF-86IB%252C%2520NPF-86IIA%252C%2520and%2520NPF-86IIB%2520from%2520Areca%2520catechu%253B%2520Part%25201.%2520Isolation%2520and%2520biological%2520properties%26jtitle%3DPlanta%2520Med.%26date%3D1988%26volume%3D54%26spage%3D419%26epage%3D422%26doi%3D10.1055%2Fs-2006-962487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavutcu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melzig, M. F.</span></span> <span> </span><span class="NLM_article-title">In vitro effects of selected flavonoids on the 5′-nucleotidase activity</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10399192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1MXktVSru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=457-459&author=M.+Kavutcuauthor=M.+F.+Melzig&title=In+vitro+effects+of+selected+flavonoids+on+the+5%E2%80%B2-nucleotidase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro effects of selected flavonoids on the 5'-nucleotidase activity</span></div><div class="casAuthors">Kavutcu, M.; Melzig, Matthias F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazie</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">457-459</span>CODEN:
                <span class="NLM_cas:coden">PHARAT</span>;
        ISSN:<span class="NLM_cas:issn">0031-7144</span>.
    
            (<span class="NLM_cas:orgname">Govi-Verlag Pharmazeutischer Verlag</span>)
        </div><div class="casAbstract">A series of structurally related flavonoids and related compds. were evaluated whether they have inhibitory properties on the 5'-nucleotidase (5'-ribonucleotide phosphohydrolase; EC 3.1.3.5, 5'-NT) activity.  Some of the flavonoids tested inhibit the enzyme such as quercetin, morin, apigenin, chrysin, myricetin, luteolin, diosmetin, (±)naringenin and diosmin.  Rutin, naringin, hyperosid, (±)catechin, caffeic acid and rosmarinic acid had no inhibitory effect on the 5'-NT activity.  Myricetin and quercetin were the most potent inhibitors for 5'-NT with IC50 values of 1.1 and 1.4 μM, resp.  Kinetic anal. showed a mixed type of inhibitor for both myricetin (Ki = 1.5 μM at pH 7.45), and quercetin (Ki = 0.6 μM at pH 7.45).  The Km value for 5'-adenosine monophosphate (5-AMP) was detd. with 77 μM at pH 7.45.  The differential inhibitory potencies of flavonoids seem to be structurally related (hydroxylation pattern).  The results demonstrate that some flavonoids are strong inhibitors of 5'-NT activity which can be correlated to their pharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgp6as4odj4rVg90H21EOLACvtfcHk0lgfUqZkoVW3GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVSru78%253D&md5=dd3a9fe428cd51373b8dfdc944fd60f9</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKavutcu%26aufirst%3DM.%26aulast%3DMelzig%26aufirst%3DM.%2BF.%26atitle%3DIn%2520vitro%2520effects%2520of%2520selected%2520flavonoids%2520on%2520the%25205%25E2%2580%25B2-nucleotidase%2520activity%26jtitle%3DPharmazie%26date%3D1999%26volume%3D54%26spage%3D457%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripphausen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiff, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Development of potent and selective inhibitors of ecto-5′-nucleotidase based on an anthraquinone scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2076</span>– <span class="NLM_lpage">2086</span>, <span class="refDoi"> DOI: 10.1021/jm901851t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901851t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslKnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2076-2086&author=Y.+Baqiauthor=S.-Y.+Leeauthor=J.+Iqbalauthor=P.+Ripphausenauthor=A.+Lehrauthor=A.+B.+Scheiffauthor=H.+Zimmermannauthor=J.+Bajorathauthor=C.+E.+M%C3%BCller&title=Development+of+potent+and+selective+inhibitors+of+ecto-5%E2%80%B2-nucleotidase+based+on+an+anthraquinone+scaffold&doi=10.1021%2Fjm901851t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Potent and Selective Inhibitors of ecto-5'-Nucleotidase Based on an Anthraquinone Scaffold</span></div><div class="casAuthors">Baqi, Younis; Lee, Sang-Yong; Iqbal, Jamshed; Ripphausen, Peter; Lehr, Anne; Scheiff, Anja B.; Zimmermann, Herbert; Bajorath, Jurgen; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2076-2086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-Nucleotidase (eN, CD73) plays a major role in controlling extracellular adenosine levels.  EN inhibitors have potential as novel drugs, for example, for the treatment of cancer.  In the present study, we synthesized and investigated a series of 55 anthraquinone derivs. as potential inhibitors of eN, 11 of which are novel compds. and another 11 of which had previously been described but have now been synthesized by an improved method.  We identified several potent inhibitors of rat eN.  The most potent compds. were 1-amino-4-[4-fluoro-2-carboxyphenylamino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate (PSB-0952, Ki = 260 nM) and 1-amino-4-[2-anthracenylamino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate (PSB-0963, 150 nM), with the latter being the most potent eN inhibitor described to date.  Selected compds. were further characterized and found to exhibit a competitive mechanism of inhibition.  Investigations of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the P2Y receptor subtypes P2Y2, P2Y4, P2Y6, and P2Y12 showed that compd. PSB-0952 exhibited the highest degree of selectivity (>150-fold).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnJKU5mUcJOrVg90H21EOLACvtfcHk0li4e6adU3ZYyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslKnurw%253D&md5=b9e4c62d6423478d5cd4d95f702f689e</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm901851t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901851t%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DRipphausen%26aufirst%3DP.%26aulast%3DLehr%26aufirst%3DA.%26aulast%3DScheiff%26aufirst%3DA.%2BB.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDevelopment%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ecto-5%25E2%2580%25B2-nucleotidase%2520based%2520on%2520an%2520anthraquinone%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2076%26epage%3D2086%26doi%3D10.1021%2Fjm901851t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">945</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1038/nprot.2010.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fnprot.2010.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20431540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVamsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=945-953&author=Y.+Baqiauthor=C.+E.+M%C3%BCller&title=Synthesis+of+alkyl-+and+aryl-amino-substituted+anthraquinone+derivatives+by+microwave-assisted+copper%280%29-catalyzed+Ullmann+coupling+reactions&doi=10.1038%2Fnprot.2010.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of alkyl- and arylamino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions</span></div><div class="casAuthors">Baqi, Younis; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">945-953</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This protocol describes the efficient, generally applicable Ullmann coupling reaction of bromaminic acid with alkyl- or arylamines in phosphate buffer under microwave irradn. using elemental copper as a catalyst.  The reaction leads to a no. of biol. active compds.  As a prototypical example, the synthesis of a new, potent antagonist of human platelet P2Y12 receptors, which has potential as an antithrombotic drug, is described in detail.  The optimized protocol includes a description of an appropriate reaction setup, thin layer chromatog. for monitoring the reaction, and a procedure for the isolation, purifn., and characterization of the anticipated product.  The reaction is performed without the use of a glove box and there is no requirement for an inert atm.  The reaction typically proceeds within 2-30 min; the protocol, including workup, generally takes 1-3 h to complete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJlwRtH9c8TbVg90H21EOLACvtfcHk0li4e6adU3ZYyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVamsbo%253D&md5=4148604240cd7e098fb1050aceb893ed</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2010.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2010.63%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%2520of%2520alkyl-%2520and%2520aryl-amino-substituted%2520anthraquinone%2520derivatives%2520by%2520microwave-assisted%2520copper%25280%2529-catalyzed%2520Ullmann%2520coupling%2520reactions%26jtitle%3DNat.%2520Protoc.%26date%3D2010%26volume%3D5%26spage%3D945%26epage%3D953%26doi%3D10.1038%2Fnprot.2010.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Identification of sulfonic acids as efficient ecto-5′-nucleotidase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ejmech.2013.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24215819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOqur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=685-691&author=J.+Iqbalauthor=A.+Saeedauthor=R.+Razaauthor=A.+Matinauthor=A.+Hameedauthor=N.+Furtmannauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=J.+Bajorath&title=Identification+of+sulfonic+acids+as+efficient+ecto-5%E2%80%B2-nucleotidase+inhibitors&doi=10.1016%2Fj.ejmech.2013.10.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors</span></div><div class="casAuthors">Iqbal, Jamshed; Saeed, Aamer; Raza, Rabia; Matin, Abdul; Hameed, Abdul; Furtmann, Norbert; Lecka, Joanna; Sevigny, Jean; Bajorath, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">685-691</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (CD73) is well known for its implication in cancer.  Inhibition of ecto-5'-nucleotidases is thought to provide an attractive approach to cancer therapy.  This study identifies sulfonic acid compds. as efficient inhibitors of ecto-5'-nucleotidases.  The compds. were tested against recombinant human and rat ecto-5'-nucleotidases.  The most potent new sulfonic acid inhibitor 6-amino-4-hydroxynaphthalene-2-sulfonic acid (1) of ecto-5'-nucleotidase had an IC50 of 1.32 ± 0.09 μM for the human and 10.4 ± 3.3 μM for the rat enzyme.  Generally, all compds. were more active against the human enzyme.  Plausible binding mode models were developed for this new class of inhibitors.  Furthermore, several sulfonic acid inhibitors were efficient cytotoxic agents when tested on H157 cancer cell lines.  Hence, new ecto-5'-nucleotidases inhibitors displayed significant potential for further development as compds. for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTaWZD3jljR7Vg90H21EOLACvtfcHk0liBgfFKu_DL6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOqur3J&md5=60a9a0b81f2acdb7f272ac3cf3a4c872</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DRaza%26aufirst%3DR.%26aulast%3DMatin%26aufirst%3DA.%26aulast%3DHameed%26aufirst%3DA.%26aulast%3DFurtmann%26aufirst%3DN.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520sulfonic%2520acids%2520as%2520efficient%2520ecto-5%25E2%2580%25B2-nucleotidase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D685%26epage%3D691%26doi%3D10.1016%2Fj.ejmech.2013.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brylev, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietzsch, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Polyoxometalates—potent and selective ecto-nucleotidase inhibitors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2014.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bcp.2014.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25449596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGitLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=171-181&author=S.-Y.+Leeauthor=A.+Fieneauthor=W.+Liauthor=T.+Hanckauthor=K.+A.+Brylevauthor=V.+E.+Fedorovauthor=J.+Leckaauthor=A.+Haiderauthor=H.+J.+Pietzschauthor=H.+Zimmermannauthor=J.+S%C3%A9vignyauthor=U.+Kortzauthor=H.+Stephanauthor=C.+E.+M%C3%BCller&title=Polyoxometalates%E2%80%94potent+and+selective+ecto-nucleotidase+inhibitors&doi=10.1016%2Fj.bcp.2014.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Polyoxometalates-Potent and selective ecto-nucleotidase inhibitors</span></div><div class="casAuthors">Lee, Sang-Yong; Fiene, Amelie; Li, Wenjin; Hanck, Theodor; Brylev, Konstantin A.; Fedorov, Vladimir E.; Lecka, Joanna; Haider, Ali; Pietzsch, Hans-Juergen; Zimmermann, Herbert; Sevigny, Jean; Kortz, Ulrich; Stephan, Holger; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Polyoxometalates (POMs) are inorg. cluster metal complexes that possess versatile biol. activities, including antibacterial, anticancer, antidiabetic, and antiviral effects.  Their mechanisms of action at the mol. level are largely unknown.  However, it was suggested that the inhibition of several enzyme families (e.g., phosphatases, protein kinases, or ecto-nucleotidases) by POMs may contribute to their pharmacol. properties.  Ecto-nucleotidases are cell membrane-bound or secreted glycoproteins involved in the hydrolysis of extracellular nucleotides thereby regulating purinergic (and pyrimidinergic) signaling.  They comprise 4 distinct families: ecto-nucleoside triphosphate diphosphohydrolases (NTPDases), ecto-nucleotide pyrophosphatases/phosphodiesterases (NPPs), alk. phosphatases (APs), and ecto-5'-nucleotidase (eN).  In the present study, we evaluated the inhibitory potency of a series of polyoxometalates as well as chalcogenide hexarhenium cluster complexes at a broad range of ecto-nucleotidases.  [Co4(H2O)2(PW9O34)2]10- (5, PSB-POM142) was discovered to be the most potent inhibitor of human NTPDase1 described so far (Ki: 3.88 nM).  Other investigated POMs selectively inhibited human NPP1, [TiW11CoO40]8- (4, PSB-POM141, Ki: 1.46 nM) and [NaSb9W21O86]18- (6, PSB-POM143, Ki: 4.98 nM) representing the most potent and selective human NPP1 inhibitors described to date.  [NaP5W30O110]14- (8, PSB-POM144) strongly inhibited NTPDase1-3 and NPP1 and may therefore be used as a pan-inhibitor to block ATP hydrolysis.  The polyoxoanionic compds. displayed a non-competitive mechanism of inhibition of NPPs and eN, but appeared to be competitive inhibitors of TNAP.  Future in vivo studies with selected inhibitors identified in the current study are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaU1PXTD5qGrVg90H21EOLACvtfcHk0liBgfFKu_DL6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGitLfP&md5=a57c50e30d936ad8ef3b2d616ef55c07</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHanck%26aufirst%3DT.%26aulast%3DBrylev%26aufirst%3DK.%2BA.%26aulast%3DFedorov%26aufirst%3DV.%2BE.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DHaider%26aufirst%3DA.%26aulast%3DPietzsch%26aufirst%3DH.%2BJ.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DKortz%26aufirst%3DU.%26aulast%3DStephan%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DPolyoxometalates%25E2%2580%2594potent%2520and%2520selective%2520ecto-nucleotidase%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D93%26spage%3D171%26epage%3D181%26doi%3D10.1016%2Fj.bcp.2014.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viviani, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccirillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A. T.-d.</span></span> <span> </span><span class="NLM_article-title">Virtual screening approach for the identification of hydroxamic acids as novel human ecto-5′-nucleotidase inhibitors</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.9b00884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.9b00884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFCns7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2020&pages=621-630&author=L.+G.+Vivianiauthor=E.+Piccirilloauthor=H.+Ulrichauthor=A.+T.-d.+Amaral&title=Virtual+screening+approach+for+the+identification+of+hydroxamic+acids+as+novel+human+ecto-5%E2%80%B2-nucleotidase+inhibitors&doi=10.1021%2Facs.jcim.9b00884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5'-Nucleotidase Inhibitors</span></div><div class="casAuthors">Viviani, Lucas G.; Piccirillo, Erika; Ulrich, Henning; Amaral, Antonia T.-do</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">621-630</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (ecto-5'-NT, CD73) is a zinc-binding metallophosphatase that plays a key role in extracellular purinergic pathways, being implicated in several physiol. and pathophysiol. processes, such as immune homeostasis, inflammation, and tumor progression.  As such, it has been recognized as a promising biol. target for many diseases, including cancer, infections, and autoimmune diseases.  Despite its importance, so far only a few inhibitors of this target enzyme are known, most of which are not suitable as drug candidates.  Here, we aimed to search for hydroxamic acid-contg. compds. as potential human ecto-5'-NT inhibitors, since this group is known to be a strong zinc chelator.  To this end, we performed a hierarchical virtual screening (VS) search consisting of three consecutive steps (filtering for compds. bearing a hydroxamic acid group, shape-based matching, and docking followed by visual inspection), which were applied to screen the ZINC-14 database ("all purchasable subset").  Out of 25 compds. selected by this VS protocol, 12 were acquired and further submitted to enzymic assays for VS exptl. validation.  Four of them (i.e., 33.3%) were found to inhibit human ecto-5'-NT in the low micromolar range.  The most potent one showed an IC50 value of 6.2 ± 1.0μM.  All identified inhibitors satisfy drug-like criteria and provide novel scaffolds to be explored in further hit-to-lead optimization steps.  Furthermore, to the best of our knowledge, they are the first hydroxamic acid-contg. inhibitors of human ecto-5'-NT described so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP4Qiu0YGYKLVg90H21EOLACvtfcHk0lgSrJtgC5hnkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFCns7zJ&md5=e27572f72ce511b572a671b2aa4b6448</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.9b00884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.9b00884%26sid%3Dliteratum%253Aachs%26aulast%3DViviani%26aufirst%3DL.%2BG.%26aulast%3DPiccirillo%26aufirst%3DE.%26aulast%3DUlrich%26aufirst%3DH.%26aulast%3DAmaral%26aufirst%3DA.%2BT.-d.%26atitle%3DVirtual%2520screening%2520approach%2520for%2520the%2520identification%2520of%2520hydroxamic%2520acids%2520as%2520novel%2520human%2520ecto-5%25E2%2580%25B2-nucleotidase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2020%26volume%3D60%26spage%3D621%26epage%3D630%26doi%3D10.1021%2Facs.jcim.9b00884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span> </span><span class="NLM_article-title">A Study
of the CD73 Inhibitor LY3475070 Alone or in Combination with
Pembrolizumab in Participants with Advanced Cancer</span>. Last updated May 26, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04148937" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04148937</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0Aof+the+CD73+Inhibitor+LY3475070+Alone+or+in+Combination+with%0APembrolizumab+in+Participants+with+Advanced+Cancer.+Last+updated+May+26%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04148937+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%250Aof%2520the%2520CD73%2520Inhibitor%2520LY3475070%2520Alone%2520or%2520in%2520Combination%2520with%250APembrolizumab%2520in%2520Participants%2520with%2520Advanced%2520Cancer%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, D.</span>; <span class="NLM_string-name">Luu, I.</span>; <span class="NLM_string-name">Udyavar, A.</span>; <span class="NLM_string-name">Fu, L.</span>; <span class="NLM_string-name">Ginn, E.</span>; <span class="NLM_string-name">Lawson, K.</span>; <span class="NLM_string-name">Jeffrey, J.</span>; <span class="NLM_string-name">Leleti, M.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Connor, E.</span>; <span class="NLM_string-name">Pennell, A.</span>; <span class="NLM_string-name">DiRenzo, D.</span>; <span class="NLM_string-name">Piovesan, D.</span>; <span class="NLM_string-name">Tan, B. L.</span>; <span class="NLM_string-name">Garofalo, A.</span>; <span class="NLM_string-name">Berry, W.</span>; <span class="NLM_string-name">Walters, M. J.</span>; <span class="NLM_string-name">Young, S. W.</span>; <span class="NLM_string-name">Yin, F.</span>; <span class="NLM_string-name">Lai, D. W.</span>; <span class="NLM_string-name">Seitz, L.</span></span> <span> </span><span class="NLM_article-title">Phase 1 Safety Study in Healthy Volunteers of AB680, a Small-Molecule Inhibitor of CD73 and Rationale for Combination Therapy in Patients with Gastrointestinal Malignancies</span>. Presented at the 34th Annual Meeting of the Society for Immuno-Therapy of Cancer (SITC), National Harbor, MD, Nov 6–10, <span class="NLM_year">2019</span>; Abstract P379.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+Ashok&author=I.+Luu&author=A.+Udyavar&author=L.+Fu&author=E.+Ginn&author=K.+Lawson&author=J.+Jeffrey&author=M.+Leleti&author=J.+P.+Powers&author=E.+Connor&author=A.+Pennell&author=D.+DiRenzo&author=D.+Piovesan&author=B.+L.+Tan&author=A.+Garofalo&author=W.+Berry&author=M.+J.+Walters&author=S.+W.+Young&author=F.+Yin&author=D.+W.+Lai&author=L.+Seitz&title=Phase+1+Safety+Study+in+Healthy+Volunteers+of+AB680%2C+a+Small-Molecule+Inhibitor+of+CD73+and+Rationale+for+Combination+Therapy+in+Patients+with+Gastrointestinal+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAshok%26aufirst%3DD.%26atitle%3DPhase%25201%2520Safety%2520Study%2520in%2520Healthy%2520Volunteers%2520of%2520AB680%252C%2520a%2520Small-Molecule%2520Inhibitor%2520of%2520CD73%2520and%2520Rationale%2520for%2520Combination%2520Therapy%2520in%2520Patients%2520with%2520Gastrointestinal%2520Malignancies%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9700"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9700'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit9700"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksterowicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutimantanapi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junttila, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable small molecule CD73 inhibitor (OP-5244) reverses immunosuppression through blockade of adenosine production</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=X.+Duauthor=J.+Mooreauthor=B.+R.+Blankauthor=J.+Eksterowiczauthor=D.+Sutimantanapiauthor=N.+Yuenauthor=T.+Metzgerauthor=B.+Chanauthor=T.+Huangauthor=X.+Chenauthor=Y.+Chenauthor=F.+Duongauthor=W.+Kongauthor=J.+H.+Changauthor=J.+Sunauthor=T.+Zavorotinskayaauthor=Q.+Yeauthor=M.+R.+Junttilaauthor=C.+Ndubakuauthor=L.+S.+Friedmanauthor=V.+R.+Fantinauthor=D.+Sun&title=Orally+bioavailable+small+molecule+CD73+inhibitor+%28OP-5244%29+reverses+immunosuppression+through+blockade+of+adenosine+production&doi=10.1021%2Facs.jmedchem.0c01086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9700&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01086%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DB.%2BR.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DSutimantanapi%26aufirst%3DD.%26aulast%3DYuen%26aufirst%3DN.%26aulast%3DMetzger%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDuong%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DJunttila%26aufirst%3DM.%2BR.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DOrally%2520bioavailable%2520small%2520molecule%2520CD73%2520inhibitor%2520%2528OP-5244%2529%2520reverses%2520immunosuppression%2520through%2520blockade%2520of%2520adenosine%2520production%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.0c01086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottalorda-Regairaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberici, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliaou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensussan, A.</span></span> <span> </span><span class="NLM_article-title">ENTPD1/CD39 Is a promising therapeutic target in oncology</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1743</span>– <span class="NLM_lpage">1751</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fonc.2012.269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22751118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVOltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1743-1751&author=J.+Bastidauthor=A.+Cottalorda-Regairazauthor=G.+Albericiauthor=N.+Bonnefoyauthor=J.+F.+Eliaouauthor=A.+Bensussan&title=ENTPD1%2FCD39+Is+a+promising+therapeutic+target+in+oncology&doi=10.1038%2Fonc.2012.269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">ENTPD1/CD39 is a promising therapeutic target in oncology</span></div><div class="casAuthors">Bastid, J.; Cottalorda-Regairaz, A.; Alberici, G.; Bonnefoy, N.; Eliaou, J. F.; Bensussan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1743-1751</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Regulatory T cells (Tregs) are a subpopulation of CD4+ T cells that are essential for maintaining the homeostasis of the immune system, limiting self-reactivity and excessive immune responses against foreign antigens.  In cancer, infiltrated Tregs inhibit the effector lymphocytes and create a favorable environment for the growth of the tumor.  Although Tregs mediate immunosuppression through multiple, non-redundant, cell-contact dependent and independent mechanisms, a growing body of evidence suggests an important role for the CD39-CD73-adenosine pathway.  CD39 ectonucleotidase is the rate-limiting enzyme of a cascade leading to the generation of suppressive adenosine that alters CD4 and CD8 T cell and natural killer cell antitumor activities.  Here, we review the recent literature supporting CD39 as a promising therapeutic target in oncol.  In vitro and in vivo expts. involving knockout models and surrogate inhibitors of CD39 provide evidence in support of the anticancer activity of CD39 inhibition and predict a favorable safety profile for CD39 inhibitory compds.  In addn., we report the ongoing development of CD39-blocking monoclonal antibodies as potential anticancer drugs.  Indeed, CD39 antagonistic antibodies could represent novel therapeutic tools for selectively inhibiting Treg function without depletion, a major limitation of current Treg-targeting strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr50aAvEoL0nrVg90H21EOLACvtfcHk0ljULKANVHeAxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVOltb4%253D&md5=2d0677061e148ff5f114f7a2d4c54419</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.269%26sid%3Dliteratum%253Aachs%26aulast%3DBastid%26aufirst%3DJ.%26aulast%3DCottalorda-Regairaz%26aufirst%3DA.%26aulast%3DAlberici%26aufirst%3DG.%26aulast%3DBonnefoy%26aufirst%3DN.%26aulast%3DEliaou%26aufirst%3DJ.%2BF.%26aulast%3DBensussan%26aufirst%3DA.%26atitle%3DENTPD1%252FCD39%2520Is%2520a%2520promising%2520therapeutic%2520target%2520in%2520oncology%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1743%26epage%3D1751%26doi%3D10.1038%2Fonc.2012.269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandapathil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepanski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szajnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenzner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, T. L.</span></span> <span> </span><span class="NLM_article-title">Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6348</span>– <span class="NLM_lpage">6357</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F1078-0432.CCR-09-1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=19825957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyqsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=6348-6357&author=M.+Mandapathilauthor=M.+J.+Szczepanskiauthor=M.+Szajnikauthor=J.+Renauthor=D.+E.+Lenznerauthor=E.+K.+Jacksonauthor=E.+Gorelikauthor=S.+Langauthor=J.+T.+Johnsonauthor=T.+L.+Whiteside&title=Increased+ectonucleotidase+expression+and+activity+in+regulatory+T+cells+of+patients+with+head+and+neck+cancer&doi=10.1158%2F1078-0432.CCR-09-1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer</span></div><div class="casAuthors">Mandapathil, Magis; Szczepanski, Miroslaw J.; Szajnik, Marta; Ren, Jin; Lenzner, Diana E.; Jackson, Edwin K.; Gorelik, Elieser; Lang, Stephan; Johnson, Jonas T.; Whiteside, Theresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6348-6357</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Regulatory T cell (Treg) frequency and activity are increased in cancer patients and play a major role in tumor escape.  Although disease progression is favored by the presence of Treg, mechanisms used by Treg to suppress antitumor immunity are unknown.  The ectonucleotidases CD39 and CD73 are expressed in Treg and convert ATP into immunosuppressive adenosine.  In this study, the involvement of the adenosinergic pathway in Treg-mediated suppression in head and neck squamous cell carcinoma (HNSCC) patients was evaluated.  Exptl. Design: HNSCC patients with an active disease (n = 19) and patients with no evident disease after therapy (n = 14) were studied.  Ectonucleotidase expression on CD4+ T cells and CD4+CD25high Treg was evaluated by flow cytometry and compared with normal controls.  Ectonucleotidase activity was also compared within these three groups.  The data were analyzed for assocns. of ectonucleotidase expression/function with disease stage.  Results: The percentages and expression levels of CD39 and CD73 in CD4+ T cells and Treg were greater in HNSCC than in normal controls and highest in patients with no evident disease.  Patients' Treg hydrolyzed ATP at higher rates and produced higher levels of adenosine than normal controls' Treg.  The increased frequency and enzymic activity of CD4+CD39+ cells corresponded to increased adenosine-mediated suppression of effector T cells, which was partly inhibited by ARL67156, an ectonucleotidase inhibitor, and by ZM241385, a selective A2a/A2b receptor antagonist.  Conclusions: CD39+Treg frequency and adenosine-mediated suppression are significantly increased in HNSCC patients.  The adenosinergic pathway is involved in Treg-mediated immunosuppression in cancer and its attenuation could be a promising immunotherapeutic strategy for patients with HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYndOcRS70DrVg90H21EOLACvtfcHk0ljULKANVHeAxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyqsLfF&md5=1ebc36ba5441dc792a81690e753fdce0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1143%26sid%3Dliteratum%253Aachs%26aulast%3DMandapathil%26aufirst%3DM.%26aulast%3DSzczepanski%26aufirst%3DM.%2BJ.%26aulast%3DSzajnik%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLenzner%26aufirst%3DD.%2BE.%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DGorelik%26aufirst%3DE.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BT.%26aulast%3DWhiteside%26aufirst%3DT.%2BL.%26atitle%3DIncreased%2520ectonucleotidase%2520expression%2520and%2520activity%2520in%2520regulatory%2520T%2520cells%2520of%2520patients%2520with%2520head%2520and%2520neck%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D6348%26epage%3D6357%26doi%3D10.1158%2F1078-0432.CCR-09-1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandapathil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilldorfer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepanski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czystowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szajnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, T. L.</span></span> <span> </span><span class="NLM_article-title">Generation and accumulation of immunosuppressive adenosine by human CD4<sup>+</sup>CD25<sup>high</sup>FOXP3<sup>+</sup> regulatory T cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">7176</span>– <span class="NLM_lpage">7186</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.047423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1074%2Fjbc.M109.047423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=19858205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFaksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=7176-7186&author=M.+Mandapathilauthor=B.+Hilldorferauthor=M.+J.+Szczepanskiauthor=M.+Czystowskaauthor=M.+Szajnikauthor=J.+Renauthor=S.+Langauthor=E.+K.+Jacksonauthor=E.+Gorelikauthor=T.+L.+Whiteside&title=Generation+and+accumulation+of+immunosuppressive+adenosine+by+human+CD4%2BCD25highFOXP3%2B+regulatory+T+cells&doi=10.1074%2Fjbc.M109.047423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells</span></div><div class="casAuthors">Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J.; Czystowska, Malgorzata; Szajnik, Marta; Ren, Jin; Lang, Stephan; Jackson, Edwin K.; Gorelik, Elieser; Whiteside, Theresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7176-7186</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Naturally occurring regulatory T cells (nTreg) are crucial for maintaining tolerance to self and thus preventing autoimmune diseases and allograft rejections.  In cancer, Treg down-regulate antitumor responses by several distinct mechanisms.  This study analyzes the role the adenosinergic pathway plays in suppressive activities of human nTreg.  Human CD4+CD25highFOXP3+ Treg overexpress CD39 and CD73, ectonucleotidases sequentially converting ATP into AMP and adenosine, which then binds to A2a receptors on effector T cells, suppressing their functions.  CD4+CD39+ and CD4+CD25high T cells express low levels of adenosine deaminase (ADA), the enzyme responsible for adenosine breakdown, and of CD26, a surface-bound glycoprotein assocd. with ADA.  In contrast, T effector cells are enriched in CD26/ADA but express low levels of CD39 and CD73.  Inhibitors of ectonucleotidase activity (e.g. ARL67156) and antagonists of the A2a receptor (e.g. ZM241385) blocked Treg-mediated immunosuppression.  The inhibition of ADA activity on effector T cells enhanced Treg-mediated immunosuppression.  Thus, human nTreg characterized by the presence of CD39 and the low expression of CD26/ADA are responsible for the generation of adenosine, which plays a major role in Treg-mediated immunosuppression.  The data suggest that the adenosinergic pathway represents a potential therapeutic target for regulation of immunosuppression in a broad variety of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkCxeLBuGhILVg90H21EOLACvtfcHk0lgwFCt9TaeJdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFaksrw%253D&md5=bb34f7c663b8107948e4f60e04ddebdc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.047423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.047423%26sid%3Dliteratum%253Aachs%26aulast%3DMandapathil%26aufirst%3DM.%26aulast%3DHilldorfer%26aufirst%3DB.%26aulast%3DSzczepanski%26aufirst%3DM.%2BJ.%26aulast%3DCzystowska%26aufirst%3DM.%26aulast%3DSzajnik%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DGorelik%26aufirst%3DE.%26aulast%3DWhiteside%26aufirst%3DT.%2BL.%26atitle%3DGeneration%2520and%2520accumulation%2520of%2520immunosuppressive%2520adenosine%2520by%2520human%2520CD4%252BCD25highFOXP3%252B%2520regulatory%2520T%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D7176%26epage%3D7186%26doi%3D10.1074%2Fjbc.M109.047423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pulte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broekman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosopoulos, J. H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, A. J.</span></span> <span> </span><span class="NLM_article-title">CD39 Expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia</span>. <i>Clinical Lymphoma, Myeloma and Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.clml.2011.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.clml.2011.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=21816376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGrt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=367-372&author=D.+Pulteauthor=R.+R.+Furmanauthor=M.+J.+Broekmanauthor=J.+H.+F.+Drosopoulosauthor=H.+S.+Ballardauthor=K.+E.+Olsonauthor=J.+R.+Kizerauthor=A.+J.+Marcus&title=CD39+Expression+on+T+lymphocytes+correlates+with+severity+of+disease+in+patients+with+chronic+lymphocytic+leukemia&doi=10.1016%2Fj.clml.2011.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia</span></div><div class="casAuthors">Pulte, Dianne; Furman, Richard R.; Broekman, M. Johan; Drosopoulos, Joan H. F.; Ballard, Harold S.; Olson, Kim E.; Kizer, Jorge R.; Marcus, Aaron J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lymphoma, Myeloma & Leukemia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">367-372</span>CODEN:
                <span class="NLM_cas:coden">CLMLCQ</span>;
        ISSN:<span class="NLM_cas:issn">2152-2650</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Chronic lymphocytic leukemia (CLL) is a B-cell disorder, but it is also assocd. with abnormalities in T-lymphocyte function.  In this study we examine changes in T-lymphocyte CD39 and CD73 expression in patients with CLL.  Methods: Blood samples were drawn from 34 patients with CLL and 31 controls.  The cells were stained for CD3, CD4, CD8, CD19, CD39, and CD73 and analyzed by flow cytometry.  Results: Overall, patients with CLL had a higher percentage of CD39+ T lymphocytes than did controls.  The percentage of cells expressing CD39 was higher in both CD4+ cells and CD8+ cells.  Higher CD3/CD39 expression was assocd. with a later disease stage.  No correlations between T-lymphocyte CD39 levels and CD38 or Zap-70 expression were obsd.  In contrast, the percentage of T lymphocytes and B lymphocytes that expressed CD73 was decreased in patients with CLL.  Av. B-lymphocyte CD73 expression was decreased in CLL because the majority of CLL clones were CD73.  However a minority of CLL clones were CD73+, and patients with CD73+ clones tended to have earlier stage disease.  Conclusion: T-lymphocyte CD39 and CD73 expression may be useful prognostic markers in patients with CLL.  Expression of CD73 on the malignant cell population in CLL may be a marker of better prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyhFRSnxJheLVg90H21EOLACvtfcHk0lgwFCt9TaeJdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGrt77F&md5=0290aba84b6873d5e0d4c2b9732debfd</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.clml.2011.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clml.2011.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DPulte%26aufirst%3DD.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DBroekman%26aufirst%3DM.%2BJ.%26aulast%3DDrosopoulos%26aufirst%3DJ.%2BH.%2BF.%26aulast%3DBallard%26aufirst%3DH.%2BS.%26aulast%3DOlson%26aufirst%3DK.%2BE.%26aulast%3DKizer%26aufirst%3DJ.%2BR.%26aulast%3DMarcus%26aufirst%3DA.%2BJ.%26atitle%3DCD39%2520Expression%2520on%2520T%2520lymphocytes%2520correlates%2520with%2520severity%2520of%2520disease%2520in%2520patients%2520with%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DClinical%2520Lymphoma%252C%2520Myeloma%2520and%2520Leukemia%26date%3D2011%26volume%3D11%26spage%3D367%26epage%3D372%26doi%3D10.1016%2Fj.clml.2011.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">On the mechanism of anti-CD39 immune checkpoint therapy</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e000186</span> <span class="refDoi"> DOI: 10.1136/jitc-2019-000186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1136%2Fjitc-2019-000186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=32098829" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&author=D.+Allardauthor=B.+Allardauthor=J.+Stagg&title=On+the+mechanism+of+anti-CD39+immune+checkpoint+therapy&doi=10.1136%2Fjitc-2019-000186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1136%2Fjitc-2019-000186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjitc-2019-000186%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DOn%2520the%2520mechanism%2520of%2520anti-CD39%2520immune%2520checkpoint%2520therapy%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2020%26volume%3D8%26doi%3D10.1136%2Fjitc-2019-000186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjyoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cszimadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span> <span> </span><span class="NLM_article-title">Disordered purinergic signaling inhibits pathological angiogenesis in <i>Cd39</i>/<i>Entpd1</i>-null mice</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1395</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2007.070190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.2353%2Fajpath.2007.070190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17823293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1SmtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2007&pages=1395-1404&author=S.+W.+Jacksonauthor=T.+Hoshiauthor=Y.+Wuauthor=X.+Sunauthor=K.+Enjyojiauthor=E.+Cszimadiaauthor=C.+Sundbergauthor=S.+C.+Robson&title=Disordered+purinergic+signaling+inhibits+pathological+angiogenesis+in+Cd39%2FEntpd1-null+mice&doi=10.2353%2Fajpath.2007.070190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Disordered purinergic signaling inhibits pathological angiogenesis in Cd39/Entpd1-null mice</span></div><div class="casAuthors">Jackson, Shaun W.; Hoshi, Tomokazu; Wu, Yan; Sun, Xiaofeng; Enjyoji, Keiichi; Cszimadia, Eva; Sundberg, Christian; Robson, Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1395-1404</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">CD39/ecto-nucleoside triphosphate diphosphohydrolase-type-1 (ENTPD1) is the dominant vascular ectonucleotidase that catalyzes the phosphohydrolysis of extracellular nucleotides in the blood and extracellular space.  This ecto-enzymic process modulates endothelial cell, leukocyte, and platelet purinergic receptor-mediated responses to extracellular nucleotides in the setting of thrombosis and vascular inflammation.  We show here that deletion of Cd39/Entpd1 results in abrogation of angiogenesis, causing decreased growth of implanted tumors and inhibiting development of pulmonary metastases.  Qual. abnormalities of Cd39-null endothelial cell adhesion and integrin dysfunction were demonstrated in vitro.  These changes were assocd. with decreased activation of focal adhesion kinase and extracellular signaling-regulated kinase-1 and -2 in endothelial cells.  Our data indicate novel links between CD39/ENTPD1, extracellular nucleotide-mediated signaling, and vascular endothelial cell integrin function that impact on angiogenesis and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF1z2AzfbxBrVg90H21EOLACvtfcHk0ljzWsupALwOyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1SmtrrL&md5=e6fc10b7af795a8cfb3571d9dc72e574</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2007.070190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2007.070190%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BW.%26aulast%3DHoshi%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DEnjyoji%26aufirst%3DK.%26aulast%3DCszimadia%26aufirst%3DE.%26aulast%3DSundberg%26aufirst%3DC.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26atitle%3DDisordered%2520purinergic%2520signaling%2520inhibits%2520pathological%2520angiogenesis%2520in%2520Cd39%252FEntpd1-null%2520mice%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2007%26volume%3D171%26spage%3D1395%26epage%3D1404%26doi%3D10.2353%2Fajpath.2007.070190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjyoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csizmadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span> <span> </span><span class="NLM_article-title">CD39/ENTPD1 Expression by CD4<sup>+</sup> Foxp3<sup>+</sup> regulatory T cells promotes hepatic metastatic tumor growth in mice</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">1030</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2010.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1053%2Fj.gastro.2010.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20546740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2iurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2010&pages=1030-1040&author=X.+Sunauthor=Y.+Wuauthor=W.+Gaoauthor=K.+Enjyojiauthor=E.+Csizmadiaauthor=C.+E.+M%C3%BCllerauthor=T.+Murakamiauthor=S.+C.+Robson&title=CD39%2FENTPD1+Expression+by+CD4%2B+Foxp3%2B+regulatory+T+cells+promotes+hepatic+metastatic+tumor+growth+in+mice&doi=10.1053%2Fj.gastro.2010.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice</span></div><div class="casAuthors">Sun, Xiaofeng; Wu, Yan; Gao, Wenda; Enjyoji, Keiichi; Csizmadia, Eva; Mueller, Christa E.; Murakami, Takashi; Robson, Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1030-1040</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Adenosine mediates immune suppression and is generated by the ectonucleotidases CD39 (ENTPD1) and CD73 that are expressed on vascular endothelial cells and regulatory T cells (Tregs).  Although tumor-infiltrating immune cells include Foxp3+ Tregs, it is not clear whether local adenosine generation by Tregs promotes tumor growth in a CD39-dependent manner.  In this study, we have examd. the effect of CD39 expression by Tregs on effector immune cell responses to hepatic metastases in vivo.  A model of hepatic metastatic cancer was developed with portal vein infusion of luciferase-expressing melanoma B16/F10 cells and MCA38 colon cancer cells in wild-type (wt) and mutant mice null for Cd39.  Chimeric mice were generated by bone marrow transplantation (BMT) using Cd39 null or wt C57BL6 donors and irradiated recipient mice.  We demonstrate that hepatic growth of melanoma metastatic tumors was strongly inhibited in mice with Cd39 null vasculature or in wt mice with circulating Cd39 null bone marrow-derived cells.  We show functional CD39 expression on CD4+Foxp3+ Tregs suppressed antitumor immunity mediated by natural killer (NK) cells in vitro and in vivo.  Finally, inhibition of CD39 activity by polyoxometalate-1, a pharmacol. inhibitor of nucleoside triphosphate diphosphohydrolase activity, significantly inhibited tumor growth (P < .001).  CD39 expression on Tregs inhibits NK activity and is permissive for metastatic growth.  Pharmacol. or targeted inhibition of CD39 enzymic activity may find utility as an adjunct therapy for secondary hepatic malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpryEH4UWfyYLVg90H21EOLACvtfcHk0ljzWsupALwOyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2iurrJ&md5=513fd9d72ebf5c8e26fd2fd6d33f5eb1</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2010.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2010.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DEnjyoji%26aufirst%3DK.%26aulast%3DCsizmadia%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26atitle%3DCD39%252FENTPD1%2520Expression%2520by%2520CD4%252B%2520Foxp3%252B%2520regulatory%2520T%2520cells%2520promotes%2520hepatic%2520metastatic%2520tumor%2520growth%2520in%2520mice%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D139%26spage%3D1030%26epage%3D1040%26doi%3D10.1053%2Fj.gastro.2010.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csizmadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1593/neo.101332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1593%2Fneo.101332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=21390184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Kht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=206-216&author=L.+Fengauthor=X.+Sunauthor=E.+Csizmadiaauthor=L.+Hanauthor=S.+Bianauthor=T.+Murakamiauthor=X.+Wangauthor=S.+C.+Robsonauthor=Y.+Wu&title=Vascular+CD39%2FENTPD1+directly+promotes+tumor+cell+growth+by+scavenging+extracellular+adenosine+triphosphate&doi=10.1593%2Fneo.101332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate</span></div><div class="casAuthors">Feng, Lili; Sun, Xiaofeng; Csizmadia, Eva; Han, Lihui; Bian, Shu; Murakami, Takashi; Wang, Xin; Robson, Simon C.; Wu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-216</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Extracellular ATP is known to boost immune responses in the tumor microenvironment but might also contribute directly to cancer cell death.  CD39/ENTPD1 is the dominant ectonucleotidase expressed by endothelial cells and regulatory T cells and catalyzes the sequential hydrolysis of ATP to AMP that is further degraded to adenosine by CD73/ecto-5'-nucleotidase.  We have previously shown that deletion of Cd39 results in decreased growth of transplanted tumors in mice, as a result of both defective angiogenesis and heightened innate immune responses (secondary to loss of adenosinergic immune suppression).  Whether alterations in local extracellular ATP and adenosine levels as a result of CD39 bioactivity directly affect tumor growth and cytotoxicity has not been investigated to date.  We show here that extracellular ATP exerts antitumor activity by directly inhibiting cell proliferation and promoting cancer cell death.  ATP-induced antiproliferative effects and cell death are, in large part, mediated through P2X7 receptor signaling.  Tumors in Cd39 null mice exhibit increased necrosis in assocn. with P2X7 expression.  We further demonstrate that exogenous sol. NTPDase, or CD39 expression by cocultured liver sinusoidal endothelial cells, stimulates tumor cell proliferation and limits cell death triggered by extracellular ATP.  Collectively, our findings indicate that local expression of CD39 directly promotes tumor cell growth by scavenging extracellular ATP.  Pharmacol. or targeted inhibition of CD39 enzymic activity may find utility as an adjunct therapy in cancer management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3jztkSNuoUrVg90H21EOLACvtfcHk0lgR0usE5BvXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Kht7w%253D&md5=1d4922e913b98fcaa067387de5d7aa84</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1593%2Fneo.101332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.101332%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DCsizmadia%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DBian%26aufirst%3DS.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DVascular%2520CD39%252FENTPD1%2520directly%2520promotes%2520tumor%2520cell%2520growth%2520by%2520scavenging%2520extracellular%2520adenosine%2520triphosphate%26jtitle%3DNeoplasia%26date%3D2011%26volume%3D13%26spage%3D206%26epage%3D216%26doi%3D10.1593%2Fneo.101332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Characterization of rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">11945</span>– <span class="NLM_lpage">11956</span>, <span class="refDoi"> DOI: 10.1021/bi701103y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi701103y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=11945-11956&author=M.+Zebischauthor=N.+Str%C3%A4ter&title=Characterization+of+rat+NTPDase1%2C+-2%2C+and+-3+ectodomains+refolded+from+bacterial+inclusion+bodies&doi=10.1021%2Fbi701103y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Rat NTPDase1, -2, and -3 Ectodomains Refolded from Bacterial Inclusion Bodies</span></div><div class="casAuthors">Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">11945-11956</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecto-nucleoside triphosphate diphosphohydrolases or NTPDases are a family of membrane-bound enzymes that catalyze the sequential removal of γ- and β-phosphate from ATP, ADP, and other nucleotides.  NTPDase1, -2, -3, and -8 are the enzymes responsible for signal conversion and termination in purinergic signaling.  They are anchored to the cytoplasmic membrane by two transmembrane helixes with a large catalytic domain pointing toward the extracellular space.  Here we report the first successful expression and purifn. of the sol. extracellular domains of rat NTPDase1, -2, and -3 from bacterial inclusion bodies.  The refolded proteins show characteristics similar to the wild type enzymes, for example in that they are dependent on divalent metal ions for catalysis and hydrolyze a wide variety of nucleoside tri- and diphosphates, whereas the monophosphate AMP is not further degraded.  Nucleoside triphosphates are hydrolyzed at a higher rate than the corresponding diphosphates.  Other characteristics of the recombinant enzymes however reflect the absence of transmembrane regions and side chain glycosylation.  For example all three enzymes are monomeric and only subtly activated by Mg2+ ions as compared to Ca2+ ions.  Although having a considerably higher specificity const. kcat/Km for ADP as for ATP, the bacterially expressed variant of NTPDase1 in contrast to its wild type counterpart releases intermediate ADP to a substantial amt.  The presented expression system will allow large scale prodn. of active protein suitable for structural studies, development of inhibitors, and even clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq-ID-7je_KrVg90H21EOLACvtfcHk0lgR0usE5BvXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrM&md5=4eb2db0ed05290c45822022ff26ca094</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fbi701103y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701103y%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCharacterization%2520of%2520rat%2520NTPDase1%252C%2520-2%252C%2520and%2520-3%2520ectodomains%2520refolded%2520from%2520bacterial%2520inclusion%2520bodies%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D11945%26epage%3D11956%26doi%3D10.1021%2Fbi701103y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilbronn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.1999.00347.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1046%2Fj.1432-1327.1999.00347.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10231370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1MXjsVyqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1999&pages=102-110&author=P.+Heineauthor=N.+Braunauthor=A.+Heilbronnauthor=H.+Zimmermann&title=Functional+characterization+of+rat+ecto-ATPase+and+ecto-ATP+diphosphohydrolase+after+heterologous+expression+in+CHO+cells&doi=10.1046%2Fj.1432-1327.1999.00347.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells</span></div><div class="casAuthors">Heine, Petra; Braun, Norbert; Heilbronn, Alev; Zimmermann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The recently cloned ecto-ATPase and ecto-apyrase (ecto-ATP diphosphohydrolase) are plasma-membrane-bound enzymes responsible for the extracellular degrdn. of nucleoside 5'-triphosphates and nucleoside 5'-diphosphates.  We expressed the rat-derived enzymes in CHO cells to compare their mol. and functional properties.  Sequence-specific polyclonal antibodies differentiate between the two proteins and reveal identical mol. masses of 70-80 kDa.  Both enzymes are stimulated by either Ca2+ or Mg2+ and reveal a broad substrate specificity towards purine and pyrimidine nucleotides.  Whereas ecto-apyrase hydrolyzes nucleoside 5'-diphosphates at a rate ≈20-30% lower than nucleoside-5'-triphosphates, ecto-ATPase hydrolyzes nucleoside-5'-diphosphates only to a marginal extent.  The sensitivity of the two enzymes to the inhibitors of P2 receptors suramin, PPADS and reactive blue differs.  Hydrolysis of ATP by ecto-ATPase leads to the accumulation in the medium of extracellular ADP as an intermediate product, whereas ecto-apyrase dephosphorylates ATP directly to AMP.  Our results suggest that previous data describing extracellular hydrolysis of ATP by a variety of intact cellular systems with unidentified ecto-nucleotidases may be explained by the coexpression of ecto-ATPase and ecto-apyrase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ELN-KtM5B7Vg90H21EOLACvtfcHk0lgV57SoaEE-bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsVyqtrY%253D&md5=dcc1a94d26d470479c49a16f2a7ea0d1</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00347.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00347.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DN.%26aulast%3DHeilbronn%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DH.%26atitle%3DFunctional%2520characterization%2520of%2520rat%2520ecto-ATPase%2520and%2520ecto-ATP%2520diphosphohydrolase%2520after%2520heterologous%2520expression%2520in%2520CHO%2520cells%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D262%26spage%3D102%26epage%3D110%26doi%3D10.1046%2Fj.1432-1327.1999.00347.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidotti, G.</span></span> <span> </span><span class="NLM_article-title">Soluble apyrases release ADP during ATP hydrolysis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.4555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1006%2Fbbrc.2001.4555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=11263976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFeit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2001&pages=90-95&author=W.+Chenauthor=G.+Guidotti&title=Soluble+apyrases+release+ADP+during+ATP+hydrolysis&doi=10.1006%2Fbbrc.2001.4555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Apyrases Release ADP during ATP Hydrolysis</span></div><div class="casAuthors">Chen, Wei; Guidotti, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-95</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A sol. form of CD39 was expressed and purified from High-Five insect cells.  The sol. CD39 is a monomer with a mol. wt. of 54,000.  The kcat and Km of the purified sol. CD39 were 4.6 s-1 and 12 μM for ATP and 1.3 s-1 and 7 μM for ADP as substrates, resp.  One nucleotide binding site was detected on the monomer only in the presence of Ca2+.  In contrast to the membrane bound CD39, sol. CD39 released ADP as an intermediate during ATP hydrolysis, as did the sol. potato apyrase.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc9xynlyCGZbVg90H21EOLACvtfcHk0lgV57SoaEE-bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFeit7w%253D&md5=14e07f636f9402108c5dd3438af42af5</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.4555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.4555%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGuidotti%26aufirst%3DG.%26atitle%3DSoluble%2520apyrases%2520release%2520ADP%2520during%2520ATP%2520hydrolysis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D282%26spage%3D90%26epage%3D95%26doi%3D10.1006%2Fbbrc.2001.4555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2011.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.jmb.2011.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22100451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2012&pages=288-306&author=M.+Zebischauthor=M.+Kraussauthor=P.+Sch%C3%A4ferauthor=N.+Str%C3%A4ter&title=Crystallographic+evidence+for+a+domain+motion+in+rat+nucleoside+triphosphate+diphosphohydrolase+%28NTPDase%29+1&doi=10.1016%2Fj.jmb.2011.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Evidence for a Domain Motion in Rat Nucleoside Triphosphate Diphosphohydrolase (NTPDase) 1</span></div><div class="casAuthors">Zebisch, Matthias; Krauss, Michel; Schaefer, Petra; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-306</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nucleoside triphosphate diphosphohydrolases (NTPDases) are a physiol. important class of membrane-bound ectonucleotidases responsible for the regulation of extracellular levels of nucleotides.  CD39 or NTPDase1 is the dominant NTPDase of the vasculature.  By hydrolyzing proinflammatory ATP and platelet-activating ADP to AMP, it blocks platelet aggregation and supports blood flow.  Thus, great interest exists in understanding the structure and dynamics of this prototype member of the eukaryotic NTPDase family.  Here, we report the crystal structure of a variant of sol. NTPDase1 lacking a putative membrane interaction loop identified between the two lobes of the catalytic domain.  ATPase and ADPase activities of this variant are detd. via a newly established kinetic isothermal titrn. calorimetry assay and compared to that of the sol. NTPDase1 variant characterized previously.  Complex structures with decavanadate and heptamolybdate show that both polyoxometallates bind electrostatically to a loop that is involved in binding of the nucleobase.  In addn., a comparison of the domain orientations of the four independent proteins in the crystal asym. unit provides the first direct exptl. evidence for a domain motion of NTPDases.  An interdomain rotation angle of up to 7.4° affects the active site cleft between the two lobes of the protein.  Comparison with a previously solved bacterial NTPDase structure indicates that the domains may undergo relative rotational movements of more than 20°.  Our data support the idea that the influence of transmembrane helix dynamics on activity is achieved by coupling to a domain motion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6iK9YVkkerVg90H21EOLACvtfcHk0lgV57SoaEE-bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFyqtw%253D%253D&md5=d6b6b3be6c63324f2ffbe76a5e99afed</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DP.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystallographic%2520evidence%2520for%2520a%2520domain%2520motion%2520in%2520rat%2520nucleoside%2520triphosphate%2520diphosphohydrolase%2520%2528NTPDase%2529%25201%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D415%26spage%3D288%26epage%3D306%26doi%3D10.1016%2Fj.jmb.2011.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivian, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedmaier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Nours, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilce, M. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidberger, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Apice, A. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartland, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossjohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beddoe, T.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a legionella pneumophila ecto-triphosphate diphosphohydrolase, a structural and functional homolog of the eukaryotic NTPDases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/j.str.2009.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.str.2009.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20159467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=228-238&author=J.+P.+Vivianauthor=P.+Riedmaierauthor=H.+Geauthor=J.+Le+Noursauthor=F.+M.+Sansomauthor=M.+C.+J.+Wilceauthor=E.+Byresauthor=M.+Diasauthor=J.+W.+Schmidbergerauthor=P.+J.+Cowanauthor=A.+J.+F.+d%E2%80%99Apiceauthor=E.+L.+Hartlandauthor=J.+Rossjohnauthor=T.+Beddoe&title=Crystal+structure+of+a+legionella+pneumophila+ecto-triphosphate+diphosphohydrolase%2C+a+structural+and+functional+homolog+of+the+eukaryotic+NTPDases&doi=10.1016%2Fj.str.2009.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Legionella pneumophila Ecto -Triphosphate Diphosphohydrolase, A Structural and Functional Homolog of the Eukaryotic NTPDases</span></div><div class="casAuthors">Vivian, Julian P.; Riedmaier, Patrice; Ge, Honghua; Le Nours, Jerome; Sansom, Fiona M.; Wilce, Matthew C. J.; Byres, Emma; Dias, Manisha; Schmidberger, Jason W.; Cowan, Peter J.; d'Apice, Anthony J. F.; Hartland, Elizabeth L.; Rossjohn, Jamie; Beddoe, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">228-238</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many pathogenic bacteria have sophisticated mechanisms to interfere with the mammalian immune response.  These include the disruption of host extracellular ATP levels that, in humans, is tightly regulated by the nucleoside triphosphate diphosphohydrolase family (NTPDases).  NTPDases are found almost exclusively in eukaryotes, the notable exception being their presence in some pathogenic prokaryotes.  To address the function of bacterial NTPDases, we describe the structures of an NTPDase from the pathogen Legionella pneumophila (Lpg1905/Lp1NTPDase) in its apo state and in complex with the ATP analog AMPPNP and the subtype-specific NTPDase inhibitor ARL 67156.  Lp1NTPDase is structurally and catalytically related to eukaryotic NTPDases and the structure provides a basis for NTPDase-specific inhibition.  Furthermore, we demonstrate that the activity of Lp1NTPDase correlates directly with intracellular replication of Legionella within macrophages.  Collectively, these findings provide insight into the mechanism of this enzyme and highlight its role in host-pathogen interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNwKHFnkh7erVg90H21EOLACvtfcHk0ljIvNEzr0VULQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKjs7s%253D&md5=50da4ae0d11a25cd73f0b0d151dba2e9</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DVivian%26aufirst%3DJ.%2BP.%26aulast%3DRiedmaier%26aufirst%3DP.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DLe%2BNours%26aufirst%3DJ.%26aulast%3DSansom%26aufirst%3DF.%2BM.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DByres%26aufirst%3DE.%26aulast%3DDias%26aufirst%3DM.%26aulast%3DSchmidberger%26aufirst%3DJ.%2BW.%26aulast%3DCowan%26aufirst%3DP.%2BJ.%26aulast%3Dd%25E2%2580%2599Apice%26aufirst%3DA.%2BJ.%2BF.%26aulast%3DHartland%26aufirst%3DE.%2BL.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DBeddoe%26aufirst%3DT.%26atitle%3DCrystal%2520structure%2520of%2520a%2520legionella%2520pneumophila%2520ecto-triphosphate%2520diphosphohydrolase%252C%2520a%2520structural%2520and%2520functional%2520homolog%2520of%2520the%2520eukaryotic%2520NTPDases%26jtitle%3DStructure%26date%3D2010%26volume%3D18%26spage%3D228%26epage%3D238%26doi%3D10.1016%2Fj.str.2009.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauble, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystallographic snapshots along the reaction pathway of nucleoside triphosphate diphosphohydrolases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1460</span>– <span class="NLM_lpage">1475</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.str.2013.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23830739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKnsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1460-1475&author=M.+Zebischauthor=M.+Kraussauthor=P.+Sch%C3%A4ferauthor=P.+Laubleauthor=N.+Str%C3%A4ter&title=Crystallographic+snapshots+along+the+reaction+pathway+of+nucleoside+triphosphate+diphosphohydrolases&doi=10.1016%2Fj.str.2013.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Snapshots along the Reaction Pathway of Nucleoside Triphosphate Diphosphohydrolases</span></div><div class="casAuthors">Zebisch, Matthias; Krauss, Michel; Schaefer, Petra; Lauble, Peter; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1460-1475</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In vertebrates, membrane-bound ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) on the cell surface are responsible for signal conversion and termination in purinergic signaling by extracellular nucleotides.  Here the authors present apo and complex structures of the rat NTPDase 2 extracellular domain and Legionella pneumophila NTPDase 1, including a high-resoln. structure with a transition-state analog.  Comparison of ATP and ADP binding modes shows how NTPDases engage the same catalytic site for hydrolysis of nucleoside triphosphates and diphosphates.  This dual specificity is achieved at the expense of base specificity.  Structural and mutational studies indicate that a conserved active-site water is replaced by the phosphate product immediately after phosphoryl transfer.  Partial base specificity for purines in LpNTPDase 1 is based on a different intersubunit base binding site for pyrimidine bases.  A comparison of the bacterial enzyme in six independent crystal forms shows that NTPDases can undergo a domain closure motion of at least 17°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFe_4Yi3ztULVg90H21EOLACvtfcHk0ljIvNEzr0VULQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKnsbnL&md5=fc1194ec941017c13b40a1283752c01a</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DP.%26aulast%3DLauble%26aufirst%3DP.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystallographic%2520snapshots%2520along%2520the%2520reaction%2520pathway%2520of%2520nucleoside%2520triphosphate%2520diphosphohydrolases%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D1460%26epage%3D1475%26doi%3D10.1016%2Fj.str.2013.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Structures of Legionella pneumophila NTPDase1 in complex with polyoxometallates</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>D70</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1107/S1399004714001916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1107%2FS1399004714001916" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D70&publication_year=2014&pages=1147-1154&author=M.+Zebischauthor=M.+Kraussauthor=P.+Sch%C3%A4ferauthor=N.+Str%C3%A4ter&title=Structures+of+Legionella+pneumophila+NTPDase1+in+complex+with+polyoxometallates&doi=10.1107%2FS1399004714001916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1107%2FS1399004714001916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004714001916%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DP.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DStructures%2520of%2520Legionella%2520pneumophila%2520NTPDase1%2520in%2520complex%2520with%2520polyoxometallates%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2014%26volume%3DD70%26spage%3D1147%26epage%3D1154%26doi%3D10.1107%2FS1399004714001916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summers, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oulavallickal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcus, V. L.</span></span> <span> </span><span class="NLM_article-title">Structures and kinetics for plant nucleoside triphosphate diphosphohydrolases support a domain motion catalytic mechanism</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1638</span>, <span class="refDoi"> DOI: 10.1002/pro.3199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fpro.3199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=28543850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=1627-1638&author=E.+L.+Summersauthor=M.+H.+Cummingauthor=T.+Oulavallickalauthor=N.+J.+Robertsauthor=V.+L.+Arcus&title=Structures+and+kinetics+for+plant+nucleoside+triphosphate+diphosphohydrolases+support+a+domain+motion+catalytic+mechanism&doi=10.1002%2Fpro.3199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Structures and kinetics for plant nucleoside triphosphate diphosphohydrolases support a domain motion catalytic mechanism</span></div><div class="casAuthors">Summers, Emma L.; Cumming, Mathew H.; Oulavallickal, Tifany; Roberts, Nicholas J.; Arcus, Vickery L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1627-1638</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Extracellular nucleoside triphosphate diphosphohydrolases (NTPDases) are enzymes that hydrolyze extracellular nucleotides to the resp. monophosphate nucleotides.  In the past 20 years, NTPDases belonging to mammalian, parasitic and prokaryotic domains of life have been discovered, cloned and characterized.  We reveal the first structures of NTPDases from the legume plant species Trifolium repens (7WC) and Vigna unguiculata subsp. cylindrica (DbLNP).  Four crystal structures of 7WC and DbLNP were detd. at resolns. between 1.9 and 2.6 Å.  For 7WC, structures were detd. for an -apo form (1.89 Å) and with the product AMP (2.15 Å) and adenine and phosphate (1.76 Å) bound.  For DbLNP, a structure was solved with phosphate and manganese bound (2.60 Å).  Thorough kinetic data and anal. is presented.  The structure of 7WC and DbLNP reveals that these NTPDases can adopt two conformations depending on the mol. and co-factor bound in the active site.  A central hinge region creates a "butterfly-like" motion of the domains that reduces the width of the inter-domain active site cleft upon mol. binding.  This phenomenon has been previously described in Rattus norvegicus and Legionella pneumophila NTPDaseI and Toxoplasma gondii NTPDaseIII suggesting a common catalytic mechanism across the domains of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphRBpPUkUHu7Vg90H21EOLACvtfcHk0ljDyqQbi2AGPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSnt7k%253D&md5=20b92a2a1fb9ac9ff400c7575211131f</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2Fpro.3199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3199%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DE.%2BL.%26aulast%3DCumming%26aufirst%3DM.%2BH.%26aulast%3DOulavallickal%26aufirst%3DT.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DArcus%26aufirst%3DV.%2BL.%26atitle%3DStructures%2520and%2520kinetics%2520for%2520plant%2520nucleoside%2520triphosphate%2520diphosphohydrolases%2520support%2520a%2520domain%2520motion%2520catalytic%2520mechanism%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D1627%26epage%3D1638%26doi%3D10.1002%2Fpro.3199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Structural insight into activation mechanism of Toxoplasma gondii nucleoside triphosphate diphosphohydrolases by disulfide reduction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">3051</span>– <span class="NLM_lpage">3066</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.294348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1074%2Fjbc.M111.294348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22130673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=3051-3066&author=U.+Krugauthor=M.+Zebischauthor=M.+Kraussauthor=N.+Str%C3%A4ter&title=Structural+insight+into+activation+mechanism+of+Toxoplasma+gondii+nucleoside+triphosphate+diphosphohydrolases+by+disulfide+reduction&doi=10.1074%2Fjbc.M111.294348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insight into Activation Mechanism of Toxoplasma gondii Nucleoside Triphosphate Diphosphohydrolases by Disulfide Reduction</span></div><div class="casAuthors">Krug, Ulrike; Zebisch, Matthias; Krauss, Michel; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3051-3066</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The intracellular parasite Toxoplasma gondii produces two nucleoside triphosphate diphosphohydrolases (NTPDase1 and -3).  These tetrameric, cysteine-rich enzymes require activation by reductive cleavage of a hitherto unknown disulfide bond.  Despite a 97% sequence identity, both isoenzymes differ largely in their ability to hydrolyze ATP and ADP.  Here, we present crystal structures of inactive NTPDase3 as an apo form and in complex with the product AMP to resolns. of 2.0 and 2.2 Å, resp.  We find that the enzyme is present in an open conformation that precludes productive substrate binding and catalysis.  The cysteine bridge 258-268 is identified to be responsible for locking of activity.  Crystal structures of constitutively active variants of NTPDase1 and -3 generated by mutation of Cys258-Cys268 show that opening of the regulatory cysteine bridge induces a pronounced contraction of the whole tetramer.  This is accompanied by a 12° domain closure motion resulting in the correct arrangement of all active site residues.  A complex structure of activated NTPDase3 with a non-hydrolyzable ATP analog and the cofactor Mg2+ to a resoln. of 2.85 Å indicates that catalytic differences between the NTPDases are primarily dictated by differences in positioning of the adenine base caused by substitution of Arg492 and Glu493 in NTPDase1 by glycines in NTPDase3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAQMbHdqPIBLVg90H21EOLACvtfcHk0lgyTd55fwnc-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWjsbs%253D&md5=28ede04f51ed1282e57ec4152053ed89</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.294348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.294348%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DStructural%2520insight%2520into%2520activation%2520mechanism%2520of%2520Toxoplasma%2520gondii%2520nucleoside%2520triphosphate%2520diphosphohydrolases%2520by%2520disulfide%2520reduction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D3051%26epage%3D3066%26doi%3D10.1074%2Fjbc.M111.294348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totzauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">The ATP/ADP substrate specificity switch between <i>Toxoplasma gondii</i> NTPDase1 and NTPDase3 is caused by an altered mode of binding of the substrate base</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2292</span>– <span class="NLM_lpage">2300</span>, <span class="refDoi"> DOI: 10.1002/cbic.201300441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fcbic.201300441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24115522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ns7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=2292-2300&author=U.+Krugauthor=R.+Totzauerauthor=M.+Zebischauthor=N.+Str%C3%A4ter&title=The+ATP%2FADP+substrate+specificity+switch+between+Toxoplasma+gondii+NTPDase1+and+NTPDase3+is+caused+by+an+altered+mode+of+binding+of+the+substrate+base&doi=10.1002%2Fcbic.201300441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">The ATP/ADP Substrate Specificity Switch between Toxoplasma gondii NTPDase1 and NTPDase3 is Caused by an Altered Mode of Binding of the Substrate Base</span></div><div class="casAuthors">Krug, Ulrike; Totzauer, Robert; Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2292-2300</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two nucleoside triphosphate diphosphohydrolase isoforms (NTPDase1 and NTPDase3) are responsible for the hydrolysis of nucleotides by the intracellular protozoan Toxoplasma gondii.  They constitute about 3 % of the total parasite protein.  Despite sharing 97 % sequence identity they exhibit opposite ATP vs. ADP substrate discrimination ratios.  Here we show by mutagenesis that the residues G492/G493 in NTPDase3 and R492/E493 in NTPDase1 are predominantly responsible for the differences in substrate specificity.  Crystal structures of NTPDase1 in complexation with analogs of ATP and ADP reveal that the inverted substrate specificity of NTPDase1 relative to NTPDase3 is achieved by switching from the canonical substrate binding mode to a very different alternative one.  Instead of being stacked on top of a helix of the C-terminal domain the nucleotide base is positioned in the interdomain space between the side chains of R108 and R492, recruited from both domains.  Furthermore, we show that the NTPDase1 substrate specificity is mainly dependent on the presence of the side chain of E493, which causes repositioning of the ribose component of the nucleotide.  All in all, binding by the flexible side chains in the alternative binding mode in NTPDase1 allows for equally good positioning of ATP and ADP with increased activity toward ADP relative to what is seen in the case of NTPDase3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-yrCTB6-66bVg90H21EOLACvtfcHk0lgyTd55fwnc-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ns7zN&md5=a58033e4c88403bb1c500c56b7f5fdd0</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201300441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201300441%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DTotzauer%26aufirst%3DR.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DThe%2520ATP%252FADP%2520substrate%2520specificity%2520switch%2520between%2520Toxoplasma%2520gondii%2520NTPDase1%2520and%2520NTPDase3%2520is%2520caused%2520by%2520an%2520altered%2520mode%2520of%2520binding%2520of%2520the%2520substrate%2520base%26jtitle%3DChemBioChem%26date%3D2013%26volume%3D14%26spage%3D2292%26epage%3D2300%26doi%3D10.1002%2Fcbic.201300441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totzauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of <i>Toxoplasma gondii</i> nucleoside triphosphate diphosphohydrolase 1 represents a conformational intermediate in the reductive activation mechanism of the tetrameric enzyme</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1271</span>– <span class="NLM_lpage">1276</span>, <span class="refDoi"> DOI: 10.1002/prot.24288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fprot.24288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23526564" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=1271-1276&author=U.+Krugauthor=R.+Totzauerauthor=N.+Str%C3%A4ter&title=The+crystal+structure+of+Toxoplasma+gondii+nucleoside+triphosphate+diphosphohydrolase+1+represents+a+conformational+intermediate+in+the+reductive+activation+mechanism+of+the+tetrameric+enzyme&doi=10.1002%2Fprot.24288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1002%2Fprot.24288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24288%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DTotzauer%26aufirst%3DR.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DThe%2520crystal%2520structure%2520of%2520Toxoplasma%2520gondii%2520nucleoside%2520triphosphate%2520diphosphohydrolase%25201%2520represents%2520a%2520conformational%2520intermediate%2520in%2520the%2520reductive%2520activation%2520mechanism%2520of%2520the%2520tetrameric%2520enzyme%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2013%26volume%3D81%26spage%3D1271%26epage%3D1276%26doi%3D10.1002%2Fprot.24288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span> <span> </span><span class="NLM_article-title">Ecto-Nucleotidase inhibitors: recent developments in drug discovery</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.2174/1389557515666150219115141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.2174%2F1389557515666150219115141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25694081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=21-33&author=Y.+Baqi&title=Ecto-Nucleotidase+inhibitors%3A+recent+developments+in+drug+discovery&doi=10.2174%2F1389557515666150219115141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery</span></div><div class="casAuthors">Baqi, Younis</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-33</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotidases are nucleotide metabolizing enzymes that are divided into four different families; nucleoside triphosphate diphosphohydrolases (NTPDases), ecto-5'-nucleotidase (ecto-5'-NT), nucleotide pyrophosphatase/phosphodiesterases (NPPs), and alk. phosphatases (APs).  These enzymes are responsible for the hydrolysis of nucleotidases (nucleoside 5'-triphosphates, 5'-diphosphates and 5'-monophosphates).  Ecto-nucleotidases modulate P1- and P2-receptor-mediated signaling.  Alterations in extracellular nucleotide and adenosine level can increase or decrease P1 and P2 activity.  Potent and selective ligands for certain ectonucleotidase are important as pharmacol. tools to investigate the (patho)physiol. roles of these enzymes.  Furthermore, such ligands are required to study their potential as novel drugs, e.g., as immunomodulatory agents, for the treatment of cancer, cardiovascular or central nervous system disorders.  Hence, this review aims to provide an overview of ecto-nucleotidases inhibitors developed so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5ejE4tvN2JLVg90H21EOLACvtfcHk0lgeCy1rtUUJ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslyhtro%253D&md5=86db310d85dcef37e024fee2e6257566</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.2174%2F1389557515666150219115141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666150219115141%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26atitle%3DEcto-Nucleotidase%2520inhibitors%253A%2520recent%2520developments%2520in%2520drug%2520discovery%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D21%26epage%3D33%26doi%3D10.2174%2F1389557515666150219115141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities</span>. <i>Crit. Rev. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.3109/10409238.2014.953627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.3109%2F10409238.2014.953627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25418535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=473-497&author=G.+G.+Yegutkin&title=Enzymes+involved+in+metabolism+of+extracellular+nucleotides+and+nucleosides%3A+functional+implications+and+measurement+of+activities&doi=10.3109%2F10409238.2014.953627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities</span></div><div class="casAuthors">Yegutkin, Gennady G.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">473-497</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Extracellular nucleotides and nucleosides mediate diverse signaling effects in virtually all organs and tissues.  Most models of purinergic signaling depend on functional interactions between distinct processes, including (1) the release of endogenous ATP and other nucleotides, (2) triggering of signaling events via a series of nucleotide-selective ligand-gated P2X and metabotropic P2Y receptors as well as adenosine receptors, and (3) ectoenzymic interconversion of purinergic agonists.  The duration and magnitude of purinergic signaling is governed by a network of ectoenzymes, including the enzymes of the nucleoside triphosphate diphosphohydrolase family, the nucleotide pyrophosphatase/phosphodiesterase family, ecto-5'-nucleotidase/CD73, tissue-nonspecific alk. phosphatase, prostatic acid phosphatase, and other alk. and acid phosphatases, adenosine deaminase, and purine nucleoside phosphorylase.  Along with "classical" inactivating ectoenzymes, recent data provide evidence for the co-existence of a counteracting ATP-regenerating pathway comprising the enzymes of the adenylate kinase and nucleoside diphosphate kinase families, and ATP synthase.  This review describes recent advances in this field, with special emphasis on purine-converting ectoenzymes as a complex and integrated network regulating purinergic signaling in such (patho)physiol. states as immunomodulation, inflammation, tumorigenesis, arterial calcification, and other diseases.  The 2nd part of this review provides a comprehensive overview and basic principles of major approaches employed for studying purinergic activities, including spectrophotometric Pi-liberating assays, HPLC and TLC analyses of purine substrates and metabolites, capillary electrophoresis, bioluminescent, fluorometric and electrochem. enzyme-coupled assays, histochem. staining, and further emphasizes their advantages, drawbacks and suitability for assaying a particular catalytic reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VtKDi0CkWrVg90H21EOLACvtfcHk0lgeCy1rtUUJ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju7jO&md5=8560668a9acd255cc99f99cdd2d55bef</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.3109%2F10409238.2014.953627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409238.2014.953627%26sid%3Dliteratum%253Aachs%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DEnzymes%2520involved%2520in%2520metabolism%2520of%2520extracellular%2520nucleotides%2520and%2520nucleosides%253A%2520functional%2520implications%2520and%2520measurement%2520of%2520activities%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D49%26spage%3D473%26epage%3D497%26doi%3D10.3109%2F10409238.2014.953627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crack, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beukers, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingall, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKechnie, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span> <span> </span><span class="NLM_article-title">Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb13251.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1111%2Fj.1476-5381.1995.tb13251.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=7533620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK2MXjt12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1995&pages=475-481&author=B.+E.+Crackauthor=C.+E.+Pollardauthor=M.+W.+Beukersauthor=S.+M.+Robertsauthor=S.+F.+Huntauthor=A.+H.+Ingallauthor=K.+C.+McKechnieauthor=A.+P.+Ijzermanauthor=P.+Leff&title=Pharmacological+and+biochemical+analysis+of+FPL+67156%2C+a+novel%2C+selective+inhibitor+of+ecto-ATPase&doi=10.1111%2Fj.1476-5381.1995.tb13251.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase</span></div><div class="casAuthors">Crack, B. E.; Pollard, C. E.; Beukers, M. W.; Roberts, S. M.; Hunt, S. F.; Ingall, A. H.; McKechnie, K. C. W.; IJzerman, A. P.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">475-81</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">FPL 67156 (6-N,N-dimethyl-β,γ-dibromomethylene-D-ATP), is a newly synthesized analog of ATP.  In a rabbit isolated tracheal epithelium prepn., measuring P2U-purinoceptor-dependent chloride secretion, FPL 67156 (6-N,N-dimethyl-,-dibromomethylene--ATP), was discovered to potentiate the responses to UTP but not those to ATP-γ-S.  UTP agonist-concn. effect (E/[A]) curves were shifted to the left by 5-fold in the presence of 100 μM FPL 67156.  The differential effect of FPL 67156 on UTP and ATP-γ-S was hypothesized to be due to the greater susceptibility of UTP to enzymic dephosphorylation and the ability of FPL 67156 to inhibit this process.  FPL 67156 was tested as an ecto-ATPase inhibitor in a human blood cell assay, measuring [γ32P]-ATP dephosphorylation.  The compd. inhibited [γ32P]-ATP degrdn. with a IC50 of 4.6.  FPL 67156 was then tested for its effects on ATP and α,β-methylene-ATP responses at P2X-purinoceptors in the rabbit isolated ear artery.  In the concn. range 30 μM-1 mM, the compd. potentiated the contractile effects of ATP but not those of α,β-methylene-ATP.  At 1 mM, FPL 67156 produced a 34-fold leftward shift of ATP E/[A] curves.  The effects of FPL 67156 on ATP E/[A] curves in the rabbit ear artery were analyzed using a theor. model (R. F. Furchgott, 1972) describing the action of an enzyme inhibitor on the effects of a metabolically unstable agonist.  This anal. provided as est. of the pK1 for FPL 67156 as an ecto-ATPase inhibitor of 5.2.  Using appropriate assays, FPL 67156 was shown to have weak antagonist effects at P2X- and P2T-purinoceptors (pA2 ≈ 3.3 and 3.5 resp.), and weak agonist effects at P2U-purinoceptors (p[A50]≈3.5).  The degree of potentiation of ATP and UTP effect elicited by FPL 67156 confirms previous results concerning the influence that ecto-ATPase has on the position of E/[A] curves for metabolically unstable agonist.  The magnitude of this influence is predicted to have a major effect on the agonist potency orders currently used to designate purinoceptors.  This study indicates FPL 67156 to be a potentially valuable probe in studies on the action of nucleotides and in the classification of purinoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqzLwJkulcorVg90H21EOLACvtfcHk0lgeCy1rtUUJ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt12ltLo%253D&md5=7e2008a719ba5f90bd7525b5fe07e7b8</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb13251.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb13251.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrack%26aufirst%3DB.%2BE.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DHunt%26aufirst%3DS.%2BF.%26aulast%3DIngall%26aufirst%3DA.%2BH.%26aulast%3DMcKechnie%26aufirst%3DK.%2BC.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DPharmacological%2520and%2520biochemical%2520analysis%2520of%2520FPL%252067156%252C%2520a%2520novel%252C%2520selective%2520inhibitor%2520of%2520ecto-ATPase%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D114%26spage%3D475%26epage%3D481%26doi%3D10.1111%2Fj.1476-5381.1995.tb13251.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lévesque, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, É. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigonnesse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fsj.bjp.0707361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17603550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFOjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=141-150&author=S.+A.+L%C3%A9vesqueauthor=%C3%89.+G.+Lavoieauthor=J.+Leckaauthor=F.+Bigonnesseauthor=J.+S%C3%A9vigny&title=Specificity+of+the+ecto-ATPase+inhibitor+ARL+67156+on+human+and+mouse+ectonucleotidases&doi=10.1038%2Fsj.bjp.0707361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases</span></div><div class="casAuthors">Levesque, S. A.; Lavoie, E. G.; Lecka, J.; Bigonnesse, F.; Sevigny, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-150</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ARL 67156, 6-N,N-Diethyl-D-β-γ-dibromomethylene ATP, originally named FPL 67156, is the only com. available inhibitor of ecto-ATPases.  Since the first report on this mol., various ectonucleotidases responsible for the hydrolysis of ATP at the cell surface have been cloned and characterized.  In this work, we identified the ectonucleotidases inhibited by ARL 67156.  The effect of ARL 67156 on recombinant NTPDase1, 2, 3 & 8 (mouse and human), NPP1, NPP3 and ecto-5'-nucleotidase (human) have been evaluated.  The inhibition of the activity of NTPDases (using the substrates ATP, ADP, and UTP), NPPs (pnp-TMP, Ap3A) and ecto-5'-nucleotidase (AMP) was measured by colorimetric or HPLC assays.  ARL 67156 was a weak competitive inhibitor of human NTPDase1, NTPDase3, and NPP1 with Ki of 11 ± 3, 18 ± 4 and 12 ± 3 μM, resp.  At concns. used in the literature (50-100 μM), ARL 67156 partially but significantly inhibited the mouse and human forms of these enzymes.  NTPDase2, NTPDase8, NPP3, and ecto-5'-nucleotidase activities were less affected.  Importantly, ARL 67156 was not hydrolyzed by either human NTPDase1, 2, 3, 8, NPP1, or NPP3.  In cell environments where NTPDase1, NTPDase3, NPP1, or mouse NTPDase8 are present, ARL 67156 would prolong the effect of endogenously released ATP on P2 receptors.  However, ARL 67156 does not block any ectonucleotidases efficiently when high concns. of substrates are present, such as in biochem., pharmacol. or P2X7 assays.  In addn., ARL 67156 is not an effective inhibitor of NTPDase2, human NTPDase8, NPP3, and ecto-5'-nucleotidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokmbpiMn9xO7Vg90H21EOLACvtfcHk0liInC9h3rCQIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFOjurk%253D&md5=99ce076a3d3c615033b63bd81a635bd9</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707361%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A9vesque%26aufirst%3DS.%2BA.%26aulast%3DLavoie%26aufirst%3D%25C3%2589.%2BG.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DBigonnesse%26aufirst%3DF.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3DSpecificity%2520of%2520the%2520ecto-ATPase%2520inhibitor%2520ARL%252067156%2520on%2520human%2520and%2520mouse%2520ectonucleotidases%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D141%26epage%3D150%26doi%3D10.1038%2Fsj.bjp.0707361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbfinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Orleans-Juste, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, A. R.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2239</span>– <span class="NLM_lpage">2247</span>, <span class="refDoi"> DOI: 10.1021/jm000020b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000020b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2239-2247&author=F.+P.+Gendronauthor=E.+Halbfingerauthor=B.+Fischerauthor=M.+Duvalauthor=P.+D%E2%80%99Orleans-Justeauthor=A.+R.+Beaudoin&title=Novel+inhibitors+of+nucleoside+triphosphate+diphosphohydrolases%3A+chemical+synthesis+and+biochemical+and+pharmacological+characterizations&doi=10.1021%2Fjm000020b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of Nucleoside Triphosphate Diphosphohydrolases: Chemical Synthesis and Biochemical and Pharmacological Characterizations</span></div><div class="casAuthors">Gendron, Fernand-Pierre; Halbfinger, Efrat; Fischer, Bilha; Duval, Martine; D'Orleans-Juste, Pedro; Beaudoin, Adrien R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2239-2247</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To elucidate the physiol. role played by nucleoside triphosphate diphosphohydrolase (NTPDase; EC 3.6.1.5), adenine nucleotide analogs, modified on the purine ring, have been synthesized and tested as potential inhibitors.  Resistance of ATP analogs to hydrolysis and their potency as NTPDase inhibitors were evaluated.  For this purpose, a particulate fraction isolated from bovine spleen was used as the enzyme source.  Among the synthesized analogs, 8-thiobutyladenosine 5'-triphosphate (8-BuS-ATP) was found to be the most effective nonhydrolyzable competitive inhibitor, with an estd. Ki of 10 μM.  This nonhydrolyzable analog did not exert any P2X-receptor-mediated effect on endothelium-denuded blood vessels, from the guinea pig mesenteric bed.  In agreement with this observation, infusion of the analog did not cause any significant blood pressure variations of the precontracted vessel.  Because in previous studies on isolated turkey erythrocytes and rat astrocytes 8-BuS-ATP was not able to trigger any P2Y1-receptor-mediated effect, it therefore appears that this NTPDase inhibitor does not interfere with purinergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Em1RrMAf77Vg90H21EOLACvtfcHk0liInC9h3rCQIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVCqurc%253D&md5=b57dfc2d3849854d766cdc0838849d1d</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm000020b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000020b%26sid%3Dliteratum%253Aachs%26aulast%3DGendron%26aufirst%3DF.%2BP.%26aulast%3DHalbfinger%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DDuval%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Orleans-Juste%26aufirst%3DP.%26aulast%3DBeaudoin%26aufirst%3DA.%2BR.%26atitle%3DNovel%2520inhibitors%2520of%2520nucleoside%2520triphosphate%2520diphosphohydrolases%253A%2520chemical%2520synthesis%2520and%2520biochemical%2520and%2520pharmacological%2520characterizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2239%26epage%3D2247%26doi%3D10.1021%2Fjm000020b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillerman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munkonda, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosseau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Satué, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Orléans-Juste, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Künzli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">8-BuS -ATP Derivatives as specific NTPD ase1 inhibitors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1111/bph.12135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1111%2Fbph.12135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23425137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFaksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=179-196&author=J.+Leckaauthor=I.+Gillermanauthor=M.+Faustherauthor=M.+Salemauthor=M.+N.+Munkondaauthor=J.-P.+Brosseauauthor=C.+Cadotauthor=M.+Mart%C3%ADn-Satu%C3%A9author=P.+d%E2%80%99Orl%C3%A9ans-Justeauthor=E.+Rousseauauthor=D.+Poirierauthor=B.+K%C3%BCnzliauthor=B.+Fischerauthor=J.+S%C3%A9vigny&title=8-BuS+-ATP+Derivatives+as+specific+NTPD+ase1+inhibitors&doi=10.1111%2Fbph.12135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">8-BuS-ATP derivatives as specific NTPDase1 inhibitors</span></div><div class="casAuthors">Lecka, Joanna; Gillerman, Irina; Fausther, Michel; Salem, Mabrouka; Munkonda, Mercedes N.; Brosseau, Jean-Philippe; Cadot, Christine; Martin-Satue, Mireia; d'Orleans-Juste, Pedro; Rousseau, Eric; Poirier, Donald; Kunzli, Beat; Fischer, Bilha; Sevigny, Jean</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-196</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Ectonucleotidases control extracellular nucleotide levels and consequently, their (patho)physiol. responses.  Among these enzymes, nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), -2, -3 and -8 are the major ectonucleotidases responsible for nucleotide hydrolysis at the cell surface under physiol. conditions, and NTPDase1 is predominantly located at the surface of vascular endothelial cells and leukocytes.  Efficacious inhibitors of NTPDase1 are required to modulate responses induced by nucleotides in a no. of pathol. situations such as thrombosis, inflammation and cancer.  Exptl. Approach Here, we present the synthesis and enzymic characterization of five 8-BuS-adenine nucleotide derivs. as potent and selective inhibitors of NTPDase1.  Key Results The compds. 8-BuS-AMP, 8-BuS-ADP and 8-BuS-ATP inhibit recombinant human and mouse NTPDase1 by mixed type inhibition, predominantly competitive with Ki values <1 μM.  In contrast to 8-BuS-ATP which could be hydrolyzed by other NTPDases, the other BuS derivs. were resistant to hydrolysis by either NTPDase1, -2, -3 or -8.  8-BuS-AMP and 8-BuS-ADP were the most potent and selective inhibitors of NTPDase1 expressed in human umbilical vein endothelial cells as well as in situ in human and mouse tissues.  As expected, as a result of their inhibition of recombinant human NTPDase1, 8-BuS-AMP and 8-BuS-ADP impaired the ability of this enzyme to block platelet aggregation.  Importantly, neither of these two inhibitors triggered platelet aggregation nor prevented ADP-induced platelet aggregation, in support of their inactivity towards P2Y1 and P2Y12 receptors.  Conclusions and Implications The 8-Bus-AMP and 8-BuS-ADP have therefore potential to serve as drugs for the treatment of pathologies regulated by NTPDase1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4OP6oKkkdv7Vg90H21EOLACvtfcHk0lgLlTCknKpzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFaksrs%253D&md5=b6863b877062e1ab24248949a5c765bd</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fbph.12135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12135%26sid%3Dliteratum%253Aachs%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DGillerman%26aufirst%3DI.%26aulast%3DFausther%26aufirst%3DM.%26aulast%3DSalem%26aufirst%3DM.%26aulast%3DMunkonda%26aufirst%3DM.%2BN.%26aulast%3DBrosseau%26aufirst%3DJ.-P.%26aulast%3DCadot%26aufirst%3DC.%26aulast%3DMart%25C3%25ADn-Satu%25C3%25A9%26aufirst%3DM.%26aulast%3Dd%25E2%2580%2599Orl%25C3%25A9ans-Juste%26aufirst%3DP.%26aulast%3DRousseau%26aufirst%3DE.%26aulast%3DPoirier%26aufirst%3DD.%26aulast%3DK%25C3%25BCnzli%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3D8-BuS%2520-ATP%2520Derivatives%2520as%2520specific%2520NTPD%2520ase1%2520inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D179%26epage%3D196%26doi%3D10.1111%2Fbph.12135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munkonda, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffenstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lévesque, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legendre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, É. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1524</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bcp.2007.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17727821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1524-1534&author=M.+N.+Munkondaauthor=G.+Kauffensteinauthor=F.+Kukulskiauthor=S.+A.+L%C3%A9vesqueauthor=C.+Legendreauthor=J.+Pelletierauthor=%C3%89.+G.+Lavoieauthor=J.+Leckaauthor=J.+S%C3%A9vigny&title=Inhibition+of+human+and+mouse+plasma+membrane+bound+NTPDases+by+P2+receptor+antagonists&doi=10.1016%2Fj.bcp.2007.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists</span></div><div class="casAuthors">Munkonda, Mercedes N.; Kauffenstein, Gilles; Kukulski, Filip; Levesque, Sebastien A.; Legendre, Charlene; Pelletier, Julie; Lavoie, Elise G.; Lecka, Joanna; Sevigny, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1524-1534</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The plasma membrane bound nucleoside triphosphate diphosphohydrolase (NTPDase)-1, 2, 3 and 8 are major ectonucleotidases that modulate P2 receptor signaling by controlling nucleotides' concns. at the cell surface.  In this report, we systematically evaluated the effect of the commonly used P2 receptor antagonists reactive blue 2, suramin, NF279, NF449 and MRS2179, on recombinant human and mouse NTPDase1, 2, 3 and 8.  Enzymic reactions were performed in a Tris/calcium buffer, commonly used to evaluate NTPDase activity, and in a more physiol. Ringer modified buffer.  Although there were some minor variations, there were no major changes either in the enzymic activity or in the profile of NTPDase inhibition between the two buffers.  Except for MRS2179, all other antagonists significantly inhibited these ecto-ATPases; NTPDase3 being the most sensitive to inhibition and NTPDase8 the most resistant.  Estd. IC50 showed that human NTPDases were generally more sensitive to the P2 receptor antagonists tested than the corresponding mouse isoforms.  NF279 and reactive blue 2 were the most potent inhibitors of NTPDases which almost completely abrogated their activity at the concn. of 100 μM.  In conclusion, reactive blue 2, suramin, NF279 and NF449, at the concns. commonly used to antagonize P2 receptors, inhibit the four major ecto-ATPases.  This information may reveal useful for the interpretation of some pharmacol. studies of P2 receptors.  In addn., NF279 is a most potent non-selective NTPDase inhibitor.  Although P2 receptor antagonists do not display a strict selectivity toward NTPDases, their IC50 values may help to discriminate some of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUZK81rygd4rVg90H21EOLACvtfcHk0lgLlTCknKpzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLbO&md5=0c1f2bd829d1ff3197de121f8ee46752</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DMunkonda%26aufirst%3DM.%2BN.%26aulast%3DKauffenstein%26aufirst%3DG.%26aulast%3DKukulski%26aufirst%3DF.%26aulast%3DL%25C3%25A9vesque%26aufirst%3DS.%2BA.%26aulast%3DLegendre%26aufirst%3DC.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DLavoie%26aufirst%3D%25C3%2589.%2BG.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520human%2520and%2520mouse%2520plasma%2520membrane%2520bound%2520NTPDases%2520by%2520P2%2520receptor%2520antagonists%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1524%26epage%3D1534%26doi%3D10.1016%2Fj.bcp.2007.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vollmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1007/s11302-005-8076-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs11302-005-8076-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18404519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFOjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=349-358&author=J.+Iqbalauthor=P.+Vollmayerauthor=N.+Braunauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=A+capillary+electrophoresis+method+for+the+characterization+of+ecto-nucleoside+triphosphate+diphosphohydrolases+%28NTPDases%29+and+the+analysis+of+inhibitors+by+in-capillary+enzymatic+microreaction&doi=10.1007%2Fs11302-005-8076-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction</span></div><div class="casAuthors">Iqbal, Jamshed; Vollmayer, Petra; Braun, Norbert; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-358</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A capillary electrophoresis (CE) method for the characterization of recombinant NTPDase 1, 2, and 3, and for assaying NTPDase inhibitors has been developed performing the enzymic reaction within the capillary.  After hydrodynamic injection of plugs of substrate soln. with or without inhibitor in reaction buffer, followed by a suspension of an enzyme-contg. membrane prepn., and subsequent injection of another plug of substrate soln. with or without inhibitor, the reaction took place close to the capillary inlet.  After 5 min, the electrophoretic sepn. of the reaction products was initiated by applying a const. current of -60 μA.  The method employing a polyacrylamide-coated capillary and reverse polarity mode provided baseline resoln. of substrates and products within a short sepn. time of less than 7 min.  A 50 mM phosphate buffer (pH 6.5) was used for the sepns. and the products were detected by their UV absorbance at 210 nm.  The Michaelis-Menten consts. (Km) for the recombinant rat NTPDases 1, 2, and 3 obtained with this method were consistent with previously reported data.  The inhibition studies revealed pronounced differences in the potency of reactive blue 2, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), suramin, and N6-diethyl-β,γ-dibromomethylene-ATP (ARL67156) towards the NTPDase isoforms.  Notably, ARL67156 does not inhibit all NTPDases, having only a minor inhibitory effect on NTPDase2.  Dipyridamole is not an inhibitor of the NTPDase isoforms investigated.  The new method is fast and accurate, it requires only tiny amts. of material (nanoliter scale), no sample pretreatment and can be fully automated; thus it is clearly superior to the current std. methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo19nvLBa11GbVg90H21EOLACvtfcHk0ljc37LSjlWM8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFOjsbc%253D&md5=6f3f0cd7abad786606c0da956c5d2597</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs11302-005-8076-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-005-8076-x%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DVollmayer%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DN.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DA%2520capillary%2520electrophoresis%2520method%2520for%2520the%2520characterization%2520of%2520ecto-nucleoside%2520triphosphate%2520diphosphohydrolases%2520%2528NTPDases%2529%2520and%2520the%2520analysis%2520of%2520inhibitors%2520by%2520in-capillary%2520enzymatic%2520microreaction%26jtitle%3DPurinergic%2520Signalling%26date%3D2005%26volume%3D1%26spage%3D349%26epage%3D358%26doi%3D10.1007%2Fs11302-005-8076-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1007/s11302-008-9103-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs11302-008-9103-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18528783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=91-106&author=Y.+Baqiauthor=S.+Weylerauthor=J.+Iqbalauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=Structure-activity+relationships+of+anthraquinone+derivatives+derived+from+bromaminic+acid+as+inhibitors+of+ectonucleoside+triphosphate+diphosphohydrolases+%28E-NTPDases%29&doi=10.1007%2Fs11302-008-9103-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)</span></div><div class="casAuthors">Baqi, Younis; Weyler, Stefanie; Iqbal, Jamshed; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-106</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Reactive blue 2 (RB-2) had been characterized as a relatively potent ectonucleoside triphosphate diphosphohydrolase (E-NTPDase) inhibitor with some selectivity for NTPDase3.  In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivs. and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in prepns. of rat NTPDase1, 2, and 3 using a capillary electrophoresis assay.  Several 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinone derivs. inhibited E-NTPDases in a concn.-dependent manner.  The 2-sulfonate group was found to be required for inhibitory activity, since 2-methyl-substituted derivs. were inactive. 1-Amino-2-sulfo-4-p-chloroanilinoanthraquinone (18) was identified as a nonselective competitive blocker of NTPDases1, 2, and 3 (Ki 16-18 μM), while 1-amino-2-sulfo-4-(2-naphthylamino)anthraquinone (21) was a potent inhibitor with preference for NTPDase1 (Ki 0.328 μM) and NTPDase3 (Ki 2.22 μM).  Its isomer, 1-amino-2-sulfo-4-(1-naphthylamino)anthraquinone (20), was a potent and selective inhibitor of rat NTPDase3 (Ki 1.5 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkH7uD3ZbHUrVg90H21EOLACvtfcHk0ljc37LSjlWM8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsrg%253D&md5=de25fc453383eb25a63a101654568c91</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1007%2Fs11302-008-9103-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-008-9103-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DWeyler%26aufirst%3DS.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DStructure-activity%2520relationships%2520of%2520anthraquinone%2520derivatives%2520derived%2520from%2520bromaminic%2520acid%2520as%2520inhibitors%2520of%2520ectonucleoside%2520triphosphate%2520diphosphohydrolases%2520%2528E-NTPDases%2529%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D91%26epage%3D106%26doi%3D10.1007%2Fs11302-008-9103-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Röllich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, H.</span></span> <span> </span><span class="NLM_article-title">Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5947</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bmcl.2006.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=16997558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5943-5947&author=C.+E.+M%C3%BCllerauthor=J.+Iqbalauthor=Y.+Baqiauthor=H.+Zimmermannauthor=A.+R%C3%B6llichauthor=H.+Stephan&title=Polyoxometalates%E2%80%94a+new+class+of+potent+ecto-nucleoside+triphosphate+diphosphohydrolase+%28NTPDase%29+inhibitors&doi=10.1016%2Fj.bmcl.2006.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors</span></div><div class="casAuthors">Mueller, Christa E.; Iqbal, Jamshed; Baqi, Younis; Zimmermann, Herbert; Roellich, Anita; Stephan, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5943-5947</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Polyoxotungstates were identified as potent inhibitors of NTPDases1, 2, and 3.  The most potent compd. was K6H2[TiW11CoO40], exhibiting Ki values of 0.140 μM (NTPDase1), 0.910 μM (NTPDase2), and 0.563 μM (NTPDase3).  One of the compds., (NH4)18[NaSb9W21O86], was selective for NTPDases2 and 3 vs. NTPDase1.  NTPDase inhibition might contribute to the described biol. effects of polyoxometalates, including their anti-cancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrohfjAgJjdRLVg90H21EOLACvtfcHk0lj-M593-WGuyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrjN&md5=a33eed1259670c2ce562e53a199c0530</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DR%25C3%25B6llich%26aufirst%3DA.%26aulast%3DStephan%26aufirst%3DH.%26atitle%3DPolyoxometalates%25E2%2580%2594a%2520new%2520class%2520of%2520potent%2520ecto-nucleoside%2520triphosphate%2520diphosphohydrolase%2520%2528NTPDase%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5943%26epage%3D5947%26doi%3D10.1016%2Fj.bmcl.2006.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbronn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laucher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">CD39/Ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1784</span>– <span class="NLM_lpage">1794</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.690180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1161%2FCIRCULATIONAHA.107.690180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17909107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADC%252BD2snhtlansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=1784-1794&author=D.+K%C3%B6hlerauthor=T.+Eckleauthor=M.+Faigleauthor=A.+Grenzauthor=M.+Mittelbronnauthor=S.+Laucherauthor=M.+L.+Hartauthor=S.+C.+Robsonauthor=C.+E.+M%C3%BCllerauthor=H.+K.+Eltzschig&title=CD39%2FEctonucleoside+triphosphate+diphosphohydrolase+1+provides+myocardial+protection+during+cardiac+ischemia%2Freperfusion+injury&doi=10.1161%2FCIRCULATIONAHA.107.690180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury</span></div><div class="casAuthors">Kohler David; Eckle Tobias; Faigle Marion; Grenz Almut; Mittelbronn Michel; Laucher Stefanie; Hart Melanie L; Robson Simon C; Muller Christa E; Eltzschig Holger K</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1784-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Extracellular adenosine, generated from extracellular nucleotides via ectonucleotidases, binds to specific receptors and provides cardioprotection from ischemia and reperfusion.  In the present study, we studied ecto-enzymatic ATP/ADP-phosphohydrolysis by select members of the ectonucleoside triphosphate diphosphohydrolase (E-NTPDase) family during myocardial ischemia.  METHODS AND RESULTS:  As a first step, we used a murine model of myocardial ischemia and in situ preconditioning and performed pharmacological studies with polyoxometalate 1, a potent E-NTPDase inhibitor (Na6[H2W12O40]).  Polyoxometalate 1 treatment increased infarct sizes and abolished beneficial effects of preconditioning.  To define relative contributions of distinct E-NTPDases, we investigated transcriptional responses of E-NTPDases 1 to 3 and 8 to preconditioning.  We noted robust and selective induction of E-NTPDase 1 (CD39) transcript and protein.  Histological analysis of preconditioned myocardium localized CD39 induction to endothelia and myocytes.  Cd39-/- mice exhibited larger infarct sizes with ischemia (cd39+/+ 43.0+/-3.3% versus cd39-/- 52%+/-1.8; P<0.05), and cardioprotection was abrogated by preconditioning (cd39+/+ 13.3%+/-1.5 versus cd39-/- 50.5%+/-2.8; P<0.01).  Heightened levels of injury after myocardial ischemia and negligible preconditioning benefits in cd39-/- mice were corrected by infusion of the metabolic product (AMP) or apyrase.  Moreover, apyrase treatment of wild-type mice resulted in 43+/-4.2% infarct size reduction (P<0.01).  CONCLUSIONS:  Taken together, these studies reveal E-NTPDase 1 in cardioprotection and suggest apyrase in the treatment of myocardial ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpWEBsFPX84EHdcurJClFcfW6udTcc2ebneawYfLe4iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snhtlansg%253D%253D&md5=7441c74ed6e1d3c9179763c746e61650</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.690180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.690180%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DD.%26aulast%3DEckle%26aufirst%3DT.%26aulast%3DFaigle%26aufirst%3DM.%26aulast%3DGrenz%26aufirst%3DA.%26aulast%3DMittelbronn%26aufirst%3DM.%26aulast%3DLaucher%26aufirst%3DS.%26aulast%3DHart%26aufirst%3DM.%2BL.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DCD39%252FEctonucleoside%2520triphosphate%2520diphosphohydrolase%25201%2520provides%2520myocardial%2520protection%2520during%2520cardiac%2520ischemia%252Freperfusion%2520injury%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3D1784%26epage%3D1794%26doi%3D10.1161%2FCIRCULATIONAHA.107.690180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase1 (NTPDase1, CD39)</span>. <i>Analyst</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">5417</span>– <span class="NLM_lpage">5430</span>, <span class="refDoi"> DOI: 10.1039/C8AN01108G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1039%2FC8AN01108G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30303204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVejtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=5417-5430&author=S.-Y.+Leeauthor=X.+Luoauthor=V.+Namasivayamauthor=J.+Geissauthor=S.+Mirzaauthor=J.+Pelletierauthor=H.+Stephanauthor=J.+S%C3%A9vignyauthor=C.+E.+M%C3%BCller&title=Development+of+a+selective+and+highly+sensitive+fluorescence+assay+for+nucleoside+triphosphate+diphosphohydrolase1+%28NTPDase1%2C+CD39%29&doi=10.1039%2FC8AN01108G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase 1 (NTPDase1, CD39)</span></div><div class="casAuthors">Lee, Sang-Yong; Luo, Xihuan; Namasivayam, Vigneshwaran; Geiss, Jennifer; Mirza, Salahuddin; Pelletier, Julie; Stephan, Holger; Sevigny, Jean; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analyst (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5417-5430</span>CODEN:
                <span class="NLM_cas:coden">ANALAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-2654</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ecto-nucleoside triphosphate diphosphohydrolase 1 (NTPDase1, CD39) is a major ectonucleotidase that hydrolyzes proinflammatory ATP via ADP to AMP, which is subsequently converted by ecto-5'-nucleotidase (CD73) to immunosuppressive adenosine.  Activation of CD39 has potential for treating inflammatory diseases, while inhibition was suggested as a novel strategy for the immunotherapy of cancer.  In the present study, we developed a selective and highly sensitive capillary electrophoresis (CE) assay using a novel fluorescent CD39 substrate, a fluorescein-labeled ATP (PSB-170621A) that is converted to its AMP deriv.  To accelerate the assays, a two-directional (forward and reverse) CE system was implemented using 96-well plates, which is suitable for the screening of compd. libraries (Z'-factor: 0.7).  The detection limits for the forward and reverse operation were 11.7 and 2.00 pM, resp., indicating a large enhancement in sensitivity as compared to previous methods (e.g. malachite-green assay: 1 000 000-fold, CE-UV assay: 500 000-fold, fluorescence polarization immunoassay: 12 500-fold).  Enzyme kinetic studies at human CD39 revealed a Km value of 19.6 μM, and a kcat value of 119 × 10-3 s-1 for PSB-170621A, which shows similar substrate properties as ATP (11.4 μM and 82.5 × 10-3 s-1).  The compd. displayed similar properties at rat and mouse CD39.  Subsequent docking studies into a homol. model of human CD39 revealed a hydrophobic pocket that accommodates the fluorescein tag.  PSB-170621A was found to be preferably hydrolyzed by CD39 as compared to other ectonucleotidases.  The new assay was validated by performing inhibition assays with several std. CD39 inhibitors yielding results that were consonant with data using the natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomBc_NvcVDVLVg90H21EOLACvtfcHk0ljOxbttjBAifw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVejtbnE&md5=2c408fc77cca922c2595e9aed4a1773d</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1039%2FC8AN01108G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8AN01108G%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DGeiss%26aufirst%3DJ.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DStephan%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDevelopment%2520of%2520a%2520selective%2520and%2520highly%2520sensitive%2520fluorescence%2520assay%2520for%2520nucleoside%2520triphosphate%2520diphosphohydrolase1%2520%2528NTPDase1%252C%2520CD39%2529%26jtitle%3DAnalyst%26date%3D2018%26volume%3D143%26spage%3D5417%26epage%3D5430%26doi%3D10.1039%2FC8AN01108G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity</span>. <i>Analyst</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1039/C4AN01694G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1039%2FC4AN01694G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25372046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOrsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2015&pages=140-148&author=A.+Fieneauthor=Y.+Baqiauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=C.+E.+M%C3%BCller&title=Fluorescence+polarization+immunoassays+for+monitoring+nucleoside+triphosphate+diphosphohydrolase+%28NTPDase%29+activity&doi=10.1039%2FC4AN01694G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity</span></div><div class="casAuthors">Fiene, Amelie; Baqi, Younis; Lecka, Joanna; Sevigny, Jean; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analyst (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">ANALAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-2654</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The following members of the ecto-nucleoside triphosphate diphosphohydrolase family, NTPDase1 (CD39), NTPDase-2, -3, and -8, play an important role in purinergic signal transduction by regulating extracellular nucleotide levels.  Potent and selective NTPDase inhibitors are required as pharmacol. tools and have potential as novel drugs, e.g. for anti-cancer and anti-bacterial therapy.  We have developed fast and sensitive NTPDase fluorescence polarization (FP) immunoassays using the natural substrates (ATP or ADP).  During the NTPDase1-catalyzed reaction, the substrate is dephosphorylated to ADP which is further dephosphorylated yielding AMP as the final product (by NTPDase1).  NTPDase3 and -8 yield AMP and ADP, while NTPDase2 results mainly in the formation of ADP.  Direct quantification of the resp. product, AMP or ADP, is achieved by displacement of an appropriate fluorescent tracer nucleotide from a specific antibody leading to a change in fluorescence polarization.  The assays are highly sensitive and can be performed with low substrate concns. (20 μM ATP or 10 μM ADP) below the Km values of NTPDases, which simplifies the identification of novel competitive inhibitors.  Optimized antibody and enzyme concns. allow the reproducible detection of 2 μM ADP and 1 μM AMP (at 10% substrate conversion).  Validation of the assays yielded excellent Z'-factors greater than 0.70 for all investigated NTPDase subtypes indicating high robustness of the anal. method.  Furthermore, we tested a std. inhibitor and performed a first exemplary screening campaign with a library consisting of >400 compds. (Z'-factor: 0.87, hit rate 0.5%).  Thereby we demonstrated the suitability of the FP assay for IC50 value detn. and high-throughput screening in a 384-well format.  The new FP assays were shown to be superior to current std. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA2NbAtEnIG7Vg90H21EOLACvtfcHk0ljOxbttjBAifw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOrsr3F&md5=ddae00c025edd9875aacaca2c26c1b8f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1039%2FC4AN01694G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4AN01694G%26sid%3Dliteratum%253Aachs%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DFluorescence%2520polarization%2520immunoassays%2520for%2520monitoring%2520nucleoside%2520triphosphate%2520diphosphohydrolase%2520%2528NTPDase%2529%2520activity%26jtitle%3DAnalyst%26date%3D2015%26volume%3D140%26spage%3D140%26epage%3D148%26doi%3D10.1039%2FC4AN01694G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staeben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleman-Leyer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermeyer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowery, R. G.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a Transcreener assay for detection of AMP- and GMP-producing enzymes</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1089/adt.2009.0254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1089%2Fadt.2009.0254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVCgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=339-350&author=M.+Staebenauthor=K.+M.+Kleman-Leyerauthor=A.+L.+Koppauthor=T.+A.+Westermeyerauthor=R.+G.+Lowery&title=Development+and+validation+of+a+Transcreener+assay+for+detection+of+AMP-+and+GMP-producing+enzymes&doi=10.1089%2Fadt.2009.0254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Validation of a Transcreener Assay for Detection of AMP- and GMP-Producing Enzymes</span></div><div class="casAuthors">Staeben, Matt; Kleman-Leyer, Karen M.; Kopp, Andrew L.; Westermeyer, Thane A.; Lowery, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">339-350</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Screening of AMP- and GMP-producing enzymes such as phosphodiesterases (PDEs), ligases, and synthetases would be simplified by the ability to directly detect unmodified nucleoside monophosphates.  To address this need, polyclonal and monoclonal antibodies were developed that recognize AMP and GMP with nanomolar sensitivity and high selectivity vs. the corresponding triphosphate and 3',5'-cyclic monophosphate nucleotides that serve as substrates for many enzymes in these classes.  One of these antibodies was used to develop a Transcreener AMP/GMP assay with a far red fluorescence polarization (FP) readout.  This polyclonal antibody exhibited extremely high selectivity, with IC50 ratios of 6,000 for ATP/AMP, 3,810 for cAMP/AMP, and 6,970 for cGMP/GMP.  Std. curves mimicking enzymic conversion of cAMP, cGMP, and ATP to the corresponding monophosphates yielded Z' values of > 0.85 at 10% conversion.  The assay reagents were shown to be stable for 24 h at room temp., both before and after dispensing.  The Transcreener AMP/GMP FP assay was used for enzymic detection of cGMP- and cAMP-dependent PDEs 4A1A, 3A, and 9A2 and ATP-dependent ligases, acetyl CoA synthetase, and ubiquitin-activating enzyme (UBE1).  Shifts of >100 mP were obsd. in the linear part of the progress curves for all enzymes tested, and the PDE isoforms exhibited the expected substrate and inhibitor selectivity.  These studies demonstrate that direct immunodetection of AMP and GMP is a flexible, robust enzyme assay method for diverse AMP- and GMP-producing enzymes.  Moreover, it eliminates many of the shortcomings of other methods including the need for fluorescently labeled substrates, the low signal:background inherent in substrate depletion assays, and the potential for interference with coupling enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_VEhlnufMKbVg90H21EOLACvtfcHk0lijRWWzi1PDCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVCgtLw%253D&md5=991febe0f2d58c1c5e8610ffba2b52ed</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1089%2Fadt.2009.0254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2009.0254%26sid%3Dliteratum%253Aachs%26aulast%3DStaeben%26aufirst%3DM.%26aulast%3DKleman-Leyer%26aufirst%3DK.%2BM.%26aulast%3DKopp%26aufirst%3DA.%2BL.%26aulast%3DWestermeyer%26aufirst%3DT.%2BA.%26aulast%3DLowery%26aufirst%3DR.%2BG.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520Transcreener%2520assay%2520for%2520detection%2520of%2520AMP-%2520and%2520GMP-producing%2520enzymes%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26spage%3D339%26epage%3D350%26doi%3D10.1089%2Fadt.2009.0254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowery, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening assays for cancer immunotherapy targets: ectonucleotidases CD39 and CD73</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1177/2472555219893632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1177%2F2472555219893632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31868071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1OktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=320-326&author=M.+Kumarauthor=R.+Loweryauthor=V.+Kumar&title=High-throughput+screening+assays+for+cancer+immunotherapy+targets%3A+ectonucleotidases+CD39+and+CD73&doi=10.1177%2F2472555219893632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73</span></div><div class="casAuthors">Kumar, Meera; Lowery, Robert; Kumar, Vaishnav</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-326</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Prodn. of adenosine in the extracellular tumor microenvironment elicits strong immunosuppression and is assocd. with tumor progression.  Thus, targeting adenosine-generating ectonucleotidases is a potential strategy to stimulate and prolong antitumor immunity.  Because the reaction products of ectonucleotidases differ by a single phosphate group, selective detection in an assay format that is compatible with high-throughput screening (HTS) has been elusive.  We report the development of biochem. assays capable of measuring the activity of ectonucleoside triphosphate diphosphohydrolase-1 (ENTPD1; also known as CD39) and ecto-5'-nucleotidase (CD73).  Both assays leverage the Transcreener HTS Assay platform, which facilitates selective immunodetection of nucleotides with homogenous fluorescent readouts, fluorescence polarization or time-resolved fluorescence energy transfer.  The Transcreener AMP2 Assay was used to measure CD39 activity, allowing detection of adenosine monophosphate (AMP) prodn. (Z' > 0.6) with subnanomolar amts. of CD39, allowing IC50 detn. for tool compds., consistent with previously reported values.  To detect the prodn. of adenosine by CD73, the Transcreener ADP2 Assay was coupled with adenosine kinase (AK); conversion of adenosine to AMP and ADP (ADP) by AK allows detection with ADP2 antibody.  The Transcreener AMP2 Assay was used to screen a 1280 Library of Pharmacol. Active Compds. (LOPAC) library and a 1600-compd. subset of a ChemBridge diversity library for CD39 inhibitors, allowing the identification of nine and eight candidate compds. from each library, resp.  The Transcreener ADP2 Assay was used to screen 1600 compds. from the ChemBridge diversity library for CD73 inhibitors and identified 14 potential candidates.  HTS-compatible assays for ectonucleotidase activity may allow identification of purinergic signaling pathway inhibitors important for tumor-specific immune responses during tumor pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMBtJQe_seGbVg90H21EOLACvtfcHk0lijRWWzi1PDCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1OktLY%253D&md5=848ab20d116fad82275e47d6974a4b9e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1177%2F2472555219893632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555219893632%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DLowery%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DHigh-throughput%2520screening%2520assays%2520for%2520cancer%2520immunotherapy%2520targets%253A%2520ectonucleotidases%2520CD39%2520and%2520CD73%26jtitle%3DSLAS%2520Discovery%26date%3D2020%26volume%3D25%26spage%3D320%26epage%3D326%26doi%3D10.1177%2F2472555219893632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C<sub>6</sub> glioma cells and RAW 264.7 macrophages</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1628</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1996.tb16082.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1111%2Fj.1476-5381.1996.tb16082.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=8982511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK2sXktlSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1628-1634&author=B.+C.+Chenauthor=C.+M.+Leeauthor=W.+W.+Lin&title=Inhibition+of+ecto-ATPase+by+PPADS%2C+suramin+and+reactive+blue+in+endothelial+cells%2C+C6+glioma+cells+and+RAW+264.7+macrophages&doi=10.1111%2Fj.1476-5381.1996.tb16082.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages</span></div><div class="casAuthors">Chen, Bin C.; Lee, Chii-M.; Lin, Wan-W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1628-1634</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Previous studies have shown that bovine pulmonary artery endothelium (CPAE) has P2Y and P2U purinoceptors, rat C6 glioma cells have P2U purinoceptors and mouse RAW 264.7 cells have pyrimidinoceptors, all of which are coupled to phosphoinositide specific phospholipase C (PI-PLC).  The dual actions of PPADS, suramin and reactive blue as antagonists of receptor subtypes and ecto-ATPase inhibitors were studied in these three cell types.  In CPAE, suramin, at 3-100 μM, competitively inhibited the PI responses induced by 2MeSATP and UTP, with pA2 values of 5.5±0.3 and 4.4±0.4, resp.  Reactive blue, at 1-3 μM, produced shifts to the right of the 2MeSATP and UTP curves, but no further right shift at 10 μM.  PPADS, at 10 μM, caused a 3 fold right shift of the 2MeSATP curve, but no further shift at concns. up to 100 μM.  In contrast, a dose-dependent shift to the left of the UTP curve and a weak inhibition of the ATP response were seen with PPADS.  In RAW 264.7 cells, suramin and reactive blue, but not PPADS, competitively inhibited the UTP response, with pA2 values of 4.8±0.5 and 5.8±0.7, resp.  In C6 glioma cells, although suramin and reactive blue inhibited the ATP response, a potentiation effect on ATP and UTP responses was seen with PPADS.  The ecto-ATPase inhibitory activity of these three receptor antagonists were detd.  All three inhibited ecto-ATPase present in CPAE, C6 and RAW 264.7 cells, with IC50 values of 4, 4.8 and 4.7 for PPADS, 4, 4.4 and » 4 for suramin, and 4.5, 4.7, 4.7 for reactive blue.  This study indicates that PPADS, suramin and reactive blue are ecto-ATPase inhibitors.  This property, combined with their antagonistic selectivity for receptor subtypes, can result in inhibition of, potentiation of, or lack of effect on agonist-mediated PI responses.  Reactive blue is a more potent antagonist than suramin on P2Y, P2U and pyrimidinoceptors, and PPADS is a weak antagonist for P2Y receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmeBK55GGeD7Vg90H21EOLACvtfcHk0lgG5mb3dkyhPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlSgtA%253D%253D&md5=e0524cb2f52f867a27f991999fd3e2f9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb16082.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb16082.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLin%26aufirst%3DW.%2BW.%26atitle%3DInhibition%2520of%2520ecto-ATPase%2520by%2520PPADS%252C%2520suramin%2520and%2520reactive%2520blue%2520in%2520endothelial%2520cells%252C%2520C6%2520glioma%2520cells%2520and%2520RAW%2520264.7%2520macrophages%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1628%26epage%3D1634%26doi%3D10.1111%2Fj.1476-5381.1996.tb16082.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieringa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span> <span> </span><span class="NLM_article-title">Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1096/fj.12-205658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1096%2Ffj.12-205658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22637533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGrsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=3875-3883&author=G.+G.+Yegutkinauthor=B.+Wieringaauthor=S.+C.+Robsonauthor=S.+Jalkanen&title=Metabolism+of+circulating+ADP+in+the+bloodstream+is+mediated+via+integrated+actions+of+soluble+adenylate+kinase-1+and+NTPDase1%2FCD39+activities&doi=10.1096%2Ffj.12-205658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities</span></div><div class="casAuthors">Yegutkin, Gennady G.; Wieringa, Be; Robson, Simon C.; Jalkanen, Sirpa</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3875-3883, 10.1096/fj.12-205658</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Extracellular ATP and ADP trigger inflammatory, vasodilatatory, and prothrombotic signaling events in the vasculature, and their turnover is governed by networks of membrane-assocd. enzymes.  The contribution of sol. activities to intravascular nucleotide homeostasis remains controversial.  By using thin-layer chromatog. assays, we revealed transphosphorylation of [γ-32P]ATP and AMP by human and murine sera, which was progressively inhibited by specific adenylate kinase (AK) inhibitor Ap5A.  This phosphotransfer reaction was diminished markedly in serum from knockout mice lacking the major AK isoform, AK1, and in human serum immunodepleted of AK1.  We also showed that ∼75% ADP in cell-free serum is metabolized via reversible AK1 reaction 2ADP ↔ ATP + AMP.  The generated ATP and AMP are then metabolized through the coupled nucleotide pyrophosphatase/phosphodiesterase and 5'-nucleotidase/CD73 reactions, resp.  Constitutive presence of another nucleotide-converting enzyme, nucleoside triphosphate diphosphohydrolase-1 (NTPDase1, known as CD39), was ascertained by the relative deficiency of serum from CD39-null mice to dephosphorylate [3H]ADP and [γ-32P]ATP, and also by diminished [3H]ADP hydrolysis by human serum pretreated with NTPDase1 inhibitors, POM-1 and ARL-67156.  In summary, we have identified hitherto unrecognized sol. forms of AK1 and NTPDase1/CD39 that contribute in the active cycling between the principal platelet-recruiting agent ADP and other circulating nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-izNSxIoi7Vg90H21EOLACvtfcHk0lgG5mb3dkyhPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGrsrrI&md5=10573cb78cc275657e2c58b7c0d5b719</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-205658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-205658%26sid%3Dliteratum%253Aachs%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DWieringa%26aufirst%3DB.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DJalkanen%26aufirst%3DS.%26atitle%3DMetabolism%2520of%2520circulating%2520ADP%2520in%2520the%2520bloodstream%2520is%2520mediated%2520via%2520integrated%2520actions%2520of%2520soluble%2520adenylate%2520kinase-1%2520and%2520NTPDase1%252FCD39%2520activities%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D3875%26epage%3D3883%26doi%3D10.1096%2Ffj.12-205658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rücker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libermann, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerbini, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkis, J. J.</span></span> <span> </span><span class="NLM_article-title">E-NTPDases and ecto-5′-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2007.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.lfs.2007.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18201730" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=477-486&author=B.+R%C3%BCckerauthor=M.+E.+Almeidaauthor=T.+A.+Libermannauthor=L.+F.+Zerbiniauthor=M.+R.+Winkauthor=J.+J.+Sarkis&title=E-NTPDases+and+ecto-5%E2%80%B2-nucleotidase+expression+profile+in+rat+heart+left+ventricle+and+the+extracellular+nucleotide+hydrolysis+by+their+nerve+terminal+endings&doi=10.1016%2Fj.lfs.2007.12.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2007.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2007.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCcker%26aufirst%3DB.%26aulast%3DAlmeida%26aufirst%3DM.%2BE.%26aulast%3DLibermann%26aufirst%3DT.%2BA.%26aulast%3DZerbini%26aufirst%3DL.%2BF.%26aulast%3DWink%26aufirst%3DM.%2BR.%26aulast%3DSarkis%26aufirst%3DJ.%2BJ.%26atitle%3DE-NTPDases%2520and%2520ecto-5%25E2%2580%25B2-nucleotidase%2520expression%2520profile%2520in%2520rat%2520heart%2520left%2520ventricle%2520and%2520the%2520extracellular%2520nucleotide%2520hydrolysis%2520by%2520their%2520nerve%2520terminal%2520endings%26jtitle%3DLife%2520Sci.%26date%3D2008%26volume%3D82%26spage%3D477%26epage%3D486%26doi%3D10.1016%2Fj.lfs.2007.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittenburg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bültmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pause, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starke, K.</span></span> <span> </span><span class="NLM_article-title">P<sub>2</sub>-purinoceptor antagonists: II. Blockade of P<sub>2</sub>-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1007/BF00168441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2FBF00168441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=8897453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK28Xms1Chs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=1996&pages=491-497&author=H.+Wittenburgauthor=R.+B%C3%BCltmannauthor=B.+Pauseauthor=C.+Ganterauthor=G.+Kurzauthor=K.+Starke&title=P2-purinoceptor+antagonists%3A+II.+Blockade+of+P2-purinoceptor+subtypes+and+ecto-nucleotidases+by+compounds+related+to+Evans+blue+and+trypan+blue&doi=10.1007%2FBF00168441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">P2-purinoceptor antagonists. Part 2. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue</span></div><div class="casAuthors">Wittenburg, Henning; Bueltmann, Ralph; Pause, Birgit; Ganter, Claudia; Kurz, Gerhart; Starke, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-497</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Effects of Evans blue and 4 derivs. as well as of trypan blue and 4 derivs., mostly smaller fragments but 2 compds. with an addnl. ethylene bridge in the center of the mol., were studied on contractions of the rat vas deferens elicited by α,β-methylene ATP (α,β-MeATP; mediated by P2X-purinoceptors), relaxations of the carbachol-precontracted guinea-pig tenia coli elicited by adenosine 5'-O-(2-thiodiphosphate) (ADPβS; mediated by P2Y-purinoceptors), and the degrdn. of ATP by rats vas deferens tissue.  All compds. shifted the concn.-response curve of α,β-MeATP in the rat vas deferens to the right, and most compds. increased the max. of the curve.  Each member of the Evans blue series was similar in potency to the corresponding member of the trypan blue series.  Where three concns. were tested, the Arunlakshana-Schild regression was linear, and the slope did not differ from 1.  The apparent Kd values were between 0.8 and 385 μM.  In the guinea-pig tenia coli , only the members of the trypan blue group were relatively potent, shifting the concn.-response curve of ADPβS to the right in a surmountable manner.  In 2 of 3 cases where three concns. were tested, the slope of the Arunlakshana-Schild regression was lower than 1.  Apparent Kd values in the trypan blue group were between 5.2 and 324 μM.  The removal of ATP from the medium by vas deferens tissue was decreases mainly by the members of the Evans blue group, with IC25% values between 13 and 158 (in 1 case > 1000) μM.  The results indicate that the position of the sulfonate residues at the terminal naphthalene rings of these compds. hardly influences P2X-purinoceptor affinity but greatly influences P2Y affinity and ecto-nucleotidase blockade.  Among active compds., apparent purinoceptor affinity and ecto-nucleotidase blockade increase with the size of the mols. up to Evans blue and trypan blue themselves; introduction of a central ethylene bridge does not result in a further gain in potency.  NH01, the desmethyl deriv. of Evans blue, seems to be interesting because it is the compd. with the highest P2x- vs. P2Y-selectivity presently available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVOvM8HdudbVg90H21EOLACvtfcHk0litBhpaHU3eoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xms1Chs70%253D&md5=d0529bbcb95032b28cd50d8c05fef791</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1007%2FBF00168441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00168441%26sid%3Dliteratum%253Aachs%26aulast%3DWittenburg%26aufirst%3DH.%26aulast%3DB%25C3%25BCltmann%26aufirst%3DR.%26aulast%3DPause%26aufirst%3DB.%26aulast%3DGanter%26aufirst%3DC.%26aulast%3DKurz%26aufirst%3DG.%26aulast%3DStarke%26aufirst%3DK.%26atitle%3DP2-purinoceptor%2520antagonists%253A%2520II.%2520Blockade%2520of%2520P2-purinoceptor%2520subtypes%2520and%2520ecto-nucleotidases%2520by%2520compounds%2520related%2520to%2520Evans%2520blue%2520and%2520trypan%2520blue%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1996%26volume%3D354%26spage%3D491%26epage%3D497%26doi%3D10.1007%2FBF00168441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuluc, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bültmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glänzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frahm, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starke, K.</span></span> <span> </span><span class="NLM_article-title">P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1007/PL00005144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2FPL00005144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=9521483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1cXks12gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1998&pages=111-120&author=F.+Tulucauthor=R.+B%C3%BCltmannauthor=M.+Gl%C3%A4nzelauthor=A.+W.+Frahmauthor=K.+Starke&title=P2-receptor+antagonists%3A+IV.+Blockade+of+P2-receptor+subtypes+and+ecto-nucleotidases+by+compounds+related+to+reactive+blue+2&doi=10.1007%2FPL00005144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2</span></div><div class="casAuthors">Tuluc, Florin; Bultmann, R.; Glanzel, Markus; Frahm, August Wilhelm; Starke, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-120</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Effects of reactive blue 2 and twelve structurally related compds. were studied on contractions of the rat vas deferens elicited by α,β-methylene ATP (α,β-MeATP; mediated by P2X-receptors), relaxations of the carbachol-precontracted guinea-pig tenia coli elicited by adenosine 5'-O-(2-thiodiphosphate) (ADPβS; mediated by P2Y-receptors), and the degrdn. of ATP by rat vas deferens tissue.  All compds., except acid blue 41 and acid blue 129 (at up to 100 M), shifted the concn.-response curve of α,β-MeATP in the rat vas deferens to the right.  Most increased, but Uniblue A greatly decreased, the max. of the curve.  In the case of Cibacron Blue 3GA and reactive blue 19, of which three concns. were tested, the Arunlakshana-Schild regression was linear, and the slope did not differ from unity.  The apparent Kd values of the effective substances ranged between 0.7 and 111 μM. Most compds. increased the contraction of the rat vas deferens elicited by high K+.  In the guinea-pig tenia coli, all compds., except uniblue A and reactive blue 19 (at up to 100 μM), shifted the concn.-response curve of ADPβS to the right in a parallel manner.  In the case of acid blue 129 and acid blue 80, of which three concns. were tested, the slope of the Arunlakshana-Schild regression did not differ from unity.  The apparent Kd values of the effective substances were between 0.7 and 69 μM. Most compds. also reduced the relaxation of the guinea-pig tenia coli elicited by noradrenaline.  The removal of ATP from the medium by vas deferens tissue was decreased only by reactive blue 2, cibacron blue 3GA, uniblue A and reactive blue 19, with IC25 values between 17 and 62 μM.The structure-activity relationships for P2X- and P2Y-receptor blockade in this series are strikingly dissimilar.  In reactive blue 2 and its isomers, for example, both the 1-amino-anthraquinone-2-sulfonate core and the 'side-chain' of the mol. are involved in P2X-receptor binding; P2Y-receptor affinity, in contrast, resides largely or totally in the anthraquinone core.  The most promising antagonists are uniblue A which is P2X- vs. P2Y-selective and acid blue 129 which is P2Y- vs. P2X-selective, both with few, if any, non-P2-receptor effects at concns. blocking the resp. P2-subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMc8GQTI_9T7Vg90H21EOLACvtfcHk0litBhpaHU3eoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks12gug%253D%253D&md5=f127b1b20007e1edc1540c84bf6f7ad9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1007%2FPL00005144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005144%26sid%3Dliteratum%253Aachs%26aulast%3DTuluc%26aufirst%3DF.%26aulast%3DB%25C3%25BCltmann%26aufirst%3DR.%26aulast%3DGl%25C3%25A4nzel%26aufirst%3DM.%26aulast%3DFrahm%26aufirst%3DA.%2BW.%26aulast%3DStarke%26aufirst%3DK.%26atitle%3DP2-receptor%2520antagonists%253A%2520IV.%2520Blockade%2520of%2520P2-receptor%2520subtypes%2520and%2520ecto-nucleotidases%2520by%2520compounds%2520related%2520to%2520reactive%2520blue%25202%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1998%26volume%3D357%26spage%3D111%26epage%3D120%26doi%3D10.1007%2FPL00005144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stout, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirley, T. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of purified chicken gizzard smooth muscle ecto-ATPAse by P2 purinoceptor antagonists</span>. <i>Biochem. Mol. Biol. Int.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=7581008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK28XjtlOit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=927-934&author=J.+G.+Stoutauthor=T.+L.+Kirley&title=Inhibition+of+purified+chicken+gizzard+smooth+muscle+ecto-ATPAse+by+P2+purinoceptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of purified chicken gizzard smooth muscle ecto-ATPase by P2 purinoceptor antagonists</span></div><div class="casAuthors">Stout, James G.; Kirley, Terence L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Molecular Biology International</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">BMBIES</span>;
        ISSN:<span class="NLM_cas:issn">1039-9712</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Several specific inhibitors of P2 purinergic receptors (purinoceptors) were evaluated for their ability to inhibit purified chicken gizzard cell membrane ecto-ATPase.  The P2 purinoceptor antagonists tested included suramin, triazine-based reactive textile dyes, and nonspecific total protein dyes.  All inhibited purified ecto-ATPase, with half maximal inhibition from ∼20 to 120 μM.  TLC-purified Cibacron Blue 3GA, also known as Reactive Blue 2, was demonstrated to inhibit immunopure ecto-ATPase with an IC50 of 44 μM.  Thus, for the 1st time, these compds. used to pharmacol. classify the subtypes of P2 purinoceptors are demonstrated to have direct inhibitory effects on purified ecto-ATPase.  Therefore, data generated using these compds. on purinoceptors must be interpreted in light of their direct inhibitory effect on the ecto-ATPase found in the same tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIfDHYD2CmpLVg90H21EOLACvtfcHk0litBhpaHU3eoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtlOit7s%253D&md5=ef8aacdc858910be83333ff0ef7f0d33</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStout%26aufirst%3DJ.%2BG.%26aulast%3DKirley%26aufirst%3DT.%2BL.%26atitle%3DInhibition%2520of%2520purified%2520chicken%2520gizzard%2520smooth%2520muscle%2520ecto-ATPAse%2520by%2520P2%2520purinoceptor%2520antagonists%26jtitle%3DBiochem.%2520Mol.%2520Biol.%2520Int.%26date%3D1995%26volume%3D36%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2863</span>– <span class="NLM_lpage">2873</span>, <span class="refDoi"> DOI: 10.1096/fj.06-7947com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1096%2Ffj.06-7947com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17442731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVars77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2863-2873&author=A.+Grenzauthor=H.+Zhangauthor=M.+Hermesauthor=T.+Eckleauthor=K.+Klingelauthor=D.+Y.+Huangauthor=C.+E.+M%C3%BCllerauthor=S.+C.+Robsonauthor=H.+Osswaldauthor=H.+K.+Eltzschig&title=Contribution+of+E-NTPDase1+%28CD39%29+to+renal+protection+from+ischemia-reperfusion+injury&doi=10.1096%2Ffj.06-7947com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury</span></div><div class="casAuthors">Grenz, Almut; Zhang, Hua; Hermes, Marina; Eckle, Tobias; Klingel, Karin; Huang, Dan Yang; Mueller, Christa E.; Robson, Simon C.; Osswald, Hartmut; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2863-2873, 10.1096/fj.06-7947</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Previous studies showed increased extracellular nucleotides during renal ischemia-reperfusion.  While nucleotides represent the main source for extracellular adenosine and adenosine signaling contributes to renal protection from ischemia, we hypothesized a role for ecto-nucleoside-triphosphate-diphosphohydrolases (E-NTPDases) in renal protection.  We used a model of murine ischemia-reperfusion and in situ ischemic preconditioning (IP) via a hanging wt. system for atraumatic renal artery occlusion.  Initial studies with a nonspecific inhibitor of E-NTPDases (POM-1) revealed inhibition of renal protection by IP.  We next pursued transcriptional responses of E-NTPDases (E- NTPDase1-3, and 8) to renal IP, and found a robust and selective induction of E-NTPDase1/CD39 transcript and protein.  Moreover, based on clearance studies, plasma electrolytes, and renal tubular histol., IP protection was abolished in gene-targeted mice for CD39 whereas increased renal adenosine content with IP was attenuated.  Furthermore, administration of apyrase reconstituted renal protection by IP in cd39-/- mice.  Finally, apyrase treatment of wild-type mice resulted in increased renal adenosine concns. and a similar degree of renal protection from ischemia as IP treatment.  Taken together, these data identify CD39-dependent nucleotide phosphohydrolysis in renal protection.  Moreover, the present studies suggest apyrase treatment as a novel pharmacol. approach to renal diseases pptd. by limited oxygen availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPDTDra9j1c7Vg90H21EOLACvtfcHk0litUumrrnKktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVars77M&md5=b06ddc0852fc4d3794dccab80b47bca4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7947com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7947com%26sid%3Dliteratum%253Aachs%26aulast%3DGrenz%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHermes%26aufirst%3DM.%26aulast%3DEckle%26aufirst%3DT.%26aulast%3DKlingel%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DOsswald%26aufirst%3DH.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DContribution%2520of%2520E-NTPDase1%2520%2528CD39%2529%2520to%2520renal%2520protection%2520from%2520ischemia-reperfusion%2520injury%26jtitle%3DFASEB%2520J.%26date%3D2007%26volume%3D21%26spage%3D2863%26epage%3D2873%26doi%3D10.1096%2Ffj.06-7947com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigmore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatár, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenguelli, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, N.</span></span> <span> </span><span class="NLM_article-title">The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.neuropharm.2008.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18768144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1251-1258&author=M.+J.+Wallauthor=G.+Wigmoreauthor=J.+Lopat%C3%A1rauthor=B.+G.+Frenguelliauthor=N.+Dale&title=The+novel+NTPDase+inhibitor+sodium+polyoxotungstate+%28POM-1%29+inhibits+ATP+breakdown+but+also+blocks+central+synaptic+transmission%2C+an+action+independent+of+NTPDase+inhibition&doi=10.1016%2Fj.neuropharm.2008.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition</span></div><div class="casAuthors">Wall, Mark J.; Wigmore, Geoffery; Lopatar, Jan; Frenguelli, Bruno G.; Dale, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1251-1258</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Understanding the mechanisms and properties of purinergic signaling would be greatly assisted by the discovery of subtype selective and potent inhibitors of the NTPDase enzymes, which metabolize nucleotides such as ATP and ADP in the extracellular space.  Currently ARL 67156 is the best available NTPDase inhibitor, but its relatively poor efficacy means that neg. results are difficult to interpret.  POM-1 (sodium polyoxotungstate) is a novel NTPDase inhibitor, which has shown promising results with the inhibition of recombinant NTPDases 1, 2 and 3.  The authors have tested the effectiveness and physiol. effects of POM-1 with cerebellar and hippocampal slices.  Using the malachite green phosphate assay, HPLC and biosensor measurements the authors have found that POM-1 is more effective at blocking ATP breakdown in cerebellar slices than ARL 67156.  The site of inhibition is at the first step of the breakdown cascade (conversion of ATP to ADP) and the effects of POM-1 appear readily reversible.  However, POM-1 has multiple effects on synaptic transmission.  At the cerebellar parallel fiber-Purkinje cell (PF) synapse POM-1 produced a long lasting inhibition of transmission, which was preceded in a minority of synapses by a transient increase in PF excitatory postsynaptic potential (EPSP) amplitude (∼20%).  This increase in PF EPSP amplitude appears to result from a redn. in the tonic activation of presynaptic A1 receptors, consistent with POM-1 preventing the breakdown of ATP to adenosine.  The redn. in PF EPSP amplitude does not however appear to result from NTPDase inhibition as it persists when both adenosine and ATP (P2Y and P2X) receptors are blocked.  An increase in paired pulse ratio and a redn. in presynaptic volley amplitude suggest that there is a presynaptic component of POM-1 action which reduces glutamate release.  POM-1 produced similar inhibition at climbing fiber synapses and at hippocampal CA1 pyramidal synapses.  Thus although POM-1 is more effective than ARL 67156 at blocking ATP breakdown its usefulness is limited by off-target actions on synaptic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4A6zZvqRBlLVg90H21EOLACvtfcHk0litUumrrnKktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvF&md5=5085f8e4daadd9385087f81b24c5d24c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DWigmore%26aufirst%3DG.%26aulast%3DLopat%25C3%25A1r%26aufirst%3DJ.%26aulast%3DFrenguelli%26aufirst%3DB.%2BG.%26aulast%3DDale%26aufirst%3DN.%26atitle%3DThe%2520novel%2520NTPDase%2520inhibitor%2520sodium%2520polyoxotungstate%2520%2528POM-1%2529%2520inhibits%2520ATP%2520breakdown%2520but%2520also%2520blocks%2520central%2520synaptic%2520transmission%252C%2520an%2520action%2520independent%2520of%2520NTPDase%2520inhibition%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1251%26epage%3D1258%26doi%3D10.1016%2Fj.neuropharm.2008.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref9700':['cit9700'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nataliia  Petruk</span>, <span class="hlFld-ContribAuthor ">Sanni  Tuominen</span>, <span class="hlFld-ContribAuthor ">Malin  Åkerfelt</span>, <span class="hlFld-ContribAuthor ">Jesse  Mattsson</span>, <span class="hlFld-ContribAuthor ">Jouko  Sandholm</span>, <span class="hlFld-ContribAuthor ">Matthias  Nees</span>, <span class="hlFld-ContribAuthor ">Gennady G.  Yegutkin</span>, <span class="hlFld-ContribAuthor ">Arja  Jukkola</span>, <span class="hlFld-ContribAuthor ">Johanna  Tuomela</span>, <span class="hlFld-ContribAuthor ">Katri S.  Selander</span>. </span><span class="cited-content_cbyCitation_article-title">CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-85379-z" title="DOI URL">https://doi.org/10.1038/s41598-021-85379-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-85379-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-85379-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCD73%252Bfacilitates%252BEMT%252Bprogression%252Band%252Bpromotes%252Blung%252Bmetastases%252Bin%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DPetruk%26aufirst%3DNataliia%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bérengère  Papegay</span>, <span class="hlFld-ContribAuthor ">Vincent  Nuyens</span>, <span class="hlFld-ContribAuthor ">Adelin  Albert</span>, <span class="hlFld-ContribAuthor ">Mustapha  Cherkaoui‐Malki</span>, <span class="hlFld-ContribAuthor ">Pierre  Andreoletti</span>, <span class="hlFld-ContribAuthor ">Oberdan  Leo</span>, <span class="hlFld-ContribAuthor ">Véronique  Kruys</span>, <span class="hlFld-ContribAuthor ">Jean G.  Boogaerts</span>, <span class="hlFld-ContribAuthor ">Joseph  Vamecq</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine Diphosphate and the P2Y13 Receptor Are Involved in the Autophagic Protection of Ex Vivo Perfused Livers From Fasted Rats: Potential Benefit for Liver Graft Preservation. </span><span class="cited-content_cbyCitation_journal-name">Liver Transplantation</span><span> <strong>2021,</strong> <em>27 </em>
                                    (7)
                                     , 997-1006. <a href="https://doi.org/10.1002/lt.25970" title="DOI URL">https://doi.org/10.1002/lt.25970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/lt.25970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Flt.25970%26sid%3Dliteratum%253Aachs%26jtitle%3DLiver%2520Transplantation%26atitle%3DAdenosine%252BDiphosphate%252Band%252Bthe%252BP2Y13%252BReceptor%252BAre%252BInvolved%252Bin%252Bthe%252BAutophagic%252BProtection%252Bof%252BEx%252BVivo%252BPerfused%252BLivers%252BFrom%252BFasted%252BRats%25253A%252BPotential%252BBenefit%252Bfor%252BLiver%252BGraft%252BPreservation%26aulast%3DPapegay%26aufirst%3DB%25C3%25A9reng%25C3%25A8re%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D7%26spage%3D997%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>22 </em>, 1-10. <a href="https://doi.org/10.1080/13543776.2021.1923694" title="DOI URL">https://doi.org/10.1080/13543776.2021.1923694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1923694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1923694%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BCD73%252Binhibitors%252Bfor%252Bthe%252Bimmunotherapy%252Bof%252Bcancer%25253A%252Ba%252Bpatent%252Band%252Bliterature%252Breview%252B%2525282017%2525E2%252580%252593present%252529%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2021%26date%3D2021%26volume%3D22%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gennady G.  Yegutkin</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine metabolism in the vascular system. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>187 </em>, 114373. <a href="https://doi.org/10.1016/j.bcp.2020.114373" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114373%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DAdenosine%252Bmetabolism%252Bin%252Bthe%252Bvascular%252Bsystem%26aulast%3DYegutkin%26aufirst%3DGennady%2BG.%26date%3D2021%26volume%3D187%26spage%3D114373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariachiara  Zuccarini</span>, <span class="hlFld-ContribAuthor ">Patricia  Giuliani</span>, <span class="hlFld-ContribAuthor ">Francesco  Caciagli</span>, <span class="hlFld-ContribAuthor ">Renata  Ciccarelli</span>, <span class="hlFld-ContribAuthor ">Patrizia  Di Iorio</span>. </span><span class="cited-content_cbyCitation_article-title">In Search of a Role for Extracellular Purine Enzymes in Bone Function. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (5)
                                     , 679. <a href="https://doi.org/10.3390/biom11050679" title="DOI URL">https://doi.org/10.3390/biom11050679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11050679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11050679%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DIn%252BSearch%252Bof%252Ba%252BRole%252Bfor%252BExtracellular%252BPurine%252BEnzymes%252Bin%252BBone%252BFunction%26aulast%3DZuccarini%26aufirst%3DMariachiara%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D5%26spage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Herbert  Zimmermann</span>. </span><span class="cited-content_cbyCitation_article-title">History of ectonucleotidases and their role in purinergic signaling. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>187 </em>, 114322. <a href="https://doi.org/10.1016/j.bcp.2020.114322" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114322%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DHistory%252Bof%252Bectonucleotidases%252Band%252Btheir%252Brole%252Bin%252Bpurinergic%252Bsignaling%26aulast%3DZimmermann%26aufirst%3DHerbert%26date%3D2021%26volume%3D187%26spage%3D114322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna M.  Chiarella</span>, <span class="hlFld-ContribAuthor ">Yun K.  Ryu</span>, <span class="hlFld-ContribAuthor ">Gulam A.  Manji</span>, <span class="hlFld-ContribAuthor ">Anil K.  Rustgi</span>. </span><span class="cited-content_cbyCitation_article-title">Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment. </span><span class="cited-content_cbyCitation_journal-name">Trends in Cancer</span><span> <strong>2021,</strong> <em>49 </em><a href="https://doi.org/10.1016/j.trecan.2021.04.008" title="DOI URL">https://doi.org/10.1016/j.trecan.2021.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trecan.2021.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trecan.2021.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Cancer%26atitle%3DExtracellular%252BATP%252Band%252BAdenosine%252Bin%252BCancer%252BPathogenesis%252Band%252BTreatment%26aulast%3DChiarella%26aufirst%3DAnna%2BM.%26date%3D2021%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Maria Oliveira  Battastini</span>, <span class="hlFld-ContribAuthor ">Fabricio  Figueiró</span>, <span class="hlFld-ContribAuthor ">Daniela Bitencourt Rosa  Leal</span>, <span class="hlFld-ContribAuthor ">Pedro Henrique  Doleski</span>, <span class="hlFld-ContribAuthor ">Maria Rosa Chitolina  Schetinger</span>. </span><span class="cited-content_cbyCitation_article-title">CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.633603" title="DOI URL">https://doi.org/10.3389/fphar.2021.633603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.633603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.633603%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DCD39%252Band%252BCD73%252Bas%252BPromising%252BTherapeutic%252BTargets%25253A%252BWhat%252BCould%252BBe%252Bthe%252BLimitations%25253F%26aulast%3DBattastini%26aufirst%3DAna%2BMaria%2BOliveira%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Herbert  Zimmermann</span>. </span><span class="cited-content_cbyCitation_article-title">Ectonucleoside triphosphate diphosphohydrolases and ecto-5′-nucleotidase in purinergic signaling: how the field developed and where we are now. </span><span class="cited-content_cbyCitation_journal-name">Purinergic Signalling</span><span> <strong>2021,</strong> <em>17 </em>
                                    (1)
                                     , 117-125. <a href="https://doi.org/10.1007/s11302-020-09755-6" title="DOI URL">https://doi.org/10.1007/s11302-020-09755-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11302-020-09755-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11302-020-09755-6%26sid%3Dliteratum%253Aachs%26jtitle%3DPurinergic%2520Signalling%26atitle%3DEctonucleoside%252Btriphosphate%252Bdiphosphohydrolases%252Band%252Becto-5%2525E2%252580%2525B2-nucleotidase%252Bin%252Bpurinergic%252Bsignaling%25253A%252Bhow%252Bthe%252Bfield%252Bdeveloped%252Band%252Bwhere%252Bwe%252Bare%252Bnow%26aulast%3DZimmermann%26aufirst%3DHerbert%26date%3D2021%26date%3D2020%26volume%3D17%26issue%3D1%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haitang  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Yao</span>, <span class="hlFld-ContribAuthor ">Paul F.  Davis</span>, <span class="hlFld-ContribAuthor ">Swee T.  Tan</span>, <span class="hlFld-ContribAuthor ">Sean R. R.  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">CD73, Tumor Plasticity and Immune Evasion in Solid Cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 177. <a href="https://doi.org/10.3390/cancers13020177" title="DOI URL">https://doi.org/10.3390/cancers13020177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13020177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13020177%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCD73%25252C%252BTumor%252BPlasticity%252Band%252BImmune%252BEvasion%252Bin%252BSolid%252BCancers%26aulast%3DYang%26aufirst%3DHaitang%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conversion of extracellular ATP to adenosine by CD39 and CD73. Upper graphic adapted from   <cite><i>Biochemistry</i></cite> <span class="NLM_year">2019</span>, <em>58</em>, 3331–3334.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Structures of ADP (<b>2</b>) and AMPCP (<b>5</b>), a nonhydrolyzable analog of <b>2</b>, along with inhibitory potency against hCD73.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (b) Schematic of the key interactions between <b>5</b> and the active site of human CD73 based on Protein Data Bank (PDB) entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Figure adapted from   <cite><i>J. Med. Chem.</i></cite> <span class="NLM_year">2020</span>, DOI: <pub-id pub-id-type="doi" type="simple">10.1021/acs.jmedchem.0c00525</pub-id>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of selected nucleoside-derived or nucleotide mimetic CD73 inhibitors. Representative compounds or those that showcase unique structural features are shown, along with reported potencies (as available), shown as IC<sub>50</sub> values or <i>K</i><sub>i</sub> ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of selected non-nucleoside derived CD73 inhibitors. Representative structures are shown, along with reported potencies (as available).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Characterization of uncompetitive CD73 inhibitor <b>20b</b> (example 2 described in patent application WO2019168744 by Eli Lilly). Increasing concentration of AMP enhances potency of <b>20b</b>. EC<sub>50</sub> value is corrected based on the fraction unbound, determined experimentally, or based on computational models.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> IC<sub>50</sub> values were determined by RF-MS/MS quantification of adenosine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Optimization of <i>in vitro</i> CD73 potency and rat iv pharmacokinetics leading to <b>31</b> and <b>6</b>.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Schematic of the X-ray cocrystal structure of AB680 bound to the closed conformation of hCD73. Figure generated from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z9D">6Z9D</a> using Pymol version 2.0.4, Schrödinger, LLC, and Microsoft PowerPoint version 2002 (H220 structure omitted for clarity) and adapted from   <cite><i>J. Med. Chem.</i></cite> <span class="NLM_year">2020</span>, DOI: <pub-id pub-id-type="doi" type="simple">10.1021/acs.jmedchem.0c00525</pub-id>. (b) Superposition of the observed hCD73 binding modes of AB680 and <b>5</b> (colored in blue, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>). (c) Minor rotational isomer of AB680 bound to hCD73. Ligand is shown as a stick model and colored according to the atom type, with C in yellow, N in blue, O in red, F in cyan, Cl in green, and P in orange.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. AB680 restores the proliferation and function of CD4<sup>+</sup> T-cells (a–c), restores the activation of CD8<sup>+</sup> T-cells (d), and reverses the activity of AMP on immune checkpoint inhibition in MLRs (e).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Charts a–e are reproduced from refs <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) X-ray cocrystal structure of <b>12</b> bound to the closed conformation of hCD73. (b) Structure and potency of <b>12</b>. (c) SAR of α substitution. <sup><i>a</i></sup>Potency data generated by ORIC Pharmaceuticals shown for direct comparison.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Overall architecture of <i>Lp</i>NTPDase1 bound to <b>37</b>-Mg<sup>2+</sup> (generated from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA">4BRA</a> using Pymol version 2.0.4, Schrödinger, LLC). (b) Chemical structures of <b>37</b> and <b>38</b>. (c) Superposition of the <i>Lp</i>NTPDase1 binding modes of <b>37</b> and <b>38</b> observed in PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA">4BRA</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRC">4BRC</a>, respectively. Ligands are shown as stick models and colored according to the atom type, with C in cyan or yellow, N in blue, O in red, and P in orange.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(111)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0014.jpeg" id="rightTab-GRAPHIC-d7e3554-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Selected nucleotide-based CD39 inhibitors <b>39</b><a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(120)</a> and <b>40</b>–<b>42</b>.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(122)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of selected sulfonate dyes with weak inhibitory activity against CD39. Potency values for <b>45</b> and <b>46</b> were determined in the presence of 100 μM ATP using the MG assay.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(123)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of select anthraquinone inhibitors of CD39 with reported inhibitory activity against rat NTPDases<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(125)</a> and rat CD73.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Compound <b>47</b> is a mixture of <i>meta-</i> and <i>para-</i>sulfonate isomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/medium/jm0c01044_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical formulas and potency of POMs <b>51</b><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(128)</a> and <b>52</b><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and comparison of the binding sites observed for AMPNP (<b>38</b>) and decavanadate ([V<sub>10</sub>O<sub>28</sub>]<sup>6–</sup>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX2">3ZX2</a>) bound to CD39 from <i>Legionella pneumophila</i> and <i>Rattus norvegicus</i>, respectively. Structure of <b>38</b> copied from superimposed structure of <i>Lp</i>NTPDase1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR7">4BR7</a>). Metal and chloride ions are omitted for clarity. <b>38</b> is shown as a stick model and colored according to the atom type, with C in cyan, N in blue, O in red, and P in orange. Decavanadate is shown in red spheres.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(109)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01044/20201120/images/large/jm0c01044_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01044&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 139 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Cellular function and molecular structure of <i>ecto</i>-nucleotidases</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9309-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs11302-012-9309-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22555564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=437-502&author=H.+Zimmermannauthor=M.+Zebischauthor=N.+Str%C3%A4ter&title=Cellular+function+and+molecular+structure+of+ecto-nucleotidases&doi=10.1007%2Fs11302-012-9309-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular function and molecular structure of ecto-nucleotidases</span></div><div class="casAuthors">Zimmermann, Herbert; Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-502</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotidases play a pivotal role in purinergic signal transmission.  They hydrolyze extracellular nucleotides and thus can control their availability at purinergic P2 receptors.  They generate extracellular nucleosides for cellular reuptake and salvage via nucleoside transporters of the plasma membrane.  The extracellular adenosine formed acts as an agonist of purinergic P1 receptors.  They also can produce and hydrolyze extracellular inorg. pyrophosphate that is of major relevance in the control of bone mineralization.  This review discusses and compares four major groups of ecto-nucleotidases: the ecto-nucleoside triphosphate diphosphohydrolases, ecto-5'-nucleotidase, ecto-nucleotide pyrophosphatase/phosphodiesterases, and alk. phosphatases.  Only recently and based on crystal structures, detailed information regarding the spatial structures and catalytic mechanisms has become available for members of these four ecto-nucleotidase families.  This permits detailed predictions of their catalytic mechanisms and a comparison between the individual enzyme groups.  The review focuses on the principal biochem., cell biol., catalytic, and structural properties of the enzymes and provides brief ref. to tissue distribution, and physiol. and pathophysiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwf4PFcTEl0LVg90H21EOLACvtfcHk0liot_wMxGkDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVCmtbg%253D&md5=d36e58f25676e47b9749e43896ac4cb2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9309-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9309-4%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCellular%2520function%2520and%2520molecular%2520structure%2520of%2520ecto-nucleotidases%26jtitle%3DPurinergic%2520Signalling%26date%3D2012%26volume%3D8%26spage%3D437%26epage%3D502%26doi%3D10.1007%2Fs11302-012-9309-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span> <span> </span><span class="NLM_article-title">Ecto-Nucleotidases</span>. In  <i>Purinergic and Pyrimidinergic Signaling I</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbrachio, M. P.</span>, <span class="NLM_string-name">Williams, M.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2001</span>; Vol.  <span class="NLM_volume">151</span>, pp  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">250</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2F978-3-662-09604-8_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=209-250&author=H.+Zimmermannauthor=M.+P.+Abbrachio&author=M.+Williams&title=Purinergic+and+Pyrimidinergic+Signaling+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F978-3-662-09604-8_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-662-09604-8_8%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26atitle%3DEcto-Nucleotidases%26btitle%3DPurinergic%2520and%2520Pyrimidinergic%2520Signaling%2520I%26aulast%3DAbbrachio%26aufirst%3DM.%2BP.%26pub%3DSpringer%26date%3D2001%26volume%3D151%26spage%3D209%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Adenosine metabolism: emerging concepts for cancer therapy</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2019.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ccell.2019.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31821783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOmtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=582-596&author=D.+Boisonauthor=G.+G.+Yegutkin&title=Adenosine+metabolism%3A+emerging+concepts+for+cancer+therapy&doi=10.1016%2Fj.ccell.2019.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Metabolism: Emerging Concepts for Cancer Therapy</span></div><div class="casAuthors">Boison, Detlev; Yegutkin, Gennady G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">582-596</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Adenosine is a key metabolic and immune-checkpoint regulator implicated in the tumor escape from the host immune system.  Major gaps in knowledge that impede the development of effective adenosine-based therapeutics include: (1) lack of consideration of redundant pathways controlling ATP and adenosine levels; (2) lack of distinction between receptor-dependent and -independent effects of adenosine, and (3) focus on extracellular adenosine without consideration of intracellular metab. and compartmentalization.  In light of current clin. trials, we provide an overview of adenosine metab. and point out the need for a more careful evaluation of the entire purinome in emerging cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2ZdU0gtISMrVg90H21EOLACvtfcHk0liot_wMxGkDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOmtL3F&md5=e087a03d692d332eca328b1cd251e4a6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2019.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2019.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBoison%26aufirst%3DD.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DAdenosine%2520metabolism%253A%2520emerging%2520concepts%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Cell%26date%3D2019%26volume%3D36%26spage%3D582%26epage%3D596%26doi%3D10.1016%2Fj.ccell.2019.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deaglio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usheva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjyoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span> <span> </span><span class="NLM_article-title">Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">1257</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1084/jem.20062512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1084%2Fjem.20062512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17502665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1aktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2007&pages=1257-1265&author=S.+Deaglioauthor=K.+M.+Dwyerauthor=W.+Gaoauthor=D.+Friedmanauthor=A.+Ushevaauthor=A.+Eratauthor=J.-F.+Chenauthor=K.+Enjyojiauthor=J.+Lindenauthor=M.+Oukkaauthor=V.+K.+Kuchrooauthor=T.+B.+Stromauthor=S.+C.+Robson&title=Adenosine+generation+catalyzed+by+CD39+and+CD73+expressed+on+regulatory+T+cells+mediates+immune+suppression&doi=10.1084%2Fjem.20062512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression</span></div><div class="casAuthors">Deaglio, Silvia; Dwyer, Karen M.; Gao, Wenda; Friedman, David; Usheva, Anny; Erat, Anna; Chen, Jiang-Fan; Enjyoji, Keiichii; Linden, Joel; Oukka, Mohamed; Kuchroo, Vijay K.; Strom, Terry B.; Robson, Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1257-1265</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The study of T regulatory cells (T reg cells) has been limited by the lack of sp. surface markers and an inability to define mechanisms of suppression.  We show that the expression of CD39/ENTPD1 in concert with CD73/ecto-5'-nucleotidase distinguishes CD4+/CD25+/Foxp3+ T reg cells from other T cells.  These ectoenzymes generate pericellular adenosine from extracellular nucleotides.  The coordinated expression of CD39/CD73 on T reg cells and the adenosine A2A receptor on activated T effector cells generates immunosuppressive loops, indicating roles in the inhibitory function of T reg cells.  Consequently, T reg cells from Cd39-null mice show impaired suppressive properties in vitro and fail to block allograft rejection in vivo.  We conclude that CD39 and CD73 are surface markers of T reg cells that impart a specific biochem. signature characterized by adenosine generation that has functional relevance for cellular immunoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaFCyxsPRZ_rVg90H21EOLACvtfcHk0lii9M9y5a7ykg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1aktrs%253D&md5=4f1c7e4fc65c0b14fc55cc0460bd2df3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1084%2Fjem.20062512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20062512%26sid%3Dliteratum%253Aachs%26aulast%3DDeaglio%26aufirst%3DS.%26aulast%3DDwyer%26aufirst%3DK.%2BM.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DFriedman%26aufirst%3DD.%26aulast%3DUsheva%26aufirst%3DA.%26aulast%3DErat%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DEnjyoji%26aufirst%3DK.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26atitle%3DAdenosine%2520generation%2520catalyzed%2520by%2520CD39%2520and%2520CD73%2520expressed%2520on%2520regulatory%2520T%2520cells%2520mediates%2520immune%2520suppression%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2007%26volume%3D204%26spage%3D1257%26epage%3D1265%26doi%3D10.1084%2Fjem.20062512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millán, J. L.</span></span> <i>Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2F3527608060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+L.+Mill%C3%A1n&title=Mammalian+Alkaline+Phosphatases%3A+From+Biology+to+Applications+in+Medicine+and+Biotechnology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F3527608060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F3527608060%26sid%3Dliteratum%253Aachs%26aulast%3DMill%25C3%25A1n%26aufirst%3DJ.%2BL.%26btitle%3DMammalian%2520Alkaline%2520Phosphatases%253A%2520From%2520Biology%2520to%2520Applications%2520in%2520Medicine%2520and%2520Biotechnology%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rader, B. A.</span></span> <span> </span><span class="NLM_article-title">Alkaline phosphatase, an unconventional immune protein</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">897</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.3389%2Ffimmu.2017.00897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=28824625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWns7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=897&author=B.+A.+Rader&title=Alkaline+phosphatase%2C+an+unconventional+immune+protein&doi=10.3389%2Ffimmu.2017.00897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Alkaline phosphatase, an unconventional immune protein</span></div><div class="casAuthors">Rader, Bethany A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">897/1-897/6</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Recent years have seen an increase in the no. of studies focusing on alk. phosphatases (APs), revealing an expanding complexity of function of these enzymes.  Of the four human AP (hAP) proteins, most is known about tissue non-specific AP (TNAP) and intestinal AP (IAP).  This review highlights current understanding of TNAP and IAP in relation to human health and disease.  TNAP plays a role in multiple processes, including bone mineralization, vitamin B6 metab., and neurogenesis, is the genetic cause of hypophosphatasia, influences inflammation through regulation of purinergic signaling, and has been implicated in Alzheimer's disease.  IAP regulates fatty acid absorption and has been implicated in the regulation of diet-induced obesity and metabolic syndrome.  IAP and TNAP can dephosphorylate bacterial-derived lipopolysaccharide, and IAP has been identified as a potential regulator of the compn. of the intestinal microbiome, an evolutionarily conserved function.  Endogenous and recombinant bovine APs and recombinant hAPs are currently being explored for their potential as pharmacol. agents to treat AP-assocd. diseases and mitigate multiple sources of inflammation.  Continued research on these versatile proteins will undoubtedly provide insight into human pathophysiol., biochem., and the human holobiont.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD-RIxFHkmWrVg90H21EOLACvtfcHk0lii9M9y5a7ykg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWns7%252FN&md5=93c424d70cb67902c028d524778c458d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00897%26sid%3Dliteratum%253Aachs%26aulast%3DRader%26aufirst%3DB.%2BA.%26atitle%3DAlkaline%2520phosphatase%252C%2520an%2520unconventional%2520immune%2520protein%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D897%26doi%3D10.3389%2Ffimmu.2017.00897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muniyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaGrange, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaney, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-F.</span></span> <span> </span><span class="NLM_article-title">Human prostatic acid phosphatase: structure, function and regulation</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">10438</span>– <span class="NLM_lpage">10464</span>, <span class="refDoi"> DOI: 10.3390/ijms140510438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.3390%2Fijms140510438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23698773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2jtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=10438-10464&author=S.+Muniyanauthor=N.+K.+Chaturvediauthor=J.+G.+Dwyerauthor=C.+A.+LaGrangeauthor=W.+G.+Chaneyauthor=M.-F.+Lin&title=Human+prostatic+acid+phosphatase%3A+structure%2C+function+and+regulation&doi=10.3390%2Fijms140510438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Human prostatic acid phosphatase: structure, function and regulation</span></div><div class="casAuthors">Muniyan, Sakthivel; Chaturvedi, Nagendra K.; Dwyer, Jennifer G.; LaGrange, Chad A.; Chaney, William G.; Lin, Ming-Fong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">10438-10464, 27 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Human prostatic acid phosphatase (PAcP) is a 100 kDa glycoprotein composed of two subunits.  Recent advances demonstrate that cellular PAcP (cPAcP) functions as a protein tyrosine phosphatase by dephosphorylating ErbB-2/Neu/HER-2 at the phosphotyrosine residues in prostate cancer (PCa) cells, which results in reduced tumorigenicity.  Further, the interaction of cPAcP and ErbB-2 regulates androgen sensitivity of PCa cells.  Knockdown of cPAcP expression allows androgen-sensitive PCa cells to develop the castration-resistant phenotype, where cells proliferate under an androgen-reduced condition.  Thus, cPAcP has a significant influence on PCa cell growth.  Interestingly, promoter anal. suggests that PAcP expression can be regulated by NF-κB, via a novel binding sequence in an androgen-independent manner.  Further understanding of PAcP function and regulation of expression will have a significant impact on understanding PCa progression and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow-MoHQNm5L7Vg90H21EOLACvtfcHk0lii9M9y5a7ykg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2jtr3L&md5=a76b7c3ee2178cf456f7ac2207e5cd03</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fijms140510438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140510438%26sid%3Dliteratum%253Aachs%26aulast%3DMuniyan%26aufirst%3DS.%26aulast%3DChaturvedi%26aufirst%3DN.%2BK.%26aulast%3DDwyer%26aufirst%3DJ.%2BG.%26aulast%3DLaGrange%26aufirst%3DC.%2BA.%26aulast%3DChaney%26aufirst%3DW.%2BG.%26aulast%3DLin%26aufirst%3DM.-F.%26atitle%3DHuman%2520prostatic%2520acid%2520phosphatase%253A%2520structure%252C%2520function%2520and%2520regulation%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D10438%26epage%3D10464%26doi%3D10.3390%2Fijms140510438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Losenkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccarini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karikoski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">jcs241463</span>, <span class="refDoi"> DOI: 10.1242/jcs.241463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1242%2Fjcs.241463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=32317394" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2020&pages=jcs241463&author=K.+Losenkovaauthor=M.+Zuccariniauthor=M.+Karikoskiauthor=J.+Laurilaauthor=D.+Boisonauthor=S.+Jalkanenauthor=G.+G.+Yegutkin&title=Compartmentalization+of+adenosine+metabolism+in+cancer+cells+and+its+modulation+during+acute+hypoxia&doi=10.1242%2Fjcs.241463"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1242%2Fjcs.241463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.241463%26sid%3Dliteratum%253Aachs%26aulast%3DLosenkova%26aufirst%3DK.%26aulast%3DZuccarini%26aufirst%3DM.%26aulast%3DKarikoski%26aufirst%3DM.%26aulast%3DLaurila%26aufirst%3DJ.%26aulast%3DBoison%26aufirst%3DD.%26aulast%3DJalkanen%26aufirst%3DS.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DCompartmentalization%2520of%2520adenosine%2520metabolism%2520in%2520cancer%2520cells%2520and%2520its%2520modulation%2520during%2520acute%2520hypoxia%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2020%26volume%3D133%26spage%3Djcs241463%26doi%3D10.1242%2Fjcs.241463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1039/C7MD00015D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1039%2FC7MD00015D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30108800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=823-840&author=S.-Y.+Leeauthor=C.+E.+M%C3%BCller&title=Nucleotide+pyrophosphatase%2Fphosphodiesterase+1+%28NPP1%29+and+its+inhibitors&doi=10.1039%2FC7MD00015D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors</span></div><div class="casAuthors">Lee, Sang-Yong; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-840</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1, EC 3.1.4.1) is a metalloenzyme that belongs to the NPP family, which comprises seven subtypes (NPP1-7).  NPP1 hydrolyzes a wide range of phosphodiester bonds, e.g. in nucleoside triphosphates, (cyclic) dinucleotides, and nucleotide sugars yielding nucleoside 5'-monophosphates as products.  Its main substrate is ATP which is cleaved to AMP and diphosphate.  The enzyme is involved in various biol. processes including bone mineralization, soft-tissue calcification, insulin receptor signalling, cancer cell proliferation and immune modulation.  Therefore, NPP1 inhibitors have potential as novel drugs, e.g. for (immuno)oncol.  In the last two decades several inhibitors of NPP1 derived from nucleotide- or non-nucleotide scaffolds have been developed.  The most potent and selective NPP1-inhibitory substrate analog is adenosine 5'-α,β-methylene-γ-thiotriphosphate (Ki = 20 nM vs. p-Nph-5'-TMP, human membrane-bound NPP1).  Non-nucleotide-derived NPP1 inhibitors comprise polysulfonates, polysaccharides, polyoxometalates and small heterocyclic compds.  The polyoxometalate [TiW11CoO40]8- (PSB-POM141) is the most potent and selective NPP1 inhibitor described to date (Ki = 1.46 nM vs. ATP, human sol. NPP1); it displays an allosteric mechanism of inhibition and represents a useful pharmacol. tool for evaluating the potential of NPP1 as a novel drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYX4x_-RuSKbVg90H21EOLACvtfcHk0ljwzzaqGJ7ozA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGmsbY%253D&md5=59169b98f5f53799ae43cde20df7c000</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1039%2FC7MD00015D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00015D%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DNucleotide%2520pyrophosphatase%252Fphosphodiesterase%25201%2520%2528NPP1%2529%2520and%2520its%2520inhibitors%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D823%26epage%3D840%26doi%3D10.1039%2FC7MD00015D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Channar, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afzal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejaz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larik, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahesar, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erben, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span> <span> </span><span class="NLM_article-title">Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ejmech.2018.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30015078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlajtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=461-478&author=P.+A.+Channarauthor=S.+Afzalauthor=S.+A.+Ejazauthor=A.+Saeedauthor=F.+A.+Larikauthor=P.+A.+Mahesarauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=M.+F.+Erbenauthor=J.+Iqbal&title=Exploration+of+carboxy+pyrazole+derivatives%3A+Synthesis%2C+alkaline+phosphatase%2C+nucleotide+pyrophosphatase%2Fphosphodiesterase+and+nucleoside+triphosphate+diphosphohydrolase+inhibition+studies+with+potential+anticancer+profile&doi=10.1016%2Fj.ejmech.2018.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile</span></div><div class="casAuthors">Channar, Pervaiz Ali; Afzal, Saira; Ejaz, Syeda Abida; Saeed, Aamer; Larik, Fayaz Ali; Mahesar, Parvez Ali; Lecka, Joanna; Sevigny, Jean; Erben, Mauricio F.; Iqbal, Jamshed</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">461-478</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the present work, the synthesis of new aryl pyrazole derivs. using 1,3-dicarbonyl motifs is reported.  The reaction was proceeded by the cyclization of pentane-2,4-dione, 3-chloropentane-2,4-dione or Et 3-oxobutanoate with different aryl hydrazides.  The products, which can be regarded as 1H-pyrazol-1-yl-one analogs and represent drug like mols. along with well-developed structure-activity relationships, were obtained in good to excellent yield.  Considering alk. phosphatases (APs), nucleotide pyrophosphatases/phosphodiesterases (NPPs) and nucleoside triphosphate diphosphohydrolase as the mol. targets, the effects of these synthesized compds. were investigated on different isoenzymes of APs, NPPs and NTPDases.  The data revealed that the synthesized compds. inhibited both enzymes but most of them inhibited tissue non-specific alk. phosphatase (TNAP) more selectively.  The antitumor activity results indicated that the synthesized derivs. have strong inhibitory effects on the growth of selected cell lines from different tissues such as breast, bone marrow and cervix (MCF-7, K-562 and Hela) but with varying intensities.  Moreover the binding mode of interactions were explained on the basis of mol. docking and in-silico studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfL-99cafVarVg90H21EOLACvtfcHk0ljwzzaqGJ7ozA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlajtLfF&md5=13958c2510afd80c6185223285990787</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DChannar%26aufirst%3DP.%2BA.%26aulast%3DAfzal%26aufirst%3DS.%26aulast%3DEjaz%26aufirst%3DS.%2BA.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DLarik%26aufirst%3DF.%2BA.%26aulast%3DMahesar%26aufirst%3DP.%2BA.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DErben%26aufirst%3DM.%2BF.%26aulast%3DIqbal%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520carboxy%2520pyrazole%2520derivatives%253A%2520Synthesis%252C%2520alkaline%2520phosphatase%252C%2520nucleotide%2520pyrophosphatase%252Fphosphodiesterase%2520and%2520nucleoside%2520triphosphate%2520diphosphohydrolase%2520inhibition%2520studies%2520with%2520potential%2520anticancer%2520profile%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D461%26epage%3D478%26doi%3D10.1016%2Fj.ejmech.2018.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">CD73: A Novel target for cancer immunotherapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">6407</span>– <span class="NLM_lpage">6411</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-10-1544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20682793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWqu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=6407-6411&author=B.+Zhang&title=CD73%3A+A+Novel+target+for+cancer+immunotherapy&doi=10.1158%2F0008-5472.CAN-10-1544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CD73: A Novel Target for Cancer Immunotherapy</span></div><div class="casAuthors">Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6407-6411</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The promise of cancer immunotherapy has not been translated into clin. successes, in large part because of tumor-assocd. immune suppression that blocks effective antitumor immunity.  Recent findings show a tumor-induced immunosuppressive mechanism, whereby tumor-derived CD73 functions as an ecto-enzyme to produce extracellular adenosine, which promotes tumor growth by limiting antitumor T-cell immunity via adenosine receptor signaling.  Results with small mol. inhibitors, or monoclonal antibodies targeting CD73 in murine tumor models, suggest that targeted CD73 therapy is an important alternative and realistic approach to effective control of tumor growth.  In particular, it helps T-cell-based therapy by enhancing the adaptive immune response machinery, which may increase the function of tumor-infiltrating T lymphocytes, and subsequently lead to improved survival in cancer patients.  Cancer Res; 70(16); 6407-11.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbHxuETqRsE7Vg90H21EOLACvtfcHk0lhwH_BgP2RsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWqu7jN&md5=837efbbd36cff106a9fde6afea427a14</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1544%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DCD73%253A%2520A%2520Novel%2520target%2520for%2520cancer%2520immunotherapy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D6407%26epage%3D6411%26doi%3D10.1158%2F0008-5472.CAN-10-1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beavis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">CD73: A Potent suppressor of antitumor immune responses</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.it.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.it.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22487321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Kks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=231-237&author=P.+A.+Beavisauthor=J.+Staggauthor=P.+K.+Darcyauthor=M.+J.+Smyth&title=CD73%3A+A+Potent+suppressor+of+antitumor+immune+responses&doi=10.1016%2Fj.it.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CD73: a potent suppressor of antitumor immune responses</span></div><div class="casAuthors">Beavis, Paul. A.; Stagg, John; Darcy, Phillip K.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">231-237</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumors use several strategies to evade immunosurveillance.  One such mechanism is the generation of adenosine within the tumor microenvironment, which potently suppresses antitumor T cell responses.  Adenosine within the tumor is generated by CD73, a membrane-bound nucleotidase that is expressed by tumor cells, suppressive immune subsets such as T regulatory cells (Tregs) and myeloid-derived suppressor cells and endothelial cells.  Recent evidence suggests that targeted inhibition of CD73 has the potential to reduce tumorigenesis and metastasis, as well as enhancing the potency of T-cell-directed therapies.  This review outlines the impact of adenosine on suppressing the antitumor response and the evidence supporting the rationale for CD73 targeting in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0nmj4rwt8J7Vg90H21EOLACvtfcHk0lhwH_BgP2RsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Kks78%253D&md5=bc393315fe03e9d3b4061c0c06fab2bb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DBeavis%26aufirst%3DP.%2BA.%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DCD73%253A%2520A%2520Potent%2520suppressor%2520of%2520antitumor%2520immune%2520responses%26jtitle%3DTrends%2520Immunol.%26date%3D2012%26volume%3D33%26spage%3D231%26epage%3D237%26doi%3D10.1016%2Fj.it.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisseret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">The adenosine pathway in immuno-oncology</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1038/s41571-020-0382-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fs41571-020-0382-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=B.+Allardauthor=D.+Allardauthor=L.+Buisseretauthor=J.+Stagg&title=The+adenosine+pathway+in+immuno-oncology&doi=10.1038%2Fs41571-020-0382-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fs41571-020-0382-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41571-020-0382-2%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DBuisseret%26aufirst%3DL.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DThe%2520adenosine%2520pathway%2520in%2520immuno-oncology%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2020%26doi%3D10.1038%2Fs41571-020-0382-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divisekera, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duret, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparwasser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">CD73-Deficient mice have increased antitumor immunity and are resistant to experimental metastasis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2892</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-4246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-10-4246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=21292811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=2892-2900&author=J.+Staggauthor=U.+Divisekeraauthor=H.+Duretauthor=T.+Sparwasserauthor=M.+W.+Tengauthor=P.+K.+Darcyauthor=M.+J.+Smyth&title=CD73-Deficient+mice+have+increased+antitumor+immunity+and+are+resistant+to+experimental+metastasis&doi=10.1158%2F0008-5472.CAN-10-4246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis</span></div><div class="casAuthors">Stagg, John; Divisekera, Upulie; Duret, Helene; Sparwasser, Tim; Teng, Michele W. L.; Darcy, Phillip K.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2892-2900</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CD73 is a cell-surface enzyme that suppresses immune responses by producing extracellular adenosine.  In this study, we employed CD73 gene-targeted mice to investigate the role of host-derived CD73 on antitumor immunity and tumor cell metastasis.  We found that CD73 ablation significantly suppressed the growth of ovalbumin-expressing MC38 colon cancer, EG7 lymphoma, AT-3 mammary tumors, and B16F10 melanoma.  The protective effect of CD73 deficiency on primary tumors was dependent on CD8+ T cells and assocd. with an increased frequency of antigen-specific CD8+ T cells in peripheral blood and tumors and increased antigen-specific IFN-γ prodn.  Replicate studies in bone marrow chimeras established that both hematopoietic and nonhematopoietic expression of CD73 was important to promote tumor immune escape.  Using adoptive reconstitution of T regulatory cell (Treg)-depleted DEREG (depletion of regulatory T cells) mice, we demonstrated that part of the protumorigenic effect of Tregs was dependent on their expression of CD73.  CD73-deficient mice were also protected against pulmonary metastasis of B16F10 melanoma cells after i.v. injection.  Unexpectedly, we found that the prometastatic effect of host-derived CD73 was dependent on CD73 expression on nonhematopoietic cells.  CD73 expression on nonhematopoietic cells, most likely endothelial cells, was crit. for promoting lung metastasis in a manner independent from immunosuppressive effects.  Notably, in vivo blockade of CD73 with a selective inhibitor or anti-CD73 monoclonal antibody significantly reduced tumor growth and metastasis of CD73-neg. tumors.  Taken together, our findings indicate that CD73 may be targeted at multiple levels to induce anticancer effects including at the level of tumor cells, Tregs, and nonhematopoietic cells.  Cancer Res; 71(8); 2892-900.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMQxUwCZ8XerVg90H21EOLACvtfcHk0lhwH_BgP2RsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWjs78%253D&md5=94cc37e9eb84e5e8cce990252cc0e7a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-4246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-4246%26sid%3Dliteratum%253Aachs%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DDivisekera%26aufirst%3DU.%26aulast%3DDuret%26aufirst%3DH.%26aulast%3DSparwasser%26aufirst%3DT.%26aulast%3DTeng%26aufirst%3DM.%2BW.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DCD73-Deficient%2520mice%2520have%2520increased%2520antitumor%2520immunity%2520and%2520are%2520resistant%2520to%2520experimental%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D2892%26epage%3D2900%26doi%3D10.1158%2F0008-5472.CAN-10-4246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. B. L.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Ginn, E.</span>; <span class="NLM_string-name">Ashok, D.</span>; <span class="NLM_string-name">Anderson, A. E.</span>; <span class="NLM_string-name">Banuelos, J.</span>; <span class="NLM_string-name">Zhang, K.</span>; <span class="NLM_string-name">Pham, A.</span>; <span class="NLM_string-name">Park, T.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Jeffrey, J. L.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Walters, M. J.</span>; <span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical Pharmacokinetic and Pharmacodynamic Characterization of AB680, a Small-Molecule CD73 Inhibitor for Cancer Immunotherapy</span>.  <i>Proceedings</i>, 4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, New York, NY, Sep 30–Oct 3, 2018; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+B.+L.+Tan&author=J.+Chen&author=E.+Ginn&author=D.+Ashok&author=A.+E.+Anderson&author=J.+Banuelos&author=K.+Zhang&author=A.+Pham&author=T.+Park&author=A.+Chen&author=X.+Zhao&author=K.+V.+Lawson&author=J.+L.+Jeffrey&author=J.+Kalisiak&author=M.+R.+Leleti&author=M.+J.+Walters&author=J.+P.+Powers&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DJ.%2BB.%2BL.%26atitle%3DPreclinical%2520Pharmacokinetic%2520and%2520Pharmacodynamic%2520Characterization%2520of%2520AB680%252C%2520a%2520Small-Molecule%2520CD73%2520Inhibitor%2520for%2520Cancer%2520Immunotherapy%26btitle%3DProceedings%26pub%3DAACR%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span>; <span class="NLM_string-name">Narasappa, N.</span>; <span class="NLM_string-name">Yin, F.</span>; <span class="NLM_string-name">Zhang, K.</span>; <span class="NLM_string-name">DiRenzo, D.</span>; <span class="NLM_string-name">Park, T.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K.</span>; <span class="NLM_string-name">Jeffrey, J. L.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Schindler, U.</span>; <span class="NLM_string-name">Walters, M. J.</span>; <span class="NLM_string-name">Tan, J. B.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors (CD73i) Reverse the AMP/Adenosine-Mediated Impairment of Immune Effector Cell Activation by Immune Checkpoint Inhibitors (ICI)</span>.  <i>Proceedings</i>, AACR Annual Meeting, Chicago, IL, Apr 14–18, 2018; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Becker&author=N.+Narasappa&author=F.+Yin&author=K.+Zhang&author=D.+DiRenzo&author=T.+Park&author=J.+Kalisiak&author=K.+Lawson&author=J.+L.+Jeffrey&author=J.+P.+Powers&author=U.+Schindler&author=M.+J.+Walters&author=J.+B.+Tan&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26atitle%3DCD73%2520Inhibitors%2520%2528CD73i%2529%2520Reverse%2520the%2520AMP%252FAdenosine-Mediated%2520Impairment%2520of%2520Immune%2520Effector%2520Cell%2520Activation%2520by%2520Immune%2520Checkpoint%2520Inhibitors%2520%2528ICI%2529%26btitle%3DProceedings%26pub%3DAACR%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousineau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendoo, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahimi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Page, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provencher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mes-Masson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Is associated with poor prognosis in high-grade serous ovarian cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">4494</span>– <span class="NLM_lpage">4503</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-14-3569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=26363007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGnu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=4494-4503&author=M.+Turcotteauthor=K.+Springauthor=S.+Pommeyauthor=G.+Chouinardauthor=I.+Cousineauauthor=J.+Georgeauthor=G.+M.+Chenauthor=D.+M.+Gendooauthor=B.+Haibe-Kainsauthor=T.+Karnauthor=K.+Rahimiauthor=C.+Le+Pageauthor=D.+Provencherauthor=A.+M.+Mes-Massonauthor=J.+Stagg&title=CD73+Is+associated+with+poor+prognosis+in+high-grade+serous+ovarian+cancer&doi=10.1158%2F0008-5472.CAN-14-3569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer</span></div><div class="casAuthors">Turcotte, Martin; Spring, Kathleen; Pommey, Sandra; Chouinard, Guillaume; Cousineau, Isabelle; George, Joshy; Chen, Gregory M.; Gendoo, Deena M. A.; Haibe-Kains, Benjamin; Karn, Thomas; Rahimi, Kurosh; Le Page, Cecile; Provencher, Diane; Mes-Masson, Anne-Marie; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4494-4503</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The cell surface nucleotidase CD73 is an immunosuppressive enzyme involved in tumor progression and metastasis.  Although preclin. studies suggest that CD73 can be targeted for cancer treatment, the clin. impact of CD73 in ovarian cancer remains unclear.  In this study, we investigated the prognostic value of CD73 in high-grade serous (HGS) ovarian cancer using gene and protein expression analyses.  Our results demonstrate that high levels of CD73 are significantly assocd. with shorter disease-free survival and overall survival in patients with HGS ovarian cancer.  Furthermore, high levels of CD73 expression in ovarian tumor cells abolished the good prognosis assocd. with intraepithelial CD8+ cells.  Notably, CD73 gene expression was highest in the C1/stromal mol. subtype of HGS ovarian cancer and pos. correlated with an epithelial-to-mesenchymal transition gene signature.  Moreover, in vitro studies revealed that CD73 and extracellular adenosine enhance ovarian tumor cell growth as well as expression of antiapoptotic BCL-2 family members.  Finally, in vivo coinjection of ID8 mouse ovarian tumor cells with mouse embryonic fibroblasts showed that CD73 expression in fibroblasts promotes tumor immune escape and thereby tumor growth.  In conclusion, our study highlights a role for CD73 as a prognostic marker of patient survival and also as a candidate therapeutic target in HGS ovarian cancers.  Cancer Res; 75(21); 4494-503. 2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0cI-iFGChprVg90H21EOLACvtfcHk0lihbPm0hNzG4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGnu7vF&md5=168775cf106084e44de08a6f6a302255</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3569%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DK.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DChouinard%26aufirst%3DG.%26aulast%3DCousineau%26aufirst%3DI.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%2BM.%26aulast%3DGendoo%26aufirst%3DD.%2BM.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DKarn%26aufirst%3DT.%26aulast%3DRahimi%26aufirst%3DK.%26aulast%3DLe%2BPage%26aufirst%3DC.%26aulast%3DProvencher%26aufirst%3DD.%26aulast%3DMes-Masson%26aufirst%3DA.%2BM.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Is%2520associated%2520with%2520poor%2520prognosis%2520in%2520high-grade%2520serous%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D4494%26epage%3D4503%26doi%3D10.1158%2F0008-5472.CAN-14-3569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, L.</span></span> <span> </span><span class="NLM_article-title">Overexpression of CD73 in prostate cancer is associated with lymph node metastasis</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">811</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1007/s12253-013-9648-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs12253-013-9648-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23653114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=811-814&author=Q.+Yangauthor=J.+Duauthor=L.+Zu&title=Overexpression+of+CD73+in+prostate+cancer+is+associated+with+lymph+node+metastasis&doi=10.1007%2Fs12253-013-9648-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis</span></div><div class="casAuthors">Yang, Qing; Du, Jun; Zu, Lingling</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">811-814</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Prostate cancer is the most common malignancy in men in Europe and North America.  At present, it is becoming an increasingly common cancer in China.  CD73 (ecto-5'-nucleotidase) is a glycosylphosphatidylinositol (GPI)-linked 70-kDa cell surface enzyme.  It is also broadly expressed in many types of tissues.  Recent studies have showed that CD73 is widely expressed on malignancies and is up-regulated in cancerous tissues.  Consequently, we analyzed the expression of CD73 in prostate cancer tissue.  The expression of the CD73 protein was evaluated by Immunohistochem. staining in 116 tissue specimens.  The expression was further examd. by quant. real-time PCR (qRT-PCR) and Western blot in the same set of patients.  The intense cell membrane staining for the CD73 protein was obsd.  The expression of CD73 in lymph node non-metastasizing prostate cancer tissues can be seen at low levels, and is generally undetectable.  RT-PCR and Western blot showed that the expression of CD73 in lymph node metastasizing prostate cancer was higher compared with non-metastasizing ones.  These results suggest that CD73 could be considered as a relevant-specific target for mol. therapy of prostate cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFnnKE3rlInrVg90H21EOLACvtfcHk0lihbPm0hNzG4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrnP&md5=d756e344be0932523aefdf2cc21e6836</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs12253-013-9648-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-013-9648-7%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DZu%26aufirst%3DL.%26atitle%3DOverexpression%2520of%2520CD73%2520in%2520prostate%2520cancer%2520is%2520associated%2520with%2520lymph%2520node%2520metastasis%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D811%26epage%3D814%26doi%3D10.1007%2Fs12253-013-9648-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlebois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Expression is an independent prognostic factor in prostate cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-15-1181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F1078-0432.CCR-15-1181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=26253870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=158-166&author=B.+G.+Leclercauthor=R.+Charleboisauthor=G.+Chouinardauthor=B.+Allardauthor=S.+Pommeyauthor=F.+Saadauthor=J.+Stagg&title=CD73+Expression+is+an+independent+prognostic+factor+in+prostate+cancer&doi=10.1158%2F1078-0432.CCR-15-1181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer</span></div><div class="casAuthors">Leclerc, Bruno G.; Charlebois, Roxanne; Chouinard, Guillaume; Allard, Bertrand; Pommey, Sandra; Saad, Fred; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">158-166</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: CD73 is an adenosine-generating ecto-enzyme that suppresses antitumor immunity in mouse models of cancer, including prostate cancer.  Although high levels of CD73 are assocd. with poor prognosis in various types of cancer, the clin. impact of CD73 in prostate cancer remains unclear.  Exptl. Design: We evaluated the prognostic value of CD73 protein expression and CD8+ cell d. in 285 cases of prostate cancer on tissue microarray (TMA).  Normal adjacent and tumor tissues were evaluated in duplicates.  Results: Univariate and multivariate analyses revealed that high levels of CD73 in normal adjacent prostate epithelium were significantly assocd. with shorter biochem. recurrence (BCR)-free survival.  Notably, CD73 expression in normal epithelium conferred a neg. prognostic value to prostate-infiltrating CD8+ cells.  Surprisingly, high levels of CD73 in the tumor stroma were assocd. with longer BCR-free survival in univariate anal.  In vitro studies revealed that adenosine signaling inhibited NF-κB activity in human prostate cancer cells via A2B adenosine receptors.  Consistent with these results, CD73 expression in the prostate tumor stroma neg. correlated with p65 expression in the nuclei of prostate tumor cells.  Conclusions: Our study revealed that CD73 is an independent prognostic factor in prostate cancer.  Our data support a model in which CD73 expression in the prostate epithelium suppresses immunosurveillance by CD8+ T cells, whereas CD73 expression in the tumor stroma reduces NF-κB signaling in tumor cells via A2B adenosine receptor signaling.  CD73 expression, including in normal adjacent prostate epithelium, can thus effectively discriminate between aggressive and indolent forms of prostate cancer.  Clin Cancer Res; 22(1); 158-66. 2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9HCI_kLOGLVg90H21EOLACvtfcHk0lj_BNROwgrxKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGqsrk%253D&md5=f775efcc9f67005fcc4d0696399ab79f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-1181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-1181%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DB.%2BG.%26aulast%3DCharlebois%26aufirst%3DR.%26aulast%3DChouinard%26aufirst%3DG.%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Expression%2520is%2520an%2520independent%2520prognostic%2520factor%2520in%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D158%26epage%3D166%26doi%3D10.1158%2F1078-0432.CCR-15-1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Promotes anthracycline resistance and poor prognosis in triple negative breast cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">11091</span>– <span class="NLM_lpage">11096</span>, <span class="refDoi"> DOI: 10.1073/pnas.1222251110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1073%2Fpnas.1222251110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23776241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=11091-11096&author=S.+Loiauthor=S.+Pommeyauthor=B.+Haibe-Kainsauthor=P.+A.+Beavisauthor=P.+K.+Darcyauthor=M.+J.+Smythauthor=J.+Stagg&title=CD73+Promotes+anthracycline+resistance+and+poor+prognosis+in+triple+negative+breast+cancer&doi=10.1073%2Fpnas.1222251110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer</span></div><div class="casAuthors">Loi, Sherene; Pommey, Sandra; Haibe-Kains, Benjamin; Beavis, Paul A.; Darcy, Phillip K.; Smyth, Mark J.; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">11091-11096,S11091/1-S11091/21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using gene-expression data from over 6,000 breast cancer patients, we report herein that high CD73 expression is assocd. with a poor prognosis in triple-neg. breast cancers (TNBC).  Because anthracycline-based chemotherapy regimens are std. treatment for TNBC, we investigated the relationship between CD73 and anthracycline efficacy.  In TNBC patients treated with anthracycline-only preoperative chemotherapy, high CD73 gene expression was significantly assocd. with a lower rate of pathol. complete response or the disappearance of invasive tumor at surgery.  Using mouse models of breast cancer, we demonstrated that CD73 overexpression in tumor cells conferred chemoresistance to doxorubicin, a commonly used anthracycline, by suppressing adaptive antitumor immune responses via activation of A2A adenosine receptors.  Targeted blockade of CD73 enhanced doxorubicin-mediated antitumor immune responses and significantly prolonged the survival of mice with established metastatic breast cancer.  Taken together, our data suggest that CD73 constitutes a therapeutic target in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6KtLUgWgbYbVg90H21EOLACvtfcHk0lj_BNROwgrxKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLrO&md5=97b58f664273accfcab7096dcbc76db6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1222251110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1222251110%26sid%3Dliteratum%253Aachs%26aulast%3DLoi%26aufirst%3DS.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DBeavis%26aufirst%3DP.%2BA.%26aulast%3DDarcy%26aufirst%3DP.%2BK.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Promotes%2520anthracycline%2520resistance%2520and%2520poor%2520prognosis%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D11091%26epage%3D11096%26doi%3D10.1073%2Fpnas.1222251110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quezada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzún, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobrevia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Martín, R.</span></span> <span> </span><span class="NLM_article-title">5′-Ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1002/jcp.24168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fjcp.24168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22833450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKht7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2013&pages=602-608&author=C.+Quezadaauthor=W.+Garridoauthor=C.+Oyarz%C3%BAnauthor=K.+Fern%C3%A1ndezauthor=R.+Seguraauthor=R.+Meloauthor=P.+Casanelloauthor=L.+Sobreviaauthor=R.+San+Mart%C3%ADn&title=5%E2%80%B2-Ectonucleotidase+mediates+multiple-drug+resistance+in+glioblastoma+multiforme+cells&doi=10.1002%2Fjcp.24168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells</span></div><div class="casAuthors">Quezada, Claudia; Garrido, Wallys; Oyarzun, Carlos; Fernandez, Katia; Segura, Rodrigo; Melo, Romulo; Casanello, Paola; Sobrevia, Luis; San Martin, Rody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">602-608</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) cells are characterised by their extreme chemoresistance.  The activity of multiple-drug resistance (MDR) transporters that extrude antitumor drugs from cells plays the most important role in this phenomenon.  To date, the mechanism controlling the expression and activity of MDR transporters is poorly understood.  Activity of the enzyme ecto-5'-nucleotidase (CD73) in tumor cells, which hydrolyzes AMP to adenosine, has been linked to immunosuppression and prometastatic effects in breast cancer and to the proliferation of glioma cells.  In this study, we identify a high expression of CD73 in surgically resected samples of human GBM.  In primary cultures of GBM, inhibition of CD73 activity or knocking down its expression by siRNA reversed the MDR phenotype and cell viability was decreased up to 60% on exposure to the antitumoral drug vincristine.  This GBM chemosensitization was caused by a decrease in the expression and activity of the multiple drug assocd. protein 1 (Mrp1), the most important transporter conferring multiple drug resistance in these cells.  Using pharmacol. modulators, we have recognized the adenosine A3 receptor subtype in mediation of the chemoresistant phenotype in these cells.  In conclusion, we have detd. that the activity of CD73 to trigger adenosine signaling sustains chemoresistant phenotype in GBM cells.  J. Cell. Physiol. 228: 602-608, 2013. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsE28rS1xXqrVg90H21EOLACvtfcHk0lj_BNROwgrxKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKht7vM&md5=fc3af89ece5197ad661f5eb50a6bd667</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjcp.24168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.24168%26sid%3Dliteratum%253Aachs%26aulast%3DQuezada%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DW.%26aulast%3DOyarz%25C3%25BAn%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DK.%26aulast%3DSegura%26aufirst%3DR.%26aulast%3DMelo%26aufirst%3DR.%26aulast%3DCasanello%26aufirst%3DP.%26aulast%3DSobrevia%26aufirst%3DL.%26aulast%3DSan%2BMart%25C3%25ADn%26aufirst%3DR.%26atitle%3D5%25E2%2580%25B2-Ectonucleotidase%2520mediates%2520multiple-drug%2520resistance%2520in%2520glioblastoma%2520multiforme%2520cells%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2013%26volume%3D228%26spage%3D602%26epage%3D608%26doi%3D10.1002%2Fjcp.24168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bareche, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisseret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">José, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delisle, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensuu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellokumpu-Lehtinen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotiriou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">CD73 Promotes resistance to HER2/ErbB2 antibody therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">5652</span>– <span class="NLM_lpage">5663</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-17-0707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F0008-5472.CAN-17-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=28855210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CqtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=5652-5663&author=M.+Turcotteauthor=D.+Allardauthor=D.+Mittalauthor=Y.+Barecheauthor=L.+Buisseretauthor=V.+Jos%C3%A9author=S.+Pommeyauthor=V.+Delisleauthor=S.+Loiauthor=H.+Joensuuauthor=P.+L.+Kellokumpu-Lehtinenauthor=C.+Sotiriouauthor=M.+J.+Smythauthor=J.+Stagg&title=CD73+Promotes+resistance+to+HER2%2FErbB2+antibody+therapy&doi=10.1158%2F0008-5472.CAN-17-0707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy</span></div><div class="casAuthors">Turcotte, Martin; Allard, David; Mittal, Deepak; Bareche, Yacine; Buisseret, Laurence; Jose, Vinu; Pommey, Sandra; Delisle, Vincent; Loi, Sherene; Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Sotiriou, Christos; Smyth, Mark J.; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5652-5663</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of the ectonucleotidase CD73 by tumor cells, stromal cells, and immune cells is assocd. in cancer with immune suppression.  In this study, we investigated the role of CD73 on the activity of the anti-HER2/ErbB2 monoclonal antibody (mAb) trastuzumab.  In a prospective, randomized phase III clin. trial evaluating the activity of trastuzumab, high levels of CD73 gene expression were assocd. significantly with poor clin. outcome.  In contrast, high levels of PD-1 and PD-L1 were assocd. with improved clin. outcome.  In immunocompetent mouse models of HER2/ErbB2-driven breast cancer, CD73 expression by tumor cells and host cells significantly suppressed immune-mediated responses mediated by anti-ErbB2 mAb.  Furthermore, anti-CD73 mAb therapy enhanced the activity of anti-ErbB2 mAb to treat engrafted or spontaneous tumors as well as lung metastases.  Gene ontol. enrichment anal. from gene-expression data revealed a pos. assocn. of CD73 expression with extracellular matrix organization, TGFβ genes, epithelial-to-mesenchymal transition (EMT) transcription factors and hypoxia-inducible-factor (HIF)-1 gene signature.  Human mammary cells treated with TGFβ or undergoing EMT upregulated CD73 cell-surface expression, confirming roles for these pathways.  In conclusion, our findings establish CD73 in mediating resistance to trastuzumab and provide new insights into how CD73 is regulated in breast cancer.  Cancer Res; 77(20); 5652-63. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSI2kxEAJ5cbVg90H21EOLACvtfcHk0lg4isFsMAAPVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CqtLnM&md5=a71749b68bb6fd0bf6c7fd79410323b4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-0707%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DM.%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DMittal%26aufirst%3DD.%26aulast%3DBareche%26aufirst%3DY.%26aulast%3DBuisseret%26aufirst%3DL.%26aulast%3DJos%25C3%25A9%26aufirst%3DV.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DDelisle%26aufirst%3DV.%26aulast%3DLoi%26aufirst%3DS.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DKellokumpu-Lehtinen%26aufirst%3DP.%2BL.%26aulast%3DSotiriou%26aufirst%3DC.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DCD73%2520Promotes%2520resistance%2520to%2520HER2%252FErbB2%2520antibody%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2017%26volume%3D77%26spage%3D5652%26epage%3D5663%26doi%3D10.1158%2F0008-5472.CAN-17-0707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horenstein, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillemi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccarello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruzzone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarona, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malavasi, F.</span></span> <span> </span><span class="NLM_article-title">A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes</span>. <i>OncoImmunology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e26246</span>, <span class="refDoi"> DOI: 10.4161/onci.26246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.4161%2Fonci.26246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24319640" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e26246&author=A.+L.+Horensteinauthor=A.+Chillemiauthor=G.+Zaccarelloauthor=S.+Bruzzoneauthor=V.+Quaronaauthor=A.+Zitoauthor=S.+Serraauthor=F.+Malavasi&title=A+CD38%2FCD203a%2FCD73+ectoenzymatic+pathway+independent+of+CD39+drives+a+novel+adenosinergic+loop+in+human+T+lymphocytes&doi=10.4161%2Fonci.26246"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fonci.26246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fonci.26246%26sid%3Dliteratum%253Aachs%26aulast%3DHorenstein%26aufirst%3DA.%2BL.%26aulast%3DChillemi%26aufirst%3DA.%26aulast%3DZaccarello%26aufirst%3DG.%26aulast%3DBruzzone%26aufirst%3DS.%26aulast%3DQuarona%26aufirst%3DV.%26aulast%3DZito%26aufirst%3DA.%26aulast%3DSerra%26aufirst%3DS.%26aulast%3DMalavasi%26aufirst%3DF.%26atitle%3DA%2520CD38%252FCD203a%252FCD73%2520ectoenzymatic%2520pathway%2520independent%2520of%2520CD39%2520drives%2520a%2520novel%2520adenosinergic%2520loop%2520in%2520human%2520T%2520lymphocytes%26jtitle%3DOncoImmunology%26date%3D2013%26volume%3D2%26spage%3De26246%26doi%3D10.4161%2Fonci.26246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regairaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déjou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustiniani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheurte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprevotte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funck-Brentano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larroque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberici, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensussan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliaou, J.-F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-14-0018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F2326-6066.CIR-14-0018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25403716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=254-265&author=J.+Bastidauthor=A.+Regairazauthor=N.+Bonnefoyauthor=C.+D%C3%A9jouauthor=J.+Giustinianiauthor=C.+Laheurteauthor=S.+Cochaudauthor=E.+Laprevotteauthor=E.+Funck-Brentanoauthor=P.+Hemonauthor=L.+Grosauthor=N.+Becauthor=C.+Larroqueauthor=G.+Albericiauthor=A.+Bensussanauthor=J.-F.+Eliaou&title=Inhibition+of+CD39+enzymatic+function+at+the+surface+of+tumor+cells+alleviates+their+immunosuppressive+activity&doi=10.1158%2F2326-6066.CIR-14-0018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity</span></div><div class="casAuthors">Bastid, Jeremy; Regairaz, Anne; Bonnefoy, Nathalie; Dejou, Cecile; Giustiniani, Jerome; Laheurte, Caroline; Cochaud, Stephanie; Laprevotte, Emilie; Funck-Brentano, Elisa; Hemon, Patrice; Gros, Laurent; Bec, Nicole; Larroque, Christian; Alberici, Gilles; Bensussan, Armand; Eliaou, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">254-265</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bastid and colleagues show that CD39 is highly expressed on tumor-infiltrating lymphocytes, tumor stroma, but also on tumor cells; treatment with CD39 inhibitors or blocking antibody alleviated the tumor-induced inhibition of T-cell proliferation and increased CTL- and NK cell-mediated cytotoxicity.  The ectonucleotidases CD39 and CD73 hydrolyze extracellular ATP and ADP to generate adenosine, which binds to adenosine receptors and inhibits T-cell and natural killer (NK)-cell responses, thereby suppressing the immune system.  The generation of adenosine via the CD39/CD73 pathway is recognized as a major mechanism of regulatory T cell (Treg) immunosuppressive function.  The no. of CD39+ Tregs is increased in some human cancers, and the importance of CD39+ Tregs in promoting tumor growth and metastasis has been demonstrated using several in vivo models.  Here, we addressed whether CD39 is expressed by tumor cells and whether CD39+ tumor cells mediate immunosuppression via the adenosine pathway.  Immunohistochem. staining of normal and tumor tissues revealed that CD39 expression is significantly higher in several types of human cancer than in normal tissues.  In cancer specimens, CD39 is expressed by infiltrating lymphocytes, the tumor stroma, and tumor cells.  Furthermore, the expression of CD39 at the cell surface of tumor cells was directly demonstrated via flow cytometry of human cancer cell lines.  CD39 in cancer cells displays ATPase activity and, together with CD73, generates adenosine.  CD39+CD73+ cancer cells inhibited the proliferation of CD4 and CD8 T cells and the generation of cytotoxic effector CD8 T cells (CTL) in a CD39- and adenosine-dependent manner.  Treatment with a CD39 inhibitor or blocking antibody alleviated the tumor-induced inhibition of CD4 and CD8 T-cell proliferation and increased CTL- and NK cell-mediated cytotoxicity.  In conclusion, interfering with the CD39-adenosine pathway may represent a novel immunotherapeutic strategy for inhibiting tumor cell-mediated immunosuppression.  Cancer Immunol Res; 3(3); 254-65. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0DdZv0TAlbVg90H21EOLACvtfcHk0lg4isFsMAAPVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFemsrw%253D&md5=a1bf760865ce195d078895fe611b992a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-14-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-14-0018%26sid%3Dliteratum%253Aachs%26aulast%3DBastid%26aufirst%3DJ.%26aulast%3DRegairaz%26aufirst%3DA.%26aulast%3DBonnefoy%26aufirst%3DN.%26aulast%3DD%25C3%25A9jou%26aufirst%3DC.%26aulast%3DGiustiniani%26aufirst%3DJ.%26aulast%3DLaheurte%26aufirst%3DC.%26aulast%3DCochaud%26aufirst%3DS.%26aulast%3DLaprevotte%26aufirst%3DE.%26aulast%3DFunck-Brentano%26aufirst%3DE.%26aulast%3DHemon%26aufirst%3DP.%26aulast%3DGros%26aufirst%3DL.%26aulast%3DBec%26aufirst%3DN.%26aulast%3DLarroque%26aufirst%3DC.%26aulast%3DAlberici%26aufirst%3DG.%26aulast%3DBensussan%26aufirst%3DA.%26aulast%3DEliaou%26aufirst%3DJ.-F.%26atitle%3DInhibition%2520of%2520CD39%2520enzymatic%2520function%2520at%2520the%2520surface%2520of%2520tumor%2520cells%2520alleviates%2520their%2520immunosuppressive%2520activity%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2015%26volume%3D3%26spage%3D254%26epage%3D265%26doi%3D10.1158%2F2326-6066.CIR-14-0018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachsenmeier, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dall’Acqua, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damschroder, M. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action</span>. <i>MABs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1080/19420862.2016.1143182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1080%2F19420862.2016.1143182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=26854859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=454-467&author=J.+C.+Geogheganauthor=G.+Diedrichauthor=X.+Luauthor=K.+Rosenthalauthor=K.+F.+Sachsenmeierauthor=H.+Wuauthor=W.+F.+Dall%E2%80%99Acquaauthor=M.+M.+Damschroder&title=Inhibition+of+CD73+AMP+hydrolysis+by+a+therapeutic+antibody+with+a+dual%2C+non-competitive+mechanism+of+action&doi=10.1080%2F19420862.2016.1143182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action</span></div><div class="casAuthors">Geoghegan, James C.; Diedrich, Gundo; Lu, Xiaojun; Rosenthal, Kim; Sachsenmeier, Kris F.; Wu, Herren; Dall'Acqua, William F.; Damschroder, Melissa M.</div><div class="citationInfo"><span class="NLM_cas:title">mAbs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">454-467</span>CODEN:
                <span class="NLM_cas:coden">MABSCP</span>;
        ISSN:<span class="NLM_cas:issn">1942-0870</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">CD73 (ecto-5'-nucleotidase) has recently been established as a promising immuno-oncol. target.  Given its role in activating purinergic signaling pathways to elicit immune suppression, antagonizing CD73 (i.e., releasing the brake) offers a complimentary pathway to inducing anti-tumor immune responses.  Here, we describe the mechanistic activity of a new clin. therapeutic, MEDI9447, a human monoclonal antibody that non-competitively inhibits CD73 activity.  Epitope mapping, structural, and mechanistic studies revealed that MEDI9447 antagonizes CD73 through dual mechanisms of inter-CD73 dimer crosslinking and/or steric blocking that prevent CD73 from adopting a catalytically active conformation.  To our knowledge, this is the first report of an antibody that inhibits an enzyme's function through 2 distinct modes of action.  These results provide a finely mapped epitope that can be targeted for selective, potent, and non-competitive inhibition of CD73, as well as establish a strategy for inhibiting enzymes that function in both membrane-bound and sol. states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgPbLcUfy-FbVg90H21EOLACvtfcHk0lhnEnRu7_YtPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVWmt7o%253D&md5=5a7d1f227f282dfe3106a7438d279b50</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F19420862.2016.1143182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F19420862.2016.1143182%26sid%3Dliteratum%253Aachs%26aulast%3DGeoghegan%26aufirst%3DJ.%2BC.%26aulast%3DDiedrich%26aufirst%3DG.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DRosenthal%26aufirst%3DK.%26aulast%3DSachsenmeier%26aufirst%3DK.%2BF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DDall%25E2%2580%2599Acqua%26aufirst%3DW.%2BF.%26aulast%3DDamschroder%26aufirst%3DM.%2BM.%26atitle%3DInhibition%2520of%2520CD73%2520AMP%2520hydrolysis%2520by%2520a%2520therapeutic%2520antibody%2520with%2520a%2520dual%252C%2520non-competitive%2520mechanism%2520of%2520action%26jtitle%3DMABs%26date%3D2016%26volume%3D8%26spage%3D454%26epage%3D467%26doi%3D10.1080%2F19420862.2016.1143182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnhart, B. C.</span>; <span class="NLM_string-name">Sega, E.</span>; <span class="NLM_string-name">Yamniuk, A.</span>; <span class="NLM_string-name">Hatcher, S.</span>; <span class="NLM_string-name">Lei, M.</span>; <span class="NLM_string-name">Ghermazien, H.</span>; <span class="NLM_string-name">Lewin, A.</span>; <span class="NLM_string-name">Wang, X.-T.</span>; <span class="NLM_string-name">Huang, H.</span>; <span class="NLM_string-name">Zhang, P.</span>; <span class="NLM_string-name">Korman, A.</span></span> <span> </span><span class="NLM_article-title">A Therapeutic Antibody that Inhibits CD73 Activity by Dual Mechanisms</span>.  <i>Proceedings</i>, 107th Annual Meeting of the AACR, New Orleans, LA, Apr 16–20, 2016; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+C.+Barnhart&author=E.+Sega&author=A.+Yamniuk&author=S.+Hatcher&author=M.+Lei&author=H.+Ghermazien&author=A.+Lewin&author=X.-T.+Wang&author=H.+Huang&author=P.+Zhang&author=A.+Korman&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBarnhart%26aufirst%3DB.%2BC.%26atitle%3DA%2520Therapeutic%2520Antibody%2520that%2520Inhibits%2520CD73%2520Activity%2520by%2520Dual%2520Mechanisms%26btitle%3DProceedings%26pub%3DAACR%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, L. L.</span>; <span class="NLM_string-name">Burris, H.</span>; <span class="NLM_string-name">Le, D. T.</span>; <span class="NLM_string-name">Hollebecque, A.</span>; <span class="NLM_string-name">Steeghs, N.</span>; <span class="NLM_string-name">Delord, J.-P.</span>; <span class="NLM_string-name">Hilton, J.</span>; <span class="NLM_string-name">Barnhart, B.</span>; <span class="NLM_string-name">Sega, E.</span>; <span class="NLM_string-name">Sanghavi, K.</span>; <span class="NLM_string-name">Klippel, A.</span>; <span class="NLM_string-name">Hedvat, C.</span>; <span class="NLM_string-name">Hilt, E.</span>; <span class="NLM_string-name">Donovan, M.</span>; <span class="NLM_string-name">Gipson, A.</span>; <span class="NLM_string-name">Basciano, P.</span>; <span class="NLM_string-name">Postelnek, J.</span>; <span class="NLM_string-name">Zhao, Y.</span>; <span class="NLM_string-name">Perez, R. P.</span>; <span class="NLM_string-name">Carvajal, R. D.</span></span> <span> </span><span class="NLM_article-title">Preliminary Phase 1 Profile of BMS-986179, an Anti-CD73 Antibody, in Combination with Nivolumab in Patients with Advanced Solid Tumors</span>.  <i>Proceedings</i>, AACR Annual Meeting; Chicago, IL, Apr 14–18, 2018; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+L.+Siu&author=H.+Burris&author=D.+T.+Le&author=A.+Hollebecque&author=N.+Steeghs&author=J.-P.+Delord&author=J.+Hilton&author=B.+Barnhart&author=E.+Sega&author=K.+Sanghavi&author=A.+Klippel&author=C.+Hedvat&author=E.+Hilt&author=M.+Donovan&author=A.+Gipson&author=P.+Basciano&author=J.+Postelnek&author=Y.+Zhao&author=R.+P.+Perez&author=R.+D.+Carvajal&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DL.%2BL.%26atitle%3DPreliminary%2520Phase%25201%2520Profile%2520of%2520BMS-986179%252C%2520an%2520Anti-CD73%2520Antibody%252C%2520in%2520Combination%2520with%2520Nivolumab%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumors%26btitle%3DProceedings%26pub%3DAACR%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickler, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasanna, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemunaitis, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Byrne, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. D.</span></span> <span> </span><span class="NLM_article-title">Safety, Efficacy and Pharmacodynamics (PD) of MEDI9447 (Oleclumab) Alone or in Combination with Durvalumab in Advanced Colorectal Cancer (CRC) or Pancreatic Cancer (Panc)</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">15, Suppl.</span>),  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4123</span>, <span class="refDoi"> DOI: 10.1200/JCO.2018.36.15_suppl.4123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1200%2FJCO.2018.36.15_suppl.4123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=4123-4123&issue=15%2C+Suppl.&author=M.+J.+Overmanauthor=P.+LoRussoauthor=J.+H.+Stricklerauthor=S.+P.+Patelauthor=S.+J.+Clarkeauthor=A.+M.+Noonanauthor=T.+Prasannaauthor=M.+A.+Aminauthor=J.+J.+Nemunaitisauthor=J.+Desaiauthor=K.+J.+O%E2%80%99Byrneauthor=T.+J.+Georgeauthor=J.+Englertauthor=D.+Sheauthor=Z.+A.+Cooperauthor=Y.+Wuauthor=A.+Khanauthor=R.+Kumarauthor=J.+D.+Bendell&title=Safety%2C+Efficacy+and+Pharmacodynamics+%28PD%29+of+MEDI9447+%28Oleclumab%29+Alone+or+in+Combination+with+Durvalumab+in+Advanced+Colorectal+Cancer+%28CRC%29+or+Pancreatic+Cancer+%28Panc%29&doi=10.1200%2FJCO.2018.36.15_suppl.4123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1200%2FJCO.2018.36.15_suppl.4123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2018.36.15_suppl.4123%26sid%3Dliteratum%253Aachs%26aulast%3DOverman%26aufirst%3DM.%2BJ.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DStrickler%26aufirst%3DJ.%2BH.%26aulast%3DPatel%26aufirst%3DS.%2BP.%26aulast%3DClarke%26aufirst%3DS.%2BJ.%26aulast%3DNoonan%26aufirst%3DA.%2BM.%26aulast%3DPrasanna%26aufirst%3DT.%26aulast%3DAmin%26aufirst%3DM.%2BA.%26aulast%3DNemunaitis%26aufirst%3DJ.%2BJ.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Byrne%26aufirst%3DK.%2BJ.%26aulast%3DGeorge%26aufirst%3DT.%2BJ.%26aulast%3DEnglert%26aufirst%3DJ.%26aulast%3DShe%26aufirst%3DD.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DBendell%26aufirst%3DJ.%2BD.%26atitle%3DSafety%252C%2520Efficacy%2520and%2520Pharmacodynamics%2520%2528PD%2529%2520of%2520MEDI9447%2520%2528Oleclumab%2529%2520Alone%2520or%2520in%2520Combination%2520with%2520Durvalumab%2520in%2520Advanced%2520Colorectal%2520Cancer%2520%2528CRC%2529%2520or%2520Pancreatic%2520Cancer%2520%2528Panc%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D36%26issue%3D15%252C%2520Suppl%26spage%3D4123%26epage%3D4123%26doi%3D10.1200%2FJCO.2018.36.15_suppl.4123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piccione, E. C.</span>; <span class="NLM_string-name">Mikesell, G.</span>; <span class="NLM_string-name">Daine-Matsuoka, B.</span>; <span class="NLM_string-name">Walter, K.</span>; <span class="NLM_string-name">Miller, R.</span>; <span class="NLM_string-name">McCaffery, I.</span></span> <span> </span><span class="NLM_article-title">A Novel CD73-Blocking Antibody Reduces Production of Immunosuppressive Adenosine and Restores T Cell Function</span>.  <i>Proceedings</i>, AACR Annual Meeting, Washington, DC, Apr 1–5, 2017; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2017</span>; <span class="refDoi"> DOI: 10.1158/1538-7445.AM2017-5577</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F1538-7445.AM2017-5577" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=E.+C.+Piccione&author=G.+Mikesell&author=B.+Daine-Matsuoka&author=K.+Walter&author=R.+Miller&author=I.+McCaffery&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2017-5577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1158%252F1538-7445.AM2017-5577%26sid%3Dliteratum%253Aachs%26aulast%3DPiccione%26aufirst%3DE.%2BC.%26atitle%3DA%2520Novel%2520CD73-Blocking%2520Antibody%2520Reduces%2520Production%2520of%2520Immunosuppressive%2520Adenosine%2520and%2520Restores%2520T%2520Cell%2520Function%26btitle%3DProceedings%26pub%3DAACR%26date%3D2017%26doi%3D10.1158%2F1538-7445.AM2017-5577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span>Surface
Oncology, Inc. <a href="https://investors.surfaceoncology.com/news-releases/news-release-details/surface-oncology-announces-initiation-phase-i-clinical-trial" class="extLink">https://investors.surfaceoncology.com/news-releases/news-release-details/surface-oncology-announces-initiation-phase-i-clinical-trial</a> (accessed Jun 1, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Surface%0AOncology%2C+Inc.+https%3A%2F%2Finvestors.surfaceoncology.com%2Fnews-releases%2Fnews-release-details%2Fsurface-oncology-announces-initiation-phase-i-clinical-trial+%28accessed+Jun+1%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span> </span><span class="NLM_article-title">Study
of TJ004309 in Combination with Atezolizumab (Tecentriq®)
in Patients with Advanced or Metastatic Cancer</span>. Last
updated Mar 2, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT03835949" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03835949</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+TJ004309+in+Combination+with+Atezolizumab+%28Tecentriq%C2%AE%29%0Ain+Patients+with+Advanced+or+Metastatic+Cancer.+Last%0Aupdated+Mar+2%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03835949+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%250Aof%2520TJ004309%2520in%2520Combination%2520with%2520Atezolizumab%2520%2528Tecentriq%25C2%25AE%2529%250Ain%2520Patients%2520with%2520Advanced%2520or%2520Metastatic%2520Cancer%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span> </span><span class="NLM_article-title">A Phase
I/II Study of TJ004309 for Advanced Solid Tumor</span>. Last
updated May 21, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04322006" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04322006</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase%0AI%2FII+Study+of+TJ004309+for+Advanced+Solid+Tumor.+Last%0Aupdated+May+21%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04322006+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%250AI%252FII%2520Study%2520of%2520TJ004309%2520for%2520Advanced%2520Solid%2520Tumor%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span> </span><span class="NLM_article-title">Study
of GS-1423 in Participants with Advanced Solid Tumors</span>. Last updated Apr 7, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT03954704" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03954704</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+GS-1423+in+Participants+with+Advanced+Solid+Tumors.+Last+updated+Apr+7%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03954704+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%250Aof%2520GS-1423%2520in%2520Participants%2520with%2520Advanced%2520Solid%2520Tumors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, N. S.</span>; <span class="NLM_string-name">Waight, J. D.</span>; <span class="NLM_string-name">Jennings, S. M.</span>; <span class="NLM_string-name">Ignatovich, O.</span>; <span class="NLM_string-name">Briend, E. C. P.</span>; <span class="NLM_string-name">Morin, B. M.</span>; <span class="NLM_string-name">Schon, O.</span>; <span class="NLM_string-name">Campbell, S.</span></span> <span> </span><span class="NLM_article-title">Anti-CD73 Antibodies and Methods of Use Thereof</span>. U.S. Patent Appl. <span class="NLM_patent">US20190352418 A1</span>, Nov 21, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=N.+S.+Wilson&author=J.+D.+Waight&author=S.+M.+Jennings&author=O.+Ignatovich&author=E.+C.+P.+Briend&author=B.+M.+Morin&author=O.+Schon&author=S.+Campbell&title=Anti-CD73+Antibodies+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DN.%2BS.%26atitle%3DAnti-CD73%2520Antibodies%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, A. G.</span>; <span class="NLM_string-name">Kovalenko, M.</span>; <span class="NLM_string-name">Welch, M.</span>; <span class="NLM_string-name">dela Cruz, T.</span>; <span class="NLM_string-name">Jones, J.</span>; <span class="NLM_string-name">Wong, C.</span>; <span class="NLM_string-name">Spatola, B.</span>; <span class="NLM_string-name">Eberhardt, M.</span>; <span class="NLM_string-name">Wong, A.</span>; <span class="NLM_string-name">Fung, W.</span>; <span class="NLM_string-name">Lagpacan, L.</span>; <span class="NLM_string-name">Losenkova, K.</span>; <span class="NLM_string-name">Yegutkin, G.</span>; <span class="NLM_string-name">Soros, V.</span>; <span class="NLM_string-name">Corbin, J.</span>; <span class="NLM_string-name">Beers, C.</span>; <span class="NLM_string-name">Moesta, A. L.</span></span> <span> </span><span class="NLM_article-title">Targeting CD39 with a First-in-Class Inhibitory Antibody Prevents ATP Processing and Increases T-Cell Activation</span>.  <i>Proceedings</i>, AACR Annual Meeting, Atlanta, GA, Mar 29–Apr 3, 2019; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=A.+G.+Lerner&author=M.+Kovalenko&author=M.+Welch&author=T.+dela+Cruz&author=J.+Jones&author=C.+Wong&author=B.+Spatola&author=M.+Eberhardt&author=A.+Wong&author=W.+Fung&author=L.+Lagpacan&author=K.+Losenkova&author=G.+Yegutkin&author=V.+Soros&author=J.+Corbin&author=C.+Beers&author=A.+L.+Moesta&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DA.%2BG.%26atitle%3DTargeting%2520CD39%2520with%2520a%2520First-in-Class%2520Inhibitory%2520Antibody%2520Prevents%2520ATP%2520Processing%2520and%2520Increases%2520T-Cell%2520Activation%26btitle%3DProceedings%26pub%3DAACR%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moesta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepletier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundarrajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacoberger-Foissac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dela Cruz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spatola, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soros, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Effern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bald, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geetha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Targeting CD39 in cancer reveals an extracellular ATP and inflammasome driven tumor immunity</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1754</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-0541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F2159-8290.CD-19-0541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31699796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Ght77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1754&author=X.-Y.+Liauthor=A.+K.+Moestaauthor=C.+Xiaoauthor=K.+Nakamuraauthor=M.+Caseyauthor=H.+Zhangauthor=J.+Madoreauthor=A.+Lepletierauthor=A.+R.+Aguileraauthor=A.+Sundarrajanauthor=C.+Jacoberger-Foissacauthor=C.+Wongauthor=T.+dela+Cruzauthor=M.+Welchauthor=A.+G.+Lernerauthor=B.+N.+Spatolaauthor=V.+B.+Sorosauthor=J.+Corbinauthor=A.+C.+Andersonauthor=M.+Effernauthor=M.+Holzelauthor=S.+C.+Robsonauthor=R.+L.+Johnstonauthor=N.+Waddellauthor=C.+Smithauthor=T.+Baldauthor=N.+Geethaauthor=C.+Beersauthor=M.+W.+L.+Tengauthor=M.+J.+Smyth&title=Targeting+CD39+in+cancer+reveals+an+extracellular+ATP+and+inflammasome+driven+tumor+immunity&doi=10.1158%2F2159-8290.CD-19-0541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity</span></div><div class="casAuthors">Li, Xian-Yang; Moesta, Achim K.; Xiao, Christos; Nakamura, Kyohei; Casey, Mika; Zhang, Haiyan; Madore, Jason; Lepletier, Ailin; Aguilera, Amelia Roman; Sundarrajan, Ashmitha; Jacoberger-Foissac, Celia; Wong, Clifford; dela Cruz, Tracy; Welch, Megan; Lerner, Alana G.; Spatola, Bradley N.; Soros, Vanessa B.; Corbin, John; Anderson, Ana C.; Effern, Maike; Hoelzel, Michael; Robson, Simon C.; Johnston, Rebecca L.; Waddell, Nicola; Smith, Corey; Bald, Tobias; Geetha, Nishamol; Beers, Courtney; Teng, Michele W. L.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1754-1773</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We explored the mechanism of action of CD39 antibodies that inhibit ectoenzyme CD39 conversion of extracellular ATP (eATP) to AMP and thus potentially augment eATP-P2-mediated proinflammatory responses.  Using syngeneic and humanized tumor models, we contrast the potency and mechanism of anti-CD39 mAbs with other agents targeting the adenosinergic pathway.  We demonstrate the crit. importance of an eATP-P2X7-ASC-NALP3-inflammasome-IL18 pathway in the antitumor activity mediated by CD39 enzyme blockade, rather than simply reducing adenosine as mechanism of action.  Efficacy of anti-CD39 activity was underpinned by CD39 and P2X7 coexpression on intratumor myeloid subsets, an early signature of macrophage depletion, and active IL18 release that facilitated the significant expansion of intratumor effector T cells.  More importantly, anti-CD39 facilitated infiltration into T cell-poor tumors and rescued anti-PD-1 resistance.  Anti-human CD39 enhanced human T-cell proliferation and Th1 cytokine prodn. and suppressed human B-cell lymphoma in the context of autologous Epstein-Barr virus-specific T-cell transfer.  Significance: Overall, these data describe a potent and novel mechanism of action of antibodies that block mouse or human CD39, triggering an eATP-P2X7-inflammasome-IL18 axis that reduces intratumor macrophage no., enhances intratumor T-cell effector function, overcomes anti-PD-1 resistance, and potentially enhances the efficacy of adoptive T-cell transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFHRZC4MnGIbVg90H21EOLACvtfcHk0lhJNY_UV9uZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Ght77K&md5=9441688a4079ec65c9c56efd6a9e6db2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-0541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-0541%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DMoesta%26aufirst%3DA.%2BK.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DCasey%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMadore%26aufirst%3DJ.%26aulast%3DLepletier%26aufirst%3DA.%26aulast%3DAguilera%26aufirst%3DA.%2BR.%26aulast%3DSundarrajan%26aufirst%3DA.%26aulast%3DJacoberger-Foissac%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DC.%26aulast%3Ddela%2BCruz%26aufirst%3DT.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DLerner%26aufirst%3DA.%2BG.%26aulast%3DSpatola%26aufirst%3DB.%2BN.%26aulast%3DSoros%26aufirst%3DV.%2BB.%26aulast%3DCorbin%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26aulast%3DEffern%26aufirst%3DM.%26aulast%3DHolzel%26aufirst%3DM.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DJohnston%26aufirst%3DR.%2BL.%26aulast%3DWaddell%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DBald%26aufirst%3DT.%26aulast%3DGeetha%26aufirst%3DN.%26aulast%3DBeers%26aufirst%3DC.%26aulast%3DTeng%26aufirst%3DM.%2BW.%2BL.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DTargeting%2520CD39%2520in%2520cancer%2520reveals%2520an%2520extracellular%2520ATP%2520and%2520inflammasome%2520driven%2520tumor%2520immunity%26jtitle%3DCancer%2520Discovery%26date%3D2019%26volume%3D9%26spage%3D1754%26doi%3D10.1158%2F2159-8290.CD-19-0541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span> </span><span class="NLM_article-title">TTX-030 Single Agent and in Combination with Immunotherapy
or Chemotherapy
for Patients with Advanced Cancers</span>. Last updated May
11, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT03884556" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03884556</a> (accessed Jun
2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TTX-030+Single+Agent+and+in+Combination+with+Immunotherapy%0Aor+Chemotherapy%0Afor+Patients+with+Advanced+Cancers.+Last+updated+May%0A11%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03884556+%28accessed+Jun%0A2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DTTX-030%2520Single%2520Agent%2520and%2520in%2520Combination%2520with%2520Immunotherapy%250Aor%2520Chemotherapy%250Afor%2520Patients%2520with%2520Advanced%2520Cancers%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span> </span><span class="NLM_article-title">TTX-030 in Combination
With Immunotherapy and/or Chemotherapy in
Subjects With Advanced Cancers</span>. Last updated May 13,
2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04306900" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04306900</a> (accessed Jun
2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TTX-030+in+Combination%0AWith+Immunotherapy+and%2For+Chemotherapy+in%0ASubjects+With+Advanced+Cancers.+Last+updated+May+13%2C%0A2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04306900+%28accessed+Jun%0A2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DTTX-030%2520in%2520Combination%250AWith%2520Immunotherapy%2520and%252For%2520Chemotherapy%2520in%250ASubjects%2520With%2520Advanced%2520Cancers%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, H.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraudon-Paoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docquier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jecko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becquart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rispaud-Blanc, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourdin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amigues, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensussan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliaou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narni-Mancinelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paturel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, N.</span></span> <span> </span><span class="NLM_article-title">Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2411</span>– <span class="NLM_lpage">2425</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2019.04.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.celrep.2019.04.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31116985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVWksb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=2411-2425&author=I.+Perrotauthor=H.-A.+Michaudauthor=M.+Giraudon-Paoliauthor=S.+Augierauthor=A.+Docquierauthor=L.+Grosauthor=R.+Courtoisauthor=C.+Dejouauthor=D.+Jeckoauthor=O.+Becquartauthor=H.+Rispaud-Blancauthor=L.+Gauthierauthor=B.+Rossiauthor=S.+Chanteuxauthor=N.+Gourdinauthor=B.+Amiguesauthor=A.+Rousselauthor=A.+Bensussanauthor=J.-F.+Eliaouauthor=J.+Bastidauthor=F.+Romagneauthor=Y.+Morelauthor=E.+Narni-Mancinelliauthor=E.+Vivierauthor=C.+Paturelauthor=N.+Bonnefoy&title=Blocking+antibodies+targeting+the+CD39%2FCD73+immunosuppressive+pathway+unleash+immune+responses+in+combination+cancer+therapies&doi=10.1016%2Fj.celrep.2019.04.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies</span></div><div class="casAuthors">Perrot, Ivan; Michaud, Henri-Alexandre; Giraudon-Paoli, Marc; Augier, Severine; Docquier, Aurelie; Gros, Laurent; Courtois, Rachel; Dejou, Cecile; Jecko, Diana; Becquart, Ondine; Rispaud-Blanc, Helene; Gauthier, Laurent; Rossi, Benjamin; Chanteux, Stephanie; Gourdin, Nicolas; Amigues, Beatrice; Roussel, Alain; Bensussan, Armand; Eliaou, Jean-Francois; Bastid, Jeremy; Romagne, Francois; Morel, Yannis; Narni-Mancinelli, Emilie; Vivier, Eric; Paturel, Carine; Bonnefoy, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2411-2425.e9</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Immune checkpoint inhibitors have revolutionized cancer treatment.  However, many cancers are resistant to ICIs, and the targeting of addnl. inhibitory signals is crucial for limiting tumor evasion.  The prodn. of adenosine via the sequential activity of CD39 and CD73 ectoenzymes participates to the generation of an immunosuppressive tumor microenvironment.  In order to disrupt the adenosine pathway, we generated two antibodies, IPH5201 and IPH5301, targeting human membrane-assocd. and sol. forms of CD39 and CD73, resp., and efficiently blocking the hydrolysis of immunogenic ATP into immunosuppressive adenosine.  These antibodies promoted antitumor immunity by stimulating dendritic cells and macrophages and by restoring the activation of T cells isolated from cancer patients.  In a human CD39 knockin mouse preclin. model, IPH5201 increased the anti-tumor activity of the ATP-inducing chemotherapeutic drug oxaliplatin.  These results support the use of anti-CD39 and anti-CD73 monoclonal antibodies and their combination with immune checkpoint inhibitors and chemotherapies in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4T46HApEaJbVg90H21EOLACvtfcHk0liY8S8arCw5aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVWksb7M&md5=b2642873d6ab147a849b16d2866c3ed6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2019.04.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2019.04.091%26sid%3Dliteratum%253Aachs%26aulast%3DPerrot%26aufirst%3DI.%26aulast%3DMichaud%26aufirst%3DH.-A.%26aulast%3DGiraudon-Paoli%26aufirst%3DM.%26aulast%3DAugier%26aufirst%3DS.%26aulast%3DDocquier%26aufirst%3DA.%26aulast%3DGros%26aufirst%3DL.%26aulast%3DCourtois%26aufirst%3DR.%26aulast%3DDejou%26aufirst%3DC.%26aulast%3DJecko%26aufirst%3DD.%26aulast%3DBecquart%26aufirst%3DO.%26aulast%3DRispaud-Blanc%26aufirst%3DH.%26aulast%3DGauthier%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DB.%26aulast%3DChanteux%26aufirst%3DS.%26aulast%3DGourdin%26aufirst%3DN.%26aulast%3DAmigues%26aufirst%3DB.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DBensussan%26aufirst%3DA.%26aulast%3DEliaou%26aufirst%3DJ.-F.%26aulast%3DBastid%26aufirst%3DJ.%26aulast%3DRomagne%26aufirst%3DF.%26aulast%3DMorel%26aufirst%3DY.%26aulast%3DNarni-Mancinelli%26aufirst%3DE.%26aulast%3DVivier%26aufirst%3DE.%26aulast%3DPaturel%26aufirst%3DC.%26aulast%3DBonnefoy%26aufirst%3DN.%26atitle%3DBlocking%2520antibodies%2520targeting%2520the%2520CD39%252FCD73%2520immunosuppressive%2520pathway%2520unleash%2520immune%2520responses%2520in%2520combination%2520cancer%2520therapies%26jtitle%3DCell%2520Rep.%26date%3D2019%26volume%3D27%26spage%3D2411%26epage%3D2425%26doi%3D10.1016%2Fj.celrep.2019.04.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span> </span><span class="NLM_article-title">IPH5201 as Monotherapy or in Combination with Durvalumab
± Oleclumab
in Subjects with Advanced Solid Tumors</span>. Last updated
May 28, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04261075" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04261075</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IPH5201+as+Monotherapy+or+in+Combination+with+Durvalumab%0A%C2%B1+Oleclumab%0Ain+Subjects+with+Advanced+Solid+Tumors.+Last+updated%0AMay+28%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04261075+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DIPH5201%2520as%2520Monotherapy%2520or%2520in%2520Combination%2520with%2520Durvalumab%250A%25C2%25B1%2520Oleclumab%250Ain%2520Subjects%2520with%2520Advanced%2520Solid%2520Tumors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, M. C.</span>; <span class="NLM_string-name">Das, S. G.</span>; <span class="NLM_string-name">Dulak, A.</span>; <span class="NLM_string-name">Zaidi, T. H.</span>; <span class="NLM_string-name">Devereaux, E.</span>; <span class="NLM_string-name">Strand, J.</span>; <span class="NLM_string-name">Koseoglu, S.</span>; <span class="NLM_string-name">Lee, B. H.</span>; <span class="NLM_string-name">Riordan, C.</span>; <span class="NLM_string-name">Holland, P. M.</span>; <span class="NLM_string-name">Palombella, V. J.</span>; <span class="NLM_string-name">Lake, A. C.</span></span> <span> </span><span class="NLM_article-title">The Fully Human Antibody SRF617 is a Potent Enzymatic Inhibitor of CD39 with Strong Immunomodulatory Activity</span>. Presented at The Society for Immunotherapy of Cancer Annual Meeting, Nov 9, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+C.+Warren&author=S.+G.+Das&author=A.+Dulak&author=T.+H.+Zaidi&author=E.+Devereaux&author=J.+Strand&author=S.+Koseoglu&author=B.+H.+Lee&author=C.+Riordan&author=P.+M.+Holland&author=V.+J.+Palombella&author=A.+C.+Lake&title=The+Fully+Human+Antibody+SRF617+is+a+Potent+Enzymatic+Inhibitor+of+CD39+with+Strong+Immunomodulatory+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DM.%2BC.%26atitle%3DThe%2520Fully%2520Human%2520Antibody%2520SRF617%2520is%2520a%2520Potent%2520Enzymatic%2520Inhibitor%2520of%2520CD39%2520with%2520Strong%2520Immunomodulatory%2520Activity%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span> </span><span class="NLM_article-title">Study of SRF617 in Patients with Advanced
Solid Tumors</span>. Last updated Apr 7, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04336098" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04336098</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+SRF617+in+Patients+with+Advanced%0ASolid+Tumors.+Last+updated+Apr+7%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04336098+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520of%2520SRF617%2520in%2520Patients%2520with%2520Advanced%250ASolid%2520Tumors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowenstein, J. M.</span></span> <span> </span><span class="NLM_article-title">Preparation and properties of 5′-nucleotidase from smooth muscle of small intestine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">6274</span>– <span class="NLM_lpage">6280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=4320834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaE3MXjvVGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1970&pages=6274-6280&author=R.+M.+Burgerauthor=J.+M.+Lowenstein&title=Preparation+and+properties+of+5%E2%80%B2-nucleotidase+from+smooth+muscle+of+small+intestine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and properties of 5'-nucleotidase from smooth muscle of small intestine</span></div><div class="casAuthors">Burger, Richard; Lowenstein, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6274-80</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">ADP strongly inhibited a 5' -nucleotidase prepd. from pig smooth muscle.  This inhibition was much stronger than the previously described inhibition of 5' -nucleotidase by ATP.  Α,β-Methylene adenosine 5' -diphosphate (I) was an exceptionally powerful inhibitor of the enzyme.  The enzyme had 3 pH optima.  The lowest of these optima was seen only when the enzyme was not inhibited by buffer anions; the highest was seen only in the presence of Mg2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdkMkr4_XWRbVg90H21EOLACvtfcHk0ljZy7_q8OvXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXjvVGgsQ%253D%253D&md5=a60b798fa2da1eb9dd34eb446040301a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DR.%2BM.%26aulast%3DLowenstein%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520and%2520properties%2520of%25205%25E2%2580%25B2-nucleotidase%2520from%2520smooth%2520muscle%2520of%2520small%2520intestine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1970%26volume%3D245%26spage%3D6274%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowenstein, J. M.</span></span> <span> </span><span class="NLM_article-title">5′-Nucleotidase from rat heart membranes. Inhibition by adenine nucleotides and related compounds</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1042/bj2260645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1042%2Fbj2260645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=2985044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaL2MXhvVWgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1985&pages=645-651&author=Y.+Naitoauthor=J.+M.+Lowenstein&title=5%E2%80%B2-Nucleotidase+from+rat+heart+membranes.+Inhibition+by+adenine+nucleotides+and+related+compounds&doi=10.1042%2Fbj2260645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">5'-Nucleotidase from rat heart membranes.  Inhibition by adenine nucleotides and related compounds</span></div><div class="casAuthors">Naito, Yoshitsugu; Lowenstein, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">645-51</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">ADP and ATP and their analogs were evaluated as inhibitors of 5'-nucleotidase purified from heart plasma membrane.  ADP analogs were more powerful inhibitors than the corresponding ATP analogs.  The most powerful inhibitor found was adenosine 5'-[αβ-methylene]diphosphate (AOPCP) for which the enzyme showed a Ki of 5 nM at pH 7.2.  Measurements of pKi values for ADP and AOPCP as a function of pH indicated that the major inhibitory species of both nucleotides was the dianion.  In the physiol. range of pH values, AOPCP was a more powerful inhibitor than ADP principally because a higher percentage of AOPCP exists in the dianion form.  The methylenephosphonate analog of AMP (ACP), although not a substrate, was a moderately effective inhibitor.  The corresponding analogs of ADP (ACPOP) and ATP (ACPOPOP) were as good inhibitors as ADP and ATP, resp.  The thiophosphate analogs of ADP all inhibited 5'-nucleotidase, although not as powerfully as ADP, the most effective of these analogs being adenosine 5'-O-(1-thiodiphosphate) diastereoisomer B [ADP[αS](B)].  Other nucleotides inhibited the enzyme, but none was as effective as AOPCP.  Inorg. tripolyphosphate and methylenediphosphonate were better inhibitors of the enzyme than was inorg. pyrophosphate.  Inorg. thiophosphate was a better inhibitor than was orthophosphate.  Hill plots of the ADP and AOPCP inhibition yielded slopes close to 1; Hill plots of the ATP inhibition yielded slopes of ∼0.6.  MgADP- was not an inhibitor, and MgATP2- was at best a very weak inhibitor of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxWq0Y0d2ubLVg90H21EOLACvtfcHk0ljZy7_q8OvXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhvVWgtrc%253D&md5=2454e331e7e1432fa7d68d1d1c5ed08f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1042%2Fbj2260645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2260645%26sid%3Dliteratum%253Aachs%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DLowenstein%26aufirst%3DJ.%2BM.%26atitle%3D5%25E2%2580%25B2-Nucleotidase%2520from%2520rat%2520heart%2520membranes.%2520Inhibition%2520by%2520adenine%2520nucleotides%2520and%2520related%2520compounds%26jtitle%3DBiochem.%2520J.%26date%3D1985%26volume%3D226%26spage%3D645%26epage%3D651%26doi%3D10.1042%2Fbj2260645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">α,β-Methylene-ADP (AOPCP) derivatives and analogues: development of potent and selective <i>ecto</i>-5′-nucleotidase (CD73) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6248</span>– <span class="NLM_lpage">6263</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6248-6263&author=S.+Bhattaraiauthor=M.+Freundliebauthor=J.+Pippelauthor=A.+Meyerauthor=A.+Abdelrahmanauthor=A.+Fieneauthor=S.-Y.+Leeauthor=H.+Zimmermannauthor=G.+G.+Yegutkinauthor=N.+Str%C3%A4terauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCller&title=%CE%B1%2C%CE%B2-Methylene-ADP+%28AOPCP%29+derivatives+and+analogues%3A+development+of+potent+and+selective+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors&doi=10.1021%2Facs.jmedchem.5b00802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors</span></div><div class="casAuthors">Bhattarai, Sanjay; Freundlieb, Marianne; Pippel, Jan; Meyer, Anne; Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert; Yegutkin, Gennady G.; Straeter, Norbert; El-Tayeb, Ali; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6248-6263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-Nucleotidase (eN, CD73) catalyzes the hydrolysis of extracellular AMP to adenosine. eN inhibitors have potential for use as cancer therapeutics.  The eN inhibitor α,β-methylene-ADP (AOPCP, adenosine-5'-O-[(phosphonomethyl)phosphonic acid]) was used as a lead structure, and derivs. modified in various positions were prepd.  Products were tested at rat recombinant eN.  6-(Ar)alkylamino substitution led to the largest improvement in potency.  N6-Monosubstitution was superior to sym. N6,N6-disubstitution.  The most potent inhibitors were N6-(4-chlorobenzyl)- (PSB-12441, Ki 7.23 nM), N6-phenylethyl- (PSB-12425, Ki 8.04 nM), and N6-benzyl-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] I (PSB-12379, Ki 9.03 nM).  Replacement of the 6-NH group in I by O (PSB-12431) or S (PSB-12553) yielded equally potent inhibitors (9.20 nM and 9.50 nM, resp.).  Selected compds. investigated at the human enzyme did not show species differences; they displayed high selectivity vs. other ecto-nucleotidases and ADP-activated P2Y receptors.  Moreover, high metabolic stability was obsd.  These compds. represent the most potent eN inhibitors described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmxberqVtKLVg90H21EOLACvtfcHk0ljZy7_q8OvXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF&md5=5f1231a662dd86345b9d3803f1c4e716</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00802%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520%2528AOPCP%2529%2520derivatives%2520and%2520analogues%253A%2520development%2520of%2520potent%2520and%2520selective%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6248%26epage%3D6263%26doi%3D10.1021%2Facs.jmedchem.5b00802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Delgado, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campoy, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Flores, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-López, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, C. J.</span></span> <span> </span><span class="NLM_article-title">The ecto-5′-nucleotidase subunits in dimers are not linked by disulfide bridges but by non-covalent bonds</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1478</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1016/S0167-4838(00)00035-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2FS0167-4838%2800%2900035-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10825541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVGht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1478&publication_year=2000&pages=300-308&author=A.+Mart%C3%ADnez-Mart%C3%ADnezauthor=E.+Mu%C3%B1oz-Delgadoauthor=F.+J.+Campoyauthor=C.+Flores-Floresauthor=J.+N.+Rodr%C3%ADguez-L%C3%B3pezauthor=C.+Finiauthor=C.+J.+Vidal&title=The+ecto-5%E2%80%B2-nucleotidase+subunits+in+dimers+are+not+linked+by+disulfide+bridges+but+by+non-covalent+bonds&doi=10.1016%2FS0167-4838%2800%2900035-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The ecto-5'-nucleotidase subunits in dimers are not linked by disulfide bridges but by non-covalent bonds</span></div><div class="casAuthors">Martinez-Martinez, A.; Munoz-Delgado, E.; Campoy, F. J.; Flores-Flores, C.; Rodriguez-Lopez, J. N.; Fini, C.; Vidal, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1478</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It has long been considered that ecto-5'-nucleotidase (eNT) dimers consist of subunits linked by disulfide bonds.  Hydrophilic (6.7S) and amphiphilic (4.0S) dimers were sepd. by sedimentation anal. of eNT purified from bull seminal plasma.  Hydrophilic (4.2S) and amphiphilic (2.6S) eNT monomers were obtained after redn. of disulfide bonds in dimers.  The amphiphilic eNT dimers or monomers were converted into their hydrophilic variants with phosphatidylinositol-specific phospholipase C.  SDS-PAGE plus Western blot showed 68-kDa subunits, regardless of the addn. of β-mercaptoethanol to the SDS mixt.  Active eNT monomers were obtained by addn. of 1M guanidinium chloride (Gdn) to dimers, and unfolded subunits by addn. of 4M Gdn.  The results unambiguously demonstrated that the subunits in eNT dimers were not linked by disulfide bridges, but by noncovalent bonds, and that dissocn. preceded inactivation and unfolding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrDHC_yimbLVg90H21EOLACvtfcHk0lj_kll9FT5FtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVGht78%253D&md5=968b20196706e45277f9fff7180f83f1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2800%2900035-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252800%252900035-2%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DMu%25C3%25B1oz-Delgado%26aufirst%3DE.%26aulast%3DCampoy%26aufirst%3DF.%2BJ.%26aulast%3DFlores-Flores%26aufirst%3DC.%26aulast%3DRodr%25C3%25ADguez-L%25C3%25B3pez%26aufirst%3DJ.%2BN.%26aulast%3DFini%26aufirst%3DC.%26aulast%3DVidal%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520ecto-5%25E2%2580%25B2-nucleotidase%2520subunits%2520in%2520dimers%2520are%2520not%2520linked%2520by%2520disulfide%2520bridges%2520but%2520by%2520non-covalent%2520bonds%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2000%26volume%3D1478%26spage%3D300%26epage%3D308%26doi%3D10.1016%2FS0167-4838%2800%2900035-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human ecto-5′-nucleotidase (CD73): insights into the regulation of purinergic signaling</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2161</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.str.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23142347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2161-2173&author=K.+Knappauthor=M.+Zebischauthor=J.+Pippelauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=Crystal+structure+of+the+human+ecto-5%E2%80%B2-nucleotidase+%28CD73%29%3A+insights+into+the+regulation+of+purinergic+signaling&doi=10.1016%2Fj.str.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling</span></div><div class="casAuthors">Knapp, Karen; Zebisch, Matthias; Pippel, Jan; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2161-2173</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In vertebrates ecto-5'-nucleotidase (e5NT) catalyzes the hydrolysis of extracellular AMP to adenosine and represents the major control point for extracellular adenosine levels.  Due to its pivotal role for activation of P1 adenosine receptors, e5NT has emerged as an appealing drug target for treatment of inflammation, chronic pain, hypoxia, and cancer.  Crystal structures of the dimeric human e5NT reveal an extensive 114° conformational switch between the open and closed forms of the enzyme.  The dimerization interface is formed by the C-terminal domains and exhibits interchain motions of up to 13°.  Complex structures with adenosine and AMPCP indicate that structural control of the domain movement dets. the selectivity for monophosphate nucleotides.  Binding modes of nucleotide-derived and flavonoid-based compds. complexed to the C-terminal domain in the open form reveal an addnl. binding pocket of ∼210 Å3 that might be explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8MOj4dwx2J7Vg90H21EOLACvtfcHk0lj_kll9FT5FtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK&md5=e108171e8079cca4dd11483dfacb909e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DK.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%253A%2520insights%2520into%2520the%2520regulation%2520of%2520purinergic%2520signaling%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D2161%26epage%3D2173%26doi%3D10.1016%2Fj.str.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambe, T.</span></span> <span> </span><span class="NLM_article-title">Zinc deficiency causes delayed ATP clearance and adenosine generation in rats and cell culture models</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">113</span>, <span class="refDoi"> DOI: 10.1038/s42003-018-0118-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fs42003-018-0118-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30271993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADC%252BB3czksVCrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&pages=113&author=T.+A.+Takedaauthor=S.+Miyazakiauthor=M.+Kobayashiauthor=K.+Nishinoauthor=T.+Gotoauthor=M.+Matsunagaauthor=M.+Ooiauthor=H.+Shirakawaauthor=F.+Taniauthor=T.+Kawamuraauthor=M.+Komaiauthor=T.+Kambe&title=Zinc+deficiency+causes+delayed+ATP+clearance+and+adenosine+generation+in+rats+and+cell+culture+models&doi=10.1038%2Fs42003-018-0118-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc deficiency causes delayed ATP clearance and adenosine generation in rats and cell culture models</span></div><div class="casAuthors">Takeda Taka-Aki; Miyazaki Shiho; Kobayashi Miki; Nishino Katsutoshi; Matsunaga Mayu; Kambe Taiho; Goto Tomoko; Ooi Minami; Shirakawa Hitoshi; Komai Michio; Goto Tomoko; Tani Fumito; Kawamura Tatsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Communications biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Zinc deficiency causes myriad pathophysiological symptoms, but why distinct phenotypes are generated by zinc deficiency remains unclear.  Considering that several ectoenzymes involved in purinergic signaling through extracellular adenine-nucleotide hydrolysis possess zinc ions in their active sites, and disorders in purinergic signaling result in diverse diseases that are frequently similar to those caused by zinc deficiency, herein we examine whether zinc deficiency affects extracellular adenine-nucleotide metabolism.  Zinc deficiency severely impairs the activities of major ectoenzymes (ENPP1, ENPP3, NT5E/CD73, and TNAP), and also strongly suppresses adenine-nucleotide hydrolysis in cell-membrane preparations or rat plasma, thereby increasing ATP and ADP levels and decreasing adenosine levels.  Thus, zinc deficiency delays both extracellular ATP clearance and adenosine generation, and zinc modulates extracellular adenine-nucleotide metabolism.  Since the finely tuned balance between extracellular adenine nucleotides and adenosine is critical for purinergic signaling, these findings provide a novel insight into why zinc deficiency results in diverse symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQilKiHIro9_DC850By6mxpfW6udTcc2eYXuNhfIMqaC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czksVCrtw%253D%253D&md5=787431754ac98418cc6e2acb43ac6bd0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs42003-018-0118-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-018-0118-3%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DT.%2BA.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DM.%26aulast%3DOoi%26aufirst%3DM.%26aulast%3DShirakawa%26aufirst%3DH.%26aulast%3DTani%26aufirst%3DF.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DKomai%26aufirst%3DM.%26aulast%3DKambe%26aufirst%3DT.%26atitle%3DZinc%2520deficiency%2520causes%2520delayed%2520ATP%2520clearance%2520and%2520adenosine%2520generation%2520in%2520rats%2520and%2520cell%2520culture%2520models%26jtitle%3DCommun.%2520Biol.%26date%3D2018%26volume%3D1%26spage%3D113%26doi%3D10.1038%2Fs42003-018-0118-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span>; <span class="NLM_string-name">Cousineau, I.</span>; <span class="NLM_string-name">Spring, K.</span>; <span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">Measurement of CD73 Enzymatic Activity Using Luminescence-Based and Colorimetric Assays</span>. In  <i>Tumor Immunology and Immunotherapy—Molecular Methods</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span>, <span class="NLM_string-name">Rudvist, N.-P.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2019</span>; Vol.  <span class="NLM_volume">629</span>, pp  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">289</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fbs.mie.2019.10.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=269-289&author=B.+Allard&author=I.+Cousineau&author=K.+Spring&author=J.+Staggauthor=L.+Galluzzi&author=N.-P.+Rudvist&title=Tumor+Immunology+and+Immunotherapy%E2%80%94Molecular+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fbs.mie.2019.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.mie.2019.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DB.%26atitle%3DMeasurement%2520of%2520CD73%2520Enzymatic%2520Activity%2520Using%2520Luminescence-Based%2520and%2520Colorimetric%2520Assays%26btitle%3DTumor%2520Immunology%2520and%2520Immunotherapy%25E2%2580%2594Molecular%2520Methods%26aulast%3DGalluzzi%26aufirst%3DL.%26pub%3DAcademic%2520Press%26date%3D2019%26volume%3D629%26spage%3D269%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baykov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evtushenko, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avaeva, S. M.</span></span> <span> </span><span class="NLM_article-title">A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(88)90484-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2F0003-2697%2888%2990484-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=3044186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADyaL1czgsl2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1988&pages=266-270&author=A.+A.+Baykovauthor=O.+A.+Evtushenkoauthor=S.+M.+Avaeva&title=A+malachite+green+procedure+for+orthophosphate+determination+and+its+use+in+alkaline+phosphatase-based+enzyme+immunoassay&doi=10.1016%2F0003-2697%2888%2990484-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay</span></div><div class="casAuthors">Baykov A A; Evtushenko O A; Avaeva S M</div><div class="citationInfo"><span class="NLM_cas:title">Analytical biochemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">266-70</span>
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">An improved procedure for phosphate determination based on a highly colored complex of phosphomolybdate and malachite green is described.  All necessary reagents are combined in one concentrated solution, making the assay sensitive and convenient.  The procedure is based on the finding that the dye is easily soluble and stable in the presence of 6 N acid.  The addition of Tween 20 is required to stabilize the dye-phosphomolybdate complex at phosphate concentrations above 10 microM.  The time of color development at 25 degrees C is about 3 min.  The procedure was adopted to measure alkaline phosphate activity in heterogeneous enzyme immunoassay with rho-nitrophenyl phosphate and pyrophosphate as substrates.  In both cases, a 4-fold increase in sensitivity in terms of absorbance readings was obtained compared to the standard method based on rho-nitrophenol measurement.  In visual analysis, the gain in sensitivity was as high as 20-fold, due to contrast color change (yellow to greenish blue).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXY80nJAkYslw2ofyr07jXfW6udTcc2eaUNFIxPM8VnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1czgsl2juw%253D%253D&md5=67f9d40723eb01ec49109c4b0c01a461</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2888%2990484-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252888%252990484-8%26sid%3Dliteratum%253Aachs%26aulast%3DBaykov%26aufirst%3DA.%2BA.%26aulast%3DEvtushenko%26aufirst%3DO.%2BA.%26aulast%3DAvaeva%26aufirst%3DS.%2BM.%26atitle%3DA%2520malachite%2520green%2520procedure%2520for%2520orthophosphate%2520determination%2520and%2520its%2520use%2520in%2520alkaline%2520phosphatase-based%2520enzyme%2520immunoassay%26jtitle%3DAnal.%2520Biochem.%26date%3D1988%26volume%3D171%26spage%3D266%26epage%3D270%26doi%3D10.1016%2F0003-2697%2888%2990484-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cogan, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, O. H.</span></span> <span> </span><span class="NLM_article-title">A robotics-based automated assay for inorganic and organic phosphates</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1006/abio.1999.4100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1006%2Fabio.1999.4100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10361001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1MXjsFKgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1999&pages=29-35&author=E.+B.+Coganauthor=G.+B.+Birrellauthor=O.+H.+Griffith&title=A+robotics-based+automated+assay+for+inorganic+and+organic+phosphates&doi=10.1006%2Fabio.1999.4100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A Robotics-Based Automated Assay for Inorganic and Organic Phosphates</span></div><div class="casAuthors">Cogan, Elizabeth B.; Birrell, G. Bruce; Griffith, O. Hayes</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Phosphate analyses are fundamental to a broad range of biochem. applications involving inorg. phosphate and org. phosphoesters such as phospholipids, phosphorylated proteins, and nucleic acids.  A practical automated method using robotics is described.  Five colorimetric methods of phosphate analyses based on formation of a phosphomolybdate complex and compatible with the automated assay were tested, and the fundamental chem. is discussed.  The relative sensitivities are malachite green > crystal violet > quinaldine red > ascorbate redn. > Sb-modified ascorbate redn., although only a 4-fold improvement was obsd. in going from the modified ascorbate procedure to malachite green.  Malachite green was selected to optimize the assay because this dye provided the highest sensitivity.  However, where color stability and low blanks are more important than sensitivity, the ascorbate redn. and quinaldine red methods are better choices than malachite green.  Automation using a robotic liq.-handling system substantially reduces the labor required to process large arrays of samples.  The result is a sensitive, nonradioactive assay of inorg. phosphate with high throughput.  A digestion step in an acid-resistant 96-well plate was developed to extend the assay to phosphate esters.  The robotic-based assay was demonstrated with inorg. phosphate and a common phospholipid, phosphatidylcholine.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_C0EvWOmKG7Vg90H21EOLACvtfcHk0lj3LFubbm5qzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsFKgu74%253D&md5=c7f9aa91fefa51c724e552fe50fce42c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4100%26sid%3Dliteratum%253Aachs%26aulast%3DCogan%26aufirst%3DE.%2BB.%26aulast%3DBirrell%26aufirst%3DG.%2BB.%26aulast%3DGriffith%26aufirst%3DO.%2BH.%26atitle%3DA%2520robotics-based%2520automated%2520assay%2520for%2520inorganic%2520and%2520organic%2520phosphates%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D271%26spage%3D29%26epage%3D35%26doi%3D10.1006%2Fabio.1999.4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Billedeau, R. J.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidase Inhibitors and Methods of Use Thereof</span>. U.S. Patent <span class="NLM_patent">10570167</span>, Feb 25, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+J.+Billedeau&author=J.+Li&author=L.+Chen&title=Ectonucleotidase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBilledeau%26aufirst%3DR.%2BJ.%26atitle%3DEctonucleotidase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span>; <span class="NLM_string-name">Bhupathi, D.</span>; <span class="NLM_string-name">Billedeau, R. J.</span>; <span class="NLM_string-name">Chen, J.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Emberley, E. D.</span>; <span class="NLM_string-name">Gross, M. I.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">Ma, Y.</span>; <span class="NLM_string-name">Mackinnon, A. L.</span>; <span class="NLM_string-name">Makkouk, A.</span>; <span class="NLM_string-name">Marguier, G. M.</span>; <span class="NLM_string-name">Neou, S.</span>; <span class="NLM_string-name">Parlati, F.</span>; <span class="NLM_string-name">Sotirovska, N.</span>; <span class="NLM_string-name">Stanton, T. F.</span>; <span class="NLM_string-name">Steggerda, S. M.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Zhang, W.</span>; <span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Reversal of Adenosine-Mediated Immune Suppression by CB-708, an Orally Bioavailable and Potent Small Molecule Inhibitor of CD73</span>.  <i>Proceedings</i>, AACR Annual Meeting, Atlanta, GA, Mar 29–Apr 3, 2019; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=C.+C.+Lee&author=D.+Bhupathi&author=R.+J.+Billedeau&author=J.+Chen&author=L.+Chen&author=E.+D.+Emberley&author=M.+I.+Gross&author=T.+Huang&author=W.+Li&author=Y.+Ma&author=A.+L.+Mackinnon&author=A.+Makkouk&author=G.+M.+Marguier&author=S.+Neou&author=F.+Parlati&author=N.+Sotirovska&author=T.+F.+Stanton&author=S.+M.+Steggerda&author=J.+Zhang&author=W.+Zhang&author=J.+Li&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BC.%26atitle%3DReversal%2520of%2520Adenosine-Mediated%2520Immune%2520Suppression%2520by%2520CB-708%252C%2520an%2520Orally%2520Bioavailable%2520and%2520Potent%2520Small%2520Molecule%2520Inhibitor%2520of%2520CD73%26btitle%3DProceedings%26pub%3DAACR%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cacatian, S.</span>; <span class="NLM_string-name">Claremon, D. A.</span>; <span class="NLM_string-name">Jia, L.</span>; <span class="NLM_string-name">Morales-Ramos, A.</span>; <span class="NLM_string-name">Singh, S. B.</span>; <span class="NLM_string-name">Venkatraman, S.</span>; <span class="NLM_string-name">Xu, Z.</span>; <span class="NLM_string-name">Zheng, Y.</span></span> <span> </span><span class="NLM_article-title">Purine Derivatives as CD73 Inhibitors for the Treatment of Cancer</span>. U.S. Patent <span class="NLM_patent">10654884</span>, May 19, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=S.+Cacatian&author=D.+A.+Claremon&author=L.+Jia&author=A.+Morales-Ramos&author=S.+B.+Singh&author=S.+Venkatraman&author=Z.+Xu&author=Y.+Zheng&title=Purine+Derivatives+as+CD73+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCacatian%26aufirst%3DS.%26atitle%3DPurine%2520Derivatives%2520as%2520CD73%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Jaen, J. C.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Modulators of 5′-Nucleotidase, Ecto and the Use Thereof</span>. U.S. Patent <span class="NLM_patent">10239912</span>, Mar 26, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=L.+P.+P.+Debien&author=J.+C.+Jaen&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=B.+R.+Rosen&author=E.+U.+Sharif&title=Modulators+of+5%E2%80%B2-Nucleotidase%2C+Ecto+and+the+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26atitle%3DModulators%2520of%25205%25E2%2580%25B2-Nucleotidase%252C%2520Ecto%2520and%2520the%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalisiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of AB680: a potent and selective inhibitor of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=K.+V.+Lawsonauthor=J.+Kalisiakauthor=E.+A.+Lindseyauthor=E.+T.+Newcombauthor=M.+R.+Leletiauthor=L.+Debienauthor=B.+R.+Rosenauthor=D.+H.+Milesauthor=E.+U.+Sharifauthor=J.+L.+Jeffreyauthor=J.+B.+L.+Tanauthor=A.+Chenauthor=S.+Zhaoauthor=G.+Xuauthor=L.+Fuauthor=L.+Jinauthor=T.+W.+Parkauthor=W.+Berryauthor=S.+Moschutzauthor=E.+Scalettiauthor=N.+Straterauthor=N.+P.+Walkerauthor=S.+W.+Youngauthor=M.+J.+Waltersauthor=U.+Schindlerauthor=J.+P.+Powers&title=Discovery+of+AB680%3A+a+potent+and+selective+inhibitor+of+CD73&doi=10.1021%2Facs.jmedchem.0c00525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00525%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BV.%26aulast%3DKalisiak%26aufirst%3DJ.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DNewcomb%26aufirst%3DE.%2BT.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DDebien%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DB.%2BR.%26aulast%3DMiles%26aufirst%3DD.%2BH.%26aulast%3DSharif%26aufirst%3DE.%2BU.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DTan%26aufirst%3DJ.%2BB.%2BL.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DT.%2BW.%26aulast%3DBerry%26aufirst%3DW.%26aulast%3DMoschutz%26aufirst%3DS.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DStrater%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DSchindler%26aufirst%3DU.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520AB680%253A%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.0c00525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Tan, J.</span>; <span class="NLM_string-name">Schindler, U.</span>; <span class="NLM_string-name">Young, S.</span>; <span class="NLM_string-name">Jaen, J.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Kalisiak, K.</span>; <span class="NLM_string-name">Lindsey, E.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Sharif, E.</span>; <span class="NLM_string-name">Miles, D.</span>; <span class="NLM_string-name">Jeffrey, J.</span>; <span class="NLM_string-name">Leleti, M.</span>; <span class="NLM_string-name">Chen, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of AB680: A Potent and Selective CD73 Inhibitor for Cancer Immunotherapy</span>.  <i>Proceedings</i>, American Chemical Society National Meeting, Orlando, FL, Apr 3, 2019; <span class="NLM_publisher-name">American Chemical Society</span>, <span class="NLM_year">2019</span>; Abstract MEDI-0257.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=K.+V.+Lawson&author=L.+Jin&author=J.+Tan&author=U.+Schindler&author=S.+Young&author=J.+Jaen&author=J.+P.+Powers&author=K.+Kalisiak&author=E.+Lindsey&author=E.+Newcomb&author=E.+Sharif&author=D.+Miles&author=J.+Jeffrey&author=M.+Leleti&author=A.+Chen&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520AB680%253A%2520A%2520Potent%2520and%2520Selective%2520CD73%2520Inhibitor%2520for%2520Cancer%2520Immunotherapy%26btitle%3DProceedings%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span> <span> </span><span class="NLM_article-title">Development of Potent and Selective CD73 Inhibitors: Discovery and Characterization of AB680</span>.  <i>Proceedings</i>, AACR Annual Meeting, Atlanta, GA, Mar 30, 2019; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.+L.+Jeffrey&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520of%2520Potent%2520and%2520Selective%2520CD73%2520Inhibitors%253A%2520Discovery%2520and%2520Characterization%2520of%2520AB680%26btitle%3DProceedings%26pub%3DAACR%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span> <span> </span><span class="NLM_article-title">An exceptionally potent inhibitor of human CD73</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3331</span>– <span class="NLM_lpage">3334</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.9b00448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.9b00448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=3331-3334&author=C.+E.+Bowmanauthor=R.+G.+da+Silvaauthor=A.+Phamauthor=S.+W.+Young&title=An+exceptionally+potent+inhibitor+of+human+CD73&doi=10.1021%2Facs.biochem.9b00448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">An Exceptionally Potent Inhibitor of Human CD73</span></div><div class="casAuthors">Bowman, Christine E.; da Silva, Rafael G.; Pham, Amber; Young, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3331-3334</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently reported the initiation of a Phase I clin. trial with AB680, a potent human CD73 inhibitor, being developed for the treatment of solid tumors (NCT03677973).  We undertook a detailed kinetic anal. of the interaction between human CD73 and AB680 to det. the mode of inhibition.  We found AB680 to be a reversible, slow-onset competitive inhibitor of human CD73 with a Ki of 5 pM.  Clin. candidates of this potency are uncommon and deserve special consideration during lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYGag3hdjGb7Vg90H21EOLACvtfcHk0lhQax9LjydIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O&md5=ad600cb74b603c4daa3c5f002e1c5f4a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.9b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.9b00448%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DC.%2BE.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BG.%26aulast%3DPham%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26atitle%3DAn%2520exceptionally%2520potent%2520inhibitor%2520of%2520human%2520CD73%26jtitle%3DBiochemistry%26date%3D2019%26volume%3D58%26spage%3D3331%26epage%3D3334%26doi%3D10.1021%2Facs.biochem.9b00448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E.</span>; <span class="NLM_string-name">Lawson, K.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lindsey, E.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Rosen, B.</span>; <span class="NLM_string-name">Walker, N.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Scaletti, E. R.</span>; <span class="NLM_string-name">Sträter, N.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Leleti, M.</span>; <span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Potent and Selective Small-Molecule Inhibitors of Ecto-Nucleotidase CD73 for Cancer Immunotherapy</span>.  <i>Proceedings</i>, American Chemical Society National Meeting, Orlando, FL, Apr 3, 2019; <span class="NLM_publisher-name">American Chemical Society</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=E.+Sharif&author=K.+Lawson&author=J.+Kalisiak&author=E.+Lindsey&author=E.+Newcomb&author=B.+Rosen&author=N.+Walker&author=L.+Jin&author=E.+R.+Scaletti&author=N.+Str%C3%A4ter&author=A.+Chen&author=M.+Leleti&author=J.+P.+Powers&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Potent%2520and%2520Selective%2520Small-Molecule%2520Inhibitors%2520of%2520Ecto-Nucleotidase%2520CD73%2520for%2520Cancer%2520Immunotherapy%26btitle%3DProceedings%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Zhao, S.</span>; <span class="NLM_string-name">Young, S. W.</span>; <span class="NLM_string-name">Walker, N.</span>; <span class="NLM_string-name">Sträter, N.</span>; <span class="NLM_string-name">Scaletti, E. R.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Xu, G.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Lawson, K. V.</span></span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sharif%2C+E.+U.%3B+Kalisiak%2C+J.%3B+Miles%2C+D.+H.%3B+Rosen%2C+B.+R.%3B+Debien%2C+L.+P.+P.%3B+Newcomb%2C+E.%3B+Lindsey%2C+E.+A.%3B+Leleti%2C+M.+R.%3B+Chen%2C+A.%3B+Zhao%2C+S.%3B+Young%2C+S.+W.%3B+Walker%2C+N.%3B+Str%C3%A4ter%2C+N.%3B+Scaletti%2C+E.+R.%3B+Jin%2C+L.%3B+Xu%2C+G.%3B+Powers%2C+J.+P.%3B+Lawson%2C+K.+V.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DE.%2BU." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas-Tran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective non-nucleotide small molecule inhibitors of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3935</span>– <span class="NLM_lpage">3955</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01713</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3935-3955&author=J.+W.+Beattyauthor=E.+A.+Lindseyauthor=R.+Thomas-Tranauthor=L.+Debienauthor=D.+Mandalauthor=J.+L.+Jeffreyauthor=A.+T.+Tranauthor=J.+Fournierauthor=S.+D.+Jacobauthor=X.+Yanauthor=S.+L.+Drewauthor=E.+Ginnauthor=A.+Chenauthor=A.+T.+Phamauthor=S.+Zhaoauthor=L.+Jinauthor=S.+W.+Youngauthor=N.+P.+Walkerauthor=M.+R.+Leletiauthor=S.+Moschutzauthor=N.+Straterauthor=J.+P.+Powersauthor=K.+V.+Lawson&title=Discovery+of+potent+and+selective+non-nucleotide+small+molecule+inhibitors+of+CD73&doi=10.1021%2Facs.jmedchem.9b01713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73</span></div><div class="casAuthors">Beatty, Joel W.; Lindsey, Erick A.; Thomas-Tran, Rhiannon; Debien, Laurent; Mandal, Debashis; Jeffrey, Jenna L.; Tran, Anh T.; Fournier, Jeremy; Jacob, Steven D.; Yan, Xuelei; Drew, Samuel L.; Ginn, Elaine; Chen, Ada; Pham, Amber T.; Zhao, Sharon; Jin, Lixia; Young, Stephen W.; Walker, Nigel P.; Leleti, Manmohan Reddy; Moschutz, Susanne; Strater, Norbert; Powers, Jay P.; Lawson, Kenneth V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3935-3955</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 is an extracellular mediator of purinergic signaling.  When upregulated in the tumor microenvironment, CD73 has been implicated in the inhibition of immune function through overprodn. of adenosine.  Traditional efforts to inhibit CD73 have involved antibody therapy or the development of small mols., the most potent of which mimic the acidic and ionizable structure of the enzyme's natural substrate, AMP (AMP).  Here, we report the systematic discovery of a novel class of non-nucleotide CD73 inhibitors that are more potent than all other nonphosphonate inhibitor classes reported to date.  These efforts have culminated in the discovery of 4-({5-[4-fluoro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (73, IC50 = 12 nM) and 4-({5-[4-chloro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (74, IC50 = 19 nM).  Cocrystn. of 74 with human CD73 demonstrates a competitive binding mode.  These compds. show promise for the improvement of drug-like character via the attenuation of the acidity and low membrane permeability inherent to known nucleoside inhibitors of CD73.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxjIt23HCPD7Vg90H21EOLACvtfcHk0lhQax9LjydIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D&md5=52f39aa24bfc4e36a2e8218404ab2079</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01713%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DThomas-Tran%26aufirst%3DR.%26aulast%3DDebien%26aufirst%3DL.%26aulast%3DMandal%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DTran%26aufirst%3DA.%2BT.%26aulast%3DFournier%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DS.%2BD.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DDrew%26aufirst%3DS.%2BL.%26aulast%3DGinn%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DPham%26aufirst%3DA.%2BT.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DMoschutz%26aufirst%3DS.%26aulast%3DStrater%26aufirst%3DN.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DLawson%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520non-nucleotide%2520small%2520molecule%2520inhibitors%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3935%26epage%3D3955%26doi%3D10.1021%2Facs.jmedchem.9b01713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Eksterowicz, J.</span>; <span class="NLM_string-name">Fantin, V. R.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Moore, J.</span>; <span class="NLM_string-name">Zavorotinskaya, T.</span>; <span class="NLM_string-name">Blank, B. R.</span>; <span class="NLM_string-name">Rew, Y.</span>; <span class="NLM_string-name">Wu, K.</span>; <span class="NLM_string-name">Zhu, L.</span>; <span class="NLM_string-name">Pham, J.</span>; <span class="NLM_string-name">Kawai, H.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors</span>. Int. Appl. PCT/US2019/030068, WO Patent <span class="NLM_patent">WO2019213174 A1</span>, Nov 7, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=X.+Du&author=J.+Eksterowicz&author=V.+R.+Fantin&author=D.+Sun&author=Q.+Ye&author=J.+Moore&author=T.+Zavorotinskaya&author=B.+R.+Blank&author=Y.+Rew&author=K.+Wu&author=L.+Zhu&author=J.+Pham&author=H.+Kawai&title=CD73+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26atitle%3DCD73%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Orally Bioavailable Small Molecule CD73 Inhibitor Reverses Immunosuppression by Reduction of Adenosine Production</span>.  <i>Proceedings</i>, AACR Annual Meeting (Virtual), Apr 4, 2020; <span class="NLM_publisher-name">AACR</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=X.+Du&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26atitle%3DOrally%2520Bioavailable%2520Small%2520Molecule%2520CD73%2520Inhibitor%2520Reverses%2520Immunosuppression%2520by%2520Reduction%2520of%2520Adenosine%2520Production%26btitle%3DProceedings%26pub%3DAACR%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, T. C.</span>; <span class="NLM_string-name">Blank, B. R.</span>; <span class="NLM_string-name">Chan, B.</span>; <span class="NLM_string-name">Chen, C.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Duong, F.</span>; <span class="NLM_string-name">Fantin, V. R.</span>; <span class="NLM_string-name">Friedman, L. S.</span>; <span class="NLM_string-name">Huang, T.</span>; <span class="NLM_string-name">Junttila, M. R.</span>; <span class="NLM_string-name">Moore, J. T.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Sun, J.</span>; <span class="NLM_string-name">Sutimantanapi, D.</span>; <span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Yuen, N.</span>; <span class="NLM_string-name">Zavorotinskaya, T.</span></span> <span> </span><span class="NLM_article-title">Intratumoral Immunosuppression Is Reversed by Blocking Adenosine Production with an Oral Inhibitor of CD73</span>.  <i>Proceedings</i>, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Boston, MA, Oct 27, 2019; <span class="NLM_publisher-name">AACR-NCI-EORTC</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=T.+C.+Metzger&author=B.+R.+Blank&author=B.+Chan&author=C.+Chen&author=Y.+Chen&author=X.+Du&author=F.+Duong&author=V.+R.+Fantin&author=L.+S.+Friedman&author=T.+Huang&author=M.+R.+Junttila&author=J.+T.+Moore&author=D.+Sun&author=J.+Sun&author=D.+Sutimantanapi&author=Q.+Ye&author=N.+Yuen&author=T.+Zavorotinskaya&title=Proceedings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DT.%2BC.%26atitle%3DIntratumoral%2520Immunosuppression%2520Is%2520Reversed%2520by%2520Blocking%2520Adenosine%2520Production%2520with%2520an%2520Oral%2520Inhibitor%2520of%2520CD73%26btitle%3DProceedings%26pub%3DAACR-NCI-EORTC%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span>; <span class="NLM_string-name">Yang, H.</span>; <span class="NLM_string-name">Bedke, K.</span>; <span class="NLM_string-name">When, P.</span>; <span class="NLM_string-name">Rizzi, J. P.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors and Uses Thereof</span>. U.S. Patent <span class="NLM_patent">16498338</span>, Apr 16, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=B.+Wang&author=H.+Yang&author=K.+Bedke&author=P.+When&author=J.+P.+Rizzi&title=CD73+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26atitle%3DCD73%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoteimi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahimova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosjean, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cros-Perrial, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttaro, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaloin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordheim, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyrottes, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted 5′-aminoadenosine derivatives and evaluation of their inhibitory potential toward CD73</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1431</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fcmdc.201900348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31264794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVaqtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1431-1443&author=R.+Ghoteimiauthor=V.+T.+Nguyenauthor=R.+Rahimovaauthor=F.+Grosjeanauthor=E.+Cros-Perrialauthor=J.-P.+Uttaroauthor=C.+Matheauthor=L.+Chaloinauthor=L.+P.+Jordheimauthor=S.+Peyrottes&title=Synthesis+of+substituted+5%E2%80%B2-aminoadenosine+derivatives+and+evaluation+of+their+inhibitory+potential+toward+CD73&doi=10.1002%2Fcmdc.201900348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73</span></div><div class="casAuthors">Ghoteimi, Rayane; Nguyen, Van Tai; Rahimova, Rahila; Grosjean, Felix; Cros-Perrial, Emeline; Uttaro, Jean-Pierre; Mathe, Christophe; Chaloin, Laurent; Jordheim, Lars Peter; Peyrottes, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1431-1443</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Derivs. of 5'-aminoadenosine contg. Me carboxylate, Me phosphonate, gem-bisphosphonate, bis(methylphosphonate), and α-carboxylmethylphosphonate or phosphonoacetate moieties were synthesized from key intermediate 5'-aminonucleoside.  These nucleotide analogs were envisaged as 5'-mono- or diphosphate nucleoside mimics.  All compds. were evaluated for CD73 inhibition in a cell-based assay (MDA-MB-231) and toward the purified recombinant protein.  Most of them failed to reach significant inhibition of AMP hydrolysis by CD73 at 100 μM.  Among the new compds., the most interesting candidates, 5 (5'-deoxy-5'-N-phosphonomethyladenosine) and 7 (5'-deoxy-5'-N-(ethoxyphosphorylacetate)adenosine), inhibited recombinant CD73 by 36 and 46 % and cellular CD73 by 61 and 45 % at 100 μM, resp.  Mol. modeling partially explains this lack of activity, as the initially predicted docking scores had been encouraging, esp. for compd. 7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn-sm5uIoznbVg90H21EOLACvtfcHk0lh_3elYbS2GEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVaqtrbM&md5=89bf0ef24f6384afe43ccb3b4e3741d9</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900348%26sid%3Dliteratum%253Aachs%26aulast%3DGhoteimi%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BT.%26aulast%3DRahimova%26aufirst%3DR.%26aulast%3DGrosjean%26aufirst%3DF.%26aulast%3DCros-Perrial%26aufirst%3DE.%26aulast%3DUttaro%26aufirst%3DJ.-P.%26aulast%3DMathe%26aufirst%3DC.%26aulast%3DChaloin%26aufirst%3DL.%26aulast%3DJordheim%26aufirst%3DL.%2BP.%26aulast%3DPeyrottes%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520substituted%25205%25E2%2580%25B2-aminoadenosine%2520derivatives%2520and%2520evaluation%2520of%2520their%2520inhibitory%2520potential%2520toward%2520CD73%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1431%26epage%3D1443%26doi%3D10.1002%2Fcmdc.201900348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sachsenmeier, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, R.</span></span> <span> </span><span class="NLM_article-title">Development of a novel ectonucleotidase assay suitable for high-throughput screening</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1177/1087057112443987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1177%2F1087057112443987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22522649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADC%252BC38rmvFCmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=993-998&author=K.+F.+Sachsenmeierauthor=C.+Hayauthor=E.+Brandauthor=L.+Clarkeauthor=K.+Rosenthalauthor=S.+Guillardauthor=S.+Rustauthor=R.+Minterauthor=R.+Hollingsworth&title=Development+of+a+novel+ectonucleotidase+assay+suitable+for+high-throughput+screening&doi=10.1177%2F1087057112443987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel ectonucleotidase assay suitable for high-throughput screening</span></div><div class="casAuthors">Sachsenmeier Kris F; Hay Carl; Brand Erin; Clarke Lori; Rosenthal Kim; Guillard Sandrine; Rust Steven; Minter Ralph; Hollingsworth Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">993-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">5'-Ectonucleotidase (NT5E) catalyzes the conversion of adenosine monophosphate to adenosine and free phosphate.  The role of this ectonucleotidase and its production of adenosine are linked with immune function, angiogenesis, and cancer.  NT5E activity is typically assayed either by chromatographic quantification of substrates and products using high-performance liquid chromatography (HPLC) or by quantification of free phosphate using malachite green.  These methods are not suitable for robust screening assays of NT5E activity.  HPLC is not readily suitable for the rapid and efficient assay of multiple samples and malachite green is highly sensitive to the phosphate-containing buffers common in various media and sample buffers.  Here the development and validation of a novel high-throughput ectonucleotidase screening assay are described, which makes use of a luciferase-based assay reagent, the Promega CellTiter-Glo kit, to measure the catabolism of AMP by NT5E.  This multiwell plate-based assay facilitates the screening of potential ectonucleotidase antagonists and is unaffected by the presence of contaminating phosphate molecules present in screening samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXoa-zA8OWpiEJCPKhJPuqfW6udTcc2eYW9gZSDFw4_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rmvFCmtQ%253D%253D&md5=3324780b5f3fcddbe9166ebec1137303</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1177%2F1087057112443987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112443987%26sid%3Dliteratum%253Aachs%26aulast%3DSachsenmeier%26aufirst%3DK.%2BF.%26aulast%3DHay%26aufirst%3DC.%26aulast%3DBrand%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DL.%26aulast%3DRosenthal%26aufirst%3DK.%26aulast%3DGuillard%26aufirst%3DS.%26aulast%3DRust%26aufirst%3DS.%26aulast%3DMinter%26aufirst%3DR.%26aulast%3DHollingsworth%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520ectonucleotidase%2520assay%2520suitable%2520for%2520high-throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D993%26epage%3D998%26doi%3D10.1177%2F1087057112443987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carleton, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, J. L.</span></span> <span> </span><span class="NLM_article-title">Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1042/bj1900421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1042%2Fbj1900421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=6258567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaL3cXmtlGku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1980&pages=421-429&author=J.+D.+Pearsonauthor=J.+S.+Carletonauthor=J.+L.+Gordon&title=Metabolism+of+adenine+nucleotides+by+ectoenzymes+of+vascular+endothelial+and+smooth-muscle+cells+in+culture&doi=10.1042%2Fbj1900421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture</span></div><div class="casAuthors">Pearson, Jeremy D.; Carleton, J. Susan; Gordon, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-9</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Pig aortic endothelial and smooth muscle cells in culture rapidly catabolized exogenous ATP, ADP, and AMP, and in both cell types catabolism was due to Mg-stimulated ectoenzymes (Km 350, 125, and 20-50 μM, resp., in endothelium and 100-50 μM in smooth muscle).  Inhibition and substrate-specificity studies suggested that both cell types possessed 3 distinct ectonucleotidases, namely nucleoside triphosphatase (EC 3.6.1.15), nucleoside diphosphatase (EC 3.6.1.6), and 5'-nucleotidase (EC 3.1.3.5), as well as nucleoside diphosphate kinase (EC 2.7.4.6).  These ectonucleotidase systems may be important in the regulation of neurotransmission, blood platelet function, and vasodilation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXudFznORhvrVg90H21EOLACvtfcHk0lh9nYSS_trbRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmtlGku78%253D&md5=c7bf5e1b4aaba6b824e530e9a3d22aeb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1042%2Fbj1900421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1900421%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DJ.%2BD.%26aulast%3DCarleton%26aufirst%3DJ.%2BS.%26aulast%3DGordon%26aufirst%3DJ.%2BL.%26atitle%3DMetabolism%2520of%2520adenine%2520nucleotides%2520by%2520ectoenzymes%2520of%2520vascular%2520endothelial%2520and%2520smooth-muscle%2520cells%2520in%2520culture%26jtitle%3DBiochem.%2520J.%26date%3D1980%26volume%3D190%26spage%3D421%26epage%3D429%26doi%3D10.1042%2Fbj1900421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henttinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span> <span> </span><span class="NLM_article-title">Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1096/fj.00-0268com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1096%2Ffj.00-0268com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=11149913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Snsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=251-260&author=G.+G.+Yegutkinauthor=T.+Henttinenauthor=S.+Jalkanen&title=Extracellular+ATP+formation+on+vascular+endothelial+cells+is+mediated+by+ecto-nucleotide+kinase+activities+via+phosphotransfer+reactions&doi=10.1096%2Ffj.00-0268com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions</span></div><div class="casAuthors">Yegutkin, Gennady G.; Henttinen, Tiina; Jalkanen, Sirpa</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Cell surface ecto-nucleotidases are considered the major effector system for inactivation of extracellular adenine nucleotides, whereas the alternative possibility of ATP synthesis has received little attention.  Using a TLC assay, we investigated the main exchange activities of 3H-labeled adenine nucleotides on the cultured human umbilical vein endothelial cells.  Stepwise nucleotide degrdn. to adenosine occurred when a particular nucleotide was present alone, whereas combined cell treatment with ATP and either [3H]AMP or [3H]ADP caused unexpected phosphorylation of 3H-nucleotides via the backward reactions AMP → ADP → ATP.  The following two groups of nucleotide-converting ecto-enzymes were identified based on inhibition and substrate specificity studies: 1) ecto-nucleotidases, ATP-diphosphohydrolase, and 5'-nucleotidase; 2) ecto-nucleotide kinases, adenylate kinase, and nucleoside diphosphate kinase.  Ecto-nucleoside diphosphate kinase possessed the highest activity, as revealed by comparative kinetic anal., and was capable of using both adenine and nonadenine nucleotides as phosphate donors and acceptors.  The transphosphorylation mechanism was confirmed by direct transfer of the γ-phosphate from [γ-32P]ATP to AMP or nucleoside diphosphates and by measurement of extracellular ATP synthesis using luciferin-luciferase luminometry.  The data demonstrate the coexistence of opposite, ATP-consuming and ATP-generating, pathways on the cell surface and provide a novel mechanism for regulating the duration and magnitude of purinergic signaling in the vasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqfei6Vec55rVg90H21EOLACvtfcHk0lh9nYSS_trbRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Snsbc%253D&md5=8217432a87f488f1e303ad8dae035dd2</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1096%2Ffj.00-0268com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.00-0268com%26sid%3Dliteratum%253Aachs%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DHenttinen%26aufirst%3DT.%26aulast%3DJalkanen%26aufirst%3DS.%26atitle%3DExtracellular%2520ATP%2520formation%2520on%2520vascular%2520endothelial%2520cells%2520is%2520mediated%2520by%2520ecto-nucleotide%2520kinase%2520activities%2520via%2520phosphotransfer%2520reactions%26jtitle%3DFASEB%2520J.%26date%3D2001%26volume%3D15%26spage%3D251%26epage%3D260%26doi%3D10.1096%2Ffj.00-0268com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">A new, sensitive ecto-5′-nucleotidase assay for compound screening</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>446</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2013.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ab.2013.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24144488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1ersg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2014&pages=53-58&author=M.+Freundliebauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=A+new%2C+sensitive+ecto-5%E2%80%B2-nucleotidase+assay+for+compound+screening&doi=10.1016%2Fj.ab.2013.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A new, sensitive ecto-5'-nucleotidase assay for compound screening</span></div><div class="casAuthors">Freundlieb, Marianne; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-58</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (eN) is a membrane-bound enzyme that hydrolyzes extracellular nucleoside-5'-monophosphates yielding the resp. nucleoside and phosphate.  Increased levels of eN expression have been obsd. in many cancer cells.  By increasing extracellular adenosine concns., they contribute to their proliferative, angiogenic, metastatic, and immunosuppressive effects.  Therefore, eN is of considerable interest as a novel drug target for the treatment of cancer as well as of inflammatory diseases.  In this study, we developed, optimized, and applied a highly sensitive radiometric assay using [3H]adenosine-5'-monophosphate (AMP) as a substrate.  The reaction product [3H]adenosine was sepd. from [3H]AMP by pptn. of the latter with lanthanum chloride and subsequent filtration through glass fiber filters.  Conditions were optimized to reproducibly collect the [3H]adenosine-contg. filtrate used for quant. detn.  Validation of the assay yielded a mean Z' factor of 0.73, which demonstrates its suitability for high-throughput screening.  The new assay shows a limit of detection that is at least 30-fold lower than those of common colorimetric methods (e.g., optimized malachite green assay and capillary electrophoresis-based assay procedures), and it is also superior to a recently developed luciferase-based assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz9O8R8a38_7Vg90H21EOLACvtfcHk0lh9nYSS_trbRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1ersg%253D%253D&md5=f7170e77a1b8677721dd8ed3b97e1a11</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DA%2520new%252C%2520sensitive%2520ecto-5%25E2%2580%25B2-nucleotidase%2520assay%2520for%2520compound%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2014%26volume%3D446%26spage%3D53%26epage%3D58%26doi%3D10.1016%2Fj.ab.2013.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationships of α,β-Methylene-ADP Derivatives: Potent and Selective ecto-5′-Nucleotidase Inhibitors</span>. Ph.D. Dissertation, University of Bonn, Bonn, Germany, <span class="NLM_year">2015</span>; <a href="https://hss.ulb.uni-bonn.de/2015/4098/4098.htm" class="extLink">https://hss.ulb.uni-bonn.de/2015/4098/4098.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Bhattarai&title=Synthesis+and+Structure-Activity+Relationships+of+%CE%B1%2C%CE%B2-Methylene-ADP+Derivatives%3A+Potent+and+Selective+ecto-5%E2%80%B2-Nucleotidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationships%2520of%2520%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520Derivatives%253A%2520Potent%2520and%2520Selective%2520ecto-5%25E2%2580%25B2-Nucleotidase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">X-Ray co-crystal structure guides the way to subnanomolar competitive ecto-5′-nucleotidase (CD73) inhibitors for cancer immunotherapy</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1900075</span>, <span class="refDoi"> DOI: 10.1002/adtp.201900075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fadtp.201900075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCjurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2019&pages=1900075&author=S.+Bhattaraiauthor=J.+Pippelauthor=A.+Meyerauthor=M.+Freundliebauthor=C.+Schmiesauthor=A.+Abdelrahmanauthor=A.+Fieneauthor=S.-Y.+Leeauthor=H.+Zimmermannauthor=A.+El-Tayebauthor=G.+G.+Yegutkinauthor=N.+Str%C3%A4terauthor=C.+E.+M%C3%BCller&title=X-Ray+co-crystal+structure+guides+the+way+to+subnanomolar+competitive+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors+for+cancer+immunotherapy&doi=10.1002%2Fadtp.201900075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">X-Ray Co-Crystal Structure Guides the Way to Subnanomolar Competitive Ecto-5'-Nucleotidase (CD73) Inhibitors for Cancer Immunotherapy</span></div><div class="casAuthors">Bhattarai, Sanjay; Pippel, Jan; Meyer, Anne; Freundlieb, Marianne; Schmies, Constanze; Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert; El-Tayeb, Ali; Yegutkin, Gennady G.; Straeter, Norbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Therapeutics (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1900075</span>CODEN:
                <span class="NLM_cas:coden">ATWGAP</span>;
        ISSN:<span class="NLM_cas:issn">2366-3987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (CD73, EC 3.1.3.5) catalyzes the extracellular hydrolysis of AMP yielding adenosine, which induces immunosuppression, angiogenesis, metastasis, and proliferation of cancer cells.  CD73 inhibition is therefore proposed as a novel strategy for cancer (immuno)therapy, and CD73 antibodies are currently undergoing clin. trials.  Despite considerable efforts, the development of small mol. CD73 inhibitors has met with limited success.  To develop a suitable drug candidate, a high resoln. (2.05 Å) co-crystal structure of the CD73 inhibitor PSB-12379, a nucleotide analog, in complex with human CD73 is detd.  This allows the rational design and development of a novel inhibitor (PSB-12489) with subnanomolar inhibitory potency toward human and rat CD73, high selectivity, as well as high metabolic stability.  A co-crystal structure of PSB-12489 with CD73 (1.85 Å) reveals the interactions responsible for increased potency.  PSB-12489 is the most potent CD73 inhibitor to date representing a powerful tool compd. and novel lead structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2d7CK7UeK87Vg90H21EOLACvtfcHk0li55UeFUTG1Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCjurnF&md5=dd24eb1f7b34714c513a8f4523b7d3d5</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fadtp.201900075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadtp.201900075%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DSchmies%26aufirst%3DC.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DX-Ray%2520co-crystal%2520structure%2520guides%2520the%2520way%2520to%2520subnanomolar%2520competitive%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%2520for%2520cancer%2520immunotherapy%26jtitle%3DAdv.%2520Ther.%26date%3D2019%26volume%3D2%26spage%3D1900075%26doi%3D10.1002%2Fadtp.201900075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Junker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobelmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Losenkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irjala, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of purine and pyrimidine nucleotides as ecto-5′-nucleotidase (CD73) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3677</span>– <span class="NLM_lpage">3695</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00164</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00164" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltlSmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3677-3695&author=A.+Junkerauthor=C.+Rennauthor=C.+Dobelmannauthor=V.+Namasivayamauthor=S.+Jainauthor=K.+Losenkovaauthor=H.+Irjalaauthor=S.+Ducaauthor=R.+Balasubramanianauthor=S.+Chakrabortyauthor=F.+Borgelauthor=H.+Zimmermannauthor=G.+G.+Yegutkinauthor=C.+E.+M%C3%BCllerauthor=K.+A.+Jacobson&title=Structure-activity+relationship+of+purine+and+pyrimidine+nucleotides+as+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors&doi=10.1021%2Facs.jmedchem.9b00164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors</span></div><div class="casAuthors">Junker, Anna; Renn, Christian; Dobelmann, Clemens; Namasivayam, Vigneshwaran; Jain, Shanu; Losenkova, Karolina; Irjala, Heikki; Duca, Sierra; Balasubramanian, Ramachandran; Chakraborty, Saibal; Borgel, Frederik; Zimmermann, Herbert; Yegutkin, Gennady G.; Muller, Christa E.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3677-3695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cluster of differentiation 73 (CD73) converts AMP to immunosuppressive adenosine, and its inhibition was proposed as a new strategy for cancer treatment.  We synthesized 5'-O-[(phosphonomethyl)phosphonic acid] derivs. of purine and pyrimidine nucleosides, which represent nucleoside diphosphate analogs, and compared their CD73 inhibitory potencies.  In the adenine series, most ribose modifications and 1-deaza and 3-deaza were detrimental, but 7-deaza was tolerated.  Uracil substitution with N3-Me, but not larger groups, or 2-thio, was tolerated. 1,2-Diphosphono-Et modifications were not tolerated.  N4-(Aryl)alkyloxy-cytosine derivs., esp. with bulky benzyloxy substituents, showed increased potency.  Among the most potent inhibitors were the 5'-O-[(phosphonomethyl)phosphonic acid] derivs. of 5-fluorouridine, N4-benzoyl-cytidine, N4-[O-(4-benzyloxy)]-cytidine, and N4-[O-(4-naphth-2-ylmethyloxy)]-cytidine (Ki values 5-10 nM at human CD73).  Selected compds. tested at the two uridine diphosphate-activated P2Y receptor subtypes showed high CD73 selectivity, esp. those with large nucleobase substituents.  These nucleotide analogs are among the most potent CD73 inhibitors reported and may be considered for development as parenteral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosmqsc2IyljbVg90H21EOLACvtfcHk0li55UeFUTG1Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltlSmsb8%253D&md5=374b1862da172f31363dc74a4545661a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00164%26sid%3Dliteratum%253Aachs%26aulast%3DJunker%26aufirst%3DA.%26aulast%3DRenn%26aufirst%3DC.%26aulast%3DDobelmann%26aufirst%3DC.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DLosenkova%26aufirst%3DK.%26aulast%3DIrjala%26aufirst%3DH.%26aulast%3DDuca%26aufirst%3DS.%26aulast%3DBalasubramanian%26aufirst%3DR.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DBorgel%26aufirst%3DF.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-activity%2520relationship%2520of%2520purine%2520and%2520pyrimidine%2520nucleotides%2520as%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3677%26epage%3D3695%26doi%3D10.1021%2Facs.jmedchem.9b00164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ripphausen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunschweiger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Virtual screening identifies novel sulfonamide inhibitors of <i>ecto</i>-5′-nucleotidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6576</span>– <span class="NLM_lpage">6581</span>, <span class="refDoi"> DOI: 10.1021/jm300658n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300658n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XptF2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6576-6581&author=P.+Ripphausenauthor=M.+Freundliebauthor=A.+Brunschweigerauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCllerauthor=J.+Bajorath&title=Virtual+screening+identifies+novel+sulfonamide+inhibitors+of+ecto-5%E2%80%B2-nucleotidase&doi=10.1021%2Fjm300658n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Identifies Novel Sulfonamide Inhibitors of ecto-5'-Nucleotidase</span></div><div class="casAuthors">Ripphausen, Peter; Freundlieb, Marianne; Brunschweiger, Andreas; Zimmermann, Herbert; Mueller, Christa E.; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6576-6581</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We aimed to identify inhibitors of ecto-5'-nucleotidase (ecto-5'-NT, CD73), a membrane-bound metallophosphoesterase that is implicated in the control of purinergic receptor signaling and a no. of assocd. therapeutically relevant effects.  Currently, only very few compds., including ADP, its more stable analog α,β-methylene-ADP, ATP, and anthraquinone derivs. are known to inhibit this enzyme.  In the search for inhibitors with more drug-like properties, we applied a model structure-based virtual screening approach augmented by chem. similarity searching.  On the basis of this anal., 51 candidate compds. were finally selected for exptl. evaluation.  A total of 13 of these mols. were confirmed to have competitive inhibitory activity.  The most potent inhibitor, 6-chloro-2-oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxylic acid amide (17), showed an IC50 value of 1.90 μM.  In contrast to the nucleotide- and anthraquinone-derived antagonists, the newly identified competitive inhibitors are uncharged at physiol. pH values, possess a drug-like structure, and are structurally distinct from known active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0goFQAkEQe7Vg90H21EOLACvtfcHk0lj-NAhnLys3Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptF2gtL4%253D&md5=106abecfd7469af4be3acfb516d237f5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm300658n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300658n%26sid%3Dliteratum%253Aachs%26aulast%3DRipphausen%26aufirst%3DP.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DBrunschweiger%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DVirtual%2520screening%2520identifies%2520novel%2520sulfonamide%2520inhibitors%2520of%2520ecto-5%25E2%2580%25B2-nucleotidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6576%26epage%3D6581%26doi%3D10.1021%2Fjm300658n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolshoven, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">2-Substituted α,β-methylene-ADP derivatives: potent competitive ecto-5′-nucleotidase (CD73) inhibitors with variable binding modes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2957</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2941-2957&author=S.+Bhattaraiauthor=J.+Pippelauthor=E.+Scalettiauthor=R.+Idrisauthor=M.+Freundliebauthor=G.+Rolshovenauthor=C.+Rennauthor=S.-Y.+Leeauthor=A.+Abdelrahmanauthor=H.+Zimmermannauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=2-Substituted+%CE%B1%2C%CE%B2-methylene-ADP+derivatives%3A+potent+competitive+ecto-5%E2%80%B2-nucleotidase+%28CD73%29+inhibitors+with+variable+binding+modes&doi=10.1021%2Facs.jmedchem.9b01611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes</span></div><div class="casAuthors">Bhattarai, Sanjay; Pippel, Jan; Scaletti, Emma; Idris, Riham; Freundlieb, Marianne; Rolshoven, Georg; Renn, Christian; Lee, Sang-Yong; Abdelrahman, Aliaa; Zimmermann, Herbert; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2941-2957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 inhibitors are promising drugs for the (immuno)therapy of cancer.  Here, we present the synthesis, structure-activity relationships, and co-crystal structures of novel derivs. of the competitive CD73 inhibitor α,β-methylene-ADP (AOPCP) substituted in the 2-position.  Small polar or lipophilic residues increased potency, 2-iodo- and 2-chloro-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] (15, 16) being the most potent inhibitors with Ki values towards human CD73 of 3-6 nM.  Subject to the size and nature of the 2-substituent, variable binding modes were obsd. by X-ray crystallog.  Depending on the binding mode, large species differences were found, e.g. 2-piperazinyl-AOPCP (21) was >12-fold less potent against rat CD73 compared to human CD73.  This study shows that high CD73-inhibitory potency can be achieved by simply introducing a small substituent into the 2-position of AOPCP without the necessity of addnl. bulky N6-substituents.  Moreover, it provides valuable insights into the binding modes of competitive CD73 inhibitors, representing an excellent basis for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0OpQBzKNX7Vg90H21EOLACvtfcHk0lj-NAhnLys3Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D&md5=453dcd3d41f20b380c951ddf6e05fe3a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01611%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DIdris%26aufirst%3DR.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DRolshoven%26aufirst%3DG.%26aulast%3DRenn%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3D2-Substituted%2520%25CE%25B1%252C%25CE%25B2-methylene-ADP%2520derivatives%253A%2520potent%2520competitive%2520ecto-5%25E2%2580%25B2-nucleotidase%2520%2528CD73%2529%2520inhibitors%2520with%2520variable%2520binding%2520modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2941%26epage%3D2957%26doi%3D10.1021%2Facs.jmedchem.9b01611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annovazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viglio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iadarola, P.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine 5′-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3270</span>– <span class="NLM_lpage">3276</span>, <span class="refDoi"> DOI: 10.1002/elps.200406057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Felps.200406057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=15472954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFCgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=3270-3276&author=C.+Zanoneauthor=L.+R.+Chiarelliauthor=G.+Valentiniauthor=E.+Peraniauthor=L.+Annovazziauthor=S.+Viglioauthor=P.+Iadarola&title=Pyrimidine+5%E2%80%B2-nucleotidase+activities+detected+in+real+samples+by+means+of+micellar+electrokinetic+chromatography&doi=10.1002%2Felps.200406057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography</span></div><div class="casAuthors">Zanone, Chiara; Chiarelli, Laurent R.; Valentini, Giovanna; Perani, Eleonora; Annovazzi, Laura; Viglio, Simona; Iadarola, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">18-19</span>),
    <span class="NLM_cas:pages">3270-3276</span>CODEN:
                <span class="NLM_cas:coden">ELCTDN</span>;
        ISSN:<span class="NLM_cas:issn">0173-0835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A micellar electrokinetic chromatog. method that allows simultaneous detn. of both nucleotidase and transferase activities of cytosolic 5'-nucleotidase III is presented.  This electrophoretic approach was successfully applied to human erythrocyte lysates to monitor the enzyme activities indicated above, using either physiol. substrate or the nucleoside analog 3'-azido-3'-deoxythymidine as the phosphate acceptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_bdHW9CdBTbVg90H21EOLACvtfcHk0ljII_t0v3YmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFCgtLs%253D&md5=b5d24392721348d35648a9993a96e97e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Felps.200406057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Felps.200406057%26sid%3Dliteratum%253Aachs%26aulast%3DZanone%26aufirst%3DC.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DValentini%26aufirst%3DG.%26aulast%3DPerani%26aufirst%3DE.%26aulast%3DAnnovazzi%26aufirst%3DL.%26aulast%3DViglio%26aufirst%3DS.%26aulast%3DIadarola%26aufirst%3DP.%26atitle%3DPyrimidine%25205%25E2%2580%25B2-nucleotidase%2520activities%2520detected%2520in%2520real%2520samples%2520by%2520means%2520of%2520micellar%2520electrokinetic%2520chromatography%26jtitle%3DElectrophoresis%26date%3D2004%26volume%3D25%26spage%3D3270%26epage%3D3276%26doi%3D10.1002%2Felps.200406057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzeng, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, H. P.</span></span> <span> </span><span class="NLM_article-title">Simultaneous determination of adenosine and its metabolites by capillary electrophoresis as a rapid monitoring tool for 5′-nucleotidase activity</span>. <i>J. Chromatogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1129</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.chroma.2006.08.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.chroma.2006.08.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1129&publication_year=2006&pages=149-152&author=H.+F.+Tzengauthor=C.+H.+Hungauthor=J.+Y.+Wangauthor=C.+H.+Chouauthor=H.+P.+Hung&title=Simultaneous+determination+of+adenosine+and+its+metabolites+by+capillary+electrophoresis+as+a+rapid+monitoring+tool+for+5%E2%80%B2-nucleotidase+activity&doi=10.1016%2Fj.chroma.2006.08.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of adenosine and its metabolites by capillary electrophoresis as a rapid monitoring tool for 5'-nucleotidase activity</span></div><div class="casAuthors">Tzeng, Huey-Fen; Hung, Chao-Hsien; Wang, Jeng-Yu; Chou, Chih-Hong; Hung, Hsueh-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-152</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A simple and rapid capillary electrophoretic method was developed for the simultaneous detn. of micro-molar adenosine, hypoxanthine and inosine in enzyme assays without using radioactive labeled substrates.  Prior to electrophoretic sepn., addn. of acetonitrile and sodium chloride to the assay soln. and brief centrifugation are recommended for the purpose of sample cleanup and sample stacking.  Under the optimal condition, the good sepn. with high efficiency was achieved in 6 min.  Using deoxyadenylate as an internal std., the linear range of the method was 5-200 μM, and the concn. limits of detection of adenosine, hypoxanthine and inosine were 2.2, 3.6 and 1.4 μM, resp.  Application of the proposed method was demonstrated by the activity assay of 5'-nucleotidase from Hep G2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptvdjqKucQ2LVg90H21EOLACvtfcHk0ljII_t0v3YmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWkt7k%253D&md5=78a352a45db61313be563c21959cacb7</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2006.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2006.08.030%26sid%3Dliteratum%253Aachs%26aulast%3DTzeng%26aufirst%3DH.%2BF.%26aulast%3DHung%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DChou%26aufirst%3DC.%2BH.%26aulast%3DHung%26aufirst%3DH.%2BP.%26atitle%3DSimultaneous%2520determination%2520of%2520adenosine%2520and%2520its%2520metabolites%2520by%2520capillary%2520electrophoresis%2520as%2520a%2520rapid%2520monitoring%2520tool%2520for%25205%25E2%2580%25B2-nucleotidase%2520activity%26jtitle%3DJ.%2520Chromatogr.%26date%3D2006%26volume%3D1129%26spage%3D149%26epage%3D152%26doi%3D10.1016%2Fj.chroma.2006.08.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirovsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Capillary electrophoresis-based nanoscale assays for monitoring ecto-5′-nucleotidase activity and inhibition in preparations of recombinant enzyme and melanoma cell membranes</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2007.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ab.2007.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17980347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCks77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=129-140&author=J.+Iqbalauthor=D.+Jirovskyauthor=S.-Y.+Leeauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=Capillary+electrophoresis-based+nanoscale+assays+for+monitoring+ecto-5%E2%80%B2-nucleotidase+activity+and+inhibition+in+preparations+of+recombinant+enzyme+and+melanoma+cell+membranes&doi=10.1016%2Fj.ab.2007.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Capillary electrophoresis-based nanoscale assays for monitoring ecto-5'-nucleotidase activity and inhibition in preparations of recombinant enzyme and melanoma cell membranes</span></div><div class="casAuthors">Iqbal, Jamshed; Jirovsky, David; Lee, Sang-Yong; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-140</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Powerful capillary electrophoresis (CE) methods were developed for monitoring the reaction of ecto-5'-nucleotidase (ecto-5'-NT, CD73), a (patho)biochem. important enzyme that hydrolyzes nucleoside-5'-monophosphates to the corresponding nucleosides.  The enzymic reaction was performed either before injection into the capillary (method A) or directly within the capillary (method B).  In method A, sepn. of substrates and products was achieved within 8 min using an eCAP fused-silica capillary (20 cm effective length, 75 μM i.d., UV detection at 260 nm), 40 mM sodium borate buffer (pH 9.1), normal polarity, and a const. voltage of 15 kV.  In method B, the sandwich technique was applied; substrate dissolved in reaction buffer (10 mM Hepes [pH 7.4], 2 mM MgCl2, and 1 mM CaCl2) was hydrodynamically injected into a fused-silica capillary (30 cm, 75 μM i.d.), followed by enzyme (recombinant rat ecto-5'-NT) and subsequent injection of substrate soln.  The reaction was initiated by the application of 1 kV voltage for 1 min.  The voltage was turned off for 1 min and again turned on at a const. voltage of 15 kV to elute products (nucleosides) within 4 min using borate buffer (40 mM, pH 9.1).  Thus, assays could be performed within 6 min, including enzymic reaction, sepn., and quantification of the formed nucleoside.  The CE methods were used for measuring enzyme kinetics and for assaying inhibitors and substrates.  In addn., the online assay was successfully applied to melanoma cell membrane prepns. natively expressing the human ecto-5'-NT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM8Kd00BurN7Vg90H21EOLACvtfcHk0lhGjxjSsnSXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCks77N&md5=5f6ec78237c4ad6c1632630d66d252a9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2007.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2007.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DJirovsky%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DCapillary%2520electrophoresis-based%2520nanoscale%2520assays%2520for%2520monitoring%2520ecto-5%25E2%2580%25B2-nucleotidase%2520activity%2520and%2520inhibition%2520in%2520preparations%2520of%2520recombinant%2520enzyme%2520and%2520melanoma%2520cell%2520membranes%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D129%26epage%3D140%26doi%3D10.1016%2Fj.ab.2007.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Therapeutically Important Enzymes with Polar Substrates or Products: Characterization by Capillary Electrophoresis and Identification of Inhibitors</span>. Ph.D. Dissertation, University of Bonn, Bonn, Germany, <span class="NLM_year">2014</span>; <a href="https://hss.ulb.uni-bonn.de/2015/3840/3840.htm" class="extLink">https://hss.ulb.uni-bonn.de/2015/3840/3840.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.+Li&title=Therapeutically+Important+Enzymes+with+Polar+Substrates+or+Products%3A+Characterization+by+Capillary+Electrophoresis+and+Identification+of+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26atitle%3DTherapeutically%2520Important%2520Enzymes%2520with%2520Polar%2520Substrates%2520or%2520Products%253A%2520Characterization%2520by%2520Capillary%2520Electrophoresis%2520and%2520Identification%2520of%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Rashida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batool, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejaz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span> <span> </span><span class="NLM_article-title">2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">494</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ejmech.2016.02.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=27054295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=484-494&author=M.+Al-Rashidaauthor=G.+Batoolauthor=A.+Sattarauthor=S.+A.+Ejazauthor=S.+Khanauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=A.+Hameedauthor=J.+Iqbal&title=2-Alkoxy-3-%28sulfonylarylaminomethylene%29-chroman-4-ones+as+potent+and+selective+inhibitors+of+ectonucleotidases&doi=10.1016%2Fj.ejmech.2016.02.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases</span></div><div class="casAuthors">al-Rashida, Mariya; Batool, Gazala; Sattar, Almas; Ejaz, Syeda Abida; Khan, Samiullah; Lecka, Joanna; Sevigny, Jean; Hameed, Abdul; Iqbal, Jamshed</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">484-494</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A facile method for the modulation of 2-alkoxy side chain of 3-formylchromone enamines was exploited for the synthesis of a series of 2-alkoxy-3-(sulfonylphenylaminomethylene)-chroman-4-ones I [R1 = H, F, Cl, etc.; R2 = H, Br, Cl; R3 = Me, Et, i-Pr, n-Bu].  This modulation was achieved by simply changing the alc. reaction media from methanol to ethanol, iso-propanol and n-butanol while reacting various 3-formylchromones with aminobenzenesulfonamides.  Alcs. were sufficiently nucleophilic and add into the C2-C3 olefinic bond of 3-formylchromones without causing any ring cleavage.  The resulting compds. I were found to be potent and selective inhibitors of ecto-5'-nucleotidase and alk. phosphatases (TNAP and IAP).  Detailed enzyme kinetics studies revealed competitive inhibition against alk. phosphatases and un-competitive inhibition against rat and human ecto-5'-nucleotidase.  The most active TNAP inhibitor I [R1 = R3 = Me; R2 = H] (Ki = 0.078 ± 0.001 μM), exhibited 28 times more selectivity for TNAP over IAP (Ki = 2.18 ± 0.12 μM).  Compd. I [ R1 = R2 = H; R3 = Me] was most active IAP inhibitor (Ki = 0.24 ± 0.01 μM) and was 300 times more selective towards IAP than TNAP (Ki = 72.9 ± 1.68 μM).  Compd. I [R1 = R2 = H; R3 = CH(CH3)2] was most active human ecto-5'-nucleotidase inhibitor exhibiting inhibition in low nanomolar range (Ki = 14 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjKeGE_sBOrVg90H21EOLACvtfcHk0lhGjxjSsnSXcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValtLk%253D&md5=6545b2e44a6ac9683776ad9f37326934</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.073%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Rashida%26aufirst%3DM.%26aulast%3DBatool%26aufirst%3DG.%26aulast%3DSattar%26aufirst%3DA.%26aulast%3DEjaz%26aufirst%3DS.%2BA.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DHameed%26aufirst%3DA.%26aulast%3DIqbal%26aufirst%3DJ.%26atitle%3D2-Alkoxy-3-%2528sulfonylarylaminomethylene%2529-chroman-4-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ectonucleotidases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D484%26epage%3D494%26doi%3D10.1016%2Fj.ejmech.2016.02.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Ator, L. E.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Kiesow, T. J.</span>; <span class="NLM_string-name">Kiesow, T. J.</span>; <span class="NLM_string-name">Lian, Y.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Ridgers, L. H.</span></span> <span> </span><span class="NLM_article-title">Benzothiadiazine Compounds</span>. Int. Appl. PCT/IB2016/057415, WO Patent <span class="NLM_patent">WO2017098421 A1</span>, Jun 15, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=L.+E.+Ator&author=K.+J.+Duffy&author=T.+L.+Graybill&author=T.+J.+Kiesow&author=T.+J.+Kiesow&author=Y.+Lian&author=M.+L.+Moore&author=J.+M.+Ralph&author=L.+H.+Ridgers&title=Benzothiadiazine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DBenzothiadiazine%2520Compounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Neipp, C. E.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Squire, M. D.</span></span> <span> </span><span class="NLM_article-title">5-Sulfamoyl-2-hydroxybenzamide Derivatives</span>. Int. Appl. PCT/IB2017/051399, WO Patent <span class="NLM_patent">WO2017153952 A1</span>, Sep 14, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=K.+J.+Duffy&author=T.+L.+Graybill&author=M.+L.+Moore&author=C.+E.+Neipp&author=J.+M.+Ralph&author=M.+D.+Squire&title=5-Sulfamoyl-2-hydroxybenzamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3D5-Sulfamoyl-2-hydroxybenzamide%2520Derivatives%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, R.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of WO2017098421: GSK’s benzothiazine compounds as CD73 inhibitor filings</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1080/13543776.2018.1407756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1080%2F13543776.2018.1407756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=29166791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGitLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=167-171&author=Y.-P.+Gongauthor=R.-Z.+Wanauthor=Z.-P.+Liu&title=Evaluation+of+WO2017098421%3A+GSK%E2%80%99s+benzothiazine+compounds+as+CD73+inhibitor+filings&doi=10.1080%2F13543776.2018.1407756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings</span></div><div class="casAuthors">Gong, Ya-Ping; Wan, Ren-Zhong; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-171</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">There are considerable interests in the development of novel small-mol. CD73 inhibitors for the treatment of cancers, autoimmune diseases, precancerous syndromes, and other diseases assocd. with CD73 activity.: The application claims novel substituted benzothiadiazine derivs. as CD73 inhibitors for the treatment of cancer, precancerous syndromes, AIDS, autoimmune diseases, infections, atherosclerosis, and ischemia-reperfusion injury.  Many of the exemplified compds. have pIC50 values between 5 to 8.4 against CD73.: These benzothiadiazine derivs. provide good leads for the discovery of potent CD73 inhibitors for the treatment of cancer and other diseases mediated by adenosine and its action on adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx1Q4KYDdU8rVg90H21EOLACvtfcHk0ljeCGffx3bVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGitLrO&md5=fff650ec1a8cf93f0f67fb5dd4f05fc0</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1080%2F13543776.2018.1407756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2018.1407756%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.-P.%26aulast%3DWan%26aufirst%3DR.-Z.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DEvaluation%2520of%2520WO2017098421%253A%2520GSK%25E2%2580%2599s%2520benzothiazine%2520compounds%2520as%2520CD73%2520inhibitor%2520filings%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2018%26volume%3D28%26spage%3D167%26epage%3D171%26doi%3D10.1080%2F13543776.2018.1407756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dally, R. D.</span>; <span class="NLM_string-name">Garcia Paredes, M. C.</span>; <span class="NLM_string-name">Heinz, L. J.,  II</span>; <span class="NLM_string-name">Howell, J. M.</span>; <span class="NLM_string-name">Njoroge, F. G.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Zhao, G.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors</span>. Int. Appl. PCT/US2019/019074, WO Patent <span class="NLM_patent">WO2019168744</span>, Sep 6, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=R.+D.+Dally&author=M.+C.+Garcia+Paredes&author=L.+J.+Heinz&author=J.+M.+Howell&author=F.+G.+Njoroge&author=Y.+Wang&author=G.+Zhao&title=CD73+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDally%26aufirst%3DR.%2BD.%26atitle%3DCD73%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McManus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavigan, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vougier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrebola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span> <span> </span><span class="NLM_article-title">A robust multiplex mass spectrometric assay for screening small-molecule inhibitors of CD73 with diverse inhibition modalities</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1177/2472555217750386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1177%2F2472555217750386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=29336194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFCqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=264-273&author=J.+McManusauthor=T.+Heauthor=J.-A.+Gaviganauthor=G.+Marchandauthor=S.+Vougierauthor=O.+Bedelauthor=P.+Ferrariauthor=R.+Arrebolaauthor=T.+Gillespyauthor=R.+C.+Gregoryauthor=S.+Lichtauthor=H.+Chengauthor=B.+Zhangauthor=G.+Deng&title=A+robust+multiplex+mass+spectrometric+assay+for+screening+small-molecule+inhibitors+of+CD73+with+diverse+inhibition+modalities&doi=10.1177%2F2472555217750386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors of CD73 with Diverse Inhibition Modalities</span></div><div class="casAuthors">McManus, Jessica; He, Timothy; Gavigan, Julie-Ann; Marchand, Ghislaine; Vougier, Stephanie; Bedel, Olivier; Ferrari, Paul; Arrebola, Rosalia; Gillespy, Timothy; Gregory, Richard C.; Licht, Stuart; Cheng, Hong; Zhang, Bailin; Deng, Gejing</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">264-273</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">CD73/Ecto-5'-nucleotidase is a membrane-tethered ecto-enzyme that works in tandem with CD39 to convert extracellular ATP (ATP) into adenosine.  CD73 is highly expressed on various types of cancer cells and on infiltrating suppressive immune cells, leading to an elevated concn. of adenosine in the tumor microenvironment, which elicits a strong immunosuppressive effect.  In preclin. studies, targeting CD73 with anti-CD73 antibody results in favorable antitumor effects.  Despite initial studies using antibodies, inhibition of CD73 catalytic activity using small-mol. inhibitors may be more effective in lowering extracellular adenosine due to better tumor penetration and distribution.  To screen small-mol. libraries, we explored multiple approaches, including colorimetric and fluorescent biochem. assays, and due to some limitations with these assays, we developed a mass spectrometry (MS)-based assay.  Only the MS-based assay offers the sensitivity and dynamic range required for screening small-mol. libraries at a substrate concn. close to the Km value of substrate and for evaluating the mode of binding of screening hits.  To achieve a throughput suitable for high-throughput screening (HTS), we developed a RapidFire-tandem mass spectrometry (RF-MS/MS)-based multiplex assay.  This assay allowed a large diverse compd. library to be screened at a speed of 1536 reactions per 40-50 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4jrxzupDntbVg90H21EOLACvtfcHk0ljeCGffx3bVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFCqsbk%253D&md5=e4a3e88707a4f4f2ecd0fe73c37cc556</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1177%2F2472555217750386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555217750386%26sid%3Dliteratum%253Aachs%26aulast%3DMcManus%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DGavigan%26aufirst%3DJ.-A.%26aulast%3DMarchand%26aufirst%3DG.%26aulast%3DVougier%26aufirst%3DS.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DFerrari%26aufirst%3DP.%26aulast%3DArrebola%26aufirst%3DR.%26aulast%3DGillespy%26aufirst%3DT.%26aulast%3DGregory%26aufirst%3DR.%2BC.%26aulast%3DLicht%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DG.%26atitle%3DA%2520robust%2520multiplex%2520mass%2520spectrometric%2520assay%2520for%2520screening%2520small-molecule%2520inhibitors%2520of%2520CD73%2520with%2520diverse%2520inhibition%2520modalities%26jtitle%3DSLAS%2520Discovery%26date%3D2018%26volume%3D23%26spage%3D264%26epage%3D273%26doi%3D10.1177%2F2472555217750386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braganhol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamajusuku, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battastini, A. M.</span></span> <span> </span><span class="NLM_article-title">Ecto-5′-Nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1770</i></span>,  <span class="NLM_fpage">1352</span>– <span class="NLM_lpage">1359</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2007.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bbagen.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17643826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1CmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1770&publication_year=2007&pages=1352-1359&author=E.+Braganholauthor=A.+S.+Tamajusukuauthor=A.+Bernardiauthor=M.+R.+Winkauthor=A.+M.+Battastini&title=Ecto-5%E2%80%B2-Nucleotidase%2FCD73+inhibition+by+quercetin+in+the+human+U138MG+glioma+cell+line&doi=10.1016%2Fj.bbagen.2007.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line</span></div><div class="casAuthors">Braganhol, Elizandra; Tamajusuku, Alessandra S. K.; Bernardi, Andressa; Wink, Marcia R.; Battastini, Ana M. O.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1770</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1352-1359</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gliomas are the most malignant of the primary brain tumors.  Nucleotides represent an important class of extracellular mols. that are crucial for the normal function of the nervous system.  ATP and adenosine can stimulate cell proliferation in different glioma cell lines; the events induced by extracellular adenine nucleotides are controlled by the action of ecto-nucleotidases, which hydrolyze ATP into adenosine in the extracellular space.  Recent studies have shown that quercetin has an anti-proliferative effect on the U138MG glioma cell line.  Since evidence suggests that purinergic signaling is involved in the growth and progression of glioma and, taking into consideration the anti-proliferative effect elicited by quercetin in this tumor type, the aim of the present study was to better investigate the extracellular metab. of AMP and evaluate the effect of quercetin on this system in the human U138MG glioma cell line.  The adenine products secreted by glioma cells were first characterized; extracellular AMP was efficiently metabolized by the glioma culture, demonstrating a very active ecto-5'-NT/CD73.  Quercetin was able to inhibit the ecto-5'-NT/CD73 activity and modulate its expression.  In addn., the cell treatment with APCP (α,β-methyleneadenosine-5'-diphosphate), an ecto-5'-NT/CD73 inhibitor, led to a significant redn. in glioma cell proliferation.  We suggest that the inhibition of ecto-5'-NT/CD73 may result in a decrease in extracellular adenosine prodn. with a consequent redn. in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq76-vFDbju7rVg90H21EOLACvtfcHk0ljWT8kOW8nxnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1CmsL8%253D&md5=120b4326e880c0780fa7efe48f50fd90</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DBraganhol%26aufirst%3DE.%26aulast%3DTamajusuku%26aufirst%3DA.%2BS.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DWink%26aufirst%3DM.%2BR.%26aulast%3DBattastini%26aufirst%3DA.%2BM.%26atitle%3DEcto-5%25E2%2580%25B2-Nucleotidase%252FCD73%2520inhibition%2520by%2520quercetin%2520in%2520the%2520human%2520U138MG%2520glioma%2520cell%2520line%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2007%26volume%3D1770%26spage%3D1352%26epage%3D1359%26doi%3D10.1016%2Fj.bbagen.2007.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonosaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuchi, A.</span></span> <span> </span><span class="NLM_article-title">New 5′-nucleotidase inhibitors, NPF-86IA, NPF-86IB, NPF-86IIA, and NPF-86IIB from Areca catechu; Part 1. Isolation and biological properties</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1055/s-2006-962487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1055%2Fs-2006-962487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=2849139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaL1MXhtFWksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1988&pages=419-422&author=K.+Uchinoauthor=T.+Matsuoauthor=M.+Iwamotoauthor=Y.+Tonosakiauthor=A.+Fukuchi&title=New+5%E2%80%B2-nucleotidase+inhibitors%2C+NPF-86IA%2C+NPF-86IB%2C+NPF-86IIA%2C+and+NPF-86IIB+from+Areca+catechu%3B+Part+1.+Isolation+and+biological+properties&doi=10.1055%2Fs-2006-962487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">New 5'-nucleotidase inhibitors, NPF-86IA, NPF-86IB, NPF-86IIA, and NPF-86IIB from Areca catechu; Part I.  Isolation and biological properties</span></div><div class="casAuthors">Uchino, Keijiro; Matsuo, Toshiharu; Iwamoto, Masaya; Tonosaki, Yasuhiro; Fukuchi, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">419-22</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    </div><div class="casAbstract">Four bioactive polyphenolic substances (NPF-86IA, NPF-86IB, NPF-86IIA, and NPF-86IIB) that inhibit the 5'-nucleotidase were isolated from the seeds of A. catechu.  These inhibitors were purified by solvent extn., dialysis bag, and reversed-phase HPLC.  Isolation, physicochem. properties, and some biol. activities of these compds. are reported.  They are polyphenolic compds. and inhibit 5'-nucleotidase from snake venom and rat liver membrane.  The av. relative mol. masses of NPF-86IA, -86IB, -86IIA, and -86IIB were estd. to be 5620, 5000, 29,400, and 8610 by GPC anal., resp.  They also showed antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxOeb4kHfOVLVg90H21EOLACvtfcHk0ljWT8kOW8nxnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtFWksr0%253D&md5=11542ea625e75973a98e70dc990c2590</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-962487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-962487%26sid%3Dliteratum%253Aachs%26aulast%3DUchino%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DT.%26aulast%3DIwamoto%26aufirst%3DM.%26aulast%3DTonosaki%26aufirst%3DY.%26aulast%3DFukuchi%26aufirst%3DA.%26atitle%3DNew%25205%25E2%2580%25B2-nucleotidase%2520inhibitors%252C%2520NPF-86IA%252C%2520NPF-86IB%252C%2520NPF-86IIA%252C%2520and%2520NPF-86IIB%2520from%2520Areca%2520catechu%253B%2520Part%25201.%2520Isolation%2520and%2520biological%2520properties%26jtitle%3DPlanta%2520Med.%26date%3D1988%26volume%3D54%26spage%3D419%26epage%3D422%26doi%3D10.1055%2Fs-2006-962487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavutcu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melzig, M. F.</span></span> <span> </span><span class="NLM_article-title">In vitro effects of selected flavonoids on the 5′-nucleotidase activity</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10399192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1MXktVSru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=457-459&author=M.+Kavutcuauthor=M.+F.+Melzig&title=In+vitro+effects+of+selected+flavonoids+on+the+5%E2%80%B2-nucleotidase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro effects of selected flavonoids on the 5'-nucleotidase activity</span></div><div class="casAuthors">Kavutcu, M.; Melzig, Matthias F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmazie</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">457-459</span>CODEN:
                <span class="NLM_cas:coden">PHARAT</span>;
        ISSN:<span class="NLM_cas:issn">0031-7144</span>.
    
            (<span class="NLM_cas:orgname">Govi-Verlag Pharmazeutischer Verlag</span>)
        </div><div class="casAbstract">A series of structurally related flavonoids and related compds. were evaluated whether they have inhibitory properties on the 5'-nucleotidase (5'-ribonucleotide phosphohydrolase; EC 3.1.3.5, 5'-NT) activity.  Some of the flavonoids tested inhibit the enzyme such as quercetin, morin, apigenin, chrysin, myricetin, luteolin, diosmetin, (±)naringenin and diosmin.  Rutin, naringin, hyperosid, (±)catechin, caffeic acid and rosmarinic acid had no inhibitory effect on the 5'-NT activity.  Myricetin and quercetin were the most potent inhibitors for 5'-NT with IC50 values of 1.1 and 1.4 μM, resp.  Kinetic anal. showed a mixed type of inhibitor for both myricetin (Ki = 1.5 μM at pH 7.45), and quercetin (Ki = 0.6 μM at pH 7.45).  The Km value for 5'-adenosine monophosphate (5-AMP) was detd. with 77 μM at pH 7.45.  The differential inhibitory potencies of flavonoids seem to be structurally related (hydroxylation pattern).  The results demonstrate that some flavonoids are strong inhibitors of 5'-NT activity which can be correlated to their pharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgp6as4odj4rVg90H21EOLACvtfcHk0lg10-t_mRt48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVSru78%253D&md5=dd3a9fe428cd51373b8dfdc944fd60f9</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKavutcu%26aufirst%3DM.%26aulast%3DMelzig%26aufirst%3DM.%2BF.%26atitle%3DIn%2520vitro%2520effects%2520of%2520selected%2520flavonoids%2520on%2520the%25205%25E2%2580%25B2-nucleotidase%2520activity%26jtitle%3DPharmazie%26date%3D1999%26volume%3D54%26spage%3D457%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripphausen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiff, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Development of potent and selective inhibitors of ecto-5′-nucleotidase based on an anthraquinone scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2076</span>– <span class="NLM_lpage">2086</span>, <span class="refDoi"> DOI: 10.1021/jm901851t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901851t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslKnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2076-2086&author=Y.+Baqiauthor=S.-Y.+Leeauthor=J.+Iqbalauthor=P.+Ripphausenauthor=A.+Lehrauthor=A.+B.+Scheiffauthor=H.+Zimmermannauthor=J.+Bajorathauthor=C.+E.+M%C3%BCller&title=Development+of+potent+and+selective+inhibitors+of+ecto-5%E2%80%B2-nucleotidase+based+on+an+anthraquinone+scaffold&doi=10.1021%2Fjm901851t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Potent and Selective Inhibitors of ecto-5'-Nucleotidase Based on an Anthraquinone Scaffold</span></div><div class="casAuthors">Baqi, Younis; Lee, Sang-Yong; Iqbal, Jamshed; Ripphausen, Peter; Lehr, Anne; Scheiff, Anja B.; Zimmermann, Herbert; Bajorath, Jurgen; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2076-2086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-Nucleotidase (eN, CD73) plays a major role in controlling extracellular adenosine levels.  EN inhibitors have potential as novel drugs, for example, for the treatment of cancer.  In the present study, we synthesized and investigated a series of 55 anthraquinone derivs. as potential inhibitors of eN, 11 of which are novel compds. and another 11 of which had previously been described but have now been synthesized by an improved method.  We identified several potent inhibitors of rat eN.  The most potent compds. were 1-amino-4-[4-fluoro-2-carboxyphenylamino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate (PSB-0952, Ki = 260 nM) and 1-amino-4-[2-anthracenylamino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate (PSB-0963, 150 nM), with the latter being the most potent eN inhibitor described to date.  Selected compds. were further characterized and found to exhibit a competitive mechanism of inhibition.  Investigations of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the P2Y receptor subtypes P2Y2, P2Y4, P2Y6, and P2Y12 showed that compd. PSB-0952 exhibited the highest degree of selectivity (>150-fold).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnJKU5mUcJOrVg90H21EOLACvtfcHk0lg10-t_mRt48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslKnurw%253D&md5=b9e4c62d6423478d5cd4d95f702f689e</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm901851t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901851t%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DRipphausen%26aufirst%3DP.%26aulast%3DLehr%26aufirst%3DA.%26aulast%3DScheiff%26aufirst%3DA.%2BB.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDevelopment%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520ecto-5%25E2%2580%25B2-nucleotidase%2520based%2520on%2520an%2520anthraquinone%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2076%26epage%3D2086%26doi%3D10.1021%2Fjm901851t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">945</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1038/nprot.2010.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fnprot.2010.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20431540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVamsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=945-953&author=Y.+Baqiauthor=C.+E.+M%C3%BCller&title=Synthesis+of+alkyl-+and+aryl-amino-substituted+anthraquinone+derivatives+by+microwave-assisted+copper%280%29-catalyzed+Ullmann+coupling+reactions&doi=10.1038%2Fnprot.2010.63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of alkyl- and arylamino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions</span></div><div class="casAuthors">Baqi, Younis; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">945-953</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This protocol describes the efficient, generally applicable Ullmann coupling reaction of bromaminic acid with alkyl- or arylamines in phosphate buffer under microwave irradn. using elemental copper as a catalyst.  The reaction leads to a no. of biol. active compds.  As a prototypical example, the synthesis of a new, potent antagonist of human platelet P2Y12 receptors, which has potential as an antithrombotic drug, is described in detail.  The optimized protocol includes a description of an appropriate reaction setup, thin layer chromatog. for monitoring the reaction, and a procedure for the isolation, purifn., and characterization of the anticipated product.  The reaction is performed without the use of a glove box and there is no requirement for an inert atm.  The reaction typically proceeds within 2-30 min; the protocol, including workup, generally takes 1-3 h to complete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJlwRtH9c8TbVg90H21EOLACvtfcHk0lg10-t_mRt48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVamsbo%253D&md5=4148604240cd7e098fb1050aceb893ed</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2010.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2010.63%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DSynthesis%2520of%2520alkyl-%2520and%2520aryl-amino-substituted%2520anthraquinone%2520derivatives%2520by%2520microwave-assisted%2520copper%25280%2529-catalyzed%2520Ullmann%2520coupling%2520reactions%26jtitle%3DNat.%2520Protoc.%26date%3D2010%26volume%3D5%26spage%3D945%26epage%3D953%26doi%3D10.1038%2Fnprot.2010.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Identification of sulfonic acids as efficient ecto-5′-nucleotidase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.ejmech.2013.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24215819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOqur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=685-691&author=J.+Iqbalauthor=A.+Saeedauthor=R.+Razaauthor=A.+Matinauthor=A.+Hameedauthor=N.+Furtmannauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=J.+Bajorath&title=Identification+of+sulfonic+acids+as+efficient+ecto-5%E2%80%B2-nucleotidase+inhibitors&doi=10.1016%2Fj.ejmech.2013.10.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors</span></div><div class="casAuthors">Iqbal, Jamshed; Saeed, Aamer; Raza, Rabia; Matin, Abdul; Hameed, Abdul; Furtmann, Norbert; Lecka, Joanna; Sevigny, Jean; Bajorath, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">685-691</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (CD73) is well known for its implication in cancer.  Inhibition of ecto-5'-nucleotidases is thought to provide an attractive approach to cancer therapy.  This study identifies sulfonic acid compds. as efficient inhibitors of ecto-5'-nucleotidases.  The compds. were tested against recombinant human and rat ecto-5'-nucleotidases.  The most potent new sulfonic acid inhibitor 6-amino-4-hydroxynaphthalene-2-sulfonic acid (1) of ecto-5'-nucleotidase had an IC50 of 1.32 ± 0.09 μM for the human and 10.4 ± 3.3 μM for the rat enzyme.  Generally, all compds. were more active against the human enzyme.  Plausible binding mode models were developed for this new class of inhibitors.  Furthermore, several sulfonic acid inhibitors were efficient cytotoxic agents when tested on H157 cancer cell lines.  Hence, new ecto-5'-nucleotidases inhibitors displayed significant potential for further development as compds. for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTaWZD3jljR7Vg90H21EOLACvtfcHk0lhzkYt5AwJpvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOqur3J&md5=60a9a0b81f2acdb7f272ac3cf3a4c872</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DRaza%26aufirst%3DR.%26aulast%3DMatin%26aufirst%3DA.%26aulast%3DHameed%26aufirst%3DA.%26aulast%3DFurtmann%26aufirst%3DN.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520sulfonic%2520acids%2520as%2520efficient%2520ecto-5%25E2%2580%25B2-nucleotidase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D685%26epage%3D691%26doi%3D10.1016%2Fj.ejmech.2013.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brylev, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietzsch, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Polyoxometalates—potent and selective ecto-nucleotidase inhibitors</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2014.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bcp.2014.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25449596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGitLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=171-181&author=S.-Y.+Leeauthor=A.+Fieneauthor=W.+Liauthor=T.+Hanckauthor=K.+A.+Brylevauthor=V.+E.+Fedorovauthor=J.+Leckaauthor=A.+Haiderauthor=H.+J.+Pietzschauthor=H.+Zimmermannauthor=J.+S%C3%A9vignyauthor=U.+Kortzauthor=H.+Stephanauthor=C.+E.+M%C3%BCller&title=Polyoxometalates%E2%80%94potent+and+selective+ecto-nucleotidase+inhibitors&doi=10.1016%2Fj.bcp.2014.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Polyoxometalates-Potent and selective ecto-nucleotidase inhibitors</span></div><div class="casAuthors">Lee, Sang-Yong; Fiene, Amelie; Li, Wenjin; Hanck, Theodor; Brylev, Konstantin A.; Fedorov, Vladimir E.; Lecka, Joanna; Haider, Ali; Pietzsch, Hans-Juergen; Zimmermann, Herbert; Sevigny, Jean; Kortz, Ulrich; Stephan, Holger; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Polyoxometalates (POMs) are inorg. cluster metal complexes that possess versatile biol. activities, including antibacterial, anticancer, antidiabetic, and antiviral effects.  Their mechanisms of action at the mol. level are largely unknown.  However, it was suggested that the inhibition of several enzyme families (e.g., phosphatases, protein kinases, or ecto-nucleotidases) by POMs may contribute to their pharmacol. properties.  Ecto-nucleotidases are cell membrane-bound or secreted glycoproteins involved in the hydrolysis of extracellular nucleotides thereby regulating purinergic (and pyrimidinergic) signaling.  They comprise 4 distinct families: ecto-nucleoside triphosphate diphosphohydrolases (NTPDases), ecto-nucleotide pyrophosphatases/phosphodiesterases (NPPs), alk. phosphatases (APs), and ecto-5'-nucleotidase (eN).  In the present study, we evaluated the inhibitory potency of a series of polyoxometalates as well as chalcogenide hexarhenium cluster complexes at a broad range of ecto-nucleotidases.  [Co4(H2O)2(PW9O34)2]10- (5, PSB-POM142) was discovered to be the most potent inhibitor of human NTPDase1 described so far (Ki: 3.88 nM).  Other investigated POMs selectively inhibited human NPP1, [TiW11CoO40]8- (4, PSB-POM141, Ki: 1.46 nM) and [NaSb9W21O86]18- (6, PSB-POM143, Ki: 4.98 nM) representing the most potent and selective human NPP1 inhibitors described to date.  [NaP5W30O110]14- (8, PSB-POM144) strongly inhibited NTPDase1-3 and NPP1 and may therefore be used as a pan-inhibitor to block ATP hydrolysis.  The polyoxoanionic compds. displayed a non-competitive mechanism of inhibition of NPPs and eN, but appeared to be competitive inhibitors of TNAP.  Future in vivo studies with selected inhibitors identified in the current study are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaU1PXTD5qGrVg90H21EOLACvtfcHk0lhzkYt5AwJpvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGitLfP&md5=a57c50e30d936ad8ef3b2d616ef55c07</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHanck%26aufirst%3DT.%26aulast%3DBrylev%26aufirst%3DK.%2BA.%26aulast%3DFedorov%26aufirst%3DV.%2BE.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DHaider%26aufirst%3DA.%26aulast%3DPietzsch%26aufirst%3DH.%2BJ.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DKortz%26aufirst%3DU.%26aulast%3DStephan%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DPolyoxometalates%25E2%2580%2594potent%2520and%2520selective%2520ecto-nucleotidase%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D93%26spage%3D171%26epage%3D181%26doi%3D10.1016%2Fj.bcp.2014.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viviani, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccirillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A. T.-d.</span></span> <span> </span><span class="NLM_article-title">Virtual screening approach for the identification of hydroxamic acids as novel human ecto-5′-nucleotidase inhibitors</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.9b00884</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.9b00884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFCns7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2020&pages=621-630&author=L.+G.+Vivianiauthor=E.+Piccirilloauthor=H.+Ulrichauthor=A.+T.-d.+Amaral&title=Virtual+screening+approach+for+the+identification+of+hydroxamic+acids+as+novel+human+ecto-5%E2%80%B2-nucleotidase+inhibitors&doi=10.1021%2Facs.jcim.9b00884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5'-Nucleotidase Inhibitors</span></div><div class="casAuthors">Viviani, Lucas G.; Piccirillo, Erika; Ulrich, Henning; Amaral, Antonia T.-do</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">621-630</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (ecto-5'-NT, CD73) is a zinc-binding metallophosphatase that plays a key role in extracellular purinergic pathways, being implicated in several physiol. and pathophysiol. processes, such as immune homeostasis, inflammation, and tumor progression.  As such, it has been recognized as a promising biol. target for many diseases, including cancer, infections, and autoimmune diseases.  Despite its importance, so far only a few inhibitors of this target enzyme are known, most of which are not suitable as drug candidates.  Here, we aimed to search for hydroxamic acid-contg. compds. as potential human ecto-5'-NT inhibitors, since this group is known to be a strong zinc chelator.  To this end, we performed a hierarchical virtual screening (VS) search consisting of three consecutive steps (filtering for compds. bearing a hydroxamic acid group, shape-based matching, and docking followed by visual inspection), which were applied to screen the ZINC-14 database ("all purchasable subset").  Out of 25 compds. selected by this VS protocol, 12 were acquired and further submitted to enzymic assays for VS exptl. validation.  Four of them (i.e., 33.3%) were found to inhibit human ecto-5'-NT in the low micromolar range.  The most potent one showed an IC50 value of 6.2 ± 1.0μM.  All identified inhibitors satisfy drug-like criteria and provide novel scaffolds to be explored in further hit-to-lead optimization steps.  Furthermore, to the best of our knowledge, they are the first hydroxamic acid-contg. inhibitors of human ecto-5'-NT described so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP4Qiu0YGYKLVg90H21EOLACvtfcHk0lgWDmjGYVljqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFCns7zJ&md5=e27572f72ce511b572a671b2aa4b6448</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.9b00884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.9b00884%26sid%3Dliteratum%253Aachs%26aulast%3DViviani%26aufirst%3DL.%2BG.%26aulast%3DPiccirillo%26aufirst%3DE.%26aulast%3DUlrich%26aufirst%3DH.%26aulast%3DAmaral%26aufirst%3DA.%2BT.-d.%26atitle%3DVirtual%2520screening%2520approach%2520for%2520the%2520identification%2520of%2520hydroxamic%2520acids%2520as%2520novel%2520human%2520ecto-5%25E2%2580%25B2-nucleotidase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2020%26volume%3D60%26spage%3D621%26epage%3D630%26doi%3D10.1021%2Facs.jcim.9b00884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span> </span><span class="NLM_article-title">A Study
of the CD73 Inhibitor LY3475070 Alone or in Combination with
Pembrolizumab in Participants with Advanced Cancer</span>. Last updated May 26, 2020. <a href="https://clinicaltrials.gov/ct2/show/NCT04148937" class="extLink">https://clinicaltrials.gov/ct2/show/NCT04148937</a> (accessed Jun 2, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0Aof+the+CD73+Inhibitor+LY3475070+Alone+or+in+Combination+with%0APembrolizumab+in+Participants+with+Advanced+Cancer.+Last+updated+May+26%2C+2020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04148937+%28accessed+Jun+2%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%250Aof%2520the%2520CD73%2520Inhibitor%2520LY3475070%2520Alone%2520or%2520in%2520Combination%2520with%250APembrolizumab%2520in%2520Participants%2520with%2520Advanced%2520Cancer%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, D.</span>; <span class="NLM_string-name">Luu, I.</span>; <span class="NLM_string-name">Udyavar, A.</span>; <span class="NLM_string-name">Fu, L.</span>; <span class="NLM_string-name">Ginn, E.</span>; <span class="NLM_string-name">Lawson, K.</span>; <span class="NLM_string-name">Jeffrey, J.</span>; <span class="NLM_string-name">Leleti, M.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Connor, E.</span>; <span class="NLM_string-name">Pennell, A.</span>; <span class="NLM_string-name">DiRenzo, D.</span>; <span class="NLM_string-name">Piovesan, D.</span>; <span class="NLM_string-name">Tan, B. L.</span>; <span class="NLM_string-name">Garofalo, A.</span>; <span class="NLM_string-name">Berry, W.</span>; <span class="NLM_string-name">Walters, M. J.</span>; <span class="NLM_string-name">Young, S. W.</span>; <span class="NLM_string-name">Yin, F.</span>; <span class="NLM_string-name">Lai, D. W.</span>; <span class="NLM_string-name">Seitz, L.</span></span> <span> </span><span class="NLM_article-title">Phase 1 Safety Study in Healthy Volunteers of AB680, a Small-Molecule Inhibitor of CD73 and Rationale for Combination Therapy in Patients with Gastrointestinal Malignancies</span>. Presented at the 34th Annual Meeting of the Society for Immuno-Therapy of Cancer (SITC), National Harbor, MD, Nov 6–10, <span class="NLM_year">2019</span>; Abstract P379.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+Ashok&author=I.+Luu&author=A.+Udyavar&author=L.+Fu&author=E.+Ginn&author=K.+Lawson&author=J.+Jeffrey&author=M.+Leleti&author=J.+P.+Powers&author=E.+Connor&author=A.+Pennell&author=D.+DiRenzo&author=D.+Piovesan&author=B.+L.+Tan&author=A.+Garofalo&author=W.+Berry&author=M.+J.+Walters&author=S.+W.+Young&author=F.+Yin&author=D.+W.+Lai&author=L.+Seitz&title=Phase+1+Safety+Study+in+Healthy+Volunteers+of+AB680%2C+a+Small-Molecule+Inhibitor+of+CD73+and+Rationale+for+Combination+Therapy+in+Patients+with+Gastrointestinal+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAshok%26aufirst%3DD.%26atitle%3DPhase%25201%2520Safety%2520Study%2520in%2520Healthy%2520Volunteers%2520of%2520AB680%252C%2520a%2520Small-Molecule%2520Inhibitor%2520of%2520CD73%2520and%2520Rationale%2520for%2520Combination%2520Therapy%2520in%2520Patients%2520with%2520Gastrointestinal%2520Malignancies%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9700"><div class="reference"><strong class="refLabel"><a href="#ref9700" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit9700"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksterowicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutimantanapi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavorotinskaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junttila, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable small molecule CD73 inhibitor (OP-5244) reverses immunosuppression through blockade of adenosine production</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=X.+Duauthor=J.+Mooreauthor=B.+R.+Blankauthor=J.+Eksterowiczauthor=D.+Sutimantanapiauthor=N.+Yuenauthor=T.+Metzgerauthor=B.+Chanauthor=T.+Huangauthor=X.+Chenauthor=Y.+Chenauthor=F.+Duongauthor=W.+Kongauthor=J.+H.+Changauthor=J.+Sunauthor=T.+Zavorotinskayaauthor=Q.+Yeauthor=M.+R.+Junttilaauthor=C.+Ndubakuauthor=L.+S.+Friedmanauthor=V.+R.+Fantinauthor=D.+Sun&title=Orally+bioavailable+small+molecule+CD73+inhibitor+%28OP-5244%29+reverses+immunosuppression+through+blockade+of+adenosine+production&doi=10.1021%2Facs.jmedchem.0c01086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9700&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01086%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DB.%2BR.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DSutimantanapi%26aufirst%3DD.%26aulast%3DYuen%26aufirst%3DN.%26aulast%3DMetzger%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDuong%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DJunttila%26aufirst%3DM.%2BR.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DOrally%2520bioavailable%2520small%2520molecule%2520CD73%2520inhibitor%2520%2528OP-5244%2529%2520reverses%2520immunosuppression%2520through%2520blockade%2520of%2520adenosine%2520production%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.0c01086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottalorda-Regairaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberici, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliaou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensussan, A.</span></span> <span> </span><span class="NLM_article-title">ENTPD1/CD39 Is a promising therapeutic target in oncology</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1743</span>– <span class="NLM_lpage">1751</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fonc.2012.269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22751118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVOltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1743-1751&author=J.+Bastidauthor=A.+Cottalorda-Regairazauthor=G.+Albericiauthor=N.+Bonnefoyauthor=J.+F.+Eliaouauthor=A.+Bensussan&title=ENTPD1%2FCD39+Is+a+promising+therapeutic+target+in+oncology&doi=10.1038%2Fonc.2012.269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">ENTPD1/CD39 is a promising therapeutic target in oncology</span></div><div class="casAuthors">Bastid, J.; Cottalorda-Regairaz, A.; Alberici, G.; Bonnefoy, N.; Eliaou, J. F.; Bensussan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1743-1751</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Regulatory T cells (Tregs) are a subpopulation of CD4+ T cells that are essential for maintaining the homeostasis of the immune system, limiting self-reactivity and excessive immune responses against foreign antigens.  In cancer, infiltrated Tregs inhibit the effector lymphocytes and create a favorable environment for the growth of the tumor.  Although Tregs mediate immunosuppression through multiple, non-redundant, cell-contact dependent and independent mechanisms, a growing body of evidence suggests an important role for the CD39-CD73-adenosine pathway.  CD39 ectonucleotidase is the rate-limiting enzyme of a cascade leading to the generation of suppressive adenosine that alters CD4 and CD8 T cell and natural killer cell antitumor activities.  Here, we review the recent literature supporting CD39 as a promising therapeutic target in oncol.  In vitro and in vivo expts. involving knockout models and surrogate inhibitors of CD39 provide evidence in support of the anticancer activity of CD39 inhibition and predict a favorable safety profile for CD39 inhibitory compds.  In addn., we report the ongoing development of CD39-blocking monoclonal antibodies as potential anticancer drugs.  Indeed, CD39 antagonistic antibodies could represent novel therapeutic tools for selectively inhibiting Treg function without depletion, a major limitation of current Treg-targeting strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr50aAvEoL0nrVg90H21EOLACvtfcHk0liZ6bKbc6czQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVOltb4%253D&md5=2d0677061e148ff5f114f7a2d4c54419</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.269%26sid%3Dliteratum%253Aachs%26aulast%3DBastid%26aufirst%3DJ.%26aulast%3DCottalorda-Regairaz%26aufirst%3DA.%26aulast%3DAlberici%26aufirst%3DG.%26aulast%3DBonnefoy%26aufirst%3DN.%26aulast%3DEliaou%26aufirst%3DJ.%2BF.%26aulast%3DBensussan%26aufirst%3DA.%26atitle%3DENTPD1%252FCD39%2520Is%2520a%2520promising%2520therapeutic%2520target%2520in%2520oncology%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1743%26epage%3D1751%26doi%3D10.1038%2Fonc.2012.269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandapathil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepanski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szajnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenzner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, T. L.</span></span> <span> </span><span class="NLM_article-title">Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6348</span>– <span class="NLM_lpage">6357</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1158%2F1078-0432.CCR-09-1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=19825957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyqsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=6348-6357&author=M.+Mandapathilauthor=M.+J.+Szczepanskiauthor=M.+Szajnikauthor=J.+Renauthor=D.+E.+Lenznerauthor=E.+K.+Jacksonauthor=E.+Gorelikauthor=S.+Langauthor=J.+T.+Johnsonauthor=T.+L.+Whiteside&title=Increased+ectonucleotidase+expression+and+activity+in+regulatory+T+cells+of+patients+with+head+and+neck+cancer&doi=10.1158%2F1078-0432.CCR-09-1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer</span></div><div class="casAuthors">Mandapathil, Magis; Szczepanski, Miroslaw J.; Szajnik, Marta; Ren, Jin; Lenzner, Diana E.; Jackson, Edwin K.; Gorelik, Elieser; Lang, Stephan; Johnson, Jonas T.; Whiteside, Theresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6348-6357</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Regulatory T cell (Treg) frequency and activity are increased in cancer patients and play a major role in tumor escape.  Although disease progression is favored by the presence of Treg, mechanisms used by Treg to suppress antitumor immunity are unknown.  The ectonucleotidases CD39 and CD73 are expressed in Treg and convert ATP into immunosuppressive adenosine.  In this study, the involvement of the adenosinergic pathway in Treg-mediated suppression in head and neck squamous cell carcinoma (HNSCC) patients was evaluated.  Exptl. Design: HNSCC patients with an active disease (n = 19) and patients with no evident disease after therapy (n = 14) were studied.  Ectonucleotidase expression on CD4+ T cells and CD4+CD25high Treg was evaluated by flow cytometry and compared with normal controls.  Ectonucleotidase activity was also compared within these three groups.  The data were analyzed for assocns. of ectonucleotidase expression/function with disease stage.  Results: The percentages and expression levels of CD39 and CD73 in CD4+ T cells and Treg were greater in HNSCC than in normal controls and highest in patients with no evident disease.  Patients' Treg hydrolyzed ATP at higher rates and produced higher levels of adenosine than normal controls' Treg.  The increased frequency and enzymic activity of CD4+CD39+ cells corresponded to increased adenosine-mediated suppression of effector T cells, which was partly inhibited by ARL67156, an ectonucleotidase inhibitor, and by ZM241385, a selective A2a/A2b receptor antagonist.  Conclusions: CD39+Treg frequency and adenosine-mediated suppression are significantly increased in HNSCC patients.  The adenosinergic pathway is involved in Treg-mediated immunosuppression in cancer and its attenuation could be a promising immunotherapeutic strategy for patients with HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYndOcRS70DrVg90H21EOLACvtfcHk0liZ6bKbc6czQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyqsLfF&md5=1ebc36ba5441dc792a81690e753fdce0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1143%26sid%3Dliteratum%253Aachs%26aulast%3DMandapathil%26aufirst%3DM.%26aulast%3DSzczepanski%26aufirst%3DM.%2BJ.%26aulast%3DSzajnik%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLenzner%26aufirst%3DD.%2BE.%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DGorelik%26aufirst%3DE.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BT.%26aulast%3DWhiteside%26aufirst%3DT.%2BL.%26atitle%3DIncreased%2520ectonucleotidase%2520expression%2520and%2520activity%2520in%2520regulatory%2520T%2520cells%2520of%2520patients%2520with%2520head%2520and%2520neck%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D6348%26epage%3D6357%26doi%3D10.1158%2F1078-0432.CCR-09-1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandapathil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilldorfer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepanski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czystowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szajnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, T. L.</span></span> <span> </span><span class="NLM_article-title">Generation and accumulation of immunosuppressive adenosine by human CD4<sup>+</sup>CD25<sup>high</sup>FOXP3<sup>+</sup> regulatory T cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">7176</span>– <span class="NLM_lpage">7186</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.047423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1074%2Fjbc.M109.047423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=19858205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFaksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=7176-7186&author=M.+Mandapathilauthor=B.+Hilldorferauthor=M.+J.+Szczepanskiauthor=M.+Czystowskaauthor=M.+Szajnikauthor=J.+Renauthor=S.+Langauthor=E.+K.+Jacksonauthor=E.+Gorelikauthor=T.+L.+Whiteside&title=Generation+and+accumulation+of+immunosuppressive+adenosine+by+human+CD4%2BCD25highFOXP3%2B+regulatory+T+cells&doi=10.1074%2Fjbc.M109.047423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells</span></div><div class="casAuthors">Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J.; Czystowska, Malgorzata; Szajnik, Marta; Ren, Jin; Lang, Stephan; Jackson, Edwin K.; Gorelik, Elieser; Whiteside, Theresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7176-7186</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Naturally occurring regulatory T cells (nTreg) are crucial for maintaining tolerance to self and thus preventing autoimmune diseases and allograft rejections.  In cancer, Treg down-regulate antitumor responses by several distinct mechanisms.  This study analyzes the role the adenosinergic pathway plays in suppressive activities of human nTreg.  Human CD4+CD25highFOXP3+ Treg overexpress CD39 and CD73, ectonucleotidases sequentially converting ATP into AMP and adenosine, which then binds to A2a receptors on effector T cells, suppressing their functions.  CD4+CD39+ and CD4+CD25high T cells express low levels of adenosine deaminase (ADA), the enzyme responsible for adenosine breakdown, and of CD26, a surface-bound glycoprotein assocd. with ADA.  In contrast, T effector cells are enriched in CD26/ADA but express low levels of CD39 and CD73.  Inhibitors of ectonucleotidase activity (e.g. ARL67156) and antagonists of the A2a receptor (e.g. ZM241385) blocked Treg-mediated immunosuppression.  The inhibition of ADA activity on effector T cells enhanced Treg-mediated immunosuppression.  Thus, human nTreg characterized by the presence of CD39 and the low expression of CD26/ADA are responsible for the generation of adenosine, which plays a major role in Treg-mediated immunosuppression.  The data suggest that the adenosinergic pathway represents a potential therapeutic target for regulation of immunosuppression in a broad variety of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkCxeLBuGhILVg90H21EOLACvtfcHk0ljN_tRO0xwaXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFaksrw%253D&md5=bb34f7c663b8107948e4f60e04ddebdc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.047423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.047423%26sid%3Dliteratum%253Aachs%26aulast%3DMandapathil%26aufirst%3DM.%26aulast%3DHilldorfer%26aufirst%3DB.%26aulast%3DSzczepanski%26aufirst%3DM.%2BJ.%26aulast%3DCzystowska%26aufirst%3DM.%26aulast%3DSzajnik%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DGorelik%26aufirst%3DE.%26aulast%3DWhiteside%26aufirst%3DT.%2BL.%26atitle%3DGeneration%2520and%2520accumulation%2520of%2520immunosuppressive%2520adenosine%2520by%2520human%2520CD4%252BCD25highFOXP3%252B%2520regulatory%2520T%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D7176%26epage%3D7186%26doi%3D10.1074%2Fjbc.M109.047423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pulte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broekman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosopoulos, J. H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, A. J.</span></span> <span> </span><span class="NLM_article-title">CD39 Expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia</span>. <i>Clinical Lymphoma, Myeloma and Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.clml.2011.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.clml.2011.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=21816376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGrt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=367-372&author=D.+Pulteauthor=R.+R.+Furmanauthor=M.+J.+Broekmanauthor=J.+H.+F.+Drosopoulosauthor=H.+S.+Ballardauthor=K.+E.+Olsonauthor=J.+R.+Kizerauthor=A.+J.+Marcus&title=CD39+Expression+on+T+lymphocytes+correlates+with+severity+of+disease+in+patients+with+chronic+lymphocytic+leukemia&doi=10.1016%2Fj.clml.2011.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia</span></div><div class="casAuthors">Pulte, Dianne; Furman, Richard R.; Broekman, M. Johan; Drosopoulos, Joan H. F.; Ballard, Harold S.; Olson, Kim E.; Kizer, Jorge R.; Marcus, Aaron J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lymphoma, Myeloma & Leukemia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">367-372</span>CODEN:
                <span class="NLM_cas:coden">CLMLCQ</span>;
        ISSN:<span class="NLM_cas:issn">2152-2650</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Chronic lymphocytic leukemia (CLL) is a B-cell disorder, but it is also assocd. with abnormalities in T-lymphocyte function.  In this study we examine changes in T-lymphocyte CD39 and CD73 expression in patients with CLL.  Methods: Blood samples were drawn from 34 patients with CLL and 31 controls.  The cells were stained for CD3, CD4, CD8, CD19, CD39, and CD73 and analyzed by flow cytometry.  Results: Overall, patients with CLL had a higher percentage of CD39+ T lymphocytes than did controls.  The percentage of cells expressing CD39 was higher in both CD4+ cells and CD8+ cells.  Higher CD3/CD39 expression was assocd. with a later disease stage.  No correlations between T-lymphocyte CD39 levels and CD38 or Zap-70 expression were obsd.  In contrast, the percentage of T lymphocytes and B lymphocytes that expressed CD73 was decreased in patients with CLL.  Av. B-lymphocyte CD73 expression was decreased in CLL because the majority of CLL clones were CD73.  However a minority of CLL clones were CD73+, and patients with CD73+ clones tended to have earlier stage disease.  Conclusion: T-lymphocyte CD39 and CD73 expression may be useful prognostic markers in patients with CLL.  Expression of CD73 on the malignant cell population in CLL may be a marker of better prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyhFRSnxJheLVg90H21EOLACvtfcHk0ljN_tRO0xwaXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGrt77F&md5=0290aba84b6873d5e0d4c2b9732debfd</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.clml.2011.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clml.2011.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DPulte%26aufirst%3DD.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DBroekman%26aufirst%3DM.%2BJ.%26aulast%3DDrosopoulos%26aufirst%3DJ.%2BH.%2BF.%26aulast%3DBallard%26aufirst%3DH.%2BS.%26aulast%3DOlson%26aufirst%3DK.%2BE.%26aulast%3DKizer%26aufirst%3DJ.%2BR.%26aulast%3DMarcus%26aufirst%3DA.%2BJ.%26atitle%3DCD39%2520Expression%2520on%2520T%2520lymphocytes%2520correlates%2520with%2520severity%2520of%2520disease%2520in%2520patients%2520with%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DClinical%2520Lymphoma%252C%2520Myeloma%2520and%2520Leukemia%26date%3D2011%26volume%3D11%26spage%3D367%26epage%3D372%26doi%3D10.1016%2Fj.clml.2011.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">On the mechanism of anti-CD39 immune checkpoint therapy</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e000186</span> <span class="refDoi"> DOI: 10.1136/jitc-2019-000186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1136%2Fjitc-2019-000186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=32098829" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&author=D.+Allardauthor=B.+Allardauthor=J.+Stagg&title=On+the+mechanism+of+anti-CD39+immune+checkpoint+therapy&doi=10.1136%2Fjitc-2019-000186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1136%2Fjitc-2019-000186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjitc-2019-000186%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DOn%2520the%2520mechanism%2520of%2520anti-CD39%2520immune%2520checkpoint%2520therapy%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2020%26volume%3D8%26doi%3D10.1136%2Fjitc-2019-000186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjyoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cszimadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span> <span> </span><span class="NLM_article-title">Disordered purinergic signaling inhibits pathological angiogenesis in <i>Cd39</i>/<i>Entpd1</i>-null mice</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1395</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2007.070190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.2353%2Fajpath.2007.070190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17823293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1SmtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2007&pages=1395-1404&author=S.+W.+Jacksonauthor=T.+Hoshiauthor=Y.+Wuauthor=X.+Sunauthor=K.+Enjyojiauthor=E.+Cszimadiaauthor=C.+Sundbergauthor=S.+C.+Robson&title=Disordered+purinergic+signaling+inhibits+pathological+angiogenesis+in+Cd39%2FEntpd1-null+mice&doi=10.2353%2Fajpath.2007.070190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Disordered purinergic signaling inhibits pathological angiogenesis in Cd39/Entpd1-null mice</span></div><div class="casAuthors">Jackson, Shaun W.; Hoshi, Tomokazu; Wu, Yan; Sun, Xiaofeng; Enjyoji, Keiichi; Cszimadia, Eva; Sundberg, Christian; Robson, Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1395-1404</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">CD39/ecto-nucleoside triphosphate diphosphohydrolase-type-1 (ENTPD1) is the dominant vascular ectonucleotidase that catalyzes the phosphohydrolysis of extracellular nucleotides in the blood and extracellular space.  This ecto-enzymic process modulates endothelial cell, leukocyte, and platelet purinergic receptor-mediated responses to extracellular nucleotides in the setting of thrombosis and vascular inflammation.  We show here that deletion of Cd39/Entpd1 results in abrogation of angiogenesis, causing decreased growth of implanted tumors and inhibiting development of pulmonary metastases.  Qual. abnormalities of Cd39-null endothelial cell adhesion and integrin dysfunction were demonstrated in vitro.  These changes were assocd. with decreased activation of focal adhesion kinase and extracellular signaling-regulated kinase-1 and -2 in endothelial cells.  Our data indicate novel links between CD39/ENTPD1, extracellular nucleotide-mediated signaling, and vascular endothelial cell integrin function that impact on angiogenesis and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF1z2AzfbxBrVg90H21EOLACvtfcHk0lhzEu_4JTxkNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1SmtrrL&md5=e6fc10b7af795a8cfb3571d9dc72e574</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2007.070190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2007.070190%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BW.%26aulast%3DHoshi%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DEnjyoji%26aufirst%3DK.%26aulast%3DCszimadia%26aufirst%3DE.%26aulast%3DSundberg%26aufirst%3DC.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26atitle%3DDisordered%2520purinergic%2520signaling%2520inhibits%2520pathological%2520angiogenesis%2520in%2520Cd39%252FEntpd1-null%2520mice%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2007%26volume%3D171%26spage%3D1395%26epage%3D1404%26doi%3D10.2353%2Fajpath.2007.070190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjyoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csizmadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span> <span> </span><span class="NLM_article-title">CD39/ENTPD1 Expression by CD4<sup>+</sup> Foxp3<sup>+</sup> regulatory T cells promotes hepatic metastatic tumor growth in mice</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">1030</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2010.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1053%2Fj.gastro.2010.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20546740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2iurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2010&pages=1030-1040&author=X.+Sunauthor=Y.+Wuauthor=W.+Gaoauthor=K.+Enjyojiauthor=E.+Csizmadiaauthor=C.+E.+M%C3%BCllerauthor=T.+Murakamiauthor=S.+C.+Robson&title=CD39%2FENTPD1+Expression+by+CD4%2B+Foxp3%2B+regulatory+T+cells+promotes+hepatic+metastatic+tumor+growth+in+mice&doi=10.1053%2Fj.gastro.2010.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice</span></div><div class="casAuthors">Sun, Xiaofeng; Wu, Yan; Gao, Wenda; Enjyoji, Keiichi; Csizmadia, Eva; Mueller, Christa E.; Murakami, Takashi; Robson, Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1030-1040</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Adenosine mediates immune suppression and is generated by the ectonucleotidases CD39 (ENTPD1) and CD73 that are expressed on vascular endothelial cells and regulatory T cells (Tregs).  Although tumor-infiltrating immune cells include Foxp3+ Tregs, it is not clear whether local adenosine generation by Tregs promotes tumor growth in a CD39-dependent manner.  In this study, we have examd. the effect of CD39 expression by Tregs on effector immune cell responses to hepatic metastases in vivo.  A model of hepatic metastatic cancer was developed with portal vein infusion of luciferase-expressing melanoma B16/F10 cells and MCA38 colon cancer cells in wild-type (wt) and mutant mice null for Cd39.  Chimeric mice were generated by bone marrow transplantation (BMT) using Cd39 null or wt C57BL6 donors and irradiated recipient mice.  We demonstrate that hepatic growth of melanoma metastatic tumors was strongly inhibited in mice with Cd39 null vasculature or in wt mice with circulating Cd39 null bone marrow-derived cells.  We show functional CD39 expression on CD4+Foxp3+ Tregs suppressed antitumor immunity mediated by natural killer (NK) cells in vitro and in vivo.  Finally, inhibition of CD39 activity by polyoxometalate-1, a pharmacol. inhibitor of nucleoside triphosphate diphosphohydrolase activity, significantly inhibited tumor growth (P < .001).  CD39 expression on Tregs inhibits NK activity and is permissive for metastatic growth.  Pharmacol. or targeted inhibition of CD39 enzymic activity may find utility as an adjunct therapy for secondary hepatic malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpryEH4UWfyYLVg90H21EOLACvtfcHk0lhzEu_4JTxkNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2iurrJ&md5=513fd9d72ebf5c8e26fd2fd6d33f5eb1</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2010.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2010.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DEnjyoji%26aufirst%3DK.%26aulast%3DCsizmadia%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26atitle%3DCD39%252FENTPD1%2520Expression%2520by%2520CD4%252B%2520Foxp3%252B%2520regulatory%2520T%2520cells%2520promotes%2520hepatic%2520metastatic%2520tumor%2520growth%2520in%2520mice%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D139%26spage%3D1030%26epage%3D1040%26doi%3D10.1053%2Fj.gastro.2010.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csizmadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1593/neo.101332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1593%2Fneo.101332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=21390184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Kht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=206-216&author=L.+Fengauthor=X.+Sunauthor=E.+Csizmadiaauthor=L.+Hanauthor=S.+Bianauthor=T.+Murakamiauthor=X.+Wangauthor=S.+C.+Robsonauthor=Y.+Wu&title=Vascular+CD39%2FENTPD1+directly+promotes+tumor+cell+growth+by+scavenging+extracellular+adenosine+triphosphate&doi=10.1593%2Fneo.101332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate</span></div><div class="casAuthors">Feng, Lili; Sun, Xiaofeng; Csizmadia, Eva; Han, Lihui; Bian, Shu; Murakami, Takashi; Wang, Xin; Robson, Simon C.; Wu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-216</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Extracellular ATP is known to boost immune responses in the tumor microenvironment but might also contribute directly to cancer cell death.  CD39/ENTPD1 is the dominant ectonucleotidase expressed by endothelial cells and regulatory T cells and catalyzes the sequential hydrolysis of ATP to AMP that is further degraded to adenosine by CD73/ecto-5'-nucleotidase.  We have previously shown that deletion of Cd39 results in decreased growth of transplanted tumors in mice, as a result of both defective angiogenesis and heightened innate immune responses (secondary to loss of adenosinergic immune suppression).  Whether alterations in local extracellular ATP and adenosine levels as a result of CD39 bioactivity directly affect tumor growth and cytotoxicity has not been investigated to date.  We show here that extracellular ATP exerts antitumor activity by directly inhibiting cell proliferation and promoting cancer cell death.  ATP-induced antiproliferative effects and cell death are, in large part, mediated through P2X7 receptor signaling.  Tumors in Cd39 null mice exhibit increased necrosis in assocn. with P2X7 expression.  We further demonstrate that exogenous sol. NTPDase, or CD39 expression by cocultured liver sinusoidal endothelial cells, stimulates tumor cell proliferation and limits cell death triggered by extracellular ATP.  Collectively, our findings indicate that local expression of CD39 directly promotes tumor cell growth by scavenging extracellular ATP.  Pharmacol. or targeted inhibition of CD39 enzymic activity may find utility as an adjunct therapy in cancer management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3jztkSNuoUrVg90H21EOLACvtfcHk0liejvVgDeETug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Kht7w%253D&md5=1d4922e913b98fcaa067387de5d7aa84</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1593%2Fneo.101332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.101332%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DCsizmadia%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DBian%26aufirst%3DS.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DVascular%2520CD39%252FENTPD1%2520directly%2520promotes%2520tumor%2520cell%2520growth%2520by%2520scavenging%2520extracellular%2520adenosine%2520triphosphate%26jtitle%3DNeoplasia%26date%3D2011%26volume%3D13%26spage%3D206%26epage%3D216%26doi%3D10.1593%2Fneo.101332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Characterization of rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">11945</span>– <span class="NLM_lpage">11956</span>, <span class="refDoi"> DOI: 10.1021/bi701103y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi701103y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=11945-11956&author=M.+Zebischauthor=N.+Str%C3%A4ter&title=Characterization+of+rat+NTPDase1%2C+-2%2C+and+-3+ectodomains+refolded+from+bacterial+inclusion+bodies&doi=10.1021%2Fbi701103y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Rat NTPDase1, -2, and -3 Ectodomains Refolded from Bacterial Inclusion Bodies</span></div><div class="casAuthors">Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">11945-11956</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecto-nucleoside triphosphate diphosphohydrolases or NTPDases are a family of membrane-bound enzymes that catalyze the sequential removal of γ- and β-phosphate from ATP, ADP, and other nucleotides.  NTPDase1, -2, -3, and -8 are the enzymes responsible for signal conversion and termination in purinergic signaling.  They are anchored to the cytoplasmic membrane by two transmembrane helixes with a large catalytic domain pointing toward the extracellular space.  Here we report the first successful expression and purifn. of the sol. extracellular domains of rat NTPDase1, -2, and -3 from bacterial inclusion bodies.  The refolded proteins show characteristics similar to the wild type enzymes, for example in that they are dependent on divalent metal ions for catalysis and hydrolyze a wide variety of nucleoside tri- and diphosphates, whereas the monophosphate AMP is not further degraded.  Nucleoside triphosphates are hydrolyzed at a higher rate than the corresponding diphosphates.  Other characteristics of the recombinant enzymes however reflect the absence of transmembrane regions and side chain glycosylation.  For example all three enzymes are monomeric and only subtly activated by Mg2+ ions as compared to Ca2+ ions.  Although having a considerably higher specificity const. kcat/Km for ADP as for ATP, the bacterially expressed variant of NTPDase1 in contrast to its wild type counterpart releases intermediate ADP to a substantial amt.  The presented expression system will allow large scale prodn. of active protein suitable for structural studies, development of inhibitors, and even clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq-ID-7je_KrVg90H21EOLACvtfcHk0liejvVgDeETug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrM&md5=4eb2db0ed05290c45822022ff26ca094</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fbi701103y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701103y%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCharacterization%2520of%2520rat%2520NTPDase1%252C%2520-2%252C%2520and%2520-3%2520ectodomains%2520refolded%2520from%2520bacterial%2520inclusion%2520bodies%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D11945%26epage%3D11956%26doi%3D10.1021%2Fbi701103y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilbronn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.1999.00347.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1046%2Fj.1432-1327.1999.00347.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10231370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1MXjsVyqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1999&pages=102-110&author=P.+Heineauthor=N.+Braunauthor=A.+Heilbronnauthor=H.+Zimmermann&title=Functional+characterization+of+rat+ecto-ATPase+and+ecto-ATP+diphosphohydrolase+after+heterologous+expression+in+CHO+cells&doi=10.1046%2Fj.1432-1327.1999.00347.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells</span></div><div class="casAuthors">Heine, Petra; Braun, Norbert; Heilbronn, Alev; Zimmermann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The recently cloned ecto-ATPase and ecto-apyrase (ecto-ATP diphosphohydrolase) are plasma-membrane-bound enzymes responsible for the extracellular degrdn. of nucleoside 5'-triphosphates and nucleoside 5'-diphosphates.  We expressed the rat-derived enzymes in CHO cells to compare their mol. and functional properties.  Sequence-specific polyclonal antibodies differentiate between the two proteins and reveal identical mol. masses of 70-80 kDa.  Both enzymes are stimulated by either Ca2+ or Mg2+ and reveal a broad substrate specificity towards purine and pyrimidine nucleotides.  Whereas ecto-apyrase hydrolyzes nucleoside 5'-diphosphates at a rate ≈20-30% lower than nucleoside-5'-triphosphates, ecto-ATPase hydrolyzes nucleoside-5'-diphosphates only to a marginal extent.  The sensitivity of the two enzymes to the inhibitors of P2 receptors suramin, PPADS and reactive blue differs.  Hydrolysis of ATP by ecto-ATPase leads to the accumulation in the medium of extracellular ADP as an intermediate product, whereas ecto-apyrase dephosphorylates ATP directly to AMP.  Our results suggest that previous data describing extracellular hydrolysis of ATP by a variety of intact cellular systems with unidentified ecto-nucleotidases may be explained by the coexpression of ecto-ATPase and ecto-apyrase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ELN-KtM5B7Vg90H21EOLACvtfcHk0ljJW4b82CycAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsVyqtrY%253D&md5=dcc1a94d26d470479c49a16f2a7ea0d1</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00347.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00347.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DN.%26aulast%3DHeilbronn%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DH.%26atitle%3DFunctional%2520characterization%2520of%2520rat%2520ecto-ATPase%2520and%2520ecto-ATP%2520diphosphohydrolase%2520after%2520heterologous%2520expression%2520in%2520CHO%2520cells%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D262%26spage%3D102%26epage%3D110%26doi%3D10.1046%2Fj.1432-1327.1999.00347.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidotti, G.</span></span> <span> </span><span class="NLM_article-title">Soluble apyrases release ADP during ATP hydrolysis</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.4555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1006%2Fbbrc.2001.4555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=11263976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFeit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2001&pages=90-95&author=W.+Chenauthor=G.+Guidotti&title=Soluble+apyrases+release+ADP+during+ATP+hydrolysis&doi=10.1006%2Fbbrc.2001.4555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Apyrases Release ADP during ATP Hydrolysis</span></div><div class="casAuthors">Chen, Wei; Guidotti, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-95</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A sol. form of CD39 was expressed and purified from High-Five insect cells.  The sol. CD39 is a monomer with a mol. wt. of 54,000.  The kcat and Km of the purified sol. CD39 were 4.6 s-1 and 12 μM for ATP and 1.3 s-1 and 7 μM for ADP as substrates, resp.  One nucleotide binding site was detected on the monomer only in the presence of Ca2+.  In contrast to the membrane bound CD39, sol. CD39 released ADP as an intermediate during ATP hydrolysis, as did the sol. potato apyrase.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc9xynlyCGZbVg90H21EOLACvtfcHk0ljJW4b82CycAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFeit7w%253D&md5=14e07f636f9402108c5dd3438af42af5</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.4555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.4555%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGuidotti%26aufirst%3DG.%26atitle%3DSoluble%2520apyrases%2520release%2520ADP%2520during%2520ATP%2520hydrolysis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D282%26spage%3D90%26epage%3D95%26doi%3D10.1006%2Fbbrc.2001.4555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2011.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.jmb.2011.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22100451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2012&pages=288-306&author=M.+Zebischauthor=M.+Kraussauthor=P.+Sch%C3%A4ferauthor=N.+Str%C3%A4ter&title=Crystallographic+evidence+for+a+domain+motion+in+rat+nucleoside+triphosphate+diphosphohydrolase+%28NTPDase%29+1&doi=10.1016%2Fj.jmb.2011.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Evidence for a Domain Motion in Rat Nucleoside Triphosphate Diphosphohydrolase (NTPDase) 1</span></div><div class="casAuthors">Zebisch, Matthias; Krauss, Michel; Schaefer, Petra; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-306</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nucleoside triphosphate diphosphohydrolases (NTPDases) are a physiol. important class of membrane-bound ectonucleotidases responsible for the regulation of extracellular levels of nucleotides.  CD39 or NTPDase1 is the dominant NTPDase of the vasculature.  By hydrolyzing proinflammatory ATP and platelet-activating ADP to AMP, it blocks platelet aggregation and supports blood flow.  Thus, great interest exists in understanding the structure and dynamics of this prototype member of the eukaryotic NTPDase family.  Here, we report the crystal structure of a variant of sol. NTPDase1 lacking a putative membrane interaction loop identified between the two lobes of the catalytic domain.  ATPase and ADPase activities of this variant are detd. via a newly established kinetic isothermal titrn. calorimetry assay and compared to that of the sol. NTPDase1 variant characterized previously.  Complex structures with decavanadate and heptamolybdate show that both polyoxometallates bind electrostatically to a loop that is involved in binding of the nucleobase.  In addn., a comparison of the domain orientations of the four independent proteins in the crystal asym. unit provides the first direct exptl. evidence for a domain motion of NTPDases.  An interdomain rotation angle of up to 7.4° affects the active site cleft between the two lobes of the protein.  Comparison with a previously solved bacterial NTPDase structure indicates that the domains may undergo relative rotational movements of more than 20°.  Our data support the idea that the influence of transmembrane helix dynamics on activity is achieved by coupling to a domain motion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6iK9YVkkerVg90H21EOLACvtfcHk0ljJW4b82CycAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFyqtw%253D%253D&md5=d6b6b3be6c63324f2ffbe76a5e99afed</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DP.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystallographic%2520evidence%2520for%2520a%2520domain%2520motion%2520in%2520rat%2520nucleoside%2520triphosphate%2520diphosphohydrolase%2520%2528NTPDase%2529%25201%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D415%26spage%3D288%26epage%3D306%26doi%3D10.1016%2Fj.jmb.2011.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivian, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedmaier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Nours, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilce, M. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidberger, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Apice, A. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartland, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossjohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beddoe, T.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a legionella pneumophila ecto-triphosphate diphosphohydrolase, a structural and functional homolog of the eukaryotic NTPDases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/j.str.2009.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.str.2009.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=20159467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=228-238&author=J.+P.+Vivianauthor=P.+Riedmaierauthor=H.+Geauthor=J.+Le+Noursauthor=F.+M.+Sansomauthor=M.+C.+J.+Wilceauthor=E.+Byresauthor=M.+Diasauthor=J.+W.+Schmidbergerauthor=P.+J.+Cowanauthor=A.+J.+F.+d%E2%80%99Apiceauthor=E.+L.+Hartlandauthor=J.+Rossjohnauthor=T.+Beddoe&title=Crystal+structure+of+a+legionella+pneumophila+ecto-triphosphate+diphosphohydrolase%2C+a+structural+and+functional+homolog+of+the+eukaryotic+NTPDases&doi=10.1016%2Fj.str.2009.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Legionella pneumophila Ecto -Triphosphate Diphosphohydrolase, A Structural and Functional Homolog of the Eukaryotic NTPDases</span></div><div class="casAuthors">Vivian, Julian P.; Riedmaier, Patrice; Ge, Honghua; Le Nours, Jerome; Sansom, Fiona M.; Wilce, Matthew C. J.; Byres, Emma; Dias, Manisha; Schmidberger, Jason W.; Cowan, Peter J.; d'Apice, Anthony J. F.; Hartland, Elizabeth L.; Rossjohn, Jamie; Beddoe, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">228-238</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many pathogenic bacteria have sophisticated mechanisms to interfere with the mammalian immune response.  These include the disruption of host extracellular ATP levels that, in humans, is tightly regulated by the nucleoside triphosphate diphosphohydrolase family (NTPDases).  NTPDases are found almost exclusively in eukaryotes, the notable exception being their presence in some pathogenic prokaryotes.  To address the function of bacterial NTPDases, we describe the structures of an NTPDase from the pathogen Legionella pneumophila (Lpg1905/Lp1NTPDase) in its apo state and in complex with the ATP analog AMPPNP and the subtype-specific NTPDase inhibitor ARL 67156.  Lp1NTPDase is structurally and catalytically related to eukaryotic NTPDases and the structure provides a basis for NTPDase-specific inhibition.  Furthermore, we demonstrate that the activity of Lp1NTPDase correlates directly with intracellular replication of Legionella within macrophages.  Collectively, these findings provide insight into the mechanism of this enzyme and highlight its role in host-pathogen interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNwKHFnkh7erVg90H21EOLACvtfcHk0lh522KhchngIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKjs7s%253D&md5=50da4ae0d11a25cd73f0b0d151dba2e9</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DVivian%26aufirst%3DJ.%2BP.%26aulast%3DRiedmaier%26aufirst%3DP.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DLe%2BNours%26aufirst%3DJ.%26aulast%3DSansom%26aufirst%3DF.%2BM.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DByres%26aufirst%3DE.%26aulast%3DDias%26aufirst%3DM.%26aulast%3DSchmidberger%26aufirst%3DJ.%2BW.%26aulast%3DCowan%26aufirst%3DP.%2BJ.%26aulast%3Dd%25E2%2580%2599Apice%26aufirst%3DA.%2BJ.%2BF.%26aulast%3DHartland%26aufirst%3DE.%2BL.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DBeddoe%26aufirst%3DT.%26atitle%3DCrystal%2520structure%2520of%2520a%2520legionella%2520pneumophila%2520ecto-triphosphate%2520diphosphohydrolase%252C%2520a%2520structural%2520and%2520functional%2520homolog%2520of%2520the%2520eukaryotic%2520NTPDases%26jtitle%3DStructure%26date%3D2010%26volume%3D18%26spage%3D228%26epage%3D238%26doi%3D10.1016%2Fj.str.2009.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauble, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystallographic snapshots along the reaction pathway of nucleoside triphosphate diphosphohydrolases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1460</span>– <span class="NLM_lpage">1475</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.str.2013.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23830739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKnsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1460-1475&author=M.+Zebischauthor=M.+Kraussauthor=P.+Sch%C3%A4ferauthor=P.+Laubleauthor=N.+Str%C3%A4ter&title=Crystallographic+snapshots+along+the+reaction+pathway+of+nucleoside+triphosphate+diphosphohydrolases&doi=10.1016%2Fj.str.2013.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Snapshots along the Reaction Pathway of Nucleoside Triphosphate Diphosphohydrolases</span></div><div class="casAuthors">Zebisch, Matthias; Krauss, Michel; Schaefer, Petra; Lauble, Peter; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1460-1475</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In vertebrates, membrane-bound ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) on the cell surface are responsible for signal conversion and termination in purinergic signaling by extracellular nucleotides.  Here the authors present apo and complex structures of the rat NTPDase 2 extracellular domain and Legionella pneumophila NTPDase 1, including a high-resoln. structure with a transition-state analog.  Comparison of ATP and ADP binding modes shows how NTPDases engage the same catalytic site for hydrolysis of nucleoside triphosphates and diphosphates.  This dual specificity is achieved at the expense of base specificity.  Structural and mutational studies indicate that a conserved active-site water is replaced by the phosphate product immediately after phosphoryl transfer.  Partial base specificity for purines in LpNTPDase 1 is based on a different intersubunit base binding site for pyrimidine bases.  A comparison of the bacterial enzyme in six independent crystal forms shows that NTPDases can undergo a domain closure motion of at least 17°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFe_4Yi3ztULVg90H21EOLACvtfcHk0lh522KhchngIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKnsbnL&md5=fc1194ec941017c13b40a1283752c01a</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DP.%26aulast%3DLauble%26aufirst%3DP.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystallographic%2520snapshots%2520along%2520the%2520reaction%2520pathway%2520of%2520nucleoside%2520triphosphate%2520diphosphohydrolases%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D1460%26epage%3D1475%26doi%3D10.1016%2Fj.str.2013.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Structures of Legionella pneumophila NTPDase1 in complex with polyoxometallates</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>D70</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1107/S1399004714001916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1107%2FS1399004714001916" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D70&publication_year=2014&pages=1147-1154&author=M.+Zebischauthor=M.+Kraussauthor=P.+Sch%C3%A4ferauthor=N.+Str%C3%A4ter&title=Structures+of+Legionella+pneumophila+NTPDase1+in+complex+with+polyoxometallates&doi=10.1107%2FS1399004714001916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1107%2FS1399004714001916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004714001916%26sid%3Dliteratum%253Aachs%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DP.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DStructures%2520of%2520Legionella%2520pneumophila%2520NTPDase1%2520in%2520complex%2520with%2520polyoxometallates%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2014%26volume%3DD70%26spage%3D1147%26epage%3D1154%26doi%3D10.1107%2FS1399004714001916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summers, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oulavallickal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcus, V. L.</span></span> <span> </span><span class="NLM_article-title">Structures and kinetics for plant nucleoside triphosphate diphosphohydrolases support a domain motion catalytic mechanism</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1638</span>, <span class="refDoi"> DOI: 10.1002/pro.3199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fpro.3199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=28543850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=1627-1638&author=E.+L.+Summersauthor=M.+H.+Cummingauthor=T.+Oulavallickalauthor=N.+J.+Robertsauthor=V.+L.+Arcus&title=Structures+and+kinetics+for+plant+nucleoside+triphosphate+diphosphohydrolases+support+a+domain+motion+catalytic+mechanism&doi=10.1002%2Fpro.3199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Structures and kinetics for plant nucleoside triphosphate diphosphohydrolases support a domain motion catalytic mechanism</span></div><div class="casAuthors">Summers, Emma L.; Cumming, Mathew H.; Oulavallickal, Tifany; Roberts, Nicholas J.; Arcus, Vickery L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1627-1638</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Extracellular nucleoside triphosphate diphosphohydrolases (NTPDases) are enzymes that hydrolyze extracellular nucleotides to the resp. monophosphate nucleotides.  In the past 20 years, NTPDases belonging to mammalian, parasitic and prokaryotic domains of life have been discovered, cloned and characterized.  We reveal the first structures of NTPDases from the legume plant species Trifolium repens (7WC) and Vigna unguiculata subsp. cylindrica (DbLNP).  Four crystal structures of 7WC and DbLNP were detd. at resolns. between 1.9 and 2.6 Å.  For 7WC, structures were detd. for an -apo form (1.89 Å) and with the product AMP (2.15 Å) and adenine and phosphate (1.76 Å) bound.  For DbLNP, a structure was solved with phosphate and manganese bound (2.60 Å).  Thorough kinetic data and anal. is presented.  The structure of 7WC and DbLNP reveals that these NTPDases can adopt two conformations depending on the mol. and co-factor bound in the active site.  A central hinge region creates a "butterfly-like" motion of the domains that reduces the width of the inter-domain active site cleft upon mol. binding.  This phenomenon has been previously described in Rattus norvegicus and Legionella pneumophila NTPDaseI and Toxoplasma gondii NTPDaseIII suggesting a common catalytic mechanism across the domains of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphRBpPUkUHu7Vg90H21EOLACvtfcHk0lj-an4agxwqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSnt7k%253D&md5=20b92a2a1fb9ac9ff400c7575211131f</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2Fpro.3199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3199%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DE.%2BL.%26aulast%3DCumming%26aufirst%3DM.%2BH.%26aulast%3DOulavallickal%26aufirst%3DT.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DArcus%26aufirst%3DV.%2BL.%26atitle%3DStructures%2520and%2520kinetics%2520for%2520plant%2520nucleoside%2520triphosphate%2520diphosphohydrolases%2520support%2520a%2520domain%2520motion%2520catalytic%2520mechanism%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D1627%26epage%3D1638%26doi%3D10.1002%2Fpro.3199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Structural insight into activation mechanism of Toxoplasma gondii nucleoside triphosphate diphosphohydrolases by disulfide reduction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">3051</span>– <span class="NLM_lpage">3066</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.294348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1074%2Fjbc.M111.294348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22130673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=3051-3066&author=U.+Krugauthor=M.+Zebischauthor=M.+Kraussauthor=N.+Str%C3%A4ter&title=Structural+insight+into+activation+mechanism+of+Toxoplasma+gondii+nucleoside+triphosphate+diphosphohydrolases+by+disulfide+reduction&doi=10.1074%2Fjbc.M111.294348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insight into Activation Mechanism of Toxoplasma gondii Nucleoside Triphosphate Diphosphohydrolases by Disulfide Reduction</span></div><div class="casAuthors">Krug, Ulrike; Zebisch, Matthias; Krauss, Michel; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3051-3066</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The intracellular parasite Toxoplasma gondii produces two nucleoside triphosphate diphosphohydrolases (NTPDase1 and -3).  These tetrameric, cysteine-rich enzymes require activation by reductive cleavage of a hitherto unknown disulfide bond.  Despite a 97% sequence identity, both isoenzymes differ largely in their ability to hydrolyze ATP and ADP.  Here, we present crystal structures of inactive NTPDase3 as an apo form and in complex with the product AMP to resolns. of 2.0 and 2.2 Å, resp.  We find that the enzyme is present in an open conformation that precludes productive substrate binding and catalysis.  The cysteine bridge 258-268 is identified to be responsible for locking of activity.  Crystal structures of constitutively active variants of NTPDase1 and -3 generated by mutation of Cys258-Cys268 show that opening of the regulatory cysteine bridge induces a pronounced contraction of the whole tetramer.  This is accompanied by a 12° domain closure motion resulting in the correct arrangement of all active site residues.  A complex structure of activated NTPDase3 with a non-hydrolyzable ATP analog and the cofactor Mg2+ to a resoln. of 2.85 Å indicates that catalytic differences between the NTPDases are primarily dictated by differences in positioning of the adenine base caused by substitution of Arg492 and Glu493 in NTPDase1 by glycines in NTPDase3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAQMbHdqPIBLVg90H21EOLACvtfcHk0lj-an4agxwqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWjsbs%253D&md5=28ede04f51ed1282e57ec4152053ed89</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.294348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.294348%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DStructural%2520insight%2520into%2520activation%2520mechanism%2520of%2520Toxoplasma%2520gondii%2520nucleoside%2520triphosphate%2520diphosphohydrolases%2520by%2520disulfide%2520reduction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D3051%26epage%3D3066%26doi%3D10.1074%2Fjbc.M111.294348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totzauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">The ATP/ADP substrate specificity switch between <i>Toxoplasma gondii</i> NTPDase1 and NTPDase3 is caused by an altered mode of binding of the substrate base</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2292</span>– <span class="NLM_lpage">2300</span>, <span class="refDoi"> DOI: 10.1002/cbic.201300441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fcbic.201300441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=24115522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ns7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=2292-2300&author=U.+Krugauthor=R.+Totzauerauthor=M.+Zebischauthor=N.+Str%C3%A4ter&title=The+ATP%2FADP+substrate+specificity+switch+between+Toxoplasma+gondii+NTPDase1+and+NTPDase3+is+caused+by+an+altered+mode+of+binding+of+the+substrate+base&doi=10.1002%2Fcbic.201300441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">The ATP/ADP Substrate Specificity Switch between Toxoplasma gondii NTPDase1 and NTPDase3 is Caused by an Altered Mode of Binding of the Substrate Base</span></div><div class="casAuthors">Krug, Ulrike; Totzauer, Robert; Zebisch, Matthias; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2292-2300</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two nucleoside triphosphate diphosphohydrolase isoforms (NTPDase1 and NTPDase3) are responsible for the hydrolysis of nucleotides by the intracellular protozoan Toxoplasma gondii.  They constitute about 3 % of the total parasite protein.  Despite sharing 97 % sequence identity they exhibit opposite ATP vs. ADP substrate discrimination ratios.  Here we show by mutagenesis that the residues G492/G493 in NTPDase3 and R492/E493 in NTPDase1 are predominantly responsible for the differences in substrate specificity.  Crystal structures of NTPDase1 in complexation with analogs of ATP and ADP reveal that the inverted substrate specificity of NTPDase1 relative to NTPDase3 is achieved by switching from the canonical substrate binding mode to a very different alternative one.  Instead of being stacked on top of a helix of the C-terminal domain the nucleotide base is positioned in the interdomain space between the side chains of R108 and R492, recruited from both domains.  Furthermore, we show that the NTPDase1 substrate specificity is mainly dependent on the presence of the side chain of E493, which causes repositioning of the ribose component of the nucleotide.  All in all, binding by the flexible side chains in the alternative binding mode in NTPDase1 allows for equally good positioning of ATP and ADP with increased activity toward ADP relative to what is seen in the case of NTPDase3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-yrCTB6-66bVg90H21EOLACvtfcHk0lhyBXNJzyfY2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ns7zN&md5=a58033e4c88403bb1c500c56b7f5fdd0</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201300441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201300441%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DTotzauer%26aufirst%3DR.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DThe%2520ATP%252FADP%2520substrate%2520specificity%2520switch%2520between%2520Toxoplasma%2520gondii%2520NTPDase1%2520and%2520NTPDase3%2520is%2520caused%2520by%2520an%2520altered%2520mode%2520of%2520binding%2520of%2520the%2520substrate%2520base%26jtitle%3DChemBioChem%26date%3D2013%26volume%3D14%26spage%3D2292%26epage%3D2300%26doi%3D10.1002%2Fcbic.201300441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totzauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of <i>Toxoplasma gondii</i> nucleoside triphosphate diphosphohydrolase 1 represents a conformational intermediate in the reductive activation mechanism of the tetrameric enzyme</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1271</span>– <span class="NLM_lpage">1276</span>, <span class="refDoi"> DOI: 10.1002/prot.24288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1002%2Fprot.24288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23526564" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=1271-1276&author=U.+Krugauthor=R.+Totzauerauthor=N.+Str%C3%A4ter&title=The+crystal+structure+of+Toxoplasma+gondii+nucleoside+triphosphate+diphosphohydrolase+1+represents+a+conformational+intermediate+in+the+reductive+activation+mechanism+of+the+tetrameric+enzyme&doi=10.1002%2Fprot.24288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1002%2Fprot.24288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24288%26sid%3Dliteratum%253Aachs%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DTotzauer%26aufirst%3DR.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DThe%2520crystal%2520structure%2520of%2520Toxoplasma%2520gondii%2520nucleoside%2520triphosphate%2520diphosphohydrolase%25201%2520represents%2520a%2520conformational%2520intermediate%2520in%2520the%2520reductive%2520activation%2520mechanism%2520of%2520the%2520tetrameric%2520enzyme%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2013%26volume%3D81%26spage%3D1271%26epage%3D1276%26doi%3D10.1002%2Fprot.24288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span> <span> </span><span class="NLM_article-title">Ecto-Nucleotidase inhibitors: recent developments in drug discovery</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.2174/1389557515666150219115141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.2174%2F1389557515666150219115141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25694081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=21-33&author=Y.+Baqi&title=Ecto-Nucleotidase+inhibitors%3A+recent+developments+in+drug+discovery&doi=10.2174%2F1389557515666150219115141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery</span></div><div class="casAuthors">Baqi, Younis</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-33</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ecto-nucleotidases are nucleotide metabolizing enzymes that are divided into four different families; nucleoside triphosphate diphosphohydrolases (NTPDases), ecto-5'-nucleotidase (ecto-5'-NT), nucleotide pyrophosphatase/phosphodiesterases (NPPs), and alk. phosphatases (APs).  These enzymes are responsible for the hydrolysis of nucleotidases (nucleoside 5'-triphosphates, 5'-diphosphates and 5'-monophosphates).  Ecto-nucleotidases modulate P1- and P2-receptor-mediated signaling.  Alterations in extracellular nucleotide and adenosine level can increase or decrease P1 and P2 activity.  Potent and selective ligands for certain ectonucleotidase are important as pharmacol. tools to investigate the (patho)physiol. roles of these enzymes.  Furthermore, such ligands are required to study their potential as novel drugs, e.g., as immunomodulatory agents, for the treatment of cancer, cardiovascular or central nervous system disorders.  Hence, this review aims to provide an overview of ecto-nucleotidases inhibitors developed so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5ejE4tvN2JLVg90H21EOLACvtfcHk0lhyBXNJzyfY2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslyhtro%253D&md5=86db310d85dcef37e024fee2e6257566</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.2174%2F1389557515666150219115141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666150219115141%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26atitle%3DEcto-Nucleotidase%2520inhibitors%253A%2520recent%2520developments%2520in%2520drug%2520discovery%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D21%26epage%3D33%26doi%3D10.2174%2F1389557515666150219115141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span> <span> </span><span class="NLM_article-title">Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities</span>. <i>Crit. Rev. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.3109/10409238.2014.953627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.3109%2F10409238.2014.953627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25418535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=473-497&author=G.+G.+Yegutkin&title=Enzymes+involved+in+metabolism+of+extracellular+nucleotides+and+nucleosides%3A+functional+implications+and+measurement+of+activities&doi=10.3109%2F10409238.2014.953627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities</span></div><div class="casAuthors">Yegutkin, Gennady G.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">473-497</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Extracellular nucleotides and nucleosides mediate diverse signaling effects in virtually all organs and tissues.  Most models of purinergic signaling depend on functional interactions between distinct processes, including (1) the release of endogenous ATP and other nucleotides, (2) triggering of signaling events via a series of nucleotide-selective ligand-gated P2X and metabotropic P2Y receptors as well as adenosine receptors, and (3) ectoenzymic interconversion of purinergic agonists.  The duration and magnitude of purinergic signaling is governed by a network of ectoenzymes, including the enzymes of the nucleoside triphosphate diphosphohydrolase family, the nucleotide pyrophosphatase/phosphodiesterase family, ecto-5'-nucleotidase/CD73, tissue-nonspecific alk. phosphatase, prostatic acid phosphatase, and other alk. and acid phosphatases, adenosine deaminase, and purine nucleoside phosphorylase.  Along with "classical" inactivating ectoenzymes, recent data provide evidence for the co-existence of a counteracting ATP-regenerating pathway comprising the enzymes of the adenylate kinase and nucleoside diphosphate kinase families, and ATP synthase.  This review describes recent advances in this field, with special emphasis on purine-converting ectoenzymes as a complex and integrated network regulating purinergic signaling in such (patho)physiol. states as immunomodulation, inflammation, tumorigenesis, arterial calcification, and other diseases.  The 2nd part of this review provides a comprehensive overview and basic principles of major approaches employed for studying purinergic activities, including spectrophotometric Pi-liberating assays, HPLC and TLC analyses of purine substrates and metabolites, capillary electrophoresis, bioluminescent, fluorometric and electrochem. enzyme-coupled assays, histochem. staining, and further emphasizes their advantages, drawbacks and suitability for assaying a particular catalytic reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VtKDi0CkWrVg90H21EOLACvtfcHk0liLGuCqNxowaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju7jO&md5=8560668a9acd255cc99f99cdd2d55bef</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.3109%2F10409238.2014.953627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409238.2014.953627%26sid%3Dliteratum%253Aachs%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26atitle%3DEnzymes%2520involved%2520in%2520metabolism%2520of%2520extracellular%2520nucleotides%2520and%2520nucleosides%253A%2520functional%2520implications%2520and%2520measurement%2520of%2520activities%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D49%26spage%3D473%26epage%3D497%26doi%3D10.3109%2F10409238.2014.953627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crack, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beukers, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingall, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKechnie, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span> <span> </span><span class="NLM_article-title">Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb13251.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1111%2Fj.1476-5381.1995.tb13251.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=7533620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK2MXjt12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1995&pages=475-481&author=B.+E.+Crackauthor=C.+E.+Pollardauthor=M.+W.+Beukersauthor=S.+M.+Robertsauthor=S.+F.+Huntauthor=A.+H.+Ingallauthor=K.+C.+McKechnieauthor=A.+P.+Ijzermanauthor=P.+Leff&title=Pharmacological+and+biochemical+analysis+of+FPL+67156%2C+a+novel%2C+selective+inhibitor+of+ecto-ATPase&doi=10.1111%2Fj.1476-5381.1995.tb13251.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase</span></div><div class="casAuthors">Crack, B. E.; Pollard, C. E.; Beukers, M. W.; Roberts, S. M.; Hunt, S. F.; Ingall, A. H.; McKechnie, K. C. W.; IJzerman, A. P.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">475-81</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">FPL 67156 (6-N,N-dimethyl-β,γ-dibromomethylene-D-ATP), is a newly synthesized analog of ATP.  In a rabbit isolated tracheal epithelium prepn., measuring P2U-purinoceptor-dependent chloride secretion, FPL 67156 (6-N,N-dimethyl-,-dibromomethylene--ATP), was discovered to potentiate the responses to UTP but not those to ATP-γ-S.  UTP agonist-concn. effect (E/[A]) curves were shifted to the left by 5-fold in the presence of 100 μM FPL 67156.  The differential effect of FPL 67156 on UTP and ATP-γ-S was hypothesized to be due to the greater susceptibility of UTP to enzymic dephosphorylation and the ability of FPL 67156 to inhibit this process.  FPL 67156 was tested as an ecto-ATPase inhibitor in a human blood cell assay, measuring [γ32P]-ATP dephosphorylation.  The compd. inhibited [γ32P]-ATP degrdn. with a IC50 of 4.6.  FPL 67156 was then tested for its effects on ATP and α,β-methylene-ATP responses at P2X-purinoceptors in the rabbit isolated ear artery.  In the concn. range 30 μM-1 mM, the compd. potentiated the contractile effects of ATP but not those of α,β-methylene-ATP.  At 1 mM, FPL 67156 produced a 34-fold leftward shift of ATP E/[A] curves.  The effects of FPL 67156 on ATP E/[A] curves in the rabbit ear artery were analyzed using a theor. model (R. F. Furchgott, 1972) describing the action of an enzyme inhibitor on the effects of a metabolically unstable agonist.  This anal. provided as est. of the pK1 for FPL 67156 as an ecto-ATPase inhibitor of 5.2.  Using appropriate assays, FPL 67156 was shown to have weak antagonist effects at P2X- and P2T-purinoceptors (pA2 ≈ 3.3 and 3.5 resp.), and weak agonist effects at P2U-purinoceptors (p[A50]≈3.5).  The degree of potentiation of ATP and UTP effect elicited by FPL 67156 confirms previous results concerning the influence that ecto-ATPase has on the position of E/[A] curves for metabolically unstable agonist.  The magnitude of this influence is predicted to have a major effect on the agonist potency orders currently used to designate purinoceptors.  This study indicates FPL 67156 to be a potentially valuable probe in studies on the action of nucleotides and in the classification of purinoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqzLwJkulcorVg90H21EOLACvtfcHk0liLGuCqNxowaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt12ltLo%253D&md5=7e2008a719ba5f90bd7525b5fe07e7b8</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb13251.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb13251.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrack%26aufirst%3DB.%2BE.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26aulast%3DBeukers%26aufirst%3DM.%2BW.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DHunt%26aufirst%3DS.%2BF.%26aulast%3DIngall%26aufirst%3DA.%2BH.%26aulast%3DMcKechnie%26aufirst%3DK.%2BC.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DPharmacological%2520and%2520biochemical%2520analysis%2520of%2520FPL%252067156%252C%2520a%2520novel%252C%2520selective%2520inhibitor%2520of%2520ecto-ATPase%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D114%26spage%3D475%26epage%3D481%26doi%3D10.1111%2Fj.1476-5381.1995.tb13251.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lévesque, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, É. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigonnesse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1038%2Fsj.bjp.0707361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17603550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFOjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=141-150&author=S.+A.+L%C3%A9vesqueauthor=%C3%89.+G.+Lavoieauthor=J.+Leckaauthor=F.+Bigonnesseauthor=J.+S%C3%A9vigny&title=Specificity+of+the+ecto-ATPase+inhibitor+ARL+67156+on+human+and+mouse+ectonucleotidases&doi=10.1038%2Fsj.bjp.0707361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases</span></div><div class="casAuthors">Levesque, S. A.; Lavoie, E. G.; Lecka, J.; Bigonnesse, F.; Sevigny, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-150</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ARL 67156, 6-N,N-Diethyl-D-β-γ-dibromomethylene ATP, originally named FPL 67156, is the only com. available inhibitor of ecto-ATPases.  Since the first report on this mol., various ectonucleotidases responsible for the hydrolysis of ATP at the cell surface have been cloned and characterized.  In this work, we identified the ectonucleotidases inhibited by ARL 67156.  The effect of ARL 67156 on recombinant NTPDase1, 2, 3 & 8 (mouse and human), NPP1, NPP3 and ecto-5'-nucleotidase (human) have been evaluated.  The inhibition of the activity of NTPDases (using the substrates ATP, ADP, and UTP), NPPs (pnp-TMP, Ap3A) and ecto-5'-nucleotidase (AMP) was measured by colorimetric or HPLC assays.  ARL 67156 was a weak competitive inhibitor of human NTPDase1, NTPDase3, and NPP1 with Ki of 11 ± 3, 18 ± 4 and 12 ± 3 μM, resp.  At concns. used in the literature (50-100 μM), ARL 67156 partially but significantly inhibited the mouse and human forms of these enzymes.  NTPDase2, NTPDase8, NPP3, and ecto-5'-nucleotidase activities were less affected.  Importantly, ARL 67156 was not hydrolyzed by either human NTPDase1, 2, 3, 8, NPP1, or NPP3.  In cell environments where NTPDase1, NTPDase3, NPP1, or mouse NTPDase8 are present, ARL 67156 would prolong the effect of endogenously released ATP on P2 receptors.  However, ARL 67156 does not block any ectonucleotidases efficiently when high concns. of substrates are present, such as in biochem., pharmacol. or P2X7 assays.  In addn., ARL 67156 is not an effective inhibitor of NTPDase2, human NTPDase8, NPP3, and ecto-5'-nucleotidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokmbpiMn9xO7Vg90H21EOLACvtfcHk0lieSEn8rKcNSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFOjurk%253D&md5=99ce076a3d3c615033b63bd81a635bd9</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707361%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A9vesque%26aufirst%3DS.%2BA.%26aulast%3DLavoie%26aufirst%3D%25C3%2589.%2BG.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DBigonnesse%26aufirst%3DF.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3DSpecificity%2520of%2520the%2520ecto-ATPase%2520inhibitor%2520ARL%252067156%2520on%2520human%2520and%2520mouse%2520ectonucleotidases%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D141%26epage%3D150%26doi%3D10.1038%2Fsj.bjp.0707361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbfinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Orleans-Juste, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, A. R.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2239</span>– <span class="NLM_lpage">2247</span>, <span class="refDoi"> DOI: 10.1021/jm000020b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000020b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2239-2247&author=F.+P.+Gendronauthor=E.+Halbfingerauthor=B.+Fischerauthor=M.+Duvalauthor=P.+D%E2%80%99Orleans-Justeauthor=A.+R.+Beaudoin&title=Novel+inhibitors+of+nucleoside+triphosphate+diphosphohydrolases%3A+chemical+synthesis+and+biochemical+and+pharmacological+characterizations&doi=10.1021%2Fjm000020b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of Nucleoside Triphosphate Diphosphohydrolases: Chemical Synthesis and Biochemical and Pharmacological Characterizations</span></div><div class="casAuthors">Gendron, Fernand-Pierre; Halbfinger, Efrat; Fischer, Bilha; Duval, Martine; D'Orleans-Juste, Pedro; Beaudoin, Adrien R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2239-2247</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To elucidate the physiol. role played by nucleoside triphosphate diphosphohydrolase (NTPDase; EC 3.6.1.5), adenine nucleotide analogs, modified on the purine ring, have been synthesized and tested as potential inhibitors.  Resistance of ATP analogs to hydrolysis and their potency as NTPDase inhibitors were evaluated.  For this purpose, a particulate fraction isolated from bovine spleen was used as the enzyme source.  Among the synthesized analogs, 8-thiobutyladenosine 5'-triphosphate (8-BuS-ATP) was found to be the most effective nonhydrolyzable competitive inhibitor, with an estd. Ki of 10 μM.  This nonhydrolyzable analog did not exert any P2X-receptor-mediated effect on endothelium-denuded blood vessels, from the guinea pig mesenteric bed.  In agreement with this observation, infusion of the analog did not cause any significant blood pressure variations of the precontracted vessel.  Because in previous studies on isolated turkey erythrocytes and rat astrocytes 8-BuS-ATP was not able to trigger any P2Y1-receptor-mediated effect, it therefore appears that this NTPDase inhibitor does not interfere with purinergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Em1RrMAf77Vg90H21EOLACvtfcHk0lieSEn8rKcNSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVCqurc%253D&md5=b57dfc2d3849854d766cdc0838849d1d</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm000020b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000020b%26sid%3Dliteratum%253Aachs%26aulast%3DGendron%26aufirst%3DF.%2BP.%26aulast%3DHalbfinger%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DDuval%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Orleans-Juste%26aufirst%3DP.%26aulast%3DBeaudoin%26aufirst%3DA.%2BR.%26atitle%3DNovel%2520inhibitors%2520of%2520nucleoside%2520triphosphate%2520diphosphohydrolases%253A%2520chemical%2520synthesis%2520and%2520biochemical%2520and%2520pharmacological%2520characterizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2239%26epage%3D2247%26doi%3D10.1021%2Fjm000020b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillerman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munkonda, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosseau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Satué, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Orléans-Juste, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Künzli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">8-BuS -ATP Derivatives as specific NTPD ase1 inhibitors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1111/bph.12135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1111%2Fbph.12135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=23425137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFaksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=179-196&author=J.+Leckaauthor=I.+Gillermanauthor=M.+Faustherauthor=M.+Salemauthor=M.+N.+Munkondaauthor=J.-P.+Brosseauauthor=C.+Cadotauthor=M.+Mart%C3%ADn-Satu%C3%A9author=P.+d%E2%80%99Orl%C3%A9ans-Justeauthor=E.+Rousseauauthor=D.+Poirierauthor=B.+K%C3%BCnzliauthor=B.+Fischerauthor=J.+S%C3%A9vigny&title=8-BuS+-ATP+Derivatives+as+specific+NTPD+ase1+inhibitors&doi=10.1111%2Fbph.12135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">8-BuS-ATP derivatives as specific NTPDase1 inhibitors</span></div><div class="casAuthors">Lecka, Joanna; Gillerman, Irina; Fausther, Michel; Salem, Mabrouka; Munkonda, Mercedes N.; Brosseau, Jean-Philippe; Cadot, Christine; Martin-Satue, Mireia; d'Orleans-Juste, Pedro; Rousseau, Eric; Poirier, Donald; Kunzli, Beat; Fischer, Bilha; Sevigny, Jean</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-196</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Ectonucleotidases control extracellular nucleotide levels and consequently, their (patho)physiol. responses.  Among these enzymes, nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), -2, -3 and -8 are the major ectonucleotidases responsible for nucleotide hydrolysis at the cell surface under physiol. conditions, and NTPDase1 is predominantly located at the surface of vascular endothelial cells and leukocytes.  Efficacious inhibitors of NTPDase1 are required to modulate responses induced by nucleotides in a no. of pathol. situations such as thrombosis, inflammation and cancer.  Exptl. Approach Here, we present the synthesis and enzymic characterization of five 8-BuS-adenine nucleotide derivs. as potent and selective inhibitors of NTPDase1.  Key Results The compds. 8-BuS-AMP, 8-BuS-ADP and 8-BuS-ATP inhibit recombinant human and mouse NTPDase1 by mixed type inhibition, predominantly competitive with Ki values <1 μM.  In contrast to 8-BuS-ATP which could be hydrolyzed by other NTPDases, the other BuS derivs. were resistant to hydrolysis by either NTPDase1, -2, -3 or -8.  8-BuS-AMP and 8-BuS-ADP were the most potent and selective inhibitors of NTPDase1 expressed in human umbilical vein endothelial cells as well as in situ in human and mouse tissues.  As expected, as a result of their inhibition of recombinant human NTPDase1, 8-BuS-AMP and 8-BuS-ADP impaired the ability of this enzyme to block platelet aggregation.  Importantly, neither of these two inhibitors triggered platelet aggregation nor prevented ADP-induced platelet aggregation, in support of their inactivity towards P2Y1 and P2Y12 receptors.  Conclusions and Implications The 8-Bus-AMP and 8-BuS-ADP have therefore potential to serve as drugs for the treatment of pathologies regulated by NTPDase1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4OP6oKkkdv7Vg90H21EOLACvtfcHk0licTO8hGY5xaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFaksrs%253D&md5=b6863b877062e1ab24248949a5c765bd</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fbph.12135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12135%26sid%3Dliteratum%253Aachs%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DGillerman%26aufirst%3DI.%26aulast%3DFausther%26aufirst%3DM.%26aulast%3DSalem%26aufirst%3DM.%26aulast%3DMunkonda%26aufirst%3DM.%2BN.%26aulast%3DBrosseau%26aufirst%3DJ.-P.%26aulast%3DCadot%26aufirst%3DC.%26aulast%3DMart%25C3%25ADn-Satu%25C3%25A9%26aufirst%3DM.%26aulast%3Dd%25E2%2580%2599Orl%25C3%25A9ans-Juste%26aufirst%3DP.%26aulast%3DRousseau%26aufirst%3DE.%26aulast%3DPoirier%26aufirst%3DD.%26aulast%3DK%25C3%25BCnzli%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3D8-BuS%2520-ATP%2520Derivatives%2520as%2520specific%2520NTPD%2520ase1%2520inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D179%26epage%3D196%26doi%3D10.1111%2Fbph.12135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munkonda, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffenstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lévesque, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legendre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, É. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1524</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bcp.2007.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17727821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1524-1534&author=M.+N.+Munkondaauthor=G.+Kauffensteinauthor=F.+Kukulskiauthor=S.+A.+L%C3%A9vesqueauthor=C.+Legendreauthor=J.+Pelletierauthor=%C3%89.+G.+Lavoieauthor=J.+Leckaauthor=J.+S%C3%A9vigny&title=Inhibition+of+human+and+mouse+plasma+membrane+bound+NTPDases+by+P2+receptor+antagonists&doi=10.1016%2Fj.bcp.2007.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists</span></div><div class="casAuthors">Munkonda, Mercedes N.; Kauffenstein, Gilles; Kukulski, Filip; Levesque, Sebastien A.; Legendre, Charlene; Pelletier, Julie; Lavoie, Elise G.; Lecka, Joanna; Sevigny, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1524-1534</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The plasma membrane bound nucleoside triphosphate diphosphohydrolase (NTPDase)-1, 2, 3 and 8 are major ectonucleotidases that modulate P2 receptor signaling by controlling nucleotides' concns. at the cell surface.  In this report, we systematically evaluated the effect of the commonly used P2 receptor antagonists reactive blue 2, suramin, NF279, NF449 and MRS2179, on recombinant human and mouse NTPDase1, 2, 3 and 8.  Enzymic reactions were performed in a Tris/calcium buffer, commonly used to evaluate NTPDase activity, and in a more physiol. Ringer modified buffer.  Although there were some minor variations, there were no major changes either in the enzymic activity or in the profile of NTPDase inhibition between the two buffers.  Except for MRS2179, all other antagonists significantly inhibited these ecto-ATPases; NTPDase3 being the most sensitive to inhibition and NTPDase8 the most resistant.  Estd. IC50 showed that human NTPDases were generally more sensitive to the P2 receptor antagonists tested than the corresponding mouse isoforms.  NF279 and reactive blue 2 were the most potent inhibitors of NTPDases which almost completely abrogated their activity at the concn. of 100 μM.  In conclusion, reactive blue 2, suramin, NF279 and NF449, at the concns. commonly used to antagonize P2 receptors, inhibit the four major ecto-ATPases.  This information may reveal useful for the interpretation of some pharmacol. studies of P2 receptors.  In addn., NF279 is a most potent non-selective NTPDase inhibitor.  Although P2 receptor antagonists do not display a strict selectivity toward NTPDases, their IC50 values may help to discriminate some of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUZK81rygd4rVg90H21EOLACvtfcHk0licTO8hGY5xaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLbO&md5=0c1f2bd829d1ff3197de121f8ee46752</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DMunkonda%26aufirst%3DM.%2BN.%26aulast%3DKauffenstein%26aufirst%3DG.%26aulast%3DKukulski%26aufirst%3DF.%26aulast%3DL%25C3%25A9vesque%26aufirst%3DS.%2BA.%26aulast%3DLegendre%26aufirst%3DC.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DLavoie%26aufirst%3D%25C3%2589.%2BG.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520human%2520and%2520mouse%2520plasma%2520membrane%2520bound%2520NTPDases%2520by%2520P2%2520receptor%2520antagonists%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1524%26epage%3D1534%26doi%3D10.1016%2Fj.bcp.2007.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vollmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1007/s11302-005-8076-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs11302-005-8076-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18404519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFOjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=349-358&author=J.+Iqbalauthor=P.+Vollmayerauthor=N.+Braunauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=A+capillary+electrophoresis+method+for+the+characterization+of+ecto-nucleoside+triphosphate+diphosphohydrolases+%28NTPDases%29+and+the+analysis+of+inhibitors+by+in-capillary+enzymatic+microreaction&doi=10.1007%2Fs11302-005-8076-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction</span></div><div class="casAuthors">Iqbal, Jamshed; Vollmayer, Petra; Braun, Norbert; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-358</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A capillary electrophoresis (CE) method for the characterization of recombinant NTPDase 1, 2, and 3, and for assaying NTPDase inhibitors has been developed performing the enzymic reaction within the capillary.  After hydrodynamic injection of plugs of substrate soln. with or without inhibitor in reaction buffer, followed by a suspension of an enzyme-contg. membrane prepn., and subsequent injection of another plug of substrate soln. with or without inhibitor, the reaction took place close to the capillary inlet.  After 5 min, the electrophoretic sepn. of the reaction products was initiated by applying a const. current of -60 μA.  The method employing a polyacrylamide-coated capillary and reverse polarity mode provided baseline resoln. of substrates and products within a short sepn. time of less than 7 min.  A 50 mM phosphate buffer (pH 6.5) was used for the sepns. and the products were detected by their UV absorbance at 210 nm.  The Michaelis-Menten consts. (Km) for the recombinant rat NTPDases 1, 2, and 3 obtained with this method were consistent with previously reported data.  The inhibition studies revealed pronounced differences in the potency of reactive blue 2, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), suramin, and N6-diethyl-β,γ-dibromomethylene-ATP (ARL67156) towards the NTPDase isoforms.  Notably, ARL67156 does not inhibit all NTPDases, having only a minor inhibitory effect on NTPDase2.  Dipyridamole is not an inhibitor of the NTPDase isoforms investigated.  The new method is fast and accurate, it requires only tiny amts. of material (nanoliter scale), no sample pretreatment and can be fully automated; thus it is clearly superior to the current std. methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo19nvLBa11GbVg90H21EOLACvtfcHk0licTO8hGY5xaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFOjsbc%253D&md5=6f3f0cd7abad786606c0da956c5d2597</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs11302-005-8076-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-005-8076-x%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DVollmayer%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DN.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DA%2520capillary%2520electrophoresis%2520method%2520for%2520the%2520characterization%2520of%2520ecto-nucleoside%2520triphosphate%2520diphosphohydrolases%2520%2528NTPDases%2529%2520and%2520the%2520analysis%2520of%2520inhibitors%2520by%2520in-capillary%2520enzymatic%2520microreaction%26jtitle%3DPurinergic%2520Signalling%26date%3D2005%26volume%3D1%26spage%3D349%26epage%3D358%26doi%3D10.1007%2Fs11302-005-8076-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1007/s11302-008-9103-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2Fs11302-008-9103-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18528783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=91-106&author=Y.+Baqiauthor=S.+Weylerauthor=J.+Iqbalauthor=H.+Zimmermannauthor=C.+E.+M%C3%BCller&title=Structure-activity+relationships+of+anthraquinone+derivatives+derived+from+bromaminic+acid+as+inhibitors+of+ectonucleoside+triphosphate+diphosphohydrolases+%28E-NTPDases%29&doi=10.1007%2Fs11302-008-9103-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)</span></div><div class="casAuthors">Baqi, Younis; Weyler, Stefanie; Iqbal, Jamshed; Zimmermann, Herbert; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-106</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Reactive blue 2 (RB-2) had been characterized as a relatively potent ectonucleoside triphosphate diphosphohydrolase (E-NTPDase) inhibitor with some selectivity for NTPDase3.  In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivs. and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in prepns. of rat NTPDase1, 2, and 3 using a capillary electrophoresis assay.  Several 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinone derivs. inhibited E-NTPDases in a concn.-dependent manner.  The 2-sulfonate group was found to be required for inhibitory activity, since 2-methyl-substituted derivs. were inactive. 1-Amino-2-sulfo-4-p-chloroanilinoanthraquinone (18) was identified as a nonselective competitive blocker of NTPDases1, 2, and 3 (Ki 16-18 μM), while 1-amino-2-sulfo-4-(2-naphthylamino)anthraquinone (21) was a potent inhibitor with preference for NTPDase1 (Ki 0.328 μM) and NTPDase3 (Ki 2.22 μM).  Its isomer, 1-amino-2-sulfo-4-(1-naphthylamino)anthraquinone (20), was a potent and selective inhibitor of rat NTPDase3 (Ki 1.5 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkH7uD3ZbHUrVg90H21EOLACvtfcHk0lh5ViWO29mmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCqsrg%253D&md5=de25fc453383eb25a63a101654568c91</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1007%2Fs11302-008-9103-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-008-9103-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DWeyler%26aufirst%3DS.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DStructure-activity%2520relationships%2520of%2520anthraquinone%2520derivatives%2520derived%2520from%2520bromaminic%2520acid%2520as%2520inhibitors%2520of%2520ectonucleoside%2520triphosphate%2520diphosphohydrolases%2520%2528E-NTPDases%2529%26jtitle%3DPurinergic%2520Signalling%26date%3D2009%26volume%3D5%26spage%3D91%26epage%3D106%26doi%3D10.1007%2Fs11302-008-9103-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Röllich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, H.</span></span> <span> </span><span class="NLM_article-title">Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5947</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.bmcl.2006.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=16997558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5943-5947&author=C.+E.+M%C3%BCllerauthor=J.+Iqbalauthor=Y.+Baqiauthor=H.+Zimmermannauthor=A.+R%C3%B6llichauthor=H.+Stephan&title=Polyoxometalates%E2%80%94a+new+class+of+potent+ecto-nucleoside+triphosphate+diphosphohydrolase+%28NTPDase%29+inhibitors&doi=10.1016%2Fj.bmcl.2006.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors</span></div><div class="casAuthors">Mueller, Christa E.; Iqbal, Jamshed; Baqi, Younis; Zimmermann, Herbert; Roellich, Anita; Stephan, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5943-5947</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Polyoxotungstates were identified as potent inhibitors of NTPDases1, 2, and 3.  The most potent compd. was K6H2[TiW11CoO40], exhibiting Ki values of 0.140 μM (NTPDase1), 0.910 μM (NTPDase2), and 0.563 μM (NTPDase3).  One of the compds., (NH4)18[NaSb9W21O86], was selective for NTPDases2 and 3 vs. NTPDase1.  NTPDase inhibition might contribute to the described biol. effects of polyoxometalates, including their anti-cancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrohfjAgJjdRLVg90H21EOLACvtfcHk0lh5ViWO29mmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2jsrjN&md5=a33eed1259670c2ce562e53a199c0530</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DZimmermann%26aufirst%3DH.%26aulast%3DR%25C3%25B6llich%26aufirst%3DA.%26aulast%3DStephan%26aufirst%3DH.%26atitle%3DPolyoxometalates%25E2%2580%2594a%2520new%2520class%2520of%2520potent%2520ecto-nucleoside%2520triphosphate%2520diphosphohydrolase%2520%2528NTPDase%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5943%26epage%3D5947%26doi%3D10.1016%2Fj.bmcl.2006.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelbronn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laucher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">CD39/Ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1784</span>– <span class="NLM_lpage">1794</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.690180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1161%2FCIRCULATIONAHA.107.690180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17909107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A280%3ADC%252BD2snhtlansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=1784-1794&author=D.+K%C3%B6hlerauthor=T.+Eckleauthor=M.+Faigleauthor=A.+Grenzauthor=M.+Mittelbronnauthor=S.+Laucherauthor=M.+L.+Hartauthor=S.+C.+Robsonauthor=C.+E.+M%C3%BCllerauthor=H.+K.+Eltzschig&title=CD39%2FEctonucleoside+triphosphate+diphosphohydrolase+1+provides+myocardial+protection+during+cardiac+ischemia%2Freperfusion+injury&doi=10.1161%2FCIRCULATIONAHA.107.690180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury</span></div><div class="casAuthors">Kohler David; Eckle Tobias; Faigle Marion; Grenz Almut; Mittelbronn Michel; Laucher Stefanie; Hart Melanie L; Robson Simon C; Muller Christa E; Eltzschig Holger K</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1784-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Extracellular adenosine, generated from extracellular nucleotides via ectonucleotidases, binds to specific receptors and provides cardioprotection from ischemia and reperfusion.  In the present study, we studied ecto-enzymatic ATP/ADP-phosphohydrolysis by select members of the ectonucleoside triphosphate diphosphohydrolase (E-NTPDase) family during myocardial ischemia.  METHODS AND RESULTS:  As a first step, we used a murine model of myocardial ischemia and in situ preconditioning and performed pharmacological studies with polyoxometalate 1, a potent E-NTPDase inhibitor (Na6[H2W12O40]).  Polyoxometalate 1 treatment increased infarct sizes and abolished beneficial effects of preconditioning.  To define relative contributions of distinct E-NTPDases, we investigated transcriptional responses of E-NTPDases 1 to 3 and 8 to preconditioning.  We noted robust and selective induction of E-NTPDase 1 (CD39) transcript and protein.  Histological analysis of preconditioned myocardium localized CD39 induction to endothelia and myocytes.  Cd39-/- mice exhibited larger infarct sizes with ischemia (cd39+/+ 43.0+/-3.3% versus cd39-/- 52%+/-1.8; P<0.05), and cardioprotection was abrogated by preconditioning (cd39+/+ 13.3%+/-1.5 versus cd39-/- 50.5%+/-2.8; P<0.01).  Heightened levels of injury after myocardial ischemia and negligible preconditioning benefits in cd39-/- mice were corrected by infusion of the metabolic product (AMP) or apyrase.  Moreover, apyrase treatment of wild-type mice resulted in 43+/-4.2% infarct size reduction (P<0.01).  CONCLUSIONS:  Taken together, these studies reveal E-NTPDase 1 in cardioprotection and suggest apyrase in the treatment of myocardial ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpWEBsFPX84EHdcurJClFcfW6udTcc2eZPh7tyQ80Xnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snhtlansg%253D%253D&md5=7441c74ed6e1d3c9179763c746e61650</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.690180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.690180%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DD.%26aulast%3DEckle%26aufirst%3DT.%26aulast%3DFaigle%26aufirst%3DM.%26aulast%3DGrenz%26aufirst%3DA.%26aulast%3DMittelbronn%26aufirst%3DM.%26aulast%3DLaucher%26aufirst%3DS.%26aulast%3DHart%26aufirst%3DM.%2BL.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DCD39%252FEctonucleoside%2520triphosphate%2520diphosphohydrolase%25201%2520provides%2520myocardial%2520protection%2520during%2520cardiac%2520ischemia%252Freperfusion%2520injury%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3D1784%26epage%3D1794%26doi%3D10.1161%2FCIRCULATIONAHA.107.690180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase1 (NTPDase1, CD39)</span>. <i>Analyst</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">5417</span>– <span class="NLM_lpage">5430</span>, <span class="refDoi"> DOI: 10.1039/C8AN01108G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1039%2FC8AN01108G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=30303204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVejtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=5417-5430&author=S.-Y.+Leeauthor=X.+Luoauthor=V.+Namasivayamauthor=J.+Geissauthor=S.+Mirzaauthor=J.+Pelletierauthor=H.+Stephanauthor=J.+S%C3%A9vignyauthor=C.+E.+M%C3%BCller&title=Development+of+a+selective+and+highly+sensitive+fluorescence+assay+for+nucleoside+triphosphate+diphosphohydrolase1+%28NTPDase1%2C+CD39%29&doi=10.1039%2FC8AN01108G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase 1 (NTPDase1, CD39)</span></div><div class="casAuthors">Lee, Sang-Yong; Luo, Xihuan; Namasivayam, Vigneshwaran; Geiss, Jennifer; Mirza, Salahuddin; Pelletier, Julie; Stephan, Holger; Sevigny, Jean; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analyst (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5417-5430</span>CODEN:
                <span class="NLM_cas:coden">ANALAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-2654</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ecto-nucleoside triphosphate diphosphohydrolase 1 (NTPDase1, CD39) is a major ectonucleotidase that hydrolyzes proinflammatory ATP via ADP to AMP, which is subsequently converted by ecto-5'-nucleotidase (CD73) to immunosuppressive adenosine.  Activation of CD39 has potential for treating inflammatory diseases, while inhibition was suggested as a novel strategy for the immunotherapy of cancer.  In the present study, we developed a selective and highly sensitive capillary electrophoresis (CE) assay using a novel fluorescent CD39 substrate, a fluorescein-labeled ATP (PSB-170621A) that is converted to its AMP deriv.  To accelerate the assays, a two-directional (forward and reverse) CE system was implemented using 96-well plates, which is suitable for the screening of compd. libraries (Z'-factor: 0.7).  The detection limits for the forward and reverse operation were 11.7 and 2.00 pM, resp., indicating a large enhancement in sensitivity as compared to previous methods (e.g. malachite-green assay: 1 000 000-fold, CE-UV assay: 500 000-fold, fluorescence polarization immunoassay: 12 500-fold).  Enzyme kinetic studies at human CD39 revealed a Km value of 19.6 μM, and a kcat value of 119 × 10-3 s-1 for PSB-170621A, which shows similar substrate properties as ATP (11.4 μM and 82.5 × 10-3 s-1).  The compd. displayed similar properties at rat and mouse CD39.  Subsequent docking studies into a homol. model of human CD39 revealed a hydrophobic pocket that accommodates the fluorescein tag.  PSB-170621A was found to be preferably hydrolyzed by CD39 as compared to other ectonucleotidases.  The new assay was validated by performing inhibition assays with several std. CD39 inhibitors yielding results that were consonant with data using the natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomBc_NvcVDVLVg90H21EOLACvtfcHk0lhN6dNCiE9w4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVejtbnE&md5=2c408fc77cca922c2595e9aed4a1773d</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1039%2FC8AN01108G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8AN01108G%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DGeiss%26aufirst%3DJ.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DStephan%26aufirst%3DH.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDevelopment%2520of%2520a%2520selective%2520and%2520highly%2520sensitive%2520fluorescence%2520assay%2520for%2520nucleoside%2520triphosphate%2520diphosphohydrolase1%2520%2528NTPDase1%252C%2520CD39%2529%26jtitle%3DAnalyst%26date%3D2018%26volume%3D143%26spage%3D5417%26epage%3D5430%26doi%3D10.1039%2FC8AN01108G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baqi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sévigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity</span>. <i>Analyst</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1039/C4AN01694G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1039%2FC4AN01694G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=25372046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOrsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2015&pages=140-148&author=A.+Fieneauthor=Y.+Baqiauthor=J.+Leckaauthor=J.+S%C3%A9vignyauthor=C.+E.+M%C3%BCller&title=Fluorescence+polarization+immunoassays+for+monitoring+nucleoside+triphosphate+diphosphohydrolase+%28NTPDase%29+activity&doi=10.1039%2FC4AN01694G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity</span></div><div class="casAuthors">Fiene, Amelie; Baqi, Younis; Lecka, Joanna; Sevigny, Jean; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Analyst (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">ANALAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-2654</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The following members of the ecto-nucleoside triphosphate diphosphohydrolase family, NTPDase1 (CD39), NTPDase-2, -3, and -8, play an important role in purinergic signal transduction by regulating extracellular nucleotide levels.  Potent and selective NTPDase inhibitors are required as pharmacol. tools and have potential as novel drugs, e.g. for anti-cancer and anti-bacterial therapy.  We have developed fast and sensitive NTPDase fluorescence polarization (FP) immunoassays using the natural substrates (ATP or ADP).  During the NTPDase1-catalyzed reaction, the substrate is dephosphorylated to ADP which is further dephosphorylated yielding AMP as the final product (by NTPDase1).  NTPDase3 and -8 yield AMP and ADP, while NTPDase2 results mainly in the formation of ADP.  Direct quantification of the resp. product, AMP or ADP, is achieved by displacement of an appropriate fluorescent tracer nucleotide from a specific antibody leading to a change in fluorescence polarization.  The assays are highly sensitive and can be performed with low substrate concns. (20 μM ATP or 10 μM ADP) below the Km values of NTPDases, which simplifies the identification of novel competitive inhibitors.  Optimized antibody and enzyme concns. allow the reproducible detection of 2 μM ADP and 1 μM AMP (at 10% substrate conversion).  Validation of the assays yielded excellent Z'-factors greater than 0.70 for all investigated NTPDase subtypes indicating high robustness of the anal. method.  Furthermore, we tested a std. inhibitor and performed a first exemplary screening campaign with a library consisting of >400 compds. (Z'-factor: 0.87, hit rate 0.5%).  Thereby we demonstrated the suitability of the FP assay for IC50 value detn. and high-throughput screening in a 384-well format.  The new FP assays were shown to be superior to current std. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA2NbAtEnIG7Vg90H21EOLACvtfcHk0ljiivNt_M2lNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOrsr3F&md5=ddae00c025edd9875aacaca2c26c1b8f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1039%2FC4AN01694G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4AN01694G%26sid%3Dliteratum%253Aachs%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DBaqi%26aufirst%3DY.%26aulast%3DLecka%26aufirst%3DJ.%26aulast%3DS%25C3%25A9vigny%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DFluorescence%2520polarization%2520immunoassays%2520for%2520monitoring%2520nucleoside%2520triphosphate%2520diphosphohydrolase%2520%2528NTPDase%2529%2520activity%26jtitle%3DAnalyst%26date%3D2015%26volume%3D140%26spage%3D140%26epage%3D148%26doi%3D10.1039%2FC4AN01694G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staeben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleman-Leyer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermeyer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowery, R. G.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a Transcreener assay for detection of AMP- and GMP-producing enzymes</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1089/adt.2009.0254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1089%2Fadt.2009.0254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVCgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=339-350&author=M.+Staebenauthor=K.+M.+Kleman-Leyerauthor=A.+L.+Koppauthor=T.+A.+Westermeyerauthor=R.+G.+Lowery&title=Development+and+validation+of+a+Transcreener+assay+for+detection+of+AMP-+and+GMP-producing+enzymes&doi=10.1089%2Fadt.2009.0254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Validation of a Transcreener Assay for Detection of AMP- and GMP-Producing Enzymes</span></div><div class="casAuthors">Staeben, Matt; Kleman-Leyer, Karen M.; Kopp, Andrew L.; Westermeyer, Thane A.; Lowery, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">339-350</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Screening of AMP- and GMP-producing enzymes such as phosphodiesterases (PDEs), ligases, and synthetases would be simplified by the ability to directly detect unmodified nucleoside monophosphates.  To address this need, polyclonal and monoclonal antibodies were developed that recognize AMP and GMP with nanomolar sensitivity and high selectivity vs. the corresponding triphosphate and 3',5'-cyclic monophosphate nucleotides that serve as substrates for many enzymes in these classes.  One of these antibodies was used to develop a Transcreener AMP/GMP assay with a far red fluorescence polarization (FP) readout.  This polyclonal antibody exhibited extremely high selectivity, with IC50 ratios of 6,000 for ATP/AMP, 3,810 for cAMP/AMP, and 6,970 for cGMP/GMP.  Std. curves mimicking enzymic conversion of cAMP, cGMP, and ATP to the corresponding monophosphates yielded Z' values of > 0.85 at 10% conversion.  The assay reagents were shown to be stable for 24 h at room temp., both before and after dispensing.  The Transcreener AMP/GMP FP assay was used for enzymic detection of cGMP- and cAMP-dependent PDEs 4A1A, 3A, and 9A2 and ATP-dependent ligases, acetyl CoA synthetase, and ubiquitin-activating enzyme (UBE1).  Shifts of >100 mP were obsd. in the linear part of the progress curves for all enzymes tested, and the PDE isoforms exhibited the expected substrate and inhibitor selectivity.  These studies demonstrate that direct immunodetection of AMP and GMP is a flexible, robust enzyme assay method for diverse AMP- and GMP-producing enzymes.  Moreover, it eliminates many of the shortcomings of other methods including the need for fluorescently labeled substrates, the low signal:background inherent in substrate depletion assays, and the potential for interference with coupling enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_VEhlnufMKbVg90H21EOLACvtfcHk0ljiivNt_M2lNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVCgtLw%253D&md5=991febe0f2d58c1c5e8610ffba2b52ed</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1089%2Fadt.2009.0254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2009.0254%26sid%3Dliteratum%253Aachs%26aulast%3DStaeben%26aufirst%3DM.%26aulast%3DKleman-Leyer%26aufirst%3DK.%2BM.%26aulast%3DKopp%26aufirst%3DA.%2BL.%26aulast%3DWestermeyer%26aufirst%3DT.%2BA.%26aulast%3DLowery%26aufirst%3DR.%2BG.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520Transcreener%2520assay%2520for%2520detection%2520of%2520AMP-%2520and%2520GMP-producing%2520enzymes%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26spage%3D339%26epage%3D350%26doi%3D10.1089%2Fadt.2009.0254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowery, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening assays for cancer immunotherapy targets: ectonucleotidases CD39 and CD73</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1177/2472555219893632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1177%2F2472555219893632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=31868071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1OktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=320-326&author=M.+Kumarauthor=R.+Loweryauthor=V.+Kumar&title=High-throughput+screening+assays+for+cancer+immunotherapy+targets%3A+ectonucleotidases+CD39+and+CD73&doi=10.1177%2F2472555219893632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73</span></div><div class="casAuthors">Kumar, Meera; Lowery, Robert; Kumar, Vaishnav</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-326</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Prodn. of adenosine in the extracellular tumor microenvironment elicits strong immunosuppression and is assocd. with tumor progression.  Thus, targeting adenosine-generating ectonucleotidases is a potential strategy to stimulate and prolong antitumor immunity.  Because the reaction products of ectonucleotidases differ by a single phosphate group, selective detection in an assay format that is compatible with high-throughput screening (HTS) has been elusive.  We report the development of biochem. assays capable of measuring the activity of ectonucleoside triphosphate diphosphohydrolase-1 (ENTPD1; also known as CD39) and ecto-5'-nucleotidase (CD73).  Both assays leverage the Transcreener HTS Assay platform, which facilitates selective immunodetection of nucleotides with homogenous fluorescent readouts, fluorescence polarization or time-resolved fluorescence energy transfer.  The Transcreener AMP2 Assay was used to measure CD39 activity, allowing detection of adenosine monophosphate (AMP) prodn. (Z' > 0.6) with subnanomolar amts. of CD39, allowing IC50 detn. for tool compds., consistent with previously reported values.  To detect the prodn. of adenosine by CD73, the Transcreener ADP2 Assay was coupled with adenosine kinase (AK); conversion of adenosine to AMP and ADP (ADP) by AK allows detection with ADP2 antibody.  The Transcreener AMP2 Assay was used to screen a 1280 Library of Pharmacol. Active Compds. (LOPAC) library and a 1600-compd. subset of a ChemBridge diversity library for CD39 inhibitors, allowing the identification of nine and eight candidate compds. from each library, resp.  The Transcreener ADP2 Assay was used to screen 1600 compds. from the ChemBridge diversity library for CD73 inhibitors and identified 14 potential candidates.  HTS-compatible assays for ectonucleotidase activity may allow identification of purinergic signaling pathway inhibitors important for tumor-specific immune responses during tumor pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMBtJQe_seGbVg90H21EOLACvtfcHk0ljiivNt_M2lNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1OktLY%253D&md5=848ab20d116fad82275e47d6974a4b9e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1177%2F2472555219893632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555219893632%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DLowery%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DV.%26atitle%3DHigh-throughput%2520screening%2520assays%2520for%2520cancer%2520immunotherapy%2520targets%253A%2520ectonucleotidases%2520CD39%2520and%2520CD73%26jtitle%3DSLAS%2520Discovery%26date%3D2020%26volume%3D25%26spage%3D320%26epage%3D326%26doi%3D10.1177%2F2472555219893632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C<sub>6</sub> glioma cells and RAW 264.7 macrophages</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1628</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1996.tb16082.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1111%2Fj.1476-5381.1996.tb16082.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=8982511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK2sXktlSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1628-1634&author=B.+C.+Chenauthor=C.+M.+Leeauthor=W.+W.+Lin&title=Inhibition+of+ecto-ATPase+by+PPADS%2C+suramin+and+reactive+blue+in+endothelial+cells%2C+C6+glioma+cells+and+RAW+264.7+macrophages&doi=10.1111%2Fj.1476-5381.1996.tb16082.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages</span></div><div class="casAuthors">Chen, Bin C.; Lee, Chii-M.; Lin, Wan-W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1628-1634</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Previous studies have shown that bovine pulmonary artery endothelium (CPAE) has P2Y and P2U purinoceptors, rat C6 glioma cells have P2U purinoceptors and mouse RAW 264.7 cells have pyrimidinoceptors, all of which are coupled to phosphoinositide specific phospholipase C (PI-PLC).  The dual actions of PPADS, suramin and reactive blue as antagonists of receptor subtypes and ecto-ATPase inhibitors were studied in these three cell types.  In CPAE, suramin, at 3-100 μM, competitively inhibited the PI responses induced by 2MeSATP and UTP, with pA2 values of 5.5±0.3 and 4.4±0.4, resp.  Reactive blue, at 1-3 μM, produced shifts to the right of the 2MeSATP and UTP curves, but no further right shift at 10 μM.  PPADS, at 10 μM, caused a 3 fold right shift of the 2MeSATP curve, but no further shift at concns. up to 100 μM.  In contrast, a dose-dependent shift to the left of the UTP curve and a weak inhibition of the ATP response were seen with PPADS.  In RAW 264.7 cells, suramin and reactive blue, but not PPADS, competitively inhibited the UTP response, with pA2 values of 4.8±0.5 and 5.8±0.7, resp.  In C6 glioma cells, although suramin and reactive blue inhibited the ATP response, a potentiation effect on ATP and UTP responses was seen with PPADS.  The ecto-ATPase inhibitory activity of these three receptor antagonists were detd.  All three inhibited ecto-ATPase present in CPAE, C6 and RAW 264.7 cells, with IC50 values of 4, 4.8 and 4.7 for PPADS, 4, 4.4 and » 4 for suramin, and 4.5, 4.7, 4.7 for reactive blue.  This study indicates that PPADS, suramin and reactive blue are ecto-ATPase inhibitors.  This property, combined with their antagonistic selectivity for receptor subtypes, can result in inhibition of, potentiation of, or lack of effect on agonist-mediated PI responses.  Reactive blue is a more potent antagonist than suramin on P2Y, P2U and pyrimidinoceptors, and PPADS is a weak antagonist for P2Y receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmeBK55GGeD7Vg90H21EOLACvtfcHk0lir-6cZPX4ofw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlSgtA%253D%253D&md5=e0524cb2f52f867a27f991999fd3e2f9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb16082.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb16082.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLin%26aufirst%3DW.%2BW.%26atitle%3DInhibition%2520of%2520ecto-ATPase%2520by%2520PPADS%252C%2520suramin%2520and%2520reactive%2520blue%2520in%2520endothelial%2520cells%252C%2520C6%2520glioma%2520cells%2520and%2520RAW%2520264.7%2520macrophages%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1628%26epage%3D1634%26doi%3D10.1111%2Fj.1476-5381.1996.tb16082.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieringa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalkanen, S.</span></span> <span> </span><span class="NLM_article-title">Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1096/fj.12-205658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1096%2Ffj.12-205658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=22637533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGrsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=3875-3883&author=G.+G.+Yegutkinauthor=B.+Wieringaauthor=S.+C.+Robsonauthor=S.+Jalkanen&title=Metabolism+of+circulating+ADP+in+the+bloodstream+is+mediated+via+integrated+actions+of+soluble+adenylate+kinase-1+and+NTPDase1%2FCD39+activities&doi=10.1096%2Ffj.12-205658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities</span></div><div class="casAuthors">Yegutkin, Gennady G.; Wieringa, Be; Robson, Simon C.; Jalkanen, Sirpa</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3875-3883, 10.1096/fj.12-205658</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Extracellular ATP and ADP trigger inflammatory, vasodilatatory, and prothrombotic signaling events in the vasculature, and their turnover is governed by networks of membrane-assocd. enzymes.  The contribution of sol. activities to intravascular nucleotide homeostasis remains controversial.  By using thin-layer chromatog. assays, we revealed transphosphorylation of [γ-32P]ATP and AMP by human and murine sera, which was progressively inhibited by specific adenylate kinase (AK) inhibitor Ap5A.  This phosphotransfer reaction was diminished markedly in serum from knockout mice lacking the major AK isoform, AK1, and in human serum immunodepleted of AK1.  We also showed that ∼75% ADP in cell-free serum is metabolized via reversible AK1 reaction 2ADP ↔ ATP + AMP.  The generated ATP and AMP are then metabolized through the coupled nucleotide pyrophosphatase/phosphodiesterase and 5'-nucleotidase/CD73 reactions, resp.  Constitutive presence of another nucleotide-converting enzyme, nucleoside triphosphate diphosphohydrolase-1 (NTPDase1, known as CD39), was ascertained by the relative deficiency of serum from CD39-null mice to dephosphorylate [3H]ADP and [γ-32P]ATP, and also by diminished [3H]ADP hydrolysis by human serum pretreated with NTPDase1 inhibitors, POM-1 and ARL-67156.  In summary, we have identified hitherto unrecognized sol. forms of AK1 and NTPDase1/CD39 that contribute in the active cycling between the principal platelet-recruiting agent ADP and other circulating nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-izNSxIoi7Vg90H21EOLACvtfcHk0lir-6cZPX4ofw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGrsrrI&md5=10573cb78cc275657e2c58b7c0d5b719</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-205658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-205658%26sid%3Dliteratum%253Aachs%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DWieringa%26aufirst%3DB.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DJalkanen%26aufirst%3DS.%26atitle%3DMetabolism%2520of%2520circulating%2520ADP%2520in%2520the%2520bloodstream%2520is%2520mediated%2520via%2520integrated%2520actions%2520of%2520soluble%2520adenylate%2520kinase-1%2520and%2520NTPDase1%252FCD39%2520activities%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D3875%26epage%3D3883%26doi%3D10.1096%2Ffj.12-205658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rücker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libermann, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerbini, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkis, J. J.</span></span> <span> </span><span class="NLM_article-title">E-NTPDases and ecto-5′-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2007.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.lfs.2007.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18201730" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=477-486&author=B.+R%C3%BCckerauthor=M.+E.+Almeidaauthor=T.+A.+Libermannauthor=L.+F.+Zerbiniauthor=M.+R.+Winkauthor=J.+J.+Sarkis&title=E-NTPDases+and+ecto-5%E2%80%B2-nucleotidase+expression+profile+in+rat+heart+left+ventricle+and+the+extracellular+nucleotide+hydrolysis+by+their+nerve+terminal+endings&doi=10.1016%2Fj.lfs.2007.12.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2007.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2007.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCcker%26aufirst%3DB.%26aulast%3DAlmeida%26aufirst%3DM.%2BE.%26aulast%3DLibermann%26aufirst%3DT.%2BA.%26aulast%3DZerbini%26aufirst%3DL.%2BF.%26aulast%3DWink%26aufirst%3DM.%2BR.%26aulast%3DSarkis%26aufirst%3DJ.%2BJ.%26atitle%3DE-NTPDases%2520and%2520ecto-5%25E2%2580%25B2-nucleotidase%2520expression%2520profile%2520in%2520rat%2520heart%2520left%2520ventricle%2520and%2520the%2520extracellular%2520nucleotide%2520hydrolysis%2520by%2520their%2520nerve%2520terminal%2520endings%26jtitle%3DLife%2520Sci.%26date%3D2008%26volume%3D82%26spage%3D477%26epage%3D486%26doi%3D10.1016%2Fj.lfs.2007.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittenburg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bültmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pause, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starke, K.</span></span> <span> </span><span class="NLM_article-title">P<sub>2</sub>-purinoceptor antagonists: II. Blockade of P<sub>2</sub>-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1007/BF00168441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2FBF00168441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=8897453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK28Xms1Chs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=1996&pages=491-497&author=H.+Wittenburgauthor=R.+B%C3%BCltmannauthor=B.+Pauseauthor=C.+Ganterauthor=G.+Kurzauthor=K.+Starke&title=P2-purinoceptor+antagonists%3A+II.+Blockade+of+P2-purinoceptor+subtypes+and+ecto-nucleotidases+by+compounds+related+to+Evans+blue+and+trypan+blue&doi=10.1007%2FBF00168441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">P2-purinoceptor antagonists. Part 2. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue</span></div><div class="casAuthors">Wittenburg, Henning; Bueltmann, Ralph; Pause, Birgit; Ganter, Claudia; Kurz, Gerhart; Starke, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-497</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Effects of Evans blue and 4 derivs. as well as of trypan blue and 4 derivs., mostly smaller fragments but 2 compds. with an addnl. ethylene bridge in the center of the mol., were studied on contractions of the rat vas deferens elicited by α,β-methylene ATP (α,β-MeATP; mediated by P2X-purinoceptors), relaxations of the carbachol-precontracted guinea-pig tenia coli elicited by adenosine 5'-O-(2-thiodiphosphate) (ADPβS; mediated by P2Y-purinoceptors), and the degrdn. of ATP by rats vas deferens tissue.  All compds. shifted the concn.-response curve of α,β-MeATP in the rat vas deferens to the right, and most compds. increased the max. of the curve.  Each member of the Evans blue series was similar in potency to the corresponding member of the trypan blue series.  Where three concns. were tested, the Arunlakshana-Schild regression was linear, and the slope did not differ from 1.  The apparent Kd values were between 0.8 and 385 μM.  In the guinea-pig tenia coli , only the members of the trypan blue group were relatively potent, shifting the concn.-response curve of ADPβS to the right in a surmountable manner.  In 2 of 3 cases where three concns. were tested, the slope of the Arunlakshana-Schild regression was lower than 1.  Apparent Kd values in the trypan blue group were between 5.2 and 324 μM.  The removal of ATP from the medium by vas deferens tissue was decreases mainly by the members of the Evans blue group, with IC25% values between 13 and 158 (in 1 case > 1000) μM.  The results indicate that the position of the sulfonate residues at the terminal naphthalene rings of these compds. hardly influences P2X-purinoceptor affinity but greatly influences P2Y affinity and ecto-nucleotidase blockade.  Among active compds., apparent purinoceptor affinity and ecto-nucleotidase blockade increase with the size of the mols. up to Evans blue and trypan blue themselves; introduction of a central ethylene bridge does not result in a further gain in potency.  NH01, the desmethyl deriv. of Evans blue, seems to be interesting because it is the compd. with the highest P2x- vs. P2Y-selectivity presently available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVOvM8HdudbVg90H21EOLACvtfcHk0lhSqtKKix4azQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xms1Chs70%253D&md5=d0529bbcb95032b28cd50d8c05fef791</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1007%2FBF00168441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00168441%26sid%3Dliteratum%253Aachs%26aulast%3DWittenburg%26aufirst%3DH.%26aulast%3DB%25C3%25BCltmann%26aufirst%3DR.%26aulast%3DPause%26aufirst%3DB.%26aulast%3DGanter%26aufirst%3DC.%26aulast%3DKurz%26aufirst%3DG.%26aulast%3DStarke%26aufirst%3DK.%26atitle%3DP2-purinoceptor%2520antagonists%253A%2520II.%2520Blockade%2520of%2520P2-purinoceptor%2520subtypes%2520and%2520ecto-nucleotidases%2520by%2520compounds%2520related%2520to%2520Evans%2520blue%2520and%2520trypan%2520blue%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1996%26volume%3D354%26spage%3D491%26epage%3D497%26doi%3D10.1007%2FBF00168441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuluc, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bültmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glänzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frahm, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starke, K.</span></span> <span> </span><span class="NLM_article-title">P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1007/PL00005144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1007%2FPL00005144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=9521483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK1cXks12gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1998&pages=111-120&author=F.+Tulucauthor=R.+B%C3%BCltmannauthor=M.+Gl%C3%A4nzelauthor=A.+W.+Frahmauthor=K.+Starke&title=P2-receptor+antagonists%3A+IV.+Blockade+of+P2-receptor+subtypes+and+ecto-nucleotidases+by+compounds+related+to+reactive+blue+2&doi=10.1007%2FPL00005144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2</span></div><div class="casAuthors">Tuluc, Florin; Bultmann, R.; Glanzel, Markus; Frahm, August Wilhelm; Starke, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-120</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Effects of reactive blue 2 and twelve structurally related compds. were studied on contractions of the rat vas deferens elicited by α,β-methylene ATP (α,β-MeATP; mediated by P2X-receptors), relaxations of the carbachol-precontracted guinea-pig tenia coli elicited by adenosine 5'-O-(2-thiodiphosphate) (ADPβS; mediated by P2Y-receptors), and the degrdn. of ATP by rat vas deferens tissue.  All compds., except acid blue 41 and acid blue 129 (at up to 100 M), shifted the concn.-response curve of α,β-MeATP in the rat vas deferens to the right.  Most increased, but Uniblue A greatly decreased, the max. of the curve.  In the case of Cibacron Blue 3GA and reactive blue 19, of which three concns. were tested, the Arunlakshana-Schild regression was linear, and the slope did not differ from unity.  The apparent Kd values of the effective substances ranged between 0.7 and 111 μM. Most compds. increased the contraction of the rat vas deferens elicited by high K+.  In the guinea-pig tenia coli, all compds., except uniblue A and reactive blue 19 (at up to 100 μM), shifted the concn.-response curve of ADPβS to the right in a parallel manner.  In the case of acid blue 129 and acid blue 80, of which three concns. were tested, the slope of the Arunlakshana-Schild regression did not differ from unity.  The apparent Kd values of the effective substances were between 0.7 and 69 μM. Most compds. also reduced the relaxation of the guinea-pig tenia coli elicited by noradrenaline.  The removal of ATP from the medium by vas deferens tissue was decreased only by reactive blue 2, cibacron blue 3GA, uniblue A and reactive blue 19, with IC25 values between 17 and 62 μM.The structure-activity relationships for P2X- and P2Y-receptor blockade in this series are strikingly dissimilar.  In reactive blue 2 and its isomers, for example, both the 1-amino-anthraquinone-2-sulfonate core and the 'side-chain' of the mol. are involved in P2X-receptor binding; P2Y-receptor affinity, in contrast, resides largely or totally in the anthraquinone core.  The most promising antagonists are uniblue A which is P2X- vs. P2Y-selective and acid blue 129 which is P2Y- vs. P2X-selective, both with few, if any, non-P2-receptor effects at concns. blocking the resp. P2-subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMc8GQTI_9T7Vg90H21EOLACvtfcHk0lhSqtKKix4azQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks12gug%253D%253D&md5=f127b1b20007e1edc1540c84bf6f7ad9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1007%2FPL00005144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005144%26sid%3Dliteratum%253Aachs%26aulast%3DTuluc%26aufirst%3DF.%26aulast%3DB%25C3%25BCltmann%26aufirst%3DR.%26aulast%3DGl%25C3%25A4nzel%26aufirst%3DM.%26aulast%3DFrahm%26aufirst%3DA.%2BW.%26aulast%3DStarke%26aufirst%3DK.%26atitle%3DP2-receptor%2520antagonists%253A%2520IV.%2520Blockade%2520of%2520P2-receptor%2520subtypes%2520and%2520ecto-nucleotidases%2520by%2520compounds%2520related%2520to%2520reactive%2520blue%25202%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1998%26volume%3D357%26spage%3D111%26epage%3D120%26doi%3D10.1007%2FPL00005144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stout, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirley, T. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of purified chicken gizzard smooth muscle ecto-ATPAse by P2 purinoceptor antagonists</span>. <i>Biochem. Mol. Biol. Int.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=7581008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADyaK28XjtlOit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=927-934&author=J.+G.+Stoutauthor=T.+L.+Kirley&title=Inhibition+of+purified+chicken+gizzard+smooth+muscle+ecto-ATPAse+by+P2+purinoceptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of purified chicken gizzard smooth muscle ecto-ATPase by P2 purinoceptor antagonists</span></div><div class="casAuthors">Stout, James G.; Kirley, Terence L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Molecular Biology International</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">BMBIES</span>;
        ISSN:<span class="NLM_cas:issn">1039-9712</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Several specific inhibitors of P2 purinergic receptors (purinoceptors) were evaluated for their ability to inhibit purified chicken gizzard cell membrane ecto-ATPase.  The P2 purinoceptor antagonists tested included suramin, triazine-based reactive textile dyes, and nonspecific total protein dyes.  All inhibited purified ecto-ATPase, with half maximal inhibition from ∼20 to 120 μM.  TLC-purified Cibacron Blue 3GA, also known as Reactive Blue 2, was demonstrated to inhibit immunopure ecto-ATPase with an IC50 of 44 μM.  Thus, for the 1st time, these compds. used to pharmacol. classify the subtypes of P2 purinoceptors are demonstrated to have direct inhibitory effects on purified ecto-ATPase.  Therefore, data generated using these compds. on purinoceptors must be interpreted in light of their direct inhibitory effect on the ecto-ATPase found in the same tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIfDHYD2CmpLVg90H21EOLACvtfcHk0lg6n1k4El5_ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtlOit7s%253D&md5=ef8aacdc858910be83333ff0ef7f0d33</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStout%26aufirst%3DJ.%2BG.%26aulast%3DKirley%26aufirst%3DT.%2BL.%26atitle%3DInhibition%2520of%2520purified%2520chicken%2520gizzard%2520smooth%2520muscle%2520ecto-ATPAse%2520by%2520P2%2520purinoceptor%2520antagonists%26jtitle%3DBiochem.%2520Mol.%2520Biol.%2520Int.%26date%3D1995%26volume%3D36%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span> <span> </span><span class="NLM_article-title">Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2863</span>– <span class="NLM_lpage">2873</span>, <span class="refDoi"> DOI: 10.1096/fj.06-7947com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1096%2Ffj.06-7947com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=17442731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVars77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2863-2873&author=A.+Grenzauthor=H.+Zhangauthor=M.+Hermesauthor=T.+Eckleauthor=K.+Klingelauthor=D.+Y.+Huangauthor=C.+E.+M%C3%BCllerauthor=S.+C.+Robsonauthor=H.+Osswaldauthor=H.+K.+Eltzschig&title=Contribution+of+E-NTPDase1+%28CD39%29+to+renal+protection+from+ischemia-reperfusion+injury&doi=10.1096%2Ffj.06-7947com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury</span></div><div class="casAuthors">Grenz, Almut; Zhang, Hua; Hermes, Marina; Eckle, Tobias; Klingel, Karin; Huang, Dan Yang; Mueller, Christa E.; Robson, Simon C.; Osswald, Hartmut; Eltzschig, Holger K.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2863-2873, 10.1096/fj.06-7947</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Previous studies showed increased extracellular nucleotides during renal ischemia-reperfusion.  While nucleotides represent the main source for extracellular adenosine and adenosine signaling contributes to renal protection from ischemia, we hypothesized a role for ecto-nucleoside-triphosphate-diphosphohydrolases (E-NTPDases) in renal protection.  We used a model of murine ischemia-reperfusion and in situ ischemic preconditioning (IP) via a hanging wt. system for atraumatic renal artery occlusion.  Initial studies with a nonspecific inhibitor of E-NTPDases (POM-1) revealed inhibition of renal protection by IP.  We next pursued transcriptional responses of E-NTPDases (E- NTPDase1-3, and 8) to renal IP, and found a robust and selective induction of E-NTPDase1/CD39 transcript and protein.  Moreover, based on clearance studies, plasma electrolytes, and renal tubular histol., IP protection was abolished in gene-targeted mice for CD39 whereas increased renal adenosine content with IP was attenuated.  Furthermore, administration of apyrase reconstituted renal protection by IP in cd39-/- mice.  Finally, apyrase treatment of wild-type mice resulted in increased renal adenosine concns. and a similar degree of renal protection from ischemia as IP treatment.  Taken together, these data identify CD39-dependent nucleotide phosphohydrolysis in renal protection.  Moreover, the present studies suggest apyrase treatment as a novel pharmacol. approach to renal diseases pptd. by limited oxygen availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPDTDra9j1c7Vg90H21EOLACvtfcHk0lg6n1k4El5_ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVars77M&md5=b06ddc0852fc4d3794dccab80b47bca4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7947com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7947com%26sid%3Dliteratum%253Aachs%26aulast%3DGrenz%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHermes%26aufirst%3DM.%26aulast%3DEckle%26aufirst%3DT.%26aulast%3DKlingel%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DD.%2BY.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DOsswald%26aufirst%3DH.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26atitle%3DContribution%2520of%2520E-NTPDase1%2520%2528CD39%2529%2520to%2520renal%2520protection%2520from%2520ischemia-reperfusion%2520injury%26jtitle%3DFASEB%2520J.%26date%3D2007%26volume%3D21%26spage%3D2863%26epage%3D2873%26doi%3D10.1096%2Ffj.06-7947com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigmore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopatár, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenguelli, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, N.</span></span> <span> </span><span class="NLM_article-title">The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=10.1016%2Fj.neuropharm.2008.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=18768144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1251-1258&author=M.+J.+Wallauthor=G.+Wigmoreauthor=J.+Lopat%C3%A1rauthor=B.+G.+Frenguelliauthor=N.+Dale&title=The+novel+NTPDase+inhibitor+sodium+polyoxotungstate+%28POM-1%29+inhibits+ATP+breakdown+but+also+blocks+central+synaptic+transmission%2C+an+action+independent+of+NTPDase+inhibition&doi=10.1016%2Fj.neuropharm.2008.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition</span></div><div class="casAuthors">Wall, Mark J.; Wigmore, Geoffery; Lopatar, Jan; Frenguelli, Bruno G.; Dale, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1251-1258</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Understanding the mechanisms and properties of purinergic signaling would be greatly assisted by the discovery of subtype selective and potent inhibitors of the NTPDase enzymes, which metabolize nucleotides such as ATP and ADP in the extracellular space.  Currently ARL 67156 is the best available NTPDase inhibitor, but its relatively poor efficacy means that neg. results are difficult to interpret.  POM-1 (sodium polyoxotungstate) is a novel NTPDase inhibitor, which has shown promising results with the inhibition of recombinant NTPDases 1, 2 and 3.  The authors have tested the effectiveness and physiol. effects of POM-1 with cerebellar and hippocampal slices.  Using the malachite green phosphate assay, HPLC and biosensor measurements the authors have found that POM-1 is more effective at blocking ATP breakdown in cerebellar slices than ARL 67156.  The site of inhibition is at the first step of the breakdown cascade (conversion of ATP to ADP) and the effects of POM-1 appear readily reversible.  However, POM-1 has multiple effects on synaptic transmission.  At the cerebellar parallel fiber-Purkinje cell (PF) synapse POM-1 produced a long lasting inhibition of transmission, which was preceded in a minority of synapses by a transient increase in PF excitatory postsynaptic potential (EPSP) amplitude (∼20%).  This increase in PF EPSP amplitude appears to result from a redn. in the tonic activation of presynaptic A1 receptors, consistent with POM-1 preventing the breakdown of ATP to adenosine.  The redn. in PF EPSP amplitude does not however appear to result from NTPDase inhibition as it persists when both adenosine and ATP (P2Y and P2X) receptors are blocked.  An increase in paired pulse ratio and a redn. in presynaptic volley amplitude suggest that there is a presynaptic component of POM-1 action which reduces glutamate release.  POM-1 produced similar inhibition at climbing fiber synapses and at hippocampal CA1 pyramidal synapses.  Thus although POM-1 is more effective than ARL 67156 at blocking ATP breakdown its usefulness is limited by off-target actions on synaptic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4A6zZvqRBlLVg90H21EOLACvtfcHk0lhLVPFDa5xcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvF&md5=5085f8e4daadd9385087f81b24c5d24c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DWigmore%26aufirst%3DG.%26aulast%3DLopat%25C3%25A1r%26aufirst%3DJ.%26aulast%3DFrenguelli%26aufirst%3DB.%2BG.%26aulast%3DDale%26aufirst%3DN.%26atitle%3DThe%2520novel%2520NTPDase%2520inhibitor%2520sodium%2520polyoxotungstate%2520%2528POM-1%2529%2520inhibits%2520ATP%2520breakdown%2520but%2520also%2520blocks%2520central%2520synaptic%2520transmission%252C%2520an%2520action%2520independent%2520of%2520NTPDase%2520inhibition%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1251%26epage%3D1258%26doi%3D10.1016%2Fj.neuropharm.2008.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I','PDB','4H2I'); return false;">PDB: 4H2I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z9D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z9D','PDB','6Z9D'); return false;">PDB: 6Z9D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX2','PDB','3ZX2'); return false;">PDB: 3ZX2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX0','PDB','3ZX0'); return false;">PDB: 3ZX0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZX3','PDB','3ZX3'); return false;">PDB: 3ZX3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAR','PDB','3AAR'); return false;">PDB: 3AAR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAQ','PDB','3AAQ'); return false;">PDB: 3AAQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AAP','PDB','3AAP'); return false;">PDB: 3AAP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRE','PDB','4BRE'); return false;">PDB: 4BRE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR7','PDB','4BR7'); return false;">PDB: 4BR7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRF','PDB','4BRF'); return false;">PDB: 4BRF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRL','PDB','4BRL'); return false;">PDB: 4BRL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRN','PDB','4BRN'); return false;">PDB: 4BRN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRD','PDB','4BRD'); return false;">PDB: 4BRD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRG','PDB','4BRG'); return false;">PDB: 4BRG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRI','PDB','4BRI'); return false;">PDB: 4BRI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRK','PDB','4BRK'); return false;">PDB: 4BRK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRC','PDB','4BRC'); return false;">PDB: 4BRC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRA','PDB','4BRA'); return false;">PDB: 4BRA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRH','PDB','4BRH'); return false;">PDB: 4BRH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRM','PDB','4BRM'); return false;">PDB: 4BRM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRQ','PDB','4BRQ'); return false;">PDB: 4BRQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRO','PDB','4BRO'); return false;">PDB: 4BRO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR4','PDB','4BR4'); return false;">PDB: 4BR4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BR9','PDB','4BR9'); return false;">PDB: 4BR9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BRP','PDB','4BRP'); return false;">PDB: 4BRP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BVP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BVP','PDB','4BVP'); return false;">PDB: 4BVP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BVO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BVO','PDB','4BVO'); return false;">PDB: 4BVO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A5B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A5B','PDB','4A5B'); return false;">PDB: 4A5B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH5','PDB','4KH5'); return false;">PDB: 4KH5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH6','PDB','4KH6'); return false;">PDB: 4KH6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KH4','PDB','4KH4'); return false;">PDB: 4KH4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JEP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JEP','PDB','4JEP'); return false;">PDB: 4JEP</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01044&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01044%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01044" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996e933e1b3c76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
